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The rising prevalence and burden of musculoskeletal disorders (MSDs) is a major 
health concern, affecting quality of life and causing an economic burden to the 
individual as well as society as a whole. Integrative medicine (IM), a complex 
intervention which includes complementary and alternative medicine (CAM) and 
conventional medicine, emphasising a holistic approach and patient-practitioner 
relationship, is a popular option for people with MSDs. The Medical Research 
Council’s (MRC) framework for evaluating complex interventions was used to 
explore IM for MSDs and to provide future guidance. The aims of this research 
study were to develop a theoretical understanding of IM; and to determine the 
feasibility of carrying out a mixed methods study of IM for MSDs in the UK. 
For the initial development stage of the MRC framework, a mixed methods review 
consisting of a mapping review, a systematic review, and a narrative review was 
performed to develop a theoretical understanding of IM for MSDs. There was 
promising evidence for integrative treatments provided for low back pain and 
patients perceived benefits in receiving CAM for their MSDs. However, the 
components identified in the review as essential in IM were rarely discussed or 
reported in research. The lack of a standard definition of IM and an absence of 
guidelines for reporting IM has hindered the process of developing its evidence base. 
Identification of authentic IM research was challenging, and evidence on IM for 
MSDs remains inadequate. In particular, no research studies explored IM as a 
package of care for MSDs in a secondary National Health Service (NHS) setting in 
the United Kingdom (UK). 
As part of the second stage of the MRC framework, the feasibility stage, a mixed 
methods research study was conducted to assess the feasibility of evaluating IM for 
MSDs at the Royal London Hospital for Integrated Medicine (RLHIM). The results 
of this mixed methods study of 60 patients followed up over 12 months suggested 
that the approach was generally feasible. Feasibility was reflected in four aspects: 1). 
Integrative treatments potentially produced moderate pain relief and improved health 
related quality of life (HRQoL) at four months which was sustained at 12 months, 2). 
Patients’ general acceptability of treatment was good, 3). Patients demanded 
integrative treatment, and 4). Overall research design was feasible with patients 
reporting positive experiences by participating in the research study. Issues and 
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challenges were identified in the research procedure, including difficulties 
identifying and recruiting eligible patients, working with busy NHS practitioners, 
and failure of accessing unit cost data from the hospital. These issues need to be 
considered in future IM research. In addition, patients suggested particular outcome 
measures, and a narrative approach was preferred. An IM model was hypothesised 
from the findings of this research study which represented patients’ perception of 
good IM care.  
This research study is the first step in evaluating IM for MSDs. It has provided 
essential information needed to move the evidence base for IM; and provided 
original data on the feasibility and practicality of conducting the study. Following the 
next stage of the MRC framework, future research evaluating IM effectiveness, 
exploring the potential interaction between the components of the model, and 
whether these components were associated with the overall effects of IM, using a 
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Chapter 1 Introduction 
1.1 Overview of thesis 
This thesis describes mixed-methods research (MMR) on the use of integrative 
medicine (IM) for musculoskeletal disorders (MSDs). IM in this study represents a 
holistic approach that usually involves complementary and alternative medicine 
(CAM) and the use of conventional treatment. This research study was designed in 
alignment with the Medical Research Council’s (MRC) framework for evaluating 
complex interventions, and used pragmatism as the philosophy underpinning the 
research study. In alignment with the MRC framework, the aims of this research 
study were: 1). To develop a theoretical understanding of IM; and 2). To determine 
the feasibility of carrying out MMR on integrative treatment for MSDs in a National 
Health Service (NHS) hospital in the United Kingdom (UK). 
The thesis comprises seven chapters, with each chapter (except Chapters 1 and 7) 
beginning with an introduction and concluding with a summary. An outline of each 
chapter is given below.  
Chapter 1 (introduction) provides an overview of the structure of the PhD thesis and 
outlines each chapter. The research student’s personal background and philosophical 
stance in conducting and interpreting this research study are discussed. A brief 
review on the epidemiological background of MSDs, including their definition, 
prevalence, and currently available interventions, are given. How IM is considered 
as a complex intervention and the conceptual MRC framework used to guide 
evaluating IM as a complex intervention is discussed. This is followed by the aims 
and objectives of the whole research study and how it was aligned with the 
framework of this research study. 
In keeping with the MRC framework development stage and the first research aim, 
Chapter 2 (literature review) explores the theoretical background and evidence for 
IM as a complex intervention. It consists of three distinct Sections: 1). Background 
of IM, including terminology, current available definitions; and the key elements and 
possible components in defining IM; 2). A systematic review evaluating integrative 
treatment for low back pain (LBP); and 3). A narrative review exploring patients’ 
experiences in receiving CAM treatment for MSDs. The reasons for choosing the 
topic LBP for the systematic review and CAM for MSDs for the narrative review are 
given in detail in chapter 2.  
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Chapter 3 (methodology and methods) presents the overarching methodology and 
detailed methods of the mixed methods feasibility study, which is in alignment with 
the feasibility stage of the MRC framework and the second research aim. The 
chapter starts with justification of each aspect of study design, followed by a full 
description of the procedure of the convergent mixed methods feasibility study. 
Details of the research procedures, outcome measures, data collection and analysis 
are presented separately for quantitative and qualitative design, followed by the 
methods used in interpretation and reporting of the final MMR results. Ethical 
considerations at the design stage are presented at the end of this chapter.  
Chapter 4 presents the results of quantitative data collected in the feasibility study. 
Findings on response and completion rate, participants’ sociodemographic and other 
baseline characteristics are presented. A summary of the integrative treatments 
provided for MSDs at the Royal London Hospital for Integrated Medicine (RLHIM), 
with changes in primary and secondary outcome measures perceived during the 
study period are reported. At the end of the chapter, potential predictors of treatment 
effects and subgroup analyses are explored. 
Chapter 5 presents the results of the two qualitative studies, one of which was 
conducted immediately before participants’ initial hospital appointments and the 
other one year after. In order to ensure interviewed participants were representative 
of the total sample, their baseline characteristics are compared with those not 
interviewed. Themes and sub-themes generated from the pre-treatment and follow-
up interviews are reported separately (Sections 5.2-5.8, and Sections 5.9-5.15 
respectively). A summary of the pre-and-follow-up interview results, pointing out 
similarities and differences between the two, is presented at the end of this chapter 
(Section 5.16).  
Chapter 6 is where the quantitative and qualitative results are compared and 
triangulated. Final results on feasibility are presented in terms of the limited-
outcome testing, acceptability, and demands for the integrative treatments provided 
for MSDs; and the feasibility of research design and details in research procedures. 
Both quantitative and qualitative findings are presented using side-by-side 
comparison tables as the final MMR findings.  
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Chapter 7 discusses the findings of both the theoretical understanding of IM 
identified from the mixed methods review in Chapter 2 and the findings from the 
mixed methods feasibility study. Patients’ perspectives on the essential components 
of IM identified from this research study are discussed and an IM model 
hypothesised. This is followed by a discussion on the triangulated feasibility findings 
in terms of the four Bowen’s feasibility issues. Strengths and limitations of 
conducting the research study, original contribution to knowledge, and implications 
and future research directions are discussed. At the end of the thesis, the final 
conclusion of the research study is given.  
1.2 Personal background 
The research student is aware that her worldview, values, sociodemographic and 
educational background, and her experiences may naturally influence the research 
process (Creswell and Clark, 2011). The research student was born in China. She 
was originally educated at Nanjing University of Traditional Chinese Medicine, 
graduating with a BSc (Hons) in acupuncture and tuina, and gained two years 
clinical experience in two Chinese integrative medicine hospitals in Beijing. 
Growing up in China, where Chinese medicine (part of CAM in the west) and 
western medicine (conventional medicine in the west) are highly integrated in terms 
of education, practice, insurance, policy and regulation, the research student, her 
family and friends experienced the benefits of being able to access an integrative 
treatment approach for various conditions. After her clinical internship in China, she 
obtained an MSc in musculoskeletal science at University College London and 
conducted her masters project on balance assessment for joint hypermobility 
syndrome at the Royal National Orthopaedic Hospital (RNOH). This was her first 
exposure to an NHS setting in the UK and she realised that CAM and IM practices 
and their regulations in the UK were different compared to her experience in China. 
These experiences allowed the research student to be an ‘insider’ regarding  certain 
CAM treatments such as acupuncture, but an ‘outsider’ sociodemographically 
(Dwyer and Buckle, 2009). 
IM is an emerging and a potentially promising field in the UK. Considering the high 
prevalence and the research student’s interests in MSDs, she was passionate to add 
knowledge to the field, especially in understanding and exploring the potential of IM 
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models, and particularly in the NHS setting. This also fitted with her previous 
education, research and clinical experiences. 
1.3 Epistemological and ontological stance 
In order to create knowledge, achieve credibility and provide the ‘power to elicit 
belief’, researchers should critically examine their own ontological perspective and 
determine an appropriate worldview and assumptions, aims and objectives of the 
research and methodological approaches (O'Leary, 2004). To understand the 
researcher’s philosophical belief is vitally important for both researchers and readers 
as this influences and informs the research student’s decisions in selecting research 
questions, designing the study, and reflexivity during the research processes and 
interpretation of results (Morgan, 2007).  
An understanding of the underlying paradigm is essential to provide a world view 
and social contexts, guide actions, and allow a framework for research design 
(Morgan, 2007). Researchers should be able to rigorously defend their paradigmatic 
stance. The research student’s epistemological and ontological stances, which were 
bound with methodology (Greene, 2007) were taken into consideration throughout 
the research study.  
She was born and educated in a country where two medical systems, namely Chinese 
medicine and western medicine, are both implemented and integrated. Her ontology 
of evidence-based western medicine and traditional Chinese medicine (TCM) based 
on Confucianism and Taoism has been gradually influencing her perspective 
throughout her life. This has been further developed after she took undergraduate 
and postgraduate courses in both the east and west, where she understood the 
conflict in philosophical concepts between the two medical paradigms; and 
differences in ways of evaluation. Originally, the effects of TCM therapies were 
based on explanations of experts’ or practitioners’ experiences in treating individuals 
and collecting a series of case reports. This empirical approach of assessing is very 
different from evidence-based medicine (EBM), which has developed in western 
medicine. In evidence based research, evaluating the efficacy of target treatment in 
ideal clinical circumstances with a specifically selected population using a 
randomised controlled trial (RCT) design,  under a reductionist framework, which 
can be measured scientifically and is supposedly devoid of subjective bias, is seen as 
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representative (Sackett et al., 1996). Similarly, other therapies that may be involved 
in IM are yoga and Ayurveda which originated from Hindu/Buddhist philosophies.  
Pragmatism is a philosophical concept which originated in the United States of 
America (USA) around 1870, developed by Charles Sanders Peirce (1839–1914), 
William James (1842–1910) and John Dewey (1859–1952). It is the third research 
paradigm, seeking the middle ground between (post) positivism/objectivism on 
which pure quantitative approaches are based and interpretivism/constructivism on 
which pure qualitative approaches are based  (Johnson and Onwuegbuzie, 2004). 
Pragmatism, as a philosophical concept, goes well beyond “what works” (John 
Dewey), and points to the importance of joining beliefs and actions in a process of 
inquiry that underlies any search for knowledge, including the specialised activity 
referred to as research (Morgan, 2007). Pragmatism considers resolving the problem 
as the priority, using the best philosophical or methodological approach to answer a 
research question (Mackenzie and Knipe, 2005). Pragmatists believe both positivist 
and constructivist paradigms share many commonalities with seeking truth and pays 
more attention to ‘lines of action’, ‘warranted assertions’, and ‘workability’ 
(Morgan, 2007).  
By re-evaluating the research student’s epistemological stance in researching IM as 
part of this research study, pragmatism was considered appropriate as it aligns well 
with the research topic and research methodology. Integration of the two medical 
paradigms requires an inclusive ontological stance to understand, research, and 
practice IM. Clinically, IM treatments provide complex optimum treatments to suit 
personalised needs (Section 2.2). Epistemologically, IM acknowledges the 
importance of a real world environment and non-specific aspects of treatment; it is 
not purely radical empiricism as it emphasises the importance of evidence-based 
research. Methodologically, MMR including a qualitative approach to explain 
certain phenomena in IM (e.g. patients’ perception and experience with practitioners 
and treatments) is considered essential (Section 3.1). Both are addressed by the aims 
of pragmatism to “use pluralistic approaches to derive knowledge about the 
problem” (Creswell and Clark, 2011). A pragmatic approach has been suggested as 
the most appropriate methodology for exploring complex interventions such as IM as 
it reflects model validity and credibility in real world routine practice (MacPherson, 
2004b; Witt, 2009). 
6 
Chapter 1 Introduction 
1.4 Epidemiology and treatment of musculoskeletal disorders 
1.4.1 Definition of MSDs 
As defined by the Centre for Disease Control and Prevention (CDCP), MSDs are 
“injuries or disorders of the muscles, nerves, tendons, joints, cartilage, and disorders 
of the nerves, tendons, muscles and supporting structures of the upper and lower 
limbs, neck, and lower back that are caused, precipitated or exacerbated by sudden 
exertion or prolonged exposure to physical factors such as repetition, force, 
vibration, or awkward posture” (CDCP, 2012). The World Health Organisation 
(WHO) International Classification of Diseases (ICD) version 10 categorises 
diseases of the musculoskeletal system and connective tissue (Chapter XIII, M00-
M99) to include; arthropathies, systemic connective tissue disorders, dorsopathies, 
soft tissue disorders, osteopathies and chondropathies, and other disorders of the 
musculoskeletal system and connective tissue (ICD-10, 2010). The importance of 
MSDs was highlighted by the following statement by the director-general of the 
WHO (WHO Scientific Group, 2003), page 1: 
“Musculoskeletal or rheumatic diseases are the major cause of morbidity 
throughout the world, having a substantial influence on health and quality of 
life, and inflicting an enormous burden of cost on health systems.”  
1.4.2 Prevalence of musculoskeletal disorders 
MSDs are associated with pain and impaired mobility, and affect people’s lives and 
work. In the UK, 70%-84% of adults experience nonspecific low back pain 
(McIntosh and Hall, 2011) and 70% experience neck pain during their lifetime 
(Falco et al., 2009; Falco et al., 2012). The incidence of MSDs appears to be 
increasing, with a corresponding impact on primary health care provision (Cimmino 
et al., 2011). The Department of Health (DH) suggests that MSDs are the most 
common reason for general practitioner (GP) consultation (DH, 2006). One in four 
UK adults has been affected by chronic MSDs and 60% of occupational sick leave is 
caused by MSDs (DH, 2006). 
Long term MSDs are closely associated with multi-morbidity (Fisher, 2015), which 
now has a huge impact on elderly people, with earlier onset (Barnett et al., 2012), 
and is strongly associated with polypharmacy and adverse drug reactions (ADRs) 
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(Nobili et al., 2011). This leads to the economic burden of increasing complex and 
chronic disease, including both direct and indirect costs (Thorpe et al., 2004). 
Estimates suggest  that with the modern epidemic of chronic disease as well as an 
ageing population, indoor living, fragmented families/communities, environmental 
toxicity, nutrition, sedentary lifestyle, chronic stress, and poverty, the costs of 
chronic disease today in the USA ($1.3 trillion) may increase to $4.2 trillion in 15 
years (Jones et al., 2009). As an example, medical costs for MSD treatments was 
$389 million to the retail industry in the USA in 2007 (Bhattacharya and Leigh, 
2011). Data reported for the UK in 2007 estimated costs of approximately £ 7.4 
billion and caused 9.5 million lost working days (The Work Foundation, 2007). 
MSDs accounted for 29% of all illnesses and injuries that required days off work in 
2012 as reported by the U.S. Bureau of Labor Statistics; and the incidence of MSDs 
among the working-age population is anticipated to increase (Summers et al., 2016).  
1.4.3 Available therapies for MSDs – a brief introduction 
Since MSDs may be associated with multi-morbidity and the complexity of which 
challenges a single-disease framework, management of MSDs may typically involve 
a multidisciplinary team approach. Medication is the most commonly used treatment 
for MSDs, which includes simple analgesics such as paracetamol, non-steroidal anti-
inflammatory drugs (NSAIDs, such as ibuprofen), taken topically or systemically, 
opioids and tricyclic antidepressants.  
Other therapies such as physiotherapy and occupational therapy are also given to 
MSD patients, to help improve their functional ability and to alleviate pain. In severe 
or complicated cases, orthopaedic surgery may be necessary, to help with 
deformities, repair or replace lesions. Apart from these, conventional management of 
MSDs also includes reduction in workload, increased rest, stress management, and 
behavioural intervention. 
CAM is commonly used to treat musculoskeletal conditions, especially for back, 
neck and shoulder pain (Thomas et al., 2003; Kanodia et al., 2010; Smith et al., 
2000). The National Institute for Health and Clinical Excellence (NICE) guidelines 
on non-specific low back pain recommends consideration of manual therapy and 
acupuncture (NICE, 2009).  The prevalence of the use of CAM in Europe varies 
(0.3-86%), with herbal medicine as the most commonly given treatment (Eardley et 
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al., 2012). Systematic reviews have identified limited but promising evidence for 
several treatments such as acupuncture (Vickers et al., 2012), manipulation (Chou et 
al., 2007; Bronfort et al., 2008a), herbs (Gagnier et al., 2004), mind and body 
therapy (Theadom et al., 2015) and nutraceuticals (Goldberg and Katz, 2007) for 
treating various musculoskeletal conditions.  
1.5 Conceptual framework of this research study 
As well as pragmatism being the paradigmatically based philosophical belief of the 
research student, recognition of the conceptual framework is a methodological 
necessity to help clarify theory prior to evaluation, and to ensure rigour of the 
research (Evans et al., 2011). The research student adopted the initial two stages of 
the MRC complex intervention guidance in evaluating complex intervention as a 
framework to inform the study design (Campbell et al., 2000; Craig et al., 2008). 
Why IM is considered a complex intervention, the purpose and contents of the MRC 
framework, and how it guided this research study will be introduced in this section.  
1.5.1 IM as a complex intervention 
As defined by the MRC framework, a complex intervention comprises of several 
interacting components (Campbell et al., 2000; Craig et al., 2008). IM treatments for 
MSD patients were considered as complex interventions due to containing a number 
of components.  
Firstly, IM practice for MSDs is complex as it may involve a variety of therapies or 
diagnostic approaches, which need coordination from a variety of professionals, 
including the orthopaedic consultants, rheumatology consultants, neurologists, 
physiotherapists, occupational therapists, and CAM practitioners. Each of these 
treatments may be an important contributor to the effectiveness of a package of IM 
intervention and it is therefore difficult to decide which is/are the “active 
ingredient(s)” of the intervention (Campbell et al., 2000).  
IM is a holistic approach tailored to the individual’s physical, psychological, 
biological and emotional well-being, and takes the context of environment into 
consideration. This requires an individualised treatment and individualised life style 
advice or self-management advice from either a single practitioner in cooperation 
with a group of health professionals, or multidisciplinary team health professionals 
9 
Chapter 1 Introduction 
(Hu et al., 2015b) (Section 2.2). A complex intervention may work best in an 
individualised rather than completely standardised environment (Craig et al., 2008). 
Similarly, IM emphasises the interaction between patients and practitioners. Active 
interaction and effective communication among collaborative team members is 
essential in providing complex interventions in an integrative setting. These aspects 
may be considered as potential components of IM that contribute to the treatment 
effects. Details of the components of IM will be explored under the guidance used 
for this framework and will be presented in Chapter 2 (Section 2.2). 
1.5.2 MRC framework for evaluating complex interventions 
In 2000, the MRC released a guidance framework for development and evaluation of 
RCTs for complex interventions to improve health (Campbell et al., 2000). Since 
then, increasing numbers of evaluations have used the MRC framework to report 
interventions where patients are provided with individualised packages of care using 
complex interventions in multi-disciplinary environments (Datta and Petticrew, 
2013; Beswick et al., 2008). In the 2008 update, the framework recommended a four 
stage ‘development, feasibility/piloting, evaluating, implementation’ process. The 
MRC framework points out the importance of developing appropriate theory and 
identifying the available evidence for the target intervention, testing the feasibility of 
or piloting a study, before establishing definitive effectiveness evaluations in a real 
world clinical setting (Campbell et al., 2000; Craig et al., 2008). The MRC also fund 
early phase developments of public health interventions (Public Health Intervention 
Development Scheme (PHIND), to develop a solid theoretical framework and 
generate evidence on the design specification and feasibility of interventions (MRC, 
2015). This guidance addresses the complicated issues in studying the various 
components and their interactions involved in a complex intervention, and to 
investigate whether a complex intervention is effective and how it works (Campbell 
et al., 2000; Craig et al., 2008).  
Although the MRC framework is mainly designed for evaluating complex 
interventions using RCTs for evaluation, it can guide observational studies (Craig et 
al., 2008)  and it has been adopted in this research study because of the lack of 
conceptual clarity for IM. The precise definition of IM is not clear. IM is not widely 
practised in most western countries and has different meanings depending on the 
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country and its access to health care (Section 2.2). The other reason is that there is no 
clear understanding about the “mechanism of action” of IM. The “active ingredient” 
of an intervention might be nonspecific, for example, does the effectiveness depend 
on the success of patient-practitioner relationship, or the achievement of a holistic 
approach; or was it a specific component such as acupuncture, or medication, or the 
practitioner’s empathy that contributed to the overall effects of the treatment. These 
are potential active components influencing the effects of IM (e.g. how each 
intervention relates/interacts with each other is not clear). 
1.5.3 The conceptual framework map for this research study 
This research study adapted the initial two stages (development and feasibility) of 
the MRC framework as a general guide of the overall study design (Figure 1.1). In 
order to suit the complex nature of IM, aspects of MMR are added in as a feature in 
the feasibility stage (details in Section 3.1.1).  
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 Figure 1 1 Conceptual framework for this research study situated under the MRC framework for developing complex interventions 
 
QUAN and QUAL represent the quantitative and qualitative strands in a convergent mixed methods design 
*Evaluation and implementation stages were not part of this research study 
Feasibility Stage (Chapters 3-6) 
QUAN  
• Test procedures 
• Estimate recruitment/retention  
• Determine sample size  
QUAL 
• Explore the experiences of participants and their 
acceptance of the study procedure 
• Explore participants’ expectations & experiences 
• Understand the change process in participants’ 
expectations and attitudes Development Stage 
(Chapter 2) 
• Identify and develop key 
components of IM 
• Identify the evidence base of IM 
for MSDs 
• Review literature on patients’ 
experiences in CAM for MSDs 
Evaluation Stage* 
• Assessing effectiveness 
• Understanding change process 
• Assessing cost-effectiveness 
Implementation* 
• Dissemination 
• Surveillance and monitoring  
• Long term follow-up 
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In the development stage (Chapter 2), issues of terminology, definition, and evidence 
of IM are reviewed and discussed. As suggested in the MRC framework, theory and 
modelling are not two separate phases and always occur at the same time (Campbell 
et al., 2000). Key components of IM were identified to build up the theoretical basis 
of IM (Section 2.2); but how those components relate to and impact on each other, as 
well as how each IM element affects outcomes and the study design, were not 
modelled as it was anticipated the feasibility study would provide information on 
this. Available evidence of IM for MSDs from the current literature was identified 
using LBP as an example in a systematic review (Section 2.3); a narrative review 
was conducted on patients’ expectations and experiences of receiving CAM for 
MSDs (Section 2.4). 
In the feasibility and piloting stage (Chapter 3-6), to understand the change process 
and provide detailed reporting on clinical outcomes, context and interventions (Datta 
and Petticrew, 2013), the procedures of the whole feasibility study, recruitment and 
retention were recorded throughout the study, with effect sizes reported for future 
sample size calculation. Participants’ expectations and their experiences of 
participating in the study and their acceptance of the procedures were explored 
through a qualitative approach. These data resulted from a mixed methods approach 
and will help with finalising the future study design for the evaluation stage.  
This framework directed the research student in developing all the stages of this 
research study, which included developing study aims, conducting literature reviews, 
identifying an appropriate study design, and exploring the most appropriate way of 
interpreting and analysing the results.  
1.6 Aims and objectives of the research study 
The aims and objectives of this research study were developed in alignment with the 
two stages of the MRC framework: 
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To develop a theoretical understanding of IM  
• To review IM definitions and identify the components of IM 
• To review the current evidence for the effectiveness and safety of integrative 
treatment for LBP 
• To review patients’ experiences of receiving CAM for MSDs 
To determine the feasibility of carrying out a mixed methods study of IM for 
MSDs in the UK 
• To evaluate ‘real world’ clinical outcomes associated with integrative 
treatment for MSDs  
• To explore patients’ expectations and experiences of receiving integrative 
treatments for MSDs 
• To identify practical issues in conducting a mixed methods feasibility study 
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Aims and structure  
Due to the pluralistic aims mentioned above, a mixed methods review (Grant and 
Booth, 2009), also called an ‘integrative review’ was performed.  Such reviews 
provide a broad summary based on a specific concept or content, with both empirical 
and theoretical, and qualitative and quantitative literature utilised (Whittemore, 
2005) and usually contain a systematic review (Grant and Booth, 2009). They fill the 
gap between rigorous systematic reviews and traditional literature reviews (Evans, 
2007).  
The mixed methods review reported in this chapter consists of three parts. Firstly, to 
align with the MRC framework requirement to identify theory (Figure 1.1), a 
mapping review on the available definitions of IM was conducted to identify and 
categorise potential components of IM (Section 2.2, Appendix 2.1). Secondly, an 
exploratory systematic review evaluating clinical effectiveness and safety of 
integrative treatment for LBP was conducted (Section 2.3, Appendix 2.2). The 
reason for selecting LBP as the topic for this systematic review is provided in 
Section 2.3. Thirdly, a narrative review on qualitative research explored patients’ 
experiences in receiving CAM treatments for MSDs was performed; the reason that a 
search was conducted on CAM rather than IM treatment is explained in Section 2.4.  
To ensure only rigorous research was included to build the evidence base, critical 
appraisal was only conducted for the trials included in the systematic review. This 
was not adopted in the mapping review or the narrative review as critical appraisal is 
not essential for these types of reviews (Grant and Booth, 2009).  
The main search of the systematic review on integrative treatment for LBP was 
conducted in Jan 2013 (Appendix 2.2) while the main search of the qualitative 
review was conducted in November 2014. In August 2015, an updated search was 
conducted for all three parts of the mixed methods review. The search strategies and 
inclusion criteria in update searches followed the same procedures described in the 
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main searches, except that Chinese literature was not searched for the systematic 
review due to inadequate access to Chinese databases in the update search.   
2.1 What is Integrative Medicine? 
According to the MRC complex intervention framework (Section 1.4.2), it is 
essential that components of the target intervention are explored. In this section, the 
change and understanding in terminology of IM over time is explained, followed by 
a mapping review of the definitions of IM, to identify the potential key components 
of IM. A paper on the issues discussed in this section has already been published (Hu 
et al., 2015b) (Appendix 2.1). 
2.1.1 Transformation in terminology 
The terms integrative medicine, also called integrated medicine, integrative 
healthcare, or integrated healthcare are frequently used inter changeably in different 
healthcare systems, education, research, and clinical practice (Bell et al., 2002; The 
Consortium of Academic Health Centers for Integrative Medicine, 2009). The 
terminology in the field has evolved over the past 20 years, from “unconventional 
medicine” to “holistic” to “CAM”, to “integrative medicine,” reflecting the dynamic 
state of this field and its terminology. IM is not the same as CAM, nor is it simply a 
combination of CAM and conventional treatment (Bell et al., 2002; Osher Center for 
Integrative Medicine, 2015; Rees and Weil, 2001; National Institute of Integrative 
Medicine, 2015; Boon et al., 2004; Snyderman and Weil, 2002). Stumpf et al. (2008) 
described this change in definition as a destined transformation of CAM going 
mainstream. 
2.1.2 Available definitions of IM  
Though there are many difficulties in defining IM, defining the concept of IM is 
believed to be the first step towards understanding the phenomenon (Stumpf et al., 
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2008). Before defining IM, it is important to state the definition of CAM and the 
potential problems in defining it.  
The WHO Collaborating Centres for Traditional Medicine defined CAM as follows 
(World Health Organization, 2015a):  
“The terms "complementary medicine" or "alternative medicine" are used inter-
changeably with traditional medicine in some countries. They refer to a broad 
set of health care practices that are not part of that country's own tradition and 
are not integrated into the dominant health care system”.  
This definition indicates CAM treatments are defined differently internationally. 
There are controversies on whether one specific discipline is regarded as 
complementary treatment or alternative treatment. And some researchers are intent 
on distinguishing their particular CAM discipline from other CAM treatments 
(Broom et al., 2012) . Similar to CAM, IM is defined variously across nations (Boon 
et al., 2004; Caspi et al., 2003). In general, IM appears to be determined or 
categorised by the use of a combination of conventional allopathic medicine and 
CAM in order to address the biological, psychological, social, and spiritual aspects 
of health and illness (MeSH, 2015). It also emphasises the importance of wellness 
and healing of the whole person and developing an effective practitioner-patient 
relationship, all of which is to be informed by evidence (Bell et al., 2002; The 
Consortium of Academic Health Centers for Integrative Medicine, 2009).  
However, this definition is not agreed by everyone. Researchers suggested IM is not 
simply a synonym of conventional medicine with CAM (Bell et al., 2002; The 
Bravewell Collaborative, 2015; Osher Center for Integrative Medicine, 2015; Rees 
and Weil, 2001; National Institute of Integrative Medicine, 2015; Boon et al., 2004). 
Studies simply combining CAM and conventional treatment without providing more 
details on the model/framework of integration are not regarded as true IM practice 
(Caspi, 2001; Morrell, 2001; Woolfson, 2001). For example, receiving acupuncture 
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and medication at the same time may not be equal to having IM treatment, as they 
might be provided by two unrelated professions, with no interaction between them. 
Also, there is no clear boundary between CAM and conventional medicine in some 
cases. For example, dietetics and nutrition are two types of therapies with overlap in 
several aspects but some differences in training and regulation. As another example, 
it is difficult to categorise acupoint injection with medications into either CAM or 
conventional medical treatment. Currently, osteopathy and chiropractic are the only 
two CAM therapies in the UK that are regulated in the same way as conventional 
medicine through statutory professional regulation (NHS choices, 2012). Other 
CAM therapies are regulated through voluntary self-regulation organisations or the 
Health and Care Professions Council, e.g. Complementary and Natural Healthcare 
Council (CNHC), and the British Acupuncture Council (BAcC).  
The mapping review 
A mapping review has been conducted in order to get a clear idea of the definition 
and the potential key components of IM (publication in Appendix 2.1). In order to 
provide an international context covering different cultural backgrounds and models 
of IM practice, this mapping review focused on available definitions and IM models 
in four countries, namely: UK, USA, Australia and China.  
Data sources and search strategies 
A range of data sources (published between 1990 and 2014) including government, 
key authorities, academic organisations, clinical sites, academic journals, textbooks, 
and research papers were searched for definitions of IM.  Search terms included 
‘integrative medicine’, ‘integrated medicine’, ‘integrative health(care)’, ‘integrated 
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Key definitions of IM identified 
Of those searched, 17 (31%) provided specific definitions of IM and were extracted. 
These were identified from the USA (13), China (2), UK (1), and Australia (1).  The 
full seventeen definitions are available in Appendix 2.3. The most commonly cited 
definition was that developed by the Consortium of Academic Health Centres for 
Integrative Medicine (CAHCIM) (The Consortium of Academic Health Centers for 
Integrative Medicine, 2009): 
Integrative medicine is the practice of medicine that reaffirms the importance of 
the relationship between practitioner and patient, focuses on the whole person, 
is informed by evidence, and makes use of all appropriate therapeutic 
approaches, healthcare professionals and disciplines to achieve optimal health 
and healing. 
In 2015, the consortium changed their name to the Academic Consortium for 
Integrative Medicine & Health (The Consortium) and updated their definition of IM 
(The Academic Consortium for Integrative Medicine & Health, 2015):  
Integrative medicine and health reaffirms the importance of the relationship 
between practitioner and patient, focuses on the whole person, is informed by 
evidence, and makes use of all appropriate therapeutic and lifestyle approaches, 
healthcare professionals and disciplines to achieve optimal health and healing. 
Recently, the consortium carried out a survey to re-evaluate the definition of IM 
which was closed in July 2015 and the results of this survey have not yet been 
published. 
2.1.3 Key components of integrative medicine 
Key elements characterising IM were identified and categorised in a thematic 
approach, in order to determine and define the elements of IM for future narrative 
and systematic reviews, to provide guidance and stimulate wider discussion in the 
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research community. Figure 2.1 shows the components identified from the 17 
definitions of IM. 
The most common component, emphasised by thirteen (out of 17), was the 
integration of CAM and conventional approaches, followed by goals of health and 
healing (12/17), holistic individualised approach (12/17), optimum treatment (8/17), 
and the body's innate healing response (4/17). Though multidisciplinary team work 
has for some time been emphasised as an integral component of complex 
interventions (Lewith, 2005), only four definitions identified in the mapping review 
emphasised a collaborative approach to patient care.  
Many definitions included elements which also define conventional medicine and so 
are not unique to IM. These were: patient-practitioner relationship (12/17), evidence-
based (9/17), effectiveness (5/17), safety (4/17)(National Center for Complementary 
and Alternative Medicine, 2015; Rakel, 2012; Chen, 2005; Royal London Hospital 
for Integrated Medicine, 2015) (National Center for Complementary and Alternative 
Medicine, 2015; Rakel, 2012; Chen, 2005; Royal London Hospital for Integrated 
Medicine, 2015), and low cost (2/17).
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 Figure 2 1 Key components identified from seventeen selected definitions of IM from four countries 
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Key: Blue: aspects of CAM/IM; Green: aspects also important in conventional medicine (not unique to IM); Yellow: originated from 
conventional medicine (not unique to IM)  
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In addition to the 11 components identified, the Chinese definition (Baidu Baike, 
2015) emphasises that integration can occur at theoretical, diagnostic, and 
therapeutic levels. Integration in at least one of the three levels, with a consideration 
of the key components suggested in Figure 2.1 would be regarded as IM for the 
purpose of this research study. 
2.2 A systematic review of integrative treatment for low back pain  
In alignment with the MRC framework for designing complex interventions 
(Campbell et al., 2000; Craig et al., 2008), the systematic review reported in this 
section answers the research aim ‘to develop theoretical understanding of IM’ by 
identifying evidence base of IM for MSDs.  
Clinical evidence for IM studies consist largely of individual CAM practices. The 
research evidence on the effectiveness of IM as a package is currently still limited 
due to its complex nature and a lack of standardisation in terminology, definition and 
reporting, and the challenges in methodological design (Khorsan et al., 2011; 
Shepperd et al., 2009; Marcus and McCullough, 2009; Nahin and Straus, 2001; Hu 
et al., 2015a). 
In this section, the topic LBP was selected as being representative of MSD. The 
research student initially conducted a review on IM for MSDs and identified over 
2000 articles after deleting duplicates, and screening titles and abstracts. This high 
number may have been due to a lack of standard terminology for IM. The research 
student included the search term ‘CAM’ and various CAM therapies to capture a 
variety types of CAM therapies used in IM, and randomised controlled trials 
published in both English and Chinese language databases. More than 1700 articles 
were published in Chinese.  
It was therefore decided to limit the review to LBP as it is one of the most common 
MSDs, which is difficult to treat and a costly medical problem throughout the world 
(Andersson, 1999; Woolf and Pfleger, 2003). In addition, considering systematic 
reviews usually focus on a specific condition, rather than a group of conditions such 
as MSDs; and the fact LBP was the most common reason that patients were referred 
to the RLHIM, a systematic review evaluating the effectiveness and safety of 
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integrative treatment for LBP was conducted. This systematic review was published 
and is available in Appendix 2.2 (Hu et al., 2015b). 
The report of this systematic review follows the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) guideline through all stages of 
the design, implementation, and reporting (Moher et al., 2009). The protocol for the 
review was registered and is available online (CRD42013003916) (Hu, 2012). As IM 
is a complex intervention, with associated difficulties in identifying and synthesising 
trials, an exploratory review using broad search terms was conducted (Shepperd et 
al., 2009)  
2.2.1 Data Sources and search strategy 
A literature search was carried out on eight English language databases: Pubmed, the 
Allied and Complementary Medicine (AMED), Embase, Cochrane Library 
resources, Cumulative Index to Nursing and Allied Health Literature (CINAHL), 
PsycINFO, ScienceDirect, Index to Theses (UK); and four Chinese databases: China 
National Knowledge Infrastructure (CNKI), VIP, Wanfang, Chinese BioMedical 
(CBM). All databases were searched from their inceptions to December 2012. An 
updated search was conducted in August 2015 (December 2012 – August 2015). 
Detailed search terms and strategies with limits used for each database are provided 
in Appendix 2.4.  
2.2.2 Inclusion criteria 
Published RCTs in English or Chinese, evaluating outcomes of clinical 
effectiveness, cost effectiveness, or safety of IM for LBP were included. Patients of 
all ages, with acute/sub-acute/chronic LBP (including pain in the lumbar or sacral 
regions, which may be associated with muscular-ligamentous sprains and strains; 
intervertebral disk displacement; and other conditions) were included. Only 
musculoskeletal related LBP was included. Internal/obstetrics and gynaecology 
related LBP were excluded. Research evaluating combined treatment in the same 
(group of) clinical setting(s) was included, with no limitations regarding the duration 
of the treatment and no limitations regarding additional (routine) care. For exercise 
interventions, the decision as to whether it was CAM or CM was based on whether it 
potentially involved a mind-body interaction in the intervention process. RCTs 
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comparing combined CAM and CM therapies plus usual care with usual care alone; 
and combined therapies with CAM or CM were included.  
2.2.3 Outcome measures and data collection 
Primary outcome of this review included any form of pain measurement or back pain 
functional status. Secondary outcomes included patients’ quality of life, mental 
condition, adverse events (AEs). Both English and Chinese research was searched 
and screened by the research student and another independent researcher. None of 
the reviewers were blinded to the authors’ affiliations, journal of publication, or trial 
results of the selected articles at this or any stage of the review.  
2.2.4 Quality analysis and risk of bias assessment 
The quality of reporting in selected trials was critically appraised using the 
Consolidated Standards of Reporting Trials (CONSORT) for all included trials 
(Moher et al., 2001)  and additional standards for reporting interventions in clinical 
trials of acupuncture (STRICTA) checklist for reporting trials that investigated 
acupuncture (MacPherson et al., 2002). A score (Yes=1, No=0, Cannot tell/Partial/ 
Not available=0.5) was given for each question for each included trial. A percentage 
(sum of the scores/number of questions) was generated to show the overall reporting 
score combining CONSORT and STRICTA of the individual trials. Appendix 2.5 
provides the detailed scores of each item for the reporting included trials. 
Methodological quality was assessed using the 2009 updated method guidelines for 
systematic review from the Cochrane Back Review Group (CBRG) (Furlan et al., 
2009). Yes (Y) = Low risk of bias, No (N) = High risk of bias, Unclear (U) = 
Insufficient information or rationale.  
2.2.5 Data extraction 
Basic characteristics of the included trials were extracted; including: authors’ initials 
and published year, whether the trial was labelled as ‘IM’ or not, sample size and 
condition of LBP, the nature of practice and practitioner, comparison groups, 
treatment regimen and notes, outcome measures, and end point.  
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All included trials were independently scored with data extracted by the research 
student and at least one independent reviewer, with disagreements resolved through 
discussion with a third researcher to achieve final consensus. 
2.2.6 Summary measures and synthesis of results  
All statistical analysis was conducted using the Review Manager (version 5.2). Pre-
set I2 values of 50% or more were considered to be highly heterogeneous (Higgins 
and Thompson, 2002). Mean difference (MD) and 95% confidence intervals (CI) 
were calculated. Relevant parameters were compared with sensitivity analysis if the 
data were adequate. For cases where there was missing data or the data were 
analysed using an inappropriate test, the data were reported separately. As there were 
various combinations of treatments, if a meta-analysis could not be carried out, a 
narrative description of selected trials was reported.  
2.2.7 Description of trials  
An initial search identified 1470 English and 3358 Chinese potential relevant 
studies. After excluding ineligible studies by screening titles and abstracts, 218 
English and 739 Chinese articles remained. By applying inclusion and exclusion 
criteria to full text articles, a final total of 56 RCTs consisting of 58 articles remained 
(Figure 2.2).  
A total of 6616 patients (ranging from 20 to 681 per study) were involved in the 56 
RCTs (Appendix 2.6). Among the trials identified, six used the term ‘integrative 
traditional and western medicine’ [中西结合] or ‘integrative’ (Eisenberg et al., 
2012; Sundberg et al., 2009; Zeng, 2011; Qin et al., 2007; Yuan et al., 2012; Cai and 
Fang, 2011). The most common condition (77%) was lumbar disk herniation (LDH), 
with duration of treatment varied from one off treatment to three months. Nearly half 
of the trials published in Chinese were conducted in a Western medical hospital, 
while most trials (67%) published in other countries were carried out in government 
regulated organisations.  
A dispersed combination of integrative treatments was reported, with acupuncture 
plus traction (8/56) was the most commonly received, followed by a package of 
CAM treatments (7/56), tuina plus epidural injection (6/56), and Chinese herbal 
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medicine (CHM) plus traction (5/56). Details of the interventions are available in 
Appendix 2.6. 
Figure 2 2 PRISMA 2009 flow diagram: screening process 
 N.B. Duplicates has been checked among English and Chinese databases 
2.2.8 Quality of the selected articles 
Quality of reporting was assessed using STRICTA and CONSORT checklists. 
Approximately half items in CONSORT (mean: 49%) and STRICTA (mean 52%) 
were reported (Appendix 2.5, using the method explained in section 2.2.4). 
The risk of bias varied across the included trials (Figure 2.3). Regarding random 
sequence generation, eight trials used computer generated statistical software for 
randomisation (Zaringhalam et al., 2010; Molsberger et al., 2002; Leibing et al., 
2002; Meng et al., 2003; Hurwitz et al., 2002; Sundberg et al., 2009; Eisenberg et 
al., 2007; Little et al., 2008);  Fifteen used random number tables (Zeng, 2011; 
Liang, 2010; Li and Wang, 2008; Tuo et al., 2011; Zhong and Wu, 2013; Qu et al., 
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2010; Wang, 2007; LI et al., 2011; Wen et al., 2012b; Zhang, 2012; Song, 2010; Zhu 
et al., 2012; Ma, 2012; Xiao et al., 2012; Grunnesjo et al., 2011); and six were 
generated sequentially by date of presentation (Qin et al., 2007; Cai and Fang, 2011; 
Chen and Tang, 2012; Jiang et al., 2010; Zheng et al., 2012; Zhou, 2008), which 
potentially had a high risk of bias. Other trials (n=24) only mentioned ‘patients were 
randomised’ without any detailed information, thus an unclear risk of bias was given 
for those trials.  
Regarding allocation concealment, apart from six trials (Molsberger et al., 2002; 
Zaringhalam et al., 2010; Meng et al., 2003; Hurwitz et al., 2002; Grunnesjo et al., 
2011; Eisenberg et al., 2007) which had central control, and one trial (Sundberg et 
al., 2009) reported that the research coordinator was informed about the allocation 
and then enrolled the patient, none of the other trials provided details regarding 
allocation concealment. 
Regarding blinding, two trials (Molsberger et al., 2002; Leibing et al., 2002)    
reported using double blinding (both participants and examiner were blinded) in 
verum and sham acupuncture by inserting needles superficially, outside meridians, 
with no ‘de qi’. Other trials did not give information on blinding, or reported 
blinding was impossible in patients and practitioners (Meng et al., 2003).  
Figure 2 3 Risk of bias graph: review authors' judgments about each risk of bias item 
presented as percentages across all included studies 
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2.2.9 Effects of interventions 
Included trials were grouped into three groups of comparisons: integrative treatment 
versus conventional treatment and integrative treatment versus CAM for equal or 
less than three months and for more than three months respectively. Different 
comparisons with different outcome measures were discussed separately in the 
subgroup analyses.  
Integrative treatment vs conventional treatment (equal or less than 3 months) 
Pain scale 
Favourable effects were shown in integrative treatment over conventional treatment 
as measured by pain scales using visual analogue scale (VAS) and numerical rating 
scale (NRS) with MD -12.78, 95% confidence interval (CI) [-14.07, -11.48], p=0.05, 
I2= 38% in 20 trials (Figure 2.4, four trials were removed due to high heterogeinety): 
Six trials favoured acupuncture plus traction over traction alone (n=450, MD -15.68, 
95% CI [-17.61, -13.75], p=0.42, I2=0%) (Zhao, 2008; Wang, 2007; Liang, 2010; 
Wen, 2011; Wang et al., 2010; Tuo et al., 2011);  Four trials favoured acupuncture 
plus medication over medication alone (n=234, MD -10.57, 95% CI [-13.83, -7.31], 
p=0.32, I2=14%) (Kuang and Chen, 2009; Qu et al., 2010; Zaringhalam et al., 2010; 
Qin et al., 2007) (one study (Zeng, 2011) was excluded from meta-analysis as it 
showed large heterogeneity I2 = 95% if it was included); One study favoured 
acupuncture plus EI over EI alone (MD -6.00, 95% CI [-8.09, -3.91]) (Li and Wang, 
2008); Although these presented positive results, because of insufficient original data 
results of three trials evaluating acupuncture plus usual care versus usual care alone 
were not synthesised in this analysis (Molsberger et al., 2002; Meng et al., 2003; 
Leibing et al., 2002).  
Three trials favoured tuina plus EI over EI (n=160, MD -11.24, 95% CI [-13.29, -
9.20], p=0.66, I2=0%) (Wen et al., 2012b; Wen et al., 2012a; Tong, 2010); but failed 
to show a favourable effect in tuina plus traction (Heng, 2011; Zhang, 2012). Three 
trials favoured CHM plus traction over traction alone (n=434, -13.20 [-15.04, -
11.37], p=0.70, I2=0%) (Song, 2010; Chen and Tang, 2012; Qi, 2012); Three trials 
favoured CHM plus EI over EI alone (n=181, -10.81 [-14.39, -7.23], p=0.16, 
I2=46%) (Li et al., 2011; Zhou, 2008; Zhen and Geng, 2005) (if included one study 
(Cao, 2006), large heterogeneity I2=73%); One study showed favourable 
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improvement in CHM plus acupuncture, medication and traction over medication 
and traction -12.20 [-16.99, -7.41]; Two trials evaluated tuina plus traction versus 
tuina alone -13.59 [-33.77, 6.59] (Zhang, 2012; Heng, 2011) and one study on a 
package of care (included Swedish massage, manipulative therapy, shiatsu, 
acupuncture, qigong) plus usual care versus usual care with -26.00 [-60.94, 8.94] 
which failed to establish a favourable effect (Eisenberg et al., 2007).  
  
30 
Chapter 2 Literature Review 








Chapter 2 Literature Review 
Modified Japanese orthopaedic association (mJOA) score 
Favourable effects were shown in integrative treatment over conventional treatment 
as measured by mJOA with -2.35 [-3.06, -1.63] in three trials (Figure 2.5): two trials 
favoured tuina plus EI over EI (n=90, -2.15 [-3.29, -1.01], p=0.18, I2=45%) and one 
study favoured acupotomy plus EI over EI -2.71 [-4.42, -1.00] (Yang et al., 2009).       
Figure 2 5 Integrative treatment versus conventional treatment as measured by mJOA 
                              
 
Integrative treatment vs CAM (equal or less than 3 months) 
Pain scale 
Favourable effects were shown in integrative treatment over CAM as measured by 
pain scales with MD -5.09 [-7.65, -2.52] in 12 trials (Figure 2.6): two trials favoured 
tuina plus physiotherapy over tuina alone (n=166, -6.87 [-13.17, -0.57], p=0.10, 
I2=67%) (Jiang et al., 2010; Zheng et al., 2012); Two trials favoured CHM plus 
usual care over CHM (n=220, -12.24 [-18.43, -6.04], p=0.09, I2=65%) (Ma, 2012; 
Xing et al., 2011); Two trials favoured acupotomy plus medication over acupotomy 
alone (n=180, -2.98 [-5.34, -0.62], p=0.09, I2=65%) (Xiao et al., 2012; Zhang, 
2012); and one showed a favourable improvement in acupotomy plus medication 
over acupotomy plus CHM (-3.00 [-5.25, -0.75]) (Yang and Tong, 2012).  
  
32 
Chapter 2 Literature Review 
Figure 2 6 Integrative treatment versus CAM as measured by pain scales 
 
(Modified) Japanese orthopaedic association score 
Two trials evaluated acupuncture plus medication over medication alone and three 
trials evaluating tuina plus EI over EI alone failed to show a favourable improvement 
in mJOA with an effect size of MD -0.29 [-6.70, 6.11] (Mi et al., 2010; Zaringhalam 
et al., 2010) and -2.73 [-8.12, 2.65] (He Yufeng, 2004; Wen et al., 2012b; Wen et 
al., 2012a) respectively. Two trials reported positive results comparing tuina plus EI 
with tuina alone (-2.87 [-4.16, -1.58] (Sun et al., 2003); -1.80 [-3.18, -0.42] (Wen et 
al., 2012a).  One reported positive results when comparing CHM plus usual care 
with CHM alone as measured by JOA (7.20 [5.53, 8.87]) (Yang et al., 2012). Two 
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Integrative treatment vs CAM (long term follow up > 3m)  
Ten trials considered long term follow up for more than three months and six trials 
reported positive improvement with statistical significance: Acupuncture plus 
medication versus medication at six months follow up as measured by the Oswestry 
pain disability index (ODI) with MD -1.10 [-1.56, -0.63] (Zheng, 2012); acupuncture 
plus usual care versus usual care at three months follow up measured by VAS with 
MD -13.00 [-20.64, -5.36] (Molsberger et al., 2002); at six months follow up as 
measured by the VAS with MD -8.00 [-16.03, 0.03], pain disability index (PDI) with 
MD -6.70 [-11.53, -1.87], and hospital anxiety and depression scale (HADS) with 
MD -2.30 [-4.48, -0.12] (Leibing et al., 2002); EI plus tuina versus EI at three and 
six months follow up measured by VAS with MD -20.80 [-30.49, -11.11] and MD -
9.50 [-18.85, -0.15], versus tuina at three and six months follow up measured by 
VAS with MD -21.50 [-32.20, -10.80] and MD -24.10 [-35.68, -12.52] (LI et al., 
2011); one study evaluated chiropractic plus physical modalities versus chiropractic 
alone at 6/12/18m as measured by mean differences of NRS (most severe pain) with 
MD -0.15 [-0.85, 0.55], -0.34 [-1.05, 0.36], and 0.25 [-0.49, 0.98], NRS(average 
pain) with MD -0.26 [-0.81, 0.29], -0.56 [-1.13, 0.02], and 0.12 [-0.46, 0.71], and 
Roland-Morris Disability score with MD 0.12 [-1.15, 1.38], -0.92 [-2.26, 0.42], and -
0.01 [-1.35, 1.32] (Hurwitz et al., 2002; Hurwitz et al., 2006).  
One study evaluated Alexander technique plus exercise versus usual care with 
positive improvements only perceived when as measured by Roland Morris 
disability score (number of activities impaired by pain) with MD -1.29 [-2.25, -0.34]; 
but not in SF36 (physical) with MD 1.9 [-1.97, 5.79], and SF36 (mental) with MD 
0.9 [-2.8, 4.6] (Hollinghurst et al., 2008).  
Two trials were unable to show statistical improvement: package of care (including 
Swedish massage, manipulative therapy, shiatsu, acupuncture, qigong) plus usual 
care compared with usual care alone at 16w follow up as measured by SF36 bodily 
pain with MD 2.10 [-7.99, 12.19] and NRS (disability) with MD -0.70 [-2.13, 0.73] 
(Sundberg et al., 2009); Integrative treatment package plus usual care versus usual 
care as measured by modified Roland Disability Questionnaire with MD -7.10 [-
14.73, 0.53], NRS (bothersomeness of worst symptom) with MD -4.30 [-7.53, -
1.07], SF12 (physical) with MD 5.80 [-4.92, 16.52], and SF12 (mental) with MD 
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0.00 [-11.65, 11.65]. The only positive result was obtained in NRS (pain) with MD   
-4.40 [-7.43, -1.37] (Eisenberg et al., 2012).  
2.2.10 Adverse events 
Thirteen out of 56 articles (23%) reported information on adverse events (AEs) in 
detail: Acupuncture related AEs (6/13) included pain (Qin et al., 2007; Li and Wang, 
2008; Eisenberg et al., 2012), circulatory problems (Qin et al., 2007), minor aching, 
bruising, light-headedness (Meng et al., 2003); minor discomfort, soreness 
(Eisenberg et al., 2007). One trial reported no adverse events during treatment (Qu et 
al., 2010). Two trials reported that the acupuncture group experienced significantly 
fewer side effects (Leibing et al., 2002; Meng et al., 2003). CHM related AEs (1/13) 
included dizziness, nausea and vomiting (Zhou, 2008). Acupotomy related AEs 
(1/13) included dizziness, nausea, vomiting and headache (Xiao et al., 2012).  
Chiropractic and massage related AEs (1/13) included: minor discomfort and 
soreness (Eisenberg et al., 2007). Four trials (29%) reported that no AEs were 
experienced by participants (Qi, 2012; Xing et al., 2011; Qu et al., 2010; Hurwitz et 
al., 2002). One trial reported no crucial AEs in patients who withdrew from the study 
(Sundberg et al., 2009). 
2.2.11 Sensitivity analysis and publication bias 
There was a high heterogeneity in the seven subgroup comparisons, the results of 
which have been presented as a narrative. Sensitivity analysis was not conducted due 
to the insufficient number of trials in the subgroups (two/three trials). Asymmetrical 
funnel plots suggested potential publication bias. 
2.2.12 Summary of evidence  
Though RCTs evaluating integrative treatment for LBP were reviewed, identification 
of whether a trial used IM (as defined in the mapping review) was difficult due to the 
lack of standardised use of the term and reporting guidelines for IM. The defining 
elements of IM proposed in Section 2.2 (Hu et al., 2015b) were not sufficiently well 
reported, particularly whether the interventions used a holistic approach. It was also 
unclear whether the patient-practitioner relationship was considered or involved 
active communication. There were no trials with sufficient details to determine 
whether treatments were explicitly an IM approach. 
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The meta-analysis showed a favourable effect of integrative treatment over 
conventional treatment in back pain and back function measured by pain intensity 
scales and mJOA at three months or less follow up. It also showed improvement 
from integrative treatment compared to CAM in back pain intensity and back 
function. For trials with a longer follow up period (> 3m), 60% reported statistically 
significant improvements in back pain and back function. However, this evidence is 
limited because of the relatively small number of included trials in each subgroup 
analysis measuring back function, high heterogeneity, and low methodological 
quality of the included trials.  
Many trials report minor AEs from CAM therapies but there is inadequate 
information on possible AEs resulting from the interaction of CAM and conventional 
treatment.  
2.3 A narrative review on patients’experiences in receiving CAM/IM therapies 
In alignment with the MRC framework stage of developing and identifying theory, 
this section reviews qualitative studies exploring patients’ experiences of receiving 
CAM treatments for MSDs. The search focused on CAM rather than IM treatments 
because there was inadequate qualitative research which can be defined as IM.  
This narrative review further adds to the overall mixed methods review, by 
identifying and understanding patients’ experiences of receiving CAM treatments for 
their MSDs. This may help in refining research questions, explaining the meta-
analysis synthesis results, assisting interpretation of the significance and 
applicability of the mixed methods review, and in giving recommendations (Evans, 
2007). Adding qualitative findings to a trial can also help explore perceptions about 
the content of intervention and delivery, outcomes, trial design, conduct and process, 
and measures of process and outcome (Lorenc et al., In process). It can help identify 
unanticipated phenomenon which may be difficult to detect using a targeted outcome 
measure and quantitative approach, especially for complex interventions like IM. 
Exploring patient experiences using a qualitative approach is one way of evaluating 
the treatment outcome. In CAM, mixed methods or qualitative studies are still rare: a 
systematic review conducted in 2012 found 84% of the studies published in the top 
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10 CAM journals were quantitative research; only 4% reported mixed methods 
studies and 1% a solely qualitative approach (Bishop and Holmes, 2013).  
Therefore, in order to explore patients’ experiences of receiving CAM/IM treatment, 
a search was conducted in five English language  databases: Web of science, AMED, 
EMBASE, OVID medicine, and PsycINFO, from their inceptions to November 
2014. An updated search was conducted in August 2015. The key words such as 
“qualitative” AND “experience(s)” were searched. A detailed search strategy is 
provided in Appendix 2.8. Included qualitative studies were analysed using a 
thematical analysis approach, with themes identified and presented in section 2.4.3. 
2.3.1 Characteristics of included qualitative studies 
The search identified nineteen qualitative studies exploring patients’ experiences of 
receiving CAM treatments for MSDs (Hughes, 2009; Beattie et al., 2010; 
Cartwright, 2007; Zhang and Verhoef, 2002; Park et al., 2011; Bronfort et al., 2011; 
Rowell and Polipnick, 2008; Therkleson, 2010; Son et al., 2013; Galantino et al., 
2004; Cramer et al., 2013; Galantino et al., 2012; Ahn et al., 2007; MacPherson and 
Thomas, 2008; MacPherson et al., 2006; Hsu et al., 2010; Andersson et al., 2012; 
Westrom et al., 2010; Brien et al., 2012), of which twelve used a mixed methods 
design (Andersson et al., 2012; Westrom et al., 2010; Hsu et al., 2010; Galantino et 
al., 2004; Cramer et al., 2013; Bronfort et al., 2011; Ahn et al., 2007; Park et al., 
2011; Rowell and Polipnick, 2008; MacPherson and Thomas, 2008; MacPherson et 
al., 2006; Beattie et al., 2010).  
The method of collecting qualitative data included interviews (Westrom et al., 2010; 
Hsu et al., 2010; Cramer et al., 2013; Bronfort et al., 2011; Rowell and Polipnick, 
2008; MacPherson and Thomas, 2008; MacPherson et al., 2006; Beattie et al., 2010; 
Cartwright, 2007; Zhang and Verhoef, 2002; Therkleson, 2010; Galantino et al., 
2012; Son et al., 2013; Brien et al., 2012; Hughes, 2009); focus group interviews 
(Park et al., 2011; Closs et al., 2007); observation (Ahn et al., 2007; Galantino et al., 
2012); and diaries/drawings (Therkleson, 2010). These qualitative studies focused on 
a variety of MSDs, e.g. back pain (Westrom et al., 2010; Hsu et al., 2010; Galantino 
et al., 2004; Cramer et al., 2013; Bronfort et al., 2011; Rowell and Polipnick, 2008; 
MacPherson and Thomas, 2008; MacPherson et al., 2006; Beattie et al., 2010), 
osteoarthritis  (Park et al., 2011; Therkleson, 2010; Zhang and Verhoef, 2002; Son et 
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al., 2013), or other musculoskeletal related pain conditions (Ahn et al., 2007; 
Cartwright, 2007; Galantino et al., 2012; Hughes, 2009; Brien et al., 2012). 
2.3.2 Positive experiences in various types of CAM 
Patient-reported positive experiences have been reported in qualitative findings for 
various CAM therapies, including acupuncture (Ahn et al., 2007; MacPherson and 
Thomas, 2008; MacPherson et al., 2006; Hughes, 2009), yoga (Galantino et al., 
2004; Cramer et al., 2013; Park et al., 2011; Galantino et al., 2012), moxa (Son et 
al., 2013), ginger compress therapy (Therkleson, 2010), chiropractic (Westrom et al., 
2010; Bronfort et al., 2011; Rowell and Polipnick, 2008), Reiki (Park et al., 2011), 
TCM (Zhang and Verhoef, 2002), homeopathy (Brien et al., 2012) and other CAM 
treatments (Westrom et al., 2010; Beattie et al., 2010; Cartwright, 2007).  
Physical improvements and reduction in medication 
Patients in many qualitative studies reported that CAM therapies had helped manage 
their MSD symptoms, which include physical symptoms such as pain (Hsu et al., 
2010; Cramer et al., 2013; Park et al., 2011; Cartwright, 2007; Zhang and Verhoef, 
2002; Galantino et al., 2012; Son et al., 2013; Hughes, 2009). They experienced 
functional improvements with more flexibility, mobility and comfort (Hsu et al., 
2010; Cramer et al., 2013; Park et al., 2011; Cartwright, 2007; Zhang and Verhoef, 
2002; Therkleson, 2010; Galantino et al., 2012; Son et al., 2013; Hughes, 2009; 
Brien et al., 2012). They also found that CAM treatments  helped with their 
breathing  (Therkleson, 2010), reduced analgesics (Son et al., 2013), increased their 
energy (Hsu et al., 2010; Therkleson, 2010; Galantino et al., 2012), and gave them a 
more balanced and natural body perception (Cramer et al., 2013). 
Emotional improvements  
Patients with MSDs experienced emotional improvement, including: relief of stress 
and anxiety (Hsu et al., 2010; Cartwright, 2007; Galantino et al., 2012); feeling 
calm, relaxed, releasing tension, providing emotional soothing, comforting and 
feeling more cheerful (Therkleson, 2010; Hsu et al., 2010; Galantino et al., 2004; 
Cramer et al., 2013; Ahn et al., 2007; Park et al., 2011; Hughes, 2009), and being 
listened to and understood (Brien et al., 2012). 
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Mind body interaction was one of the features patients reported as improved with 
CAM treatments. Patients have reported being more ‘even-tempered’ if they used 
CAM therapies, thus more likely to accept and cope with their disability (Cramer et 
al., 2013). Patients also experienced increased body/muscle awareness, which they 
described as an important precondition to help them avoid movements which 
aggravate pain (Galantino et al., 2004; Cramer et al., 2013; Hsu et al., 2010). They 
also perceived a heightened sense of connection of mind, body, and spirit (increased 
mindfulness) (Hsu et al., 2010). 
One qualitative study found that patients realised the importance of breathing as a 
result of learning yoga (Galantino et al., 2012). It has also been reported that ginger 
compression therapy could help produce constant penetrating body warmth 
throughout the body, and induce a meditative-like stillness and emotional relaxation 
for patients with osteoarthritis (Therkleson, 2010).  
Improved social interaction 
Qualitative data also suggested improved social interaction among patients receiving 
CAM treatment, including positive changes to social opportunities (Therkleson, 
2010), improved receptivity towards others (Therkleson, 2010); re-engagement with 
activities, more self-determined lives; improved efficiency in work and social lives 
(Cramer et al., 2013); and becoming  more interested in the world, with positive 
changes in their outlook (a positive shift in thinking, leading to renewed interest and 
confidence in relationship with others) (Therkleson, 2010). 
Self-reflection 
Patients were also aware of the fact that, following CAM treatment, rather than 
expecting a complete cure, they had realised that MSDs were degenerative chronic 
conditions and they wished  to maintain physical and social functioning within these 
constraints (Cartwright, 2007), and to improve their general well-being (Park et al., 
2011; Brien et al., 2012). They had greater acceptance of their pain and life burden 
(Cramer et al., 2013); and changed their way of thinking to increase their ability to 
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Empowerment 
After CAM treatment, patients obtained a sense of control because of reduced 
anxiety and a return to normal functioning (Cramer et al., 2013; Hsu et al., 2010; 
Cartwright, 2007); and realising the importance of camaraderie, community and 
sharing (Galantino et al., 2012). 
Patients’ understanding of CAM 
Patients felt that CAM is an important adjunct to conventional medical care 
(Cartwright, 2007).  Patients perceived several differences between CAM therapies 
and conventional medicine. They reported that conventionally trained physicians 
were ‘excessively dependent on diagnostic tools’ and would only help by slowing 
down the progression, but not treating the root of the condition, and did not pay 
much attention to patients’ experiences and explanations (only looking at patients’ 
biomedical results in their notes) (Zhang and Verhoef, 2002); CAM practitioners are 
more likely to trace back through patients’ medical histories (Zhang and Verhoef, 
2002). Patients also reported that CAM provides a whole package of individualised 
care whereas conventional medicine was associated with impersonal experiences 
(Cartwright, 2007).  
Qualitative research also suggested that patients required practitioners who were 
understandable, proactive, and provided timely information. They wished to receive 
treatments from caring practitioners who believed in patients, understood their 
concerns, listened; and who were knowledgeable, experienced, and actively 
managed patients. Patients also wished to receive quality care with an exchange of 
information, and treatment provided with kindness (Rowell and Polipnick, 2008). 
Patients’ perception of the challenges of CAM  
Patients stated that they need a long term intervention with continuous treatment 
(Son et al., 2013). They recognised the barriers to accessing CAM therapies as they 
were aware of the cost and restrictions to healthcare systems, as CAM are not 
covered by most national healthcare insurance schemes (Zhang and Verhoef, 2002). 
This may also lead to the issue of not having practitioners sufficiently trained in the 
field (Zhang and Verhoef, 2002). 
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Self-management 
Many chronic MSD patients, generally the older patients, had developed self-care 
management strategies by actively engaging in various activities. Attending these 
activities was one of the most common ways they exchanged medical advice and 
obtained support from their peer group (Zhang and Verhoef, 2002). Patients also 
reported yoga as a self-care coping strategy used to help reduce and prevent pain 
(Cramer et al., 2013). 
2.4 Chapter Summary 
In this chapter, a mapping review of IM definitions identified potential key 
components of IM. IM was identified as the optimum treatment which considers 
aspects of both CAM and conventional medicine. It is a holistic individualised 
approach which uses the body’s innate healing response, emphasises the patient-
practitioner relationship and multidisciplinary collaborative teamwork, and has the 
goals of both health and healing. It also emphasised the need to improve the 
evidence base, effectiveness, safety, and low cost.  
The systematic review on integrative treatments for LBP showed that integrative 
treatments appear to be useful for relieving pain and improving function in LBP, 
though evidence is limited due to heterogeneity between studies, the relatively small 
numbers available for subgroup analyses and the low methodological quality of the 
trials. Identification of studies of true IM treatments that report the components of 
IM above was not possible due to lack of reporting of the intervention details. 
Qualitative research on patients’ experiences of receiving CAM for a variety of 
MSDs indicates that patients perceive various physical and emotional improvements 
from receiving these treatments. They perceived improved self-reflection and shared 
their understanding of CAM. Patients felt empowered, and learnt self-management 
techniques from receiving CAM treatments, as well as improved social interaction. 
However, some of the components identified above were not reported by patients in 
qualitative studies, such as perspectives of multidisciplinary teamwork, or their 
relationship with practitioners. 
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These reviews have identified the need for further research to consider the 
components identified in this review; investigate the effectiveness of providing 
integrative treatment for MSDs; and explore patients’ experiences of receiving IM 
treatments, especially in an NHS environment. Since no research study was 
identified exploring IM as a package of care for MSDs in a secondary NHS setting in 
the UK, in line with the MRC framework (Section 1.4.3), a mixed methods 
feasibility study on integrative treatment for MSDs in the UK was considered to be 
an appropriate way forward. 
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Aims and structure 
Following the MRC framework for complex interventions, a feasibility study on 
integrative treatment for MSDs using a mixed methods design was conducted. This 
chapter presents the overall methodology and detailed methods of conducting the 
feasibility study. The structure of this chapter is as follows: 
Section 3.1 justifies the use of a mixed methods approach to determine the 
feasibility of carrying out a pragmatic observational research study. It links the 
research student’s epistemology (Section 1.3), conceptual framework (section 1.4) 
and the key components of IM (as identified in Section 2.2). Validation of this 
mixed methods design is stated (Section 3.2). The detailed procedures of this 
research study, including recruitment procedures, inclusion and exclusion criteria, 
outcome measures selected, data collection, and quantitative and qualitative data 
analysis are given, with reasons for their choice (Sections 3.3-3.6). In Section 3.7, 
techniques used in interpreting and triangulating quantitative and qualitative results 
are described. Finally, ethical issues are discussed in Section 3.8, followed by a 
summary of this chapter (Section 3.9).  Supporting materials are provided in 
appendices (Appendices 3.1-3.7).  
The mixed method feasibility study is reported according to the Strengthening the 
Reporting of Observational Studies in Epidemiology (STROBE) statement for the 
observational quantitative data (von Elm et al., 2014), and the Consolidated Criteria 
for reporting qualitative research (COREQ) for qualitative data (Tong et al., 2007).  
3.1 Justification of the study design 
This section specifies and justifies the methodology used for this research study. 
Under a pragmatic epistemology, mixed-methods research (MMR) is the overall 
study design. Given the complex nature of IM discussed in Section 2.2, pragmatic 
observational approaches were used. Details of the rationale for choosing these 
designs are discussed in this section. 
3.1.1 Mixed methods research 
The rationale for using a mixed methods design in this research study was briefly 
introduced in Section 2.5. Qualitative research helps to uncover the complex 
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experiences of patients, ensure the comprehensiveness of findings and stimulate 
reflexive analysis (Broom, 2005; Paterson and Britten, 2003). Therefore a 
qualitative design and a quantitative approach with comprehensive multiple 
outcome measures were adopted to provide a comprehensive understanding of IM 
practice. A previous review conducted by the research team suggested that although 
adding a qualitative approach in CAM trials is still relatively rare, it can help 
explain and interpret trial results, improve future study design and identify 
unexpected outcomes of trials (Lorenc et al., In process). 
This research study adopted a convergent parallel mixed methods design as 
described by Creswell and Clark (2011). In convergent MMR, qualitative and 
quantitative data are given equal priority with concurrent timing of the strands, and 
using them to explore the same topic, to better understand a phenomenon (Creswell 
and Clark, 2011). This feasibility study was considered as a fixed convergent mixed 
methods design, as the use of quantitative and qualitative strands were 
predetermined at the start of the research process, due to the complexity of IM as 
discussed in Chapter 2 (Section 2.2). Quantitative and qualitative approaches were 
carried out with the same overarching aim, which was to determine the feasibility 
of evaluating integrative treatments for MSDs in NHS in the UK.  
One important aspect of MMR is when and how the two strands interact. The 
interaction may happen during interpretation, data analysis, data collection, or at the 
level of design (Creswell and Clark, 2011). Convergent MMR design includes 
concurrent but independent quantitative and qualitative data collection, separate 
quantitative and qualitative analyses, and mixes the two data sets only at the overall 
interpretation stage (Creswell and Clark, 2011), which was when main interaction 
between the two strands happened in this research study. Figure 3.1 presents the 
convergent MMR adopted in this research study. Methods of data analysis 
reflecting the convergent design is provided in Sections 3.5 & 3.6.  
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 Figure 3 1 The convergent parallel mixed methods design adapted from (Creswell and Clark, 2011) 
 
QUAN=quantitative, QUAL=qualitative  








QUAN: pragmatic, observational design 
Data collection and analysis 
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3.1.2 Feasibility study design 
Feasibility studies are designed to produce a set of findings which will help 
determine whether an intervention should be recommended for 
efficacy/effectiveness testing or not. In line with the recommendations in the MRC 
complex intervention framework, a feasibility stage was implemented due to a lack 
of published research specifically referring to IM (Craig et al., 2008). In particular 
there is a lack of information on IM for MSDs in NHS settings, including patients’ 
acceptance of integrative treatment and taking part in research, recruitment rate and 
retention, variability, and the effect size for appropriate sample size calculation. 
This study aims to assess the feasibility of researching IM, rather than being a pilot 
study which is the pre-run of a small scale study to inform a future study using the 
same study design (Arain et al., 2010). 
Feasibility of research is crucial for evaluating complex interventions as there may 
be issues around recruitment and retention, intervention delivery and fidelity, and 
potential inadvertent treatment effects (Clark et al., 2014). It has been suggested 
that IM, as a complex intervention, should be evaluated using a pragmatic approach 
to mimic clinical practice and its outcomes (Witt, 2009). In general IM practice, 
participants may have different individualised treatments, beginning at different 
times and having different lengths of treatment. Although there may be a prescribed 
follow up period, some participants may not have finished their sessions at the 
hospital when the final evaluation took place. Variations in the number and types of 
integrative treatments may cause issues in achieving statistical significance, as there 
might be inadequate numbers of participants having the same combination of 
integrative treatments or similar complexities of integrative treatment. In addition, 
the reliability and validity of using multiple outcome measures, and information on 
effect-size estimation can be assessed during the feasibility phase (Craig et al., 
2008).  
Though studies have been conducted in the RLHIM on acupuncture/acupressure 
(Fisher and Hughes, 2014; Cummings, 2011a; Cummings, 2011b; Hughes et al., 
2013), autogenic training (Bowden et al., 2012), and herbal medicine (Berkovitz et 
al., 2013), no study has been conducted specifically on MSDs. The information 
collected from this research study was essential to inform the design of a future 
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large scale evaluation. Feasibility designs can test the fit of interventions in real-
world settings and can fill gaps in the literature, providing new criteria and 
suggesting measures to evaluate relevant outcomes (Glasgow et al., 2006). This is 
essential in confirming the details of recruitment, study timelines, and to propose 
outcome measures to suit the complex nature of IM.  
3.1.3 Pragmatic study design 
Clinical trials can either be designed as explanatory, in which the aim is to assess 
efficacy, robustly comparing with a sham group under controlled conditions; or 
pragmatic, which aims to evaluate effectiveness of a therapy as practised in routine 
daily clinical practice (Schwartz and Lellouch, 2009). A pragmatic design 
overcomes the issues of controlling for the everyday practice of complex 
interventions, especially when a varied complex package of care is provided 
(Bonell et al., 2012; Campbell et al., 2000). 
There are many challenges in assessing IM using conventional research 
methodologies such as RCTs. Similar to CAM treatments, IM rarely lends itself to 
being administered in a standardised or randomised manner, due to the 
individualised and holistic nature of IM. Randomisation is difficult as some patients 
who wish to try certain CAM treatments might have a belief in them and would 
insist on receiving the true intervention or may withdraw from the study if 
randomised to a control group. The components that contribute to the effects of IM 
treatment are difficult to be detected due to a lack of randomisation, e.g. is A or B 
treatment providing the treatment effect or is it an interaction of A plus B; is the 
treatment effect affected by patients’ preference/choice or their expectations; how 
does the patient-practitioner interaction contribute to the effects etc. 
Blinding is a challenge for complex and non-pharmaceutical interventions that 
involve face to face interactions such as IM.  It is nearly impossible to blind 
practitioners in IM, and many research studies criticised the blinding of patients in 
IM. For example, with integrative treatment, practitioners often do not provide 
uniform treatment, as considering all aspects of a person rather basing treatment on 
a single disease is fundamental to IM, which is tailored to an individual’s needs, 
with varied types and frequency of treatments. The ‘flexible’, ‘unrepeatable’ 
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interventions that require skills by practitioners lead to a lack of internal validity 
(IV) as sham/blinding is often impossible in face-to-face involved interventions. 
It has been suggested that pragmatic designs can overcome the difficulties of 
conducting explanatory trials of CAM or complex interventions, especially when 
testing a package of care (Bonell et al., 2012; MacPherson, 2004b). Pragmatic 
designs may result in higher external validity (EV) as it is situated in real world 
routine clinical practice (Campbell et al., 2000). Comparing the package of 
complex interventions to another treatment rather than a sham intervention may 
provide evidence to help policy makers, researchers, practitioners and patients to 
choose between the target complex intervention and the standard or routinely 
accepted treatment (MacPherson, 2004b). In this pragmatic approach, one can 
reflect the situation in routine care and provide realistic benefit estimation for future 
health care research (Bonell et al., 2012). A pragmatic approach is therefore ideal 
for the research question (Section 3.1) of this feasibility study as it explores 
packages of integrative treatment in an NHS setting in routine clinical care.  
3.1.4 Observational study design 
The published trials identified in Section 2.3 compared integrative treatment with 
CAM or conventional treatments; no trial was identified investigating the efficacy 
or effectiveness of IM treatment. It is difficult to design a control group to evaluate 
the efficacy or effectiveness of IM. For example, patients in a control group who 
receive standard usual care may use CAM on their own initiative or from another 
provider. In addition, due to the complex situation of IM intervention (including the 
influence of patients’ preferences, using individualised treatment, variation in 
practitioners’ skills, and the issues of conducting placebo-controlled studies), 
observational approaches have been recommended in healthcare research (Concato 
et al., 2000; Benson and Hartz, 2000), as well as in the field of CAM (MacPherson, 
2004b; Harlan, 2001; Vickers et al., 1997) and IM (Herman et al., 2014; Bell et al., 
2002). Prospective observational study designs have also been successfully used in 
other research areas such as pharmacoepidemiology (Hallas and Pottegard, 2014), 
mental health care (Pratt et al., 2012), and cardiology (Ramsay et al., 2011). 
There are potential methodological issues in adopting an observational study design 
with no comparison group as it can be argued that the effects are not related to the 
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intervention (Hallas and Pottegard, 2014). The limitations of using an observational 
design are discussed in Section 7.6.2. 
3.2 Validation of mixed methods research  
In terms of the rigour of the methodology, quantitative rigour in positivist paradigm 
is measured by reliability and validity. Application of reliability and validity to 
qualitative research is problematic and may not be the most appropriate tools for 
demonstrating robustness. However, if the concepts of validity and reliability are 
rejected the concept of rigour is rejected (Morse et al., 2002). Therefore, 
alternatives can be used to validate qualitative trustworthiness 
(authenticity/goodness), as subscribed by interpretivist/constructivist, 
radical/critical, and post structural/postmodern paradigms (Lincoln and Guba, 1985; 
Andrew and Halcomb, 2009). One such alternative is that proposed by Morgan, 
which uses a classic pragmatic emphasis on abduction, inter subjectivity, and 
transferability, created a range of new opportunities for thinking about classic 
methodological issues in the social sciences (Morgan, 2007). 
Validation in qualitative research uses many notions such as credibility (in 
preference to IV), dependability (in preference to reliability), transferability (in 
preference to EV or generalisability), and confirmability (in preference to 
objectivity) (Tobin and Begley, 2004; Lincoln and Guba, 1985; Malterud, 2001). 
Validation of the qualitative approach in this research study is discussed (Section 
7.6.3) following Guba’s four criteria to ensure trustworthiness, which are 
credibility, transferability, dependability, and confirmability (Lincoln and Guba, 
1985; Shenton, 2003).  
When quantitative and qualitative methods are mixed within a study, they are 
usually taken from a single worldview or paradigm. Many suggested one should 
differentiate the numerous strategies for validating MMR within different research 
paradigms and a ‘dominant paradigm’ should be examined (Andrew and Halcomb, 
2009). The researcher should be ‘vigorously self-aware’ of how his/her 
paradigmatic position may influence decisions concerning validation (Lather, 
1986), and whether more than one set of validation strategies should be applied 
(Andrew and Halcomb, 2009). The process of MMR validation should shift 
depending on either QUAN or QUAL is dominant within the research study 
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(Andrew and Halcomb, 2009).  Methods chosen to ensure MMR validity need to 
reflect the ontology and epistemology and to fit with methodology which are 
congruent with the topic specific overall research aim (Andrew and Halcomb, 
2009). For this research study, as described in Section 3.1.1, quantitative and 
qualitative approaches shared equal priority and the whole research study was 
conducted under an epistemology of pragmatism. Since this research study used a 
convergent mixed methods design, quantitative and qualitative data were collected 
and analysed separately. Validation of each strand was conducted separately.  
Validation of the quantitative approach used in this research study was more 
recognised than the qualitative approach. A research protocol was published in 
2013 at the design stage, to improve reliability by showing consistency in the 
research aims and use of outcome measures and to allow potential reproduction of 
results (Hu et al., 2013). IV was enhanced by the three outcome measures, VAS, 
sfBPI and SF36 (details in Sections 3.4.4 and 3.4.5), measuring the pre-set 
objectives of this study, namely to assess the feasibility of evaluating effectiveness 
of integrative treatment for MSDs. EV (generalisability) was weakened due to 
small sample size from a single geographic location. Therefore, findings of this 
observational design should be interpreted with caution when considering 
application to a wider context or different population. Other limitations in 
quantitative data analysis were that selection bias may have been produced by using 
complete-case analysis, as longitudinal data might violate the assumption of 
missing completely at random (MCAR) (Graham, 2009); and there were inadequate 
participants for subgroup analysis, which is common for observational research in 
such a complex environment. Missing data in completed questionnaires were rare, 
which may be due to the research student completing the first questionnaire with 
the participants, which may have enhanced their understanding of the questionnaire 
content and the process of participating in the research study. 
3.3 Research setting and recruitment 
This section introduces the routine clinical practice at the RLHIM for MSDs, and 
the recruitment procedure used for this research study.  
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3.3.1 Routine Practice for Musculoskeletal Disorders at the RLHIM 
RLHIM is the largest public sector provider of IM in Europe. The hospital receives 
20,000 to 30,000 patient referrals every year, of which MSDs are the most frequent 
(mean percentage over four years: 19%) patient referrals (including both new 
referrals and follow-up patients) to the hospital (Table 3.1). As an integrated 
hospital that is affiliated to University College Hospital (UCH) and working closely 
with the National Hospital for Neurology and Neurosurgery (NHNN), the RLHIM 
aims to integrate safe and effective CAM with conventional interventions, with 
practitioners and healthcare professionals from different departments working 
closely together.  
Table 3 1 Number of all referrals and musculoskeletal referrals per year 2010-2014 
Year* All Referrals, n MSDs Referrals, n (%) 
2010-2011 29247 6892 (23.6%) 
2011-2012 26914 5207 (19%) 
2012-2013 28159 3219 (11%) 
2013-2014 20941 4594 (22%) 
*Financial year (from the 1st April to 31st March). 
In routine standard practice, all MSD patients referred for RLHIM treatment 
receive an appointment with a MSD specialist approximately 2 months after their 
initial GP referral letter. At this time point their healthcare problems are assessed 
and if necessary they are triaged by a specialist clinician and referred to the 
department(s) that suits their condition most (Figure 3.2). All patients are 
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Figure 3 2 Musculoskeletal care pathway at the RLHIM (UCLH, 2015) 
 
Key: CM=Chinese medicine; CBT=cognitive behaviour therapy 
Patients who present with MSDs typically receive integrative packages of care at 
the RLHIM. The integrative packages of care combine conventional and 
complementary approaches.  
Treatment may include: acupuncture and trigger point therapy, osteopathy and 
spinal manipulation, physiotherapy, injection therapy, exercise therapy, Pilates, 
back pain education, and podiatry (UCLH, 2015b). Some patients may have a one-
off treatment, some may start their treatment immediately and some may be put on 
a waiting list which could potentially last for up to 5 months before they receive 
treatment. Routine packages of treatment at the hospital are individualised with a 
varying number of treatments depending on patient individualised condition and 
practitioners’ recommendation. Normally, the average course of treatment is 6-8 
sessions, and lasts approximately 2-3 months. More than one course of treatment 
may be offered. Patients are routinely discharged from the hospital if they fail to 
attend for an appointment on two consecutive occasions. 
3.3.2 Inclusion, exclusion criteria, and sample size 
Since a feasibility study does not require a calculation of the sample size, this study 
used a convenience sample, including all newly referred eligible patients with 
MSDs attending RLHIM between January 2013 and April 2014. All eligible 
patients who provided informed consent and indicated they were willing to 
participate in the study during the 12-month period were recruited. A large sample 
53 
Chapter 3 Methodology and Methods 
size with a more heterogeneous mix of participants has been suggested for a 
pragmatic design as variation between participants may dilute the treatment effect 
(MacPherson, 2004b). Wide inclusion criteria were set to target the maximum 
number of MSD patients.  
Though previous qualitative studies have suggested saturation occurs at the 12th 
interview with most themes identified within the first six interviews (Guest et al., 
2006), saturation as a conceptual guide may not provide practical guidance on 
deciding sample size prior to data collection, as the number of interviews needed to 
reach saturation highly depends on the nature of the research question and the target 
sample group (Baker & Edwards, 2012). Considering the feasibility nature of this 
research study and the fact that the research student’s first language was not 
English, it was felt that more than 12 interviews may be needed to reach saturation. 
Therefore, 30 participants in the quantitative part of the research study were 
interviewed before and at one year follow-up as it was anticipated that this would 
provide a sufficiently large enough sample to ensure theoretical saturation of 
emergent categories and themes (Baker & Edwards, 2012). Details on questionnaire 
completion, those who were interviewed and drop outs is provided for the 
participants recruited into the study in table 4.1.  
The inclusion criteria were:  
1). New referrals to RLHIM for MSDs, including all MSD patients who had 
received previous treatment for MSDs but were presenting for a new episode of 
care (either a single MSD diagnosis or with a combination MSD diagnoses were 
included);  
2). Male or female patients 16 years or older;  
3). Patients with a primary diagnosis of an ICD-10 code under musculoskeletal 
system and connective tissue disorders (ICD-10, 2012);  
4). Able to take part in the study for 12 months.  
The exclusion criteria were:  
1). Unwilling to take part in the study;  
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2). Unable to communicate in English;  
3). Unable to read and therefore understand the written study documents and the 
patient consent form or patient information form;  
4). Severe progressive disorders, life threatening conditions or poor prognosis;  
5). Patients diagnosed with cognitive impairment such as dementia or psychological 
disorders.  
3.3.3 Participant Recruitment  
3.3.3.1 Participant recruitment for the quantitative part  
Patients were recruited between January 2013 and April 2014. A musculoskeletal 
clinician who triaged and conducted assessments for patients screened and selected 
eligible patients to the study. A sticker was placed in each eligible participant’s 
clinic notes to allow patient service department (PSD) staff, clinicians to distinguish 
participating patients. The PSD sent patients the information sheet and cover letter 
explaining the research study to the patients with their routine appointment letter. 
The information sheet contained details of the observational study and is provided 
in Appendix 3.1. The research student’s contact details were provided and the 
patients were asked to contact her directly if they were interested in taking part in 
the study. 
Approximately one week after the new MSD patient’s initial referral, the PSD at 
the RLHIM routinely contacts patients to confirm hospital appointments. As part of 
this confirmation, they reminded those patients whose clinical notes had a sticker 
on them about the study. The PSD asked interested patients for permission to pass 
their contact details onto the researcher. The research student then contacted the 
patients (Section 3.3.2) by telephone. Study eligibility was then verified and the 
study explained. For those who expressed interest in the study, a questionnaire 
package including a consent form (Appendix 3.2), sociodemographic questionnaire 
(Appendix 3.3), and Patient Expectation Questionnaire (PEQ) (Appendix 3.3) with 
a reply paid envelope was posted. These questionnaires were sent at this point as 
the feedback was required prior to the first interview. Patients who had not 
consented by post, but were willing to participate, were able to join the study on the 
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day of their first assessment appointment. A flowchart showing the screening, 
recruiting, and follow-up process is available in figure 3.3 (page 65). 
3.3.3.2 Participant recruitment for the qualitative study 
Qualitative data were collected before participants’ initial appointment and at 12 
months post their initial appointments. Pre-treatment qualitative study recruitment 
took place at the same time as recruitment for the whole study when the 
information sheet and consent form was sent to the patient. At the same time, 
patients were phoned about taking part in the quantitative part of the study, they 
were also asked whether they would be willing to take part in an interview.  
In order to produce contrasting cases (comparability), the research student planned 
to recruit a purposive sample using multiple purposive techniques: (homogeneous 
and intensity sampling) (Teddlie and Yu, 2007). It was intended to select several 
participants with high PEQ scores and several with low PEQ scores through 
intensity sampling technique; and to select participants on the basis of their age and 
gender by homogeneous sampling. The decision of sample size for the two 
qualitative parts was discussed in Section 3.3.2. 
The pre-treatment interviews were arranged immediately before the patients' initial 
hospital appointment, after they completed the questionnaires or at another date and 
venue convenient for the patient (prior to their initial consultation/assessment at the 
RLHIM). The research student invited eligible patients to come to the hospital at 
least 30 minutes (quantitative part only) or 90 minutes (quantitative and qualitative 
parts) before their initial appointment. 
3.4 Integrative medicine outcome measures and baseline characteristics 
This section details the baseline characteristics collected from participants: 
sociodemographic and lifestyle (smoking and drinking history) characteristics; 
expectations; participants’ GPs’ locations; and a range of patient reported outcomes 
(PROs) including measures of pain, health related quality of life (physical and 
emotional function), and resource use, in order to understand the holistic healing 
process and whether this changed.  
GP practice locations were calculated from practice postcodes. All other 
measurements were collected using the package of questionnaires sent to the 
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participants. Participants’ sociodemographic and lifestyle characteristics were 
collected once, prior to their initial appointment at baseline; PRO measures were 
collected at four time points (five if participants were on waiting list): baseline, 
four, eight, and 12 months after baseline. All participants completed the first 
questionnaire package guided by the researcher to facilitate patients who may have 
had difficulty in understanding and completing the measurements. Completion of 
the whole questionnaire package took approximately 20 to 30 minutes. All 
questionnaires are available in Appendix 3.3.  
3.4.1 Sociodemographic questionnaire 
The sociodemographic questionnaire was designed for the research study by the 
research team, adopting the census categories (Office for National Statistics, 2011). 
It included: age, gender, marital status, education, occupational status, mother 
tongue, ethnic origin, and religious affiliation. It took less than 5 minutes to 
complete, and was administered once at the baseline in the period between the first 
appointment being booked and on attending the hospital appointment. 
3.4.2 Patient Expectation Questionnaire 
Though patient expectation measurement has not been rigorously investigated using 
standardised measurement, surveys or scales have been developed to measure and 
quantify expectancy (Schutzler and Witt, 2013; Sherman et al., 2014). Various 
measures have been used to evaluate patient expectations of CAM, including those 
with chronic pain (Tsao et al., 2005), hypersensitivity illness (Launso et al., 2007), 
patients using homeopathic treatment (Thompson et al., 2007), CAM therapies in 
general (Himmel et al., 1993); and patient expectations in using 
acupuncture/massage treatment with chronic pain (Linde et al., 2007; Sherman et 
al., 2010; Kalauokalani et al., 2001). 
Assessment of patients’ expectations of care and treatment has been recommended 
in IM and has been found essential to help understand the patient’s perspective and 
improve patient-practitioner communication (Bowling et al., 2012). Expectation of 
benefit has been shown to impact clinical effectiveness (Mondloch et al., 2001). A 
review identified 71 PRO measures for an integrative medicine primary care 
setting, from which two were related to patients’ attitudes or beliefs towards CAM 
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(Hunter and Leeder, 2013): the holistic complementary and alternative health 
questionnaire (HCAMQ) (Hyland et al., 2003), and the CAM belief inventory 
(Bishop et al., 2005). Both instruments have been validated and are thought to be 
reliable. The latter is a 17-item questionnaire which measures belief in natural 
treatments, holistic health, and additionally, participation in treatment (Bishop et 
al., 2005). A more recent systematic review identified 49 trials which measured 
expectations of benefit from acupuncture, of which most used a Likert scale or NRS 
followed by a question such as “How confident [sure] do you feel [are you/would 
you be] that this treatment can alleviate/control…” (Prady et al., 2015). However, 
the authors concluded that there is no standard or well tested instrument to assess 
patients’ expectation in the IM primary care setting (Prady et al., 2015).  
In this research study, patients’ expectation is seen as a potential predictor of 
integrative treatment for MSDs provided at the RLHIM. Adapted from Borkovec 
and Nau (Borkovec and Nau, 1972), two questions asked “How much do you 
believe that the treatment you will receive at the RLHIM will make your condition 
better?”, and “How much faith do you have in complementary therapies in 
general?”, followed by a 0 to 10 VAS below each question to assess participants’ 
expectations.  
3.4.3 Referrals and Participants’ GPs’ Location 
Participants’ referral data were collected from the hospital clinical data repository 
(CDR) workstation (the electronic hospital system). The number of participants 
whose initial appointments were cancelled or changed was recorded. Length of the 
time interval between participants receiving their referral letter and their initial 
appointment and the length of time they were on a waiting list were also recorded. 
The postcodes of the participants’ GPs were extracted from the RLHIM hospital 
system and then grouped into those within North East London (postcodes start with 
‘N’ or ‘E’), non-North East London (in greater London, apart from North East 
London), and outside greater London. Their postcodes were also converted to 
latitude and longitude (LatLong, 2015), and then entered onto a map of the UK with 
SPSS (map downloaded from Statslik) (StatSilk, 2015). Table 3.2 lists the North 
East London clinical commissioning groups (CCGs) who have contracts with the 
RLHIM.   
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Table 3 2 Codes and names of North East London CCGs (NHS England, 2013) 
CCG name 
NHS Barking & Dagenham CCG 
NHS Barnet CCG 
NHS Camden CCG 
NHS City and Hackney CCG 
NHS Enfield CCG 
NHS Haringey CCG 
NHS Havering CCG 
NHS Islington CCG 
NHS Newham CCG 
NHS Redbridge CCG 
NHS Tower Hamlets CCG 
NHS Waltham Forest CCG 
3.4.4 Primary outcome measures: improvement in pain 
There are many scales available to evaluate pain intensity or pain impact for adults, 
including pain VAS, short form brief pain inventory (sfBPI), NRS for pain, (short 
form) McGill pain questionnaire (MPQ), short form-36 bodily pain subscale (SF36 
BPS), chronic pain grade scale (CPGS), measure of intermittent and constant 
osteoarthritis pain (ICOAP), and pain impact question (Hawker et al., 2011). 
The ICOAP is an osteoarthritis specific pain measurement, while the CPGS focuses 
only on chronic pain. MPQ was not considered in this research study as it takes 
approximately 20 minutes to complete and focuses more on pain intensity and pain 
quality (sensory, affective, evaluative, and miscellaneous) (Burckhardt, 1984). Both 
MPQ and sf MPQ require sufficient experience to adequately complete them 
(Hawker et al., 2011). Therefore, VAS and SF36 BPS were pre-set as primary 
outcome measures; and other dimensions of SF36 and sfBPI were pre-set as 
secondary outcome measures. Reasons for using the two as primary outcome 
measures are provided in this section (Section 3.4.4.a). SfBPI was used as a 
secondary outcome measure which is discussed in the next section (Section 3.4.5).  
59 
Chapter 3 Methodology and Methods 
3.4.4.a) Pain visual analogue scale 
Pain VAS is a single-item scale, which has been widely used in diverse populations 
to monitor variations in intensity of pain, due to its simplicity and adaptability 
(McCormack et al., 1988), including within the field of IM (Hunter and Leeder, 
2013). VAS has good reliability and moderate validity, and is sensitive to change 
(Hunter and Leeder, 2013).  
In this research study, a horizontal VAS line of 100 mm in length was used, 
anchored by minimal extreme as ‘no pain’ and maximum extreme as ‘worst pain’. 
Participants were asked to place a vertical mark on the scale to represent their pain 
on the day of completion. Since literature suggested that VAS might be difficult for 
some people (Hawker et al., 2011), an example of how to complete the VAS was 
given to the participants on the same page.  
3.4.4.b) The SF-36 TM health survey – bodily pain dimension 
SF-36TM Health Survey (SF-36TM) is a health-related quality of life (HRQoL) 
questionnaire and is a multi-purpose, short-form health survey with 36 questions 
(Jenkinson et al., 1996). It has eight multi-item scales of functional health and well-
being scores as well as psychometrically-based physical and mental health 
summary measures. It is a generic measure, as opposed to one that targets a specific 
age, disease, or treatment group. The SF-36™ is divided into two summary 
measurements: physical component summary and the mental component summary. 
The internal consistency of the SF-36™ had been extensively evaluated with most 
studies finding a reliability coefficient (Cronbach alpha) over 0.80 (Lyons et al., 
1994). SF-36™ has been used and validated with numerous studies in a variety of 
patient populations, including patients with MSDs (Hunter and Leeder, 2013; 
Kosinski et al., 1999; Kiebzak et al., 2002; Angst et al., 2001), but the research 
student needed to be cautious as there is a high ceiling effect and substantial floor 
effect (O'Mahony et al., 1998; Busija et al., 2011). This measure has been 
recommended for routine use within the NHS (Garratt et al., 1993).                                                                                               
Bodily pain (item 21 and 22) as one dimension of SF-36™ has been extensively 
evaluated with most studies finding it is an acceptable, validated and reliable sub-
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scale, useful for making comparisons across populations (Hawker et al., 2011). It 
provides additional confirmation together with the VAS to validate patients’ reports 
of pain. 
3.4.5 Secondary outcome measures 
3.4.5.a) The SF-36™ Health Survey – Other Dimensions 
In addition to the SF-36™ bodily pain dimension, there are 34 questions on 
physical function (PF, items 3-12), physical role limitations (RP, item 13-16), 
general health (GH, items 1 and 33-36), and mental health (MH, items 24-26, 28, 
30), emotional role (RE, items 17-19), social function (SF, items 20 and 32) and 
vitality/energy or fatigue (VT, items 23, 27, 29, 31). 
3.4.5.b) Short Form Brief Pain Inventory  
The short form brief pain inventory (sfBPI) is a valid and reliable tool for 
evaluating pain status, and it has been suggested to be sensitive to change in the 
field of IM (Hunter and Leeder, 2013; Mendoza et al., 2006; Mathias et al., 2011). 
It has been used widely for various kinds of pain, especially musculoskeletal pain 
(Mendoza et al., 2006). It includes 9 questions and provides information on the 
intensity of pain (four questions), along with the degree to which the pain interferes 
with everyday functioning (seven questions) (Cleeland and Ryan, 1994). The 
internal consistency of the sfBPI has been extensively evaluated with studies 
finding a reliability coefficient (Cronbach alpha) of 0.77 to 0.91 (Zelman et al., 
2005). Numerous studies have used the sfBPI in a variety of patient populations, 
including patients with musculoskeletal disorders (McDonald et al., 2008). It is 
routinely used for patients with MSDs at RLHIM. The BPI-sf takes approximately 
five minutes to complete. 
3.4.5.c) Modified Client Service Receipt Inventory  
It has been suggested that CAM may have the potential for reducing health and 
social costs, and it is recommended that cost is evaluated for at least 6 months 
following treatment (Robinson et al., 2006). Health and social care service 
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utilisation was explored by asking participants about the quantity/frequency of 
service use. The Client Service Receipt Inventory (CSRI) is an internally validated 
and a widely used instrument originally developed by researchers at the London 
School of Economics (Chisholm et al., 2000). A modified version of the CSRI 
(mCSRI) was designed to collect data on the impact of integrated treatments for 
MSDs on use of health and social care services. The mCSRI took approximately 10 
minutes to complete.  
In this research study, an economic advisor (AP) who helped to design the 
economic outcome measure questionnaire (mCSRI) was involved. This 
questionnaire was designed for this particular study, with relevant IM interventions. 
The mCSRI is an eight pages questionnaire with 15 questions that covered the 
items below (Table 3.3). These questions focussed on service use for MSDs and 
other conditions in the past 3 months.  
Table 3 3 Items covered in the mCSRI 
NHS or social 
services cost 
• GP, physiotherapist, occupational therapist; 
• Hospital services (A&E, inpatient, outpatient); 
• Social services (e.g. meals on wheels, home help etc); 
• Hospital tests/investigations  
• Medication (prescribed and OTC); 
• CAM treatments 
Private 
healthcare cost 
• Private health insurance; 
• Private healthcare consultation; 
• CAM treatments 
State benefit • E.g. Attendance allowance, disability living allowance etc 
Personal cost 
• E.g. travel costs, lost earnings due to sick leave 
• Regular physical activity 
3.4.6 Interview questions 
In this research study, two sets of interviews were conducted: one-to-one interviews 
prior to participants’ initial appointment at the hospital (pre-treatment interview), 
and another in the forms of one-to-one and focus groups at 12 months after their 
initial appointment (follow-up interview).  
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All interview guides were developed iteratively by discussing with the research 
group and the patient representative. The questions developed were focused on the 
following research objectives:  To explore patients’ expectations and experiences of 
receiving integrative treatments for MSDs; To determine patients’ expectations and 
experiences in participating in the research study; To identify practical issues in 
conducting a mixed methods feasibility study. Participants were interviewed using a 
semi-structured interview, with some pre-set open-ended questions and probes to 
direct the interviews. The topic guide was tested with a volunteer who had been 
suffering from MSDs for a long period of time, before the interviews taken place. 
The guide was revised as new questions emerged, e.g. in the follow-up interviews, 
participants talked about their experiences in communicating with the practitioners. 
This question was refined based on what the research student learnt from asking 
participants this question in the interviews.  
Specifically, for the pre-treatment interview, topic guide covered participants' 
MSD, previous treatment experiences, decision making process, referral pathway to 
RLHIM and patients’ expectation of IM treatment at the RLHIM. Patients’ previous 
experiences with healthcare services, including communication with healthcare 
professionals have been suggested to be the most common influences on patients’ 
expectations (Bowling et al., 2012).   
The follow-up interviews were in the form of one-to-one interviews or focus groups 
depending on the participants’ choice. Rationale for using one-to-one interview or 
focus groups are presented in Section 3.5.2. The follow up interviews covered 
questions exploring the patient’s experiences of the integrated treatments they 
received at the RLHIM, and their experience of participating in the study and 
acceptability of the study design and outcome measures. Both one-to-one 
interviews and focus groups were digitally recorded and transcribed verbatim. 
Topic guides are available in Appendix 3.4.  
3.5 Data collection 
This research study used a convergent mixed methods design, with quantitative and 
qualitative data collected separately using different methods. The detailed data 
collection procedures are discussed in this section. Figure 3.3 provides the flow 
chart detailing the process of data collection procedures for the research study.   
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Figure 3 3 Study design and data collection for individual patients 
 
Δ Questionnaires include the SF-36TM health survey, sfBPI, VAS, and mCSRI 
Dashes and faded shading indicate that the treatment may or may not be still 
provided at each time point; this pattern was different for each individual. 
Notes: *In routine practice, some patients may have had a one-off treatment or 
commenced their treatment immediately at T0a; some patients may have had to 
wait for their treatment. For those who were put on the waiting list (for up to 5 
months), an additional evaluation was administered at T0b before their first 
treatment.  
3.5.1 Quantitative data collection  
In this research study, quantitative data were collected from three sources: 1). the 
completed questionnaires at four or five time points (sociodemographic and 
lifestyle characteristics, sfBPI, SF36, and VAS); 2). Participants’ clinical notes, the 
RLHIM hospital system, and 3). The practitioner treatment log. Number of 
past/new referrals, number of participants’ recruitment and follow-up at baseline 
and 4, 8, and 12 months post baseline, whether participants were on a waiting list, 
Baseline (T0)   Initial Appointment Day 
*
T0a – Started treatment right away; T0b – were on a waiting list before they 
started treatment  
Treatm




Four Month (T1) Assessment 
Eight Month (T2) Assessment 
Twelve Month (T3) Assessment 
QuestionnairesΔ by post 
QuestionnairesΔ by post 
QuestionnairesΔ by post 
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and waiting time between getting referred and the initial appointment were also 
recorded (Table 3.4).  
During recruitment, data were recorded on number of past/new referrals, eligible 
patients for the study, number of patients consenting/declining to take part, and 
reasons for not participating. At the end of the study, attendance at appointments, 
patient follow up, drop-out, and completion rates were generated from treatment 
logs and the CDR workstation. Rates of completion of the outcome measures, data 
collection and analysis were calculated by the research student. The study timeline 
as measured by the time taken to recruit and complete the study was presented. 
Table 3 4 Sources of the quantitative data 
Source Information Obtained Timing of data collection 
Questionnaires (VAS, 
sfBPI, SF36, mCSRI) 
Sociodemographic and lifestyle 
characteristics (baseline), expectation score, 
pain, HRQoL, and costs 
Baseline(s), four, 




repository  (CDR) Web 
and Workstation (Live: 
Version L1 R1 v1.0)* 
Participants’ GPs’ postcode; date of each 
treatment; did not attend (DNA); date of 
initial record in CDR; date of initial record 
in CDR on RLHIM appointment 
At baseline & 
April 2015 
Clinical Notes 
Participants’ clinical notes (paper copies) – 




Practitioner-completed treatment log 
containing appointment date, ICD codes 
(primary and secondary), treatment 
provided, practitioners’ initials, and an 
indication of participants’ progress since last 
appointment. 
April 2015 
Recruitment log Process evaluation of conducting and responding studies, including time 
For the duration 
of the study 
RLHIM data Participants’ ICD codes April 2015 
*The e-CareLogic (CDR Web and Workstation) is a clinical workstation used by 
UCLH 
Data were collected at four time points (5 for waiting list participants) (Figure 3.3): 
baseline (T0a/T0b) data were collected face to face on the day immediately before 
their initial appointment/treatment at the hospital. At four and eight months (T1, 
T2), participants’ outcome measures were collected via post. The last outcome 
measure point was at 12 months, which was collected through mail or face to face if 
the participants took part in the follow-up interview. At each of the follow-up time 
points, a questionnaire package including a copy of the SF36, BPI-sf, VAS and 
mCSRI was posted to patients with a reply paid envelope, with a follow up letter to 
remind them (Appendix 3.5).  
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As well as the measurements outlined in Sections 3.4.4 and 3.4.5, a treatment log 
for musculoskeletal practitioners to complete was put in the patient notes and 
collected by the researcher at the end of the study. Practitioners were asked to give 
their initials, ICD code of the patient, and a Likert scale rating their perception of 
the patients’ progresses (Appendix 3.6). Each practitioner was invited to complete a 
treatment log on participants’ progress each time they saw the participants.  
3.5.2 Qualitative data collection  
Three main categories of qualitative data collection: collected directly in the words 
of the participant (interview/focus group and tape recorded); collected once or 
throughout a process of change (reflective journals/field notes); and collected 
during the event(s) being studied (Anecdotal evidence and 
logs/observations/student log) (James et al., 2008). In this research study, 
qualitative data were collected at two time points; once before participants received 
their initial appointment at the RLHIM, using semi-structured, one-to-one, face to 
face interviews; and 12 months later, using either semi-structured, one-to-one 
interviews or focus groups.  
Both in-depth interviews with individual participants and groups of participants 
(focus groups) were utilised in this research study, to explore potential differences 
by using varied data collection techniques (James et al., 2008). Using a variety of 
types of qualitative data collection methods aligns well with the epistemological 
underpinning of pragmatism, using whichever approaches prove themselves to be 
useful (Ritchie and Spencer, 1994). Focus groups usually comprise a small group of 
8-12 participants, in which interaction and debate between participants is 
encouraged (Byers and Wilcox, 1991). It enables normalisation in understanding 
among a group of participants, provides an opportunity to share health experiences 
and information, and to explore similarities and differences between individuals 
(Bloor et al., 2001). Field notes were taken in both one-to-one interviews and focus 
groups. In one-to-one interviews, the research student took notes on phenomena 
which she felt may help further explain results, e.g.  “This participant has severe 
hand deformity due to RA and influenced questionnaire completion (cannot even 
sign)”; field notes were also taken of words that the research student was unfamiliar 
with, in order to secure accuracy and minimise the disadvantage of being a foreign 
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interviewer. All focus groups were facilitated with at least one of the research 
student’s supervisors (NR or AL) and notes were taken to capture interaction in 
each focus group. A reflective diary (Appendix 3.7) was kept through the whole 
process of the research study and was partially reported in qualitative results, to 
ensure the flexibility required in reviewing data and the methods used to collect 
them (Chapter 5). But the researcher was aware that reflexivity is essential in 
providing transparency and rigour in qualitative research, rather than ensuring 
strong evidence or direct methodology, and therefore should be interpreted with 
caution (Creswell and Clark, 2011). Details in the reflective diary may also inform 
future studies. Observational data from the field notes such as [laugh], [started 
crying] were recorded with ‘[]’ in the transcripts.  
All the interviews were conducted in a quiet room, in the same building as the 
RLHIM. It was planned that the follow-up interviews might take place at another 
location convenient for participants as it was anticipated that there would be 
participants who had already stopped attending RLHIM but would like to be 
interviewed. Some interviews were disrupted or took place not in the pre-set 
student room in the same building of the hospital. Five were interrupted with phone 
calls or texts; four were conducted with in a limited time due to being conducted 
immediately before their consultation at the RLHIM; three interviews were not 
conducted at RLHIM as a room was not available (two interviews were conducted 
in a café nearby, one in the park nearby). Though the study planned to interview 
only eligible participants in the study, three brought family members to the 
interview. One focus group [FG4] was conducted by the research student alone 
because although a pre-set time was sent to participants, no one confirmed their 
attendance. The research student still went along on the day just in case and 
conducted a focus group with two participants.  
3.6 Data Analysis 
As planned in this convergent mixed methods study, quantitative and qualitative 
data were analysed separately. This section firstly describes the quantitative data 
analysis methods (Section 3.6.1). Qualitative data were analysed using a framework 
analysis approach (Section 3.6.2). The timeline of this research study was planned 
to inform the development of a future study by providing data which could be used 
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to calculate the sample size for a future full pragmatic trial/observational study, 
with data being used to calculate the effect size.  
3.6.1 Quantitative data analysis 
Data collected from the three sources mentioned in Section 3.4.1 were entered 
directly to IBMⓇ Statistical Packages for Social SciencesⓇ Statistics (version 21, 
Armonk, NY, USA). Data on VAS were raw data extracted (in mm) directly from 
the initial completed questionnaires. Raw data from the sfBPI and SF36 were 
computed according to their scoring guidelines (Cleeland CS, 2009; Ware et al., 
1993).  
SfBPI can be assessed with two sub outcome variables – sfBPI pain severity and 
sfBPI pain interference. sfBPI pain severity is a mean score of worst, least, average, 
and pain right now in the 24 hours of the completion time; the sfBPI pain 
interference is a mean score of seven daily activities for which participants filled in 
scores (0-10): general activity, mood, walking ability, normal work (includes both 
work outside the home and housework), relations with other people, sleep, 
enjoyment of life (Turk and Melzack, 1991).  
The SF36 used in this research study is the second version of SF36 (SF-36v2TM, in 
this research study, it is shortened to SF36), which corrected deficiencies identified 
in the original version (Ware, 2000). Physical health and mental health are the two 
sub outcome variables of SF36. All 0-6 or 0-5 scale raw data from SF36 
questionnaires were transformed to a 0-100 scale (e.g. “1=0, 2=20, 3=40, 4=60, 
5=80, 6=100”), then regrouped under the eight sub dimensions: bodily pain (BP), 
physical function (PF), role limitations due to physical health (RLPH), general 
health (GH), role limitations due to emotional problems (RLEP), energy/fatigue 
(EF), emotional well-being (EWB), and social functioning (SF). An average score 
was computed for each dimension (Ware et al., 1993). These eight dimensions were 
grouped into physical health (BP, PF, RLPH, and GH) and mental health (RLEP, 
EF, EWB, SF). Before conducting any hypothesis tests to compare changes in 
physical health and mental health at different time points, separate files for baseline 
(T0a/b), 4 months (T1), 8 month (T2) and 12 months (T3) were set up, and then 
data from T0 were merged with T1, T2, and T3; and data at T1 were merged with 
T2 and T3, T2 with T3. Changes in the SF36 physical health and SF36 mental 
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health were calculated by the data in T0 subtracted from the data in T1, the data in 
T1 subtracted from the data in T2, and the data in T2 subtracted from the data in 
T3.  
Normality of the changes in the five outcome variables (VAS, sfBPI pain intensity, 
sfBPI pain interference, SF36 physical health, SF36 mental health) was assessed by 
screening histogram graphs with a normal curve displayed. Approximate normality 
is seen as a priority for running two sample repeated measures paired t test, 
repeated measures one way ANOVA and repeated measures mixed ANOVA. 
Details in analyses conducted and the assumptions assessed are available in 
Sections 3.6.1.1 and 3.6.1.2. Preliminary analyses, primary analyses and 
supplementary analyses were employed at a predetermined alpha level of 0.05. 
All statistical results are reported following the SAMPL Guidelines (Lang and 
Altmanb, 2013). Descriptive analyses were conducted on participants’ 
sociodemographic characteristics, lifestyle characteristics, their expectation scores 
for treatment at the RLHIM and CAM treatment in general; participants’ ICD 
codes; referrals and participants’ GPs’ location; treatment characteristics; and 
baseline on the three outcome measures (five outcome variables). Participants’ 
sociodemographic characteristics were grouped into larger groups depending on the 
data (results presented in 4.2.1). Descriptive statistics were summarised using 
means and standard deviations (SD) for continuous variables, and frequencies and 
percentages for categorical variables.  
3.6.1.1 Purpose, hypothesis, and the analyses 
Two main research questions posed by this observational design were: 
1). To assess whether participants’ outcomes changed at 4, 8, or 12 months follow-
up 
• H0: Means of VAS/sfBPI/SF36 are equal at 4, 8, and 12 months; 
• HA: Means of VAS/sfBPI/SF36 are significantly different at least 2 time points 
In order to answer this research question and to provide a robust test, repeated 
measures ANOVA test was conducted, comparing mean scores of the 5 outcome 
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variables at four time points, followed by repeated measures paired t test to 
compare the changes in the outcome variables comparing pairs of time points. 
2). To explore whether any confounding factors/predictors (e.g. sociodemographic, 
expectations etc.) are useful in explaining variability in the change of primary 
outcome measures 
• H0: There is no relationship between any factors/predictors and changes in 
primary outcome 
• HA: At least one factor/predictor could explain the changes in primary outcome 
In order to answer the second research question, multiple linear regression with 
stepwise selection process (forward selection method) was performed to look at 
possible predictors of changes in primary outcome measures at the time point when 
most changes occurred. Forward selection is one of the methods of stepwise 
selection method. It starts with no variables in the regression model, and adds in 
variables by selecting a predictor which has the highest simple correlation with the 
target outcome variable, and retains the significant predictor(s) until no predictor 
improves the model (Field, 2013).  However, there is a potential limitation of using 
stepwise selection method as it relies on the computer in selecting variables based 
upon mathematical criteria and assesses the fitness of a variable based on other 
variables in the model (Field, 2013).  
Rather than trying to develop a model, given the study design and limited sample 
size in this research study, multiple regression was used to explore possible 
predictors. A stepwise method was therefore used, as particularly useful when 
researchers do not have a clear idea which variable may be a predictor of the 
outcome variable. If any significant predictor(s) were identified, it/they were left 
out with the regression analysis rerun, in order to further explore the relationship 
between the predictor(s) and changes in primary outcome measures. 
3.6.1.2 Sensitivity analysis 
Sensitivity analysis was performed to determine potential differences in baseline 
sociodemographic and lifestyle characteristics, expectations, and baseline outcome 
measures between participants who were still receiving treatment at one year 
follow-up, and participants who were no longer receiving treatment (results will be 
presented in Section 4.5), utilising independent t test for continuous variables and 
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chi-square tests for categorical variables. 
3.6.1.3 Subgroup analysis  
Subgroup analysis was performed on baseline characteristics of participants at the 
two baselines, in order to explore whether there were differences in participants’ 
characteristics at the two baselines. Independent t tests were conducted for 
continuous variables and chi-square tests for categorical variables. 
Subgroup analyses were also performed to determine potential differences in 
changes in primary outcome measures at the time point where most changes 
occurred between participants receiving different lengths of treatment (less than 12 
months, equal or more than twelve month). Subgroup analysis was also performed 
on participants who received different complexity of integrative treatment (single or 
multiple modalities). Independent t tests were conducted for these subgroup 
analyses. 
3.6.1.4 Assumptions of using appropriate statistical analyses 
This section states the assumptions which need to meet before performing the five 
types of analyses stated previously in Sections 3.6.1.1-3.6.1.3, namely: 1). repeated 
measures ANOVA, 2) paired t test, 3). multiple regression, 4). independent t test, 
and 5) chi-square test. All assumptions were met otherwise explained when 
assumptions were violated.  
Five assumptions to meet for performing repeated measures ANOVA: 1). 
Participants’ expectations, VAS, sfBPI, SF36 variables are continuous data; 2). 
Four time points as the within-subject factors; 3). No significant outliers: In this 
study, outliers were identified using boxplot (Figure 3.4). A boxplot was used - 
values greater than 1.5 (less than 3) box-lengths from the edge of the box were seen 
as outliers and those 3 or more box-lengths from the edge of the box were seen as 
extreme outliers (Field, 2013). Only extreme outliers were noted in the report of 
analyses. In cases where there were outliers in the data, these were checked 
accuracy and included in the analysis because they were rare cases reflecting the 
real world condition of participants’ fluctuating pain and functional ability.  
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Figure 3 4 Example boxplot: No outliers identified in VAS at different time points  
 
4). Approximately normally distributed: normality of all above data were checked 
using histograms with normality curve. A bell-shaped curve indicates data meets 
‘assumption of normality’ (Figure 3.5).  According to the central limit theorem 
(CLT), normality is not crucial for a standard t test or z hypothesis test if the sample 
size is larger than or equal to 30, and ANOVA is suggested to be robust regardless 
of normality (Field, 2013). 
3 5 Example of histogram: approximately normally distributed in change in VAS at four month  
 
5). Sphericity: This was checked by screening the Mauchly's Test of 
Sphericity table. It has been suggested by many textbooks that if data has violated 
the assumption of one-way repeated measures ANOVA, Greenhouse & Geisser 
correction should be used (Field, 2013). But in this research study, Mauchly's Test 
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of Sphericity was not taken as a necessary premise of performing repeated 
measures as it is suggested it lacks statistical power especially when the sample size 
is small (violations may not be detected) and is a less robust test compared to 
ANOVA (Baguley, 2004).  
Four assumptions to meet for performing paired t test: 1). Continuous outcome 
variables, e.g. age, baseline outcome measure values; 2). Baseline data and post 
treatment data were seen as two related matched pairs; 3). No significant outliers; 
4) Approximately normally distributed in targeted outcome variables between the 
two groups. 
Six assumptions to meet for performing independent t test: 1): Outcome 
variables are continuous, e.g. baseline VAS, expectations etc; 2). Two groups of 
participants, e.g. participants on waiting list or not; 3). Independent observations in 
each group as they were not the same participants; 4). No significant outliers; 5). 
Outcome variables are approximately normally distributed; and 6). Homogeneity of 
variances. Equality of variance was checked using traditional Levene test. If the 
Levene test is statistically significant, the hypothesis of equality of variances will 
be rejected. 
Six assumptions to meet for performing multiple regression: 
1). Independence of errors (residuals): This was checked by Durbin-Watson test, a 
value close to 2 indicating that there is independence of errors (residuals); 2). A 
linear relationship between the predictor variables (and composite) and the 
dependent variable; 3). Checking homoscedasticity of residuals (equal error 
variances). The 2nd and 3rd assumption were checked by scatterplot, examples of 
linear relationship and an equally spread residuals are shown in scatter, which 
indicates a linear relationship and homoscedasticity (Figure 3.6). 
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Figure 3 6 Example scatterplots of relationship between participants’ age (left) / educational 
level (right) and change in VAS at four months 
 
4). No multicollinearity: No correlations larger than 0.7 were checked in correlation 
tables; all the tolerance values are greater than 0.1 (coefficients table); 5). No 
significant outliers or influential points: unusual data, outliers, high leverage points 
and highly influential points were checked. Checking outliers has been described 
previously. 
Whether leverage values were above the safe value of 0.2 was checked by 
screening the data column LEV. Cook's distance was checked by screening the data 
column of COO. 6). Errors (residuals) are normally distributed: same as described 
previously. 
Two assumptions to meet for performing chi-square test: 1). Target variables 
are nominal or dichotomous, e.g. gender, educational level etc.; and 2). There are 
two or more groups in each variable, e.g. female or male, secondary school or 
university degree or postgraduate. It is suggested that a maximum of 20% of counts 
should be less than 5 (Field, 2013). But it is anticipated that in the sensitivity 
analysis assessing difference between completers and participants who dropped out 
of the research study there may be low counts as the number of participants who 
dropped out may be small. This was seen as acceptable if all participant counts are 
1 or greater (Yates et al., 1999). 
3.6.1.5 Missing data 
There are several ways to address missing data. Last observation carried forward 
(LOCF) using repeat data from the last available time point is frequently used in 
pharmaceutical trials. However, it may elaborate the effect size (Field, 2013). 
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LOCF was felt to be inappropriate in this research study mainly due to the 
pragmatic nature of this research study and the complexity of length of treatment, 
e.g. participants may stop receiving treatment at very different time points. In order 
to present the real world data that suits the pragmatic exploratory nature of this 
study, casewise deletion was used to exclude all drop out patient data. 
Since casewise deletion assumes strict missing completely at random (MCAR) to 
be valid, comparisons of baseline characteristics between participants who 
completed the one year follow-up and those who withdrew from the research study 
were assessed. If there was no significant difference between the groups, casewise 
deletion was implemented. Though the data of participants who dropped out were 
not used in quantitative analysis, they were invited to participate in the second part 
qualitative study to avoid bias.  
3.6.1.6 Effect size 
Effect sizes, known as Cohen’s d, are defined as the mean change in primary 
outcome measures divided by the standard deviation the outcome measure in this 
study (Kazis et al., 1989). In this research study, effect size was calculated using 
the below equation: 
Cohen’s d = mean change in outcome measures / SD of change in outcome 
measures 
Effect sizes for significance were reported for all three outcome measures at four, 
eight, and twelve months. Effect size was defined as 0.20 for small, 0.50 for 
medium, and 0.80 for large effects (Cohen, 1988). 
3.6.1.7 Cost data analysis 
The plan was that cost data would be analysed and evaluated. Unit cost of health 
and social care would be checked with the following resources: PSSRU unit cost of 
health and social care 2012; NHS reference costs; hospital cost data; British 
National Formulary; Health span/Nutri centre; Department of Work and Pension 
Data.  
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Cost data were planned to be depicted using with bar chart presenting the above 
costs for at each time point over one year: direct CAM costs, direct conventional 
medicine costs, and indirect costs; MSDs related and non MSDs related costs; total 
cost, NHS costs; and single CAM, single conventional cost, and integrative 
treatment costs. These cost data would then be analysed depending on disease 
severity, and risk (high/low) of patients.  
However, there were insurmountable difficulties in obtaining unit costs, in 
particular to obtain the average market price and unit cost of the RLHIM treatment 
provided. In addition, obtaining the data were going to take longer than anticipated 
so has not been included in this thesis.   
3.6.2 Framework analysis approach for the qualitative study 
The qualitative analysis in this research study adopted a framework analysis 
approach, a relatively new method of qualitative data analysis, with a highly 
structured and systematic approach, and detailed practical guidance on how to 
perform analysis. It was initially developed in Britain for policy research by Ritchie 
and Spencer, and is now widely used in many areas of research (Ritchie and 
Spencer, 1994; Ritchie et al., 2003) and is gaining popularity among healthcare 
research (Smith and Firth, 2011). 
Framework analysis is a data analysis approach that does not align with a particular 
ontological or epistemological perspectives (Smith and Firth, 2011; Gale et al., 
2013; Ward et al., 2013). It is appropriate where there is existing theory and can be 
placed on an inductive-deductive continuum depending on the research question 
(Gale et al., 2013). In this research study, theoretical background of IM (following 
the MRC framework development stage) was explored by reviewing the IM 
literature; potential factors that may have an influence on IM were identified in that 
process, however, they were not adequate to understand the changes process. A 
purely inductive approach such as grounded theory was not seen as a potentially 
appropriate method. Considering the research topic and a lack of qualitative 
research experience of the research student, framework analysis with a step-by-step 
structure including a framework matrix output allowing systematic reduction of the 
data were adopted. Both pre-treatment interviews and follow-up interviews were 
analysed using framework analysis method. Framework analysis contains a five 
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stage process: data familiarisation, identifying a thematic framework, indexing, 
charting, mapping and interpreting (Ritchie and Spencer, 1994). Ritchie et al. 
identified an analytic hierarchy that is not included specifically in framework 
analysis, including data management phase (familiarisation; coding, identification 
of a thematic framework, inter-rater coding; indexing, charting); descriptive phase 
(mapping and descriptive analysis); explanatory phase (interpretation) and 
presentation phase (Ritchie et al., 2003). This analytic hierarchy was followed in 
the analysis. Details of data management, descriptive are presented in Section 
3.6.2.2.  
3.6.2.1 Computer-assisted qualitative data analysis software 
Before introducing the detailed steps in framework analysis used in this research 
study, the use of computer-assisted qualitative data analysis software (CAQDAS) is 
briefly discussed. CAQDAS is software for data administration and archiving, 
which can assist text retrieval, textbase management, coding and building code 
based theory etc (Ritchie and Lewis, 2013). It can be used to facilitate the 
organisation of large amounts of textual data, to make it more manageable, and to 
help facilitate teamwork on the same research, which could ultimately improve the 
rigour and consistency of the research (Weitzman, 2003).  
In this PhD research project, all qualitative data were stored and coded with 
frameworks developed (for the first three phases) using the qualitative data 
organising software Nvivo (version 10, QSR International, Melbourne, Australia). 
The built-in function specifically for framework analysis in Nvivo, NatCen 
framework matrix, was used in indexing, charting, mapping, descriptive analysis 
and interpretation steps to build a framework matrix for cross row interpretation 
and analysis, and to provide an explicit, clearly visible record of how categories, 
and themes arising from the original data. 
3.6.2.2 Detailed steps in framework analysis 
Transcription: All interviews were transcribed verbatim by the research student. 
Long pauses, interruptions, laughter and nodding were noted, with ‘um’s, ‘you 
know’ and repetitions included. Unclear data were recorded with “???”; basic 
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observational data such as laughs or cry and research student’s interpretation or 
notes were recorded using “[]”. A detailed reminder of these is available at the 
beginning of the qualitative results (Chapter 5 aim and structure). Notes such as the 
differences observed between interview and questionnaires were recorded 
immediately after each interview in memos. 
Familiarisation: All transcripts were checked at least twice by the research student 
listening to the audio records. All written transcripts were checked and read by her 
supervisors (NR & AL). Transcripts were printed out and read numerous times, 
with initial impressions written in the margins of transcripts. The researcher also 
highlighted potentially meaningful quotes. 
Coding: This step was used to provide a mechanism for labelling and managing 
data for subsequent retrieval and exploration (Ritchie and Spencer, 1994). In this 
step, some initial codes were entered into NVivo10 (QSR International, Pty Ltd, 
Melbourne, Australia) at first after getting familiar with the transcripts, followed by 
adding in new codes as they emerged. Transcripts were coded following a coding 
instruction: code sentences and words; notes and ideas while coding were recorded 
in memo in NVivo. In this research study, the first three steps (transcription, 
familiarisation, and part of coding) occurred during data collection process. 
Framework identification: The research student and her supervisors independently 
coded and categorised five transcripts (for both pre-treatment and follow-up 
interview data analysis) before meeting to discuss codes and constructing an initial 
framework. The researcher then re-evaluated the codes and grouped several codes 
together. All the codes were descriptively explained and grouped into different 
categories. The final framework was finalised by discussion with the supervisors 
until no new codes emerged. Changes made during updating and revising the 
framework were recorded and discussed in memos in NVivo (Appendix 3.7). This 
step was undertaken using NVivo10.  
Inter-rater coding: In order to ensure transparency, rigour, and to have a diversity of 
viewpoints, inter-rater reliability coding of three transcriptions was performed 
independently by the research student and her supervisors (Pope et al., 2006). Some 
codes were deleted or regrouped, or the description of codes changed by discussion 
on and consensus with supervisors. Regular meetings were held throughout data 
78 
Chapter 3 Methodology and Methods 
analysis, facilitating further exploration of participants’ responses, discussion of 
deviant cases, and agreement on recurring themes. Internal reliability was not 
assessed by providing alpha result as this was the first time the research student had 
worked on a qualitative project.  
Indexing: Indexing is the process of comprehensively labelling all the data using 
the final consensus framework by marking quotations which belong to a code 
(Ritchie and Spencer, 1994).  
Charting: Charting is the process of ‘scissors and paste’, with quotations firstly 
simplified and synthesised (Ritchie et al., 2003). As much as possible, participants’ 
own words were used during this step and the researcher only summarised the 
quotations without any interpretation. Nvivo was particularly useful in facilitating 
this step as target quotes can be easily found using the query function in Nvivo, and 
all quotations under a code can be exported to word from Nvivo. Since the 
researcher was not familiar with Nvivo when she analysed the pre-treatment 
interviews, the simplified quotations were then entered into Microsoft Office Excel 
(version 2010, Washington, D.C., USA), with one row per participant and one 
column per code with quotations and a spreadsheet for each theme. Page number 
and line number were noted in order to easily find the original quotations. 
Interesting quotations and important statements were marked by ‘*’, with ‘***’ 
indicates the most important and no mark for least important (Figure 3.7). With 
Nvivo, one can also re-code, un-code or combine codes during the charting with the 
whole project updated. For example, the code ‘MSDs symptoms’ was combined 
with code ‘history of MSDs’ because much fewer quotes were on their MSD 
history and symptoms is part of medical history. 
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 Figure 3 7 Example of charting using Microsoft excel 
Patients Expectations 
Concerns Expectation from CAM/IM treatment Expectations from practitioners 
 
[1506]: evidence available for 
acupuncture but not for homeopathic and 
herbal medicine; trials are needed.** 
[1526]: takes more than one hour to get 
to the hospital.  
 
[348/474]: hope to walk with pain free for longer period of 
time.  
[434]: believes that the practitioner will give her the most 
appropriate treatment or combination of treatments – ‘it is 
homeopathy, or diet, or acupuncture, or physio, or a bit of one 
two three things’, to suit her condition. * 
[502]: had tried all kinds of different medications for 15 years 
and nothing helped well so wants to try nature treatment [for 
RA] 
[539]: CAM and conventional treatment ‘all have a place’. 
*** 
[542]: would first try CAM, if not work, then try conventional 
treatment, to ‘start gentle’. *** 
[244]: believes skillful professional 
expertise helped, ‘on the whole, you 
rely very much on the practitioner, 
on his skill, or her skill’. *** 
N/A 
[444]: to have what suits best. 
[497]: hopes could help getting rid of medication. 
[518]: hopes to try something non-invasive [this is my 
impression]. 
[719]: feels that the acupuncture treatment he is having with 
his pain consultant [every two weeks] is not enough and is 






Made clear if no data 
available 
Level of interest 
Line number 
It was made clear if 
it was the 
researcher’s 
assumption 
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For the follow-up interview analysis, the NatCen framework matrix was used to 
generate the framework matrix automatically (Figure 3.8). Similarly, the 
automatically generated framework matrix contains case nodes (as rows) and theme 
nodes (as columns). By using the NatCen framework matrix, summarised and 
synthesised statements can be linked to the original quotations. Other advantages 
include easily browsing the framework matrix by exploring all participants’ 
perspectives (down a column) and exploring how different themes relate to each 
other for a particular participant (across a row) with direct participants’ quotations, 
field notes, observations, and memos by the researcher all systematically linked, 
which allowed conceptual thinking and insights to the data.  
For the follow-up focus group interviews, case nodes were created manually for each 
participant in the same interview, followed by coding each participant’ responses to 
their case node.   
81 
 Figure 3 8 Example of charting using NatCen framework matrix 
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Descriptive analysis: This is the process of defining elements and dimensions, refining 
categories and classifying data, which involves abstraction and interpretation (Ritchie et al., 
2003). The framework matrix was exported from Nvivo to Excel. The descriptive analysis 
was completed in Microsoft Excel with three columns for each code. The research student 
was aware that this process was highly influenced by her epistemological perspective as data 
were analysed interpretatively (discussed in Section 1.2). Details and examples are given in 
Figure 3.9. The contents in column A were original descriptive data that the research student 
summarised in the charting step; column B represents refined data that was close to the 
original descriptive data in column A but simplified; column C presented higher level of 
abstraction, with ‘labels’ assigned and categorisation performed. However, in some cases, the 
statements in column A were quite simplified, then only two columns (A&C) were available. 
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• [42]: felt ‘anxiety, depression, and 
isolation from social life, stress 
and tension’.* 
• [184]: bad relationship with 
husband because she ‘has to lie 
down’ and ‘not go social 
evenings’. 
• [721]: can’t sleep because of pain. 





• experienced emotional problems 
• relationship with husband was 
affected due to MSDs 
• poor sleep due to pain 
• not working due to MSDs 
Column C 
Categorisation 
• Emotional impact 
• Family and friend impact 
• Sleep disturbance 
• Work impact 
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Mapping: In this step, the framework matrix was extensively read to generate 
understanding of each patient and similarities among patients and the codes. This is 
the step where thematic or cognitive maps were made of linkages or constructions 
within the data and themes identified (Ritchie and Spencer, 1994). By selecting and 
displaying all codes in both rows and columns, Nvivo can help generate a cross table 
matrix with a number given for each two codes (Figure 3.10). This number can be 
selected to reflect the number of participants/codes/word etc. coded under two codes. 
So the ‘stand out combinations’ can be given more attention. For example, 
relationship or interaction between code ‘1.5 patient understanding of MSDs’ and 
code ‘6.5 experience of integration’, were found to require further exploration in the 
present study. This function is very helpful in mapping the interaction between two 
codes (especially under two different categories).  
Figure 3 10 Example of framework matrix built with Nvivo (cell content: number of participants) 
 
Interpretation: The interpretation step includes thoroughly reading through the 
synthesised and categorised data, following leads as they are discovered, exploring 
the patterns, going backwards and forwards between the data, and developing 
emergent explanations (Ritchie and Spencer, 1994). At this stage, there are various 
different ways to further understanding of what is causing or influencing the 
phenomena to occur: for example, a chart with where the most interaction happened 
between codes was generated; context around certain target words were identified, 
and visualisation of words that were most frequently used was provided (Figure 
3.11). Text and word frequency were used to search different themes for each 
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participant; searches were re-run when new words were found and applicable to a 
theme (QSR International, 2015). These functions were all essential and assisted in 
providing conceptual understanding in the mapping step. 
Figure 3 11Nvivo word cloud for most recent 50 words (longer than four characters in 
transcripts) 
 
N.B. certain words were removed from the figure: participants’ ID, adverb such as 
‘also’, ‘maybe’, ‘just’; ‘much’; and ‘uhmm’, ‘much’. 
Presenting: In order to provide a whole picture of the sample, the research student 
tried to include at least one quote from each participant if possible. Rare cases were 
reported. Omissions from quotes were recorded with “…”. In some cases, notes were 
made when themes were merged depending on the research student’s interpretation. 
3.6.3 Feasibility frameworks used in interpretation of findings 
Three frameworks for feasibility studies were used in the interpretation of the 
triangulated findings (quantitative and qualitative). In terms of assessing feasibility, 
the primary framework used was Bowen’s feasibility framework (Bowen et al., 
2009). Final triangulated findings are presented in four aspects of Bowen’s 
feasibility framework (Shanyinde et al., 2011; Bowen et al., 2009; O'Cathain et al., 
2015). Bowen’s feasibility framework was adopted as it guides design, evaluation, 
and interpretation and prioritizes interventions which are deemed feasible and likely 
to be efficacious (Bowen et al., 2009); and is commonly adopted and followed to 
report feasibility of carrying out various studies (Hagen et al., 2011; Parker et al., 
2013; Peddle-McIntyre et al., 2012; Kamioka et al., 2011).  
Apart from the Bowen’s feasibility framework, another two feasibility frameworks 
were adopted in reporting quantitative and qualitative research in feasibility (Table 
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3.4). Firstly, 12 of the 14 methodological dimensions of Shanyide et al’s framework 
are reported, with the aim of ensuring rigor of reporting quantitative feasibility 
research; two items (randomisation procedure and blinding procedure) were 
excluded as they did not fit with the observational study design) (Shanyinde et al., 
2011).  In addition, 19 qualitative dimensions of O’Cathain’s framework were also 
used, to ensure credibility of reporting qualitative feasibility research (O'Cathain et 
al., 2015). This combination of the three frameworks was used to cover the research 
objectives. 
The four overarching aspects of feasibility (adapted from Bowen’s framework) are: 
1). Limited outcome testing 
The limited outcome testing aspect (findings presented in Section 6.1) is used to 
determine whether the study has achieved its objective “to evaluate ‘real world’ 
clinical outcomes associated with integrative treatment for MSDs”. It provides a 
general idea of what patients have received at the RLHIM, and potential changes in 
outcome. 
2). Patients’ acceptability in integrative treatments for MSDs 
The issue of patients’ acceptability of treatment provided (findings presented in 
Section 6.2) is used to frame findings that answer the research objective ‘to explore 
patients’ experiences of receiving integrative treatments for MSDs’. Patients’ 
decision making process to seek CAM treatment and access CAM through the 
RLHIM, their referral pathway, and their acceptability of the integrative treatments 
for MSDs provided at the RLHIM during the 12 months follow up, are presented.  
3). Patients’ demands for integrative treatments for MSDs 
The issue of patient demands for the treatment (findings presented in Section 6.3) 
also answers the research objective ‘to explore patients’ experiences of receiving 
integrative treatments for MSDs’. In addition, it frames the findings on another 
research objective ‘to explore patients’ expectations of receiving integrative 
treatments for MSDs’. In this section, patients’ MSD characteristics and their 
previous experiences are presented and linked to their expectation, as well as 
participants’ perception of the demand for the treatments they were receiving.  
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4). Feasibility of study design 
In this section (findings presented in Section 6.4), the research objectives ‘to 
determine whether comprehensive and multilevel evaluations for IM in MSDs are 
justified’, and ‘to determine patients’ expectations and experiences in participating in 
the research study’ are answered. The feasibility of a number of specific 
methodological dimensions was explored, including: participant eligibility, research 
recruitment and retention, participants’ characteristics, patients’ acceptability in 
research procedures, ethical conduct, logistics of multicentre research, workability of 
the pre-set protocol, impact of research, patient involvement, and outcome measures. 
These provided detailed information on methodological issues in conducting the 
mixed methods feasibility study.  
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 Table 3 5 Combination of the three feasibility frameworks 





















1. Intervention development*** 
To what extent does the planned intervention need to be refined or adapted to make it more acceptable to users or more relevant or useful to the specific context in which it is delivered? 
2. Intervention received  
3. Cost and duration of intervention** 
Was it possible to calculate intervention costs and duration? 
Outcome 4. Sample size calculation** 
Did the feasibility/pilot study allow a sample size calculation 
for the main trial? 
Breadth of outcomes***  













Decision 1. Decision to seek RLHIM treatment  
Referral 2. Acceptability of referral pathway 
Intervention 3. Adherence to intervention** 
Did participants adhere to the intervention? 
4. Acceptability of intervention** 
Was the intervention acceptable to the participants?  
Perceived value, benefits, harms or unintended consequences of the intervention*** 
What value do service providers and intervention users place on the intervention and the outcomes it plans to deliver? What benefits and 
harms do they feel they have experienced from the intervention so that these can be measured in the full trial? 
Acceptability of intervention in principle*** 
Are service users or health care providers unhappy with any aspect of the content or delivery of the intervention? 
Feasibility and acceptability of intervention in practice*** 
What are service users or health care providers’ views of the implementation of the intervention? Has implementation varied by setting? 























Previous MSDs or healthcare experiences 
Expectations and hopes 
Imbalance in supply and demand Dose of intervention*** 




















































What factors influenced eligibility and what proportion of those approached were eligible? 
2. Recruitment** 
Was recruitment successful? 
Recruitment*** 
How do the planned recruitment practices work in the field? Do recruitment practices need to be improved to increase recruitment rates 
and levels of informed consent? If so, how? Are the trial participants willing to be randomised? Are clinicians willing to recruit patients, 
or are they uncomfortable?  
3. Retention** 
Was retention to the study good?  
Retention*** 
Are there ways in which trial procedures could be improved to increase retention rates? 
4. Participants’ characteristics Diversity of participants*** 
Are the planned recruitment practices likely to result in recruitment of the desired range of participants for the trial? If not, how might 
recruitment practices be improved? 
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5. Impact of research Trial participation*** 
How is the planned trial communication implemented by recruiters and received by participants? How can trial communication be 
improved to ensure recruiters understand patients’ views about participating in the trial? 
Acceptability of the research study in practice***  
Is the trial design acceptable to patients, recruiters and service providers in practice, or are there ways in which participants try to alter 
the procedures? 
Acceptability of the research study in principle*** 
Is the trial design acceptable to patients, recruiters and service providers in principle? 
6. Consent** 
Did eligible participants consent? 
Ethical conduct*** 
Are the informed consent procedures appropriate and acceptable to likely trial participants? 
7. Logistics of multicenter** 
Were the logistics of running a multicenter trial assessed? 
8. All components of the protocol work together** 
Did all components of the protocol work together?  
Fidelity and reach of intervention*** 
Do those delivering the intervention and/or receiving it adhere to the planned intervention? If not, what are the reasons for this? What 
are the limits of acceptable tailoring of the intervention? 
Adaptation of research study conduct to local context*** 
Will the planned trial procedures allow the trial to operate effectively in the proposed context? Do any changes need to be made to these 
procedures? 
9. Impact of research Impact of trial on staff, researchers, participants and the health system***  
Does this trial have any unanticipated negative impacts on recruiters, participants, other stakeholders and the health system? How can 
these impacts be minimised (e.g. workload involved in recruitment, numbers of measures undertaken)? 
10. Patient and public involvement*** 








11. Selection of most appropriate outcomes** 
Were outcomes measured those that were the most appropriate 
outcomes? 
Selection of outcomes*** 
Are outcomes important to service users selected for measurement in the full trial—both primary and secondary? 
12. Outcome assessment** 
Were outcome assessments completed? 
Accuracy of measures*** 
Are the process and outcome measures valid for this participant group? 
Completion of measures***  
Can completion rates of measures be improved? 
Development of measures***  
If validated measures do not exist for all the outcomes to be measured in the full trial, can they be developed in preparation for the trial? 
*indicates the four general areas in feasibility (Bowen et al., 2009); ** indicates methodological items suggested for reporting quantitative feasibility study (Shanyinde et al., 2011); *** indicated dimensions suggested for reporting 
qualitative feasibility study (O'Cathain et al., 2015). 
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3.7 Interpreting and reporting mixed methods results 
As discussed in Section 3.1.1, quantitative and qualitative data were collected and 
analysed separately and concurrently, until the interpretation stage, when the 
quantitative and qualitative designs interacted (Pluye et al., 2009). Both strands 
answered research questions that focused on three concepts: expectation, outcome 
(experience/effects), and feasibility. There were unequal sample sizes in the two 
strands (patients who participated in the pre-treatment and follow-up interviews are a 
subset of approximately half the sample size of patients who participated in the 
observational study). Results from each strand were merged and interpreted. This 
section explains the decisions on how to merge the results of the two strands. The 
final results of this MMR are presented in Chapter 6. 
Interpretation and triangulation of quantitative and qualitative results used side-by-
side comparison in a summary table, with evidence provided for each dimension. 
The overall feasibility of this research study was reported in terms of limited 
outcome testing, acceptability and demand for the intervention, and the feasibility of 
the study design, four aspects which follow Bowen’s feasibility framework (Bowen 
et al., 2009).  
In addition, the following questions were also explored: to what extent do the 
quantitative and qualitative results converge; are the qualitative findings related to 
the quantitative results; to what extent do the qualitative process findings enhance 
the understanding of the experimental outcomes; and in what ways do the qualitative 
themes and the quantitative results converge and diverge to suggest change. These 
will be presented in Chapter 6. In contradictory cases, results from both strands were 
reported and summarised with equal priority.  
Merging the two strands allowed an in-depth qualitative exploration and a rigorous 
quantitative examination of the integrative treatment provided for MSDs at the 
RLHIM, with quantitative analysis enabling generalisations to a population and 
qualitative analysis seeking in-depth understanding from a few participants. 
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3.8 Ethical Considerations  
Patient involvement is recommended to inform good practice and allows patients to 
be actively involved in organising or facilitating research (Gooberman-Hill et al., 
2013). In this research study, a patient representative (RP) contributed to study 
design, which included giving ideas on when/how to contact patients, and giving 
suggestions on acceptability and the design of questionnaires. This was taken as 
‘participating’, which is ranked comparably high in the involvement ladder (Burston 
et al., 2014). RP also contributed to agenda setting, development of patient 
information and consent procedures, and identification of outcomes (Gooberman-
Hill et al., 2013). 
Ethical approval was sought from NHS ethics. The research team applied for a 
“proportionate review” at the beginning as the research study was going to evaluate a 
package of existing integrative treatments for MSDs already given at the RLHIM 
(NHS Health Research Authority, 2014), but this was refused. A full review 
application was then carried out, in which the research team was asked to add the 
word ‘feasibility’ or ‘pilot’ given that the study was perceived as being fairly unique 
for research in an NHS hospital and that no pilot data were available to guide the 
research study.  
Ethical approval for the study was obtained from City and East London Research 
Ethics Committee on 24th Oct 2013 [REC reference number: 12/LO/1341]; UCLH 
R&D on 8th Jan 2013 [reference number: 12/0472]; LSBU ethical approval on 21st 
Jan 2013 [UREC 1280]. Anonymous data were held securely and transferred only 
between the research team members. 
Two substantial amendments were submitted to the ethics committee, based on 
changes to the study protocol to improve recruitment. They were approved on 7th 
May 2013. The annual reports to the ethics committee were submitted each year 
after receiving ethical approval and were approved. Challenges in ethical application 
are presented in Section 7.3.6. 
The principles of confidentiality, privacy and safety were preserved. Patients 
volunteered to participate in the study and no coercion took place. At the research 
student’s first point of contact with patients, detailed verbal and written information 
was provided and they had the opportunity to ask questions. They were given at least 
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24 hours to consider participating in the study. They were also encouraged to talk 
about the study to independent parties, (e.g. their GPs or friends/family) and if they 
agreed to participate they signed a consent form. Patients who consented to take part 
in the observational study were also asked to indicate their willingness to take part in 
qualitative interviews/focus groups, but could just take part in the observational 
study if they preferred not to participate in the interviews/focus groups.   
All participants were sent an information sheet (Appendix 3.1) within one week of 
recruitment. They were asked to complete three copies of a consent form (Appendix 
3.2), countersigned by the research student (one copy for the research file, one copy 
for the patient, and one copy to leave in their medical notes). Patients who withdrew 
from the study or withdrew from the treatment were also invited to the follow-up 
interview. This enabled both positive and negative experiences of treatment to be 
captured. Those who returned the consent form and indicated willingness to take part 
in an interview or focus group were contacted by the research student. The research 
student verbally provided aims and procedures of interview, and the rights of 
participants again.  
Participants were informed that if they observed any serious adverse effect from 
their hospital treatment, they could immediately withdraw from the study. However, 
no major adverse events were reported from the participants. While risks are 
minimal (if any), patients can be benefit from a better management of their 
condition, they could also benefit from the higher level of attention they would 
receive as being part of the study. For the participants who withdrew from the study, 
data already collected with consent were retained and used in the study, with no 
future data collected nor any research procedures carried out on or in relation to the 
patient.  
Potential benefit of participating in this research study include: Patients may benefit 
from a better integrated management of their musculoskeletal disorder if the 
particular packages of routine NHS treatment they receive at the RLHIM are proved 
effective. Attention to the patient's condition may also help indirectly in helping 
patients to cope better with their conditions. Participants who were interviewed may 
also benefit from discussing their expectations and/of experiences of receiving 
treatment.  
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The research student had access to participants’ personal addresses, phone numbers 
to post questionnaires, remind participants, and to arrange qualitative interviews. The 
research student could also get access to their clinical data if necessary, e.g. in the 
case of any major adverse events; or when collecting data on what treatments were 
given.  Study questionnaires only contained the patient’s unique code number. For 
those who were interviewed, participants’ details were omitted from the transcript. 
Direct quotations from respondents were anonymised so that they were not be 
identifiable and only anonymised data were transferred between the research team. 
All participants’ personal data and their consent forms were stored in locked filling 
cabinets in the research student’s office within the University and could only be 
accessed by the research student and will be shredded on university premises 5 years 
after the completion of the study. The digital audio tape recording of patient 
interviews and focus groups were destroyed once the study was completed.  
3.9 Chapter Conclusion 
This chapter provides details of the methodology and methods, which is situated 
under the research student’s pragmatic epistemological stance and the MRC 
framework of developing complex intervention. It should help readers to understand 
the study procedure and how the research student conducted each step. This also 
allows readers to assess the quality of this research study. 
Due to a lack of previous research evaluating integrative treatment for MSDs in a 
secondary care in the UK and the complexity of IM care, a feasibility study was 
designed following the MRC framework. Mixed methods and a pragmatic 
observational quantitative approach and interviews were used in order to understand 
the phenomenon of the integrative treatments and patients’ perceptions.  
Newly referred MSDs patients at the RLHIM were recruited for a period of 15 
months and each consented participant was followed up for 12 months. PROMs 
including VAS, sfBPI, and SF36 were assessed at four, eight, and 12 month post 
initial treatment appointment. Pre-treatment interviews and follow-up interviews and 
focus groups were carried out prior to participants’ initial appointment and 12 
months after the initial appointment respectively. Data collection and data analysis 
was conducted independently, with quantitative outcome measures targeted at 
evaluating the research process and the feasibility of assessing effectiveness; and 
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qualitative questions targeted at exploring participants’ expectations and experiences 
of receiving treatment at the RLHIM. Quantitative and qualitative data were 
collected and analysed separately, with the main changes in PROMs assessed by 
repeated measures ANOVA, and interview data analysed using framework analysis. 
Mixed methods findings are reported with findings from both strands triangulated in 
the interpretation stage under the guide of three feasibility frameworks. Full NHS 
ethical approval was obtained with two minor revision made to improve recruitment.  
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Chapter 4 Quantitative Results
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Aims and Structure 
This chapter answers the research question on the feasibility of researching IM for 
MSDs using the quantitative findings. It reports on recruitment and retention to the 
study and the analysis of data collected from the 60 MSDs participants who 
consented to take part during the 27 month period (Jan 2013 – April 2015). 
Quantitative results are triangulated and interpreted with qualitative data in Chapter 
6.  
This chapter details the recruitment, response and completion rates of participants 
(Section 4.1), followed by a description of participants’ baseline characteristics 
(sociodemographics and their MSDs) (Section 4.2). Other baseline characteristics 
including referral characteristics and participants’ GPs’ locations, and the 
characteristics of the integrative treatment received are provided in Section 4.3 and 
4.4. In Section 4.5 and Section 4.6, changes in participants’ expectations and pre-
specified outcome measures are given, followed by predictors of responses (Section 
4.7), sensitivity analysis (Section 4.8), and further subgroup analysis (Section 4.9). 
At the end of this chapter, a summary of the quantitative results are given. 
Results on costs are not reported in this thesis for reasons given in Section 7.5.5.  
The two sets of baseline characteristics for interviewed participants are reported 
separately in Section 5.1. The statistical reporting in this chapter follows the SAMPL 
Guidelines (Lang and Altmanb, 2013), in combination with the strengthening the 
reporting of observational studies in epidemiology (STROBE for reporting the 
observational study results (von Elm et al., 2014). 
4.1 Response and study completion rates  
Figure 4.1 shows the overall flow of participants through the study. During the 
recruitment period (Jan 2013 – April 2014), a total of 181 eligible patients identified 
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by a hospital musculoskeletal physician using the inclusion criteria (Section 3.2.2) 
were contacted by the research student (first screening). Several issues were 
challenging in identifying and recruiting eligible patients. The reasons for these 
issues are presented as a limitation to the feasibility of the study (Section 6.4) and are 
discussed in depth in Chapter 7 (Section 7.5). Twenty of the 181 patients were 
excluded at the second screening as they did not fit the inclusion criteria. Of the 
remaining patients, 101 refused to participate, the most common reason being having 
no time or no interest (n=49), three patients stated that they had no faith in CAM and 
were referred to the hospital for conventional interventions (see Figure 4.1). A final 
total of sixty patients (37%) were included in this research study. The results of the 
analysis in this chapter are based on these 60 participants.  
All 60 participants completed the first baseline questionnaires. Of these, seven had 
previously had treatment at the RLHIM but had now been referred for a new episode 
of MSD treatment. Eighteen of the participants (30%) were on a waiting list, 16 of 
whom completed second baseline measurements prior to their treatment. Some 
inevitable issues specific to hospital arrangements restricted the recruitment, for 
example, nine participants’ initial appointments were cancelled or changed. During 
the study, six participants were lost to follow-up at T1 (four months, n=54), four 
additional participants at T2 (eight months, n=50), and three additional at T3 (12 
months, n=47), leading to a completion rate of 78% at 12 months follow-up (Figure 
4.1). Table 4.1 showed a detailed information on questionnaire completion and those 
who were interviewed and drop outs into the study. 
All participants completed the VAS, SF36, and sfBPI over the 12 months follow up, 
but the completion of the mCSRI was 85% (46 participants/54) at four months, 74% 
(37/50) at eight months, and 77% (36/47) at 12 months. Completion of treatment log 
was poor, with only 22 (37%) logs (count as one if the log for one patient was filled 
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only once) filled in and none of these reflected all the treatments patients received 
etc in the 12 months’ follow-up period.   
Table 4 1 Study participants’ (n=60) basic information and questionnaire completion during the 
12 months’ period and their attendance in pre-and-follow-up interviews 
ID Age Gender 
QUAN QUAL 







1 41 F √ √ √ √ x x x 
2 85 F √ √ √ √ √ x x 
3 57 F √ √ √ √ √ x x 
4 25 F √ √ √ √ √ x x 
5 74 F √ √ √ √ √ √ x 
6 52 M √ √ √ √ √ x √ 
7 31 M √ √ √ √ √ x √ 
8 50 M √ √ √ √ √ x x 
9 67 M √ √ √ √ √ √ x 
10* 46 F √ √ √ √ √ √ √ 
11 55 M √ √ √ x √ x x 
12 38 M √ √ √ √ √ √ x 
13 36 F √ √ √ √ √ √ x 
14 78 F √ √ √ √ x x √ 
15 50 F √ √ √ √ √ x √ 
16 38 F √ x x x x x x 
17 63 F √ √ √ √ x x x 
18 70 F √ √ √ √ x x x 
19 37 F √ √ √ √ √ x x 
20 60 F √ √ √ √ √ √ x 
21 44 F √ √ √ √ √ √ x 
22 47 F √ √ √ √ x √ x 
23 53 F √ √ x x √ x x 
24 67 F √ √ √ √ x x x 
25 52 F √ √ √ √ x x x 
26 48 M √ √ √ √ √ √ x 
27 57 F √ √ √ √ √ x √ 
28 55 M √ x x x x x √ 
29 45 F √ x x x x x x 
30 30 F √ √ √ x x x x 
31* 69 F √ √ √ √ √ √ √ 
32 45 F √ √ x x √ x x 
33 64 F √ √ √ √ √ x x 
34 58 F √ x x x x √ x 
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ID Age Gender 
QUAN QUAL 







35 45 M √ √ √ √ x x √ 
36 45 F √ √ √ √ √ x x 
37 48 M √ x x x x x x 
38 29 F √ √ √ √ √ x x 
39 27 M √ √ √ √ √ x x 
40 32 F √ √ √ √ √ √ x 
41* 51 F √ √ √ √ x √ √ 
42 59 F √ √ √ √ x x x 
43 52 M √ √ x √ √ x x 
44 45 M √ √ √ √ x √ x 
45 32 M √ √ √ √ x x x 
46 63 F √ x √ √ √ x √ 
47 77 F √ √ √ √ √ x √ 
48 66 F √ √ √ √ x √ x 
49 62 F √ √ √ √ x x x 
50 38 F √ √ √ √ x x x 
51 69 F √ √ √ √ x √ x 
52 41 F √ √ √ √ x x x 
53 61 F √ √ √ √ x x x 
54 62 F √ √ x x √ x √ 
55 43 F √ √ √ √ x √ x 
56 45 F √ √ √ √ x x x 
57 67 F √ √ x x x x x 
58 55 M √ x x x x x √ 
59 65 F √ √ √ x x x x 
60 60 M √ √ √ √ x x x 
** 52 F:73% 60 53 49 47 30 28 
Key: F: female, M: male 
*Participants who were interviewed in both one-to-one interview and focus group at 
follow-up 
** Mean/percentage/counts  
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Figure 4 1 Flowchart of study recruitment and follow up assessment 
 
  
Baseline (T0) Initial Appointment Day (n=60) 
*
T0a – Started treatment right away (n=42);  
T0b – were on a waiting list before started treatment (n=18) 
T
reatm





Four Month (T1) Assessment (n=54) 
Eight Month (T2) Assessment (n=50) 
Twelve Month (T3) Assessment (n=47) 
New MSD patients identified by a musculoskeletal clinician  
(n=181) 
Exclusion (n=20) 
Already started treatment (n=11) 
Not MSD, e.g. headache (n=9) 
Refused (n=101) 
No time/no interest (n=49) 
No reason given (n=19) 
No response (n=16)  
Issue specific to RLHIM (n=9) 
Acute condition (n=5) 
No faith in CAM (n=3) 
Dropped-out (n=6) 
No time/no interest (n=4) 
No response (n=2) 
Dropped-out (n=4) 
No time (n=1) 
No response (n=3) 
Dropped-out (n=3) 
 
MSD=musculoskeletal disorders;  
Δ Questionnaires include the SF-36TM health survey, short form brief pain 
inventory, visual analogue scale, and modified client service receipt inventory 
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4.2 Baseline characteristics of the participants 
4.2.1 Sociodemographics and lifestyle characteristics 
All participants’ sociodemographic characteristics were collected from the initial 
questionnaire, with no missing data (n=60, Table 4.2). Participants’ education level 
was grouped into two categories: college education and above, and below college 
education level; occupational status was grouped into retired, not working due to ill 
health, employed (full time), employed (part time) and other; Occupational groups 
professional/technical/skilled manual and unskilled or not applicable. 
Most of the participants were female (n=44, 73%), had an average age of 52, were 
married or living with partner (n=28, 47%), and the more common education level 
was college/ diploma level or above (n=49, 82%). One quarter of the participants 
were retired, with most (n=47, 78%) participants’ occupational group coded as 
professional/technical/skilled. Most of the participants (n=46, 77%) were native 
English speakers, the majority were white British (n=40, 67%), and the most 
common stated religious affiliation was Christian (n=27, 45%).  
Data on smoking and alcohol consumption were also recorded at baseline with no 
missing data (n=60). Most participants were non-smokers (n=46, 77%) and did not 
drink alcohol (n=41, 68%). For those who did, the average weekly number of 
cigarettes was 53.36±11.434 (n=14) and the average units of alcohol consumed was 
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Table 4 2 Participants’ sociodemographic characteristics 
Sociodemographic Characteristics, n=60 Number (Percentage) 
Age (yrs), mean (SD) 52.1 (13.798) 
Female 44 (73%) 
Marital Status Married or Living with partner 28 (47%) 
Single/Divorced/Separated/Widowed 32 (53%) 
Educational 
Level 
College/Diploma and above 39 (65%) 
Below college level 21 (35%) 
Occupational 
Status 
Not Working/Employed Part-time 
Due To Ill Health/Retired 
41 (68%) 
Employed (Full-Time) or other 19 (32%) 
Occupational 
Group 
Professional/technical/skilled 47 (78%) 
Unskilled or not applicable  13 (22%) 
Mother Tongue, English as First Language 46 (77%) 
Ethnic Origin White British or White other 47 (78%) 
Others 13 (22%) 
Religious 
Affiliation 
Christian 27 (45%) 
No Beliefs/Prefer Not to Say/Others 33 (55%) 
SD=Standard Deviation, yrs=years 
4.2.2 MSDs characteristics 
Participants’ MSD characteristics were evaluated using ICD codes and the location 
of pain were documented using the sfBPI. Though it was intended to collect both 
participants’ primary and secondary ICD codes, the primary ICD codes of only 42 
participants (70%) were available; no secondary ICD codes were available. Among 
the 42 available primary ICD codes, 37 (88%) of participants’ primary ICD code was 
diseases of musculoskeletal system and connective tissues (M00-M99), with the 
most common codes being M54 (dorsalgia; n=13, 22%) and M79 (Other and 
unspecified soft tissue disorders, not elsewhere classified; n=13, 22%). 
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Participants were required to put one ‘x’ on a body figure to show the location of the 
most painful area. However, 21 participants (35%) put ‘x’ in more than three places; 
these participants were categorised as ‘complex’. This was the most commonly 
reported location of pain, followed by LBP (N=15, 25%), and knee pain (n=7, 12%). 
Figure 4.3 shows the locations of the most painful area reported by the participants.  
Figure 4 2 Locations of the most painful area as shown in sfBPI        
 
Key: Complex: pain in more than three places on the body figure; Back-C: Cervical region back 
pain; Back-T: Thoracic region back pain; Back-L: Lumbar region back pain 
4.3 Referrals and participants’ GPs’ location 
In this section, data on participants’ referrals collected from the hospital CDR system 
is reported. Just over a third of the participants’ initial appointments were cancelled 
or changed (n=21, 35%). Eighteen (30%) did not start their treatment immediately 
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after their first appointment at the RLHIM. The mean length of time between 
participants receiving their referral letter and their initial appointment (n=60) and the 
length of time they were on a waiting list (n=18) are reported (Table 4.3). Figure 4.3 
shows participants’ GPs’ practice location. The inner circle represents the broad line 
of greater London.  
Table 4 3  Referral, appointment and waiting time 
Referral Characteristics (n=60) No. (%) 
Cancelled/changed appointments, No. (%) 21 (35%) 
Waiting list, No (%) 18 (30%) 
Time interval between referral & 1st appointment, days Mean (SD): 44.0 (24.9) 
Time on waiting list, mean (SD), days 9.63 (16.79) 
GPs’ Location 
North East London 22 (37%) 
Non-North East London 16 (27%) 
Outside greater London 22 (37%) 
SD=Standard Deviation 
Figure 4 3 Sixty participants GPs’ location on map of South East England 
 
The inner circle depicts greater London  
4.4 Integrative treatments for MSDs at the RLHIM 
This section reports the characteristics of integrative treatments for MSDs the 60 
participants received during the period January 2014 to April 2015. Participants 
received complex integrative treatment with various packages of treatment or single 
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treatments of different lengths, frequencies, and types. These data were converted to 
length (days) of treatment and was categorised into four categories: finished 
treatment within 4 months; stopped treatment between 4-8 months; stopped 
treatment between 8-12 months; and still continuing treatment at 12 month follow 
up. All 60 participants received a musculoskeletal clinical assessment within their 
initial appointment and a musculoskeletal review before being discharged. Type of 
treatment received was grouped into those receiving a single CAM treatment, or 
those receiving multiple CAM treatments, and analysed using SPSS.  
Most participants received one modality plus assessment (n=32, 53%): most 
commonly received were acupuncture (n=18, 51%) and homeopathy (n=12, 34%). 
Ten (17%) participants received two modalities plus assessment; thirteen (22%) 
received three modalities plus assessment; two (3%) received four modalities plus 
assessment. In three cases (5%), participants only received an assessment without 
any intervention. Figure 4.4 shows the various types of integrative treatments 
participants received.  
The highest number of appointments/sessions of treatments (plus assessment) was 37 
sessions during the year, while the lowest, apart from the three cases who only 
received assessment, was 2 sessions (median: 11.5 sessions).  Overall, acupuncture 
(n=33), homeopathy (n=31), and physiotherapy (n=12) were the three most 
commonly received treatments at RLHIM for the participants during the follow-up 
period, followed by dietetics (n=5), hypnosis/CBT (n=5), occupational therapy 
(n=2), musculoskeletal manipulation (n=1), insomnia clinic (n=1), podiatry (n=1), 
weight loss clinic (n=1), autogenic training (n=1), massage (n=1), osteopathy (n=1), 
and mindfulness training (n=1). The complexity of the treatments participants’ 
received and frequency of treatment are given in Appendix 4.1.  
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As the most commonly provided intervention at the hospital during the study period, 
acupuncture at RLHIM may be provided in the high volume acupuncture clinic 
(group acupuncture), or as individual sessions of acupuncture, electroacupuncture, 
dry needling, TCM acupuncture, and trigger point therapy, dependent on participant 
individuals’ needs. The acupuncture treatment is provided by doctors, nurses, or 
physiotherapists and it normally lasts 15-30 minutes. Choice of points may vary and 
change depending on the progress of patients’ conditions. 
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 Figure 4 4 Types of integrative treatments received by individual participants for MSDs at the RLHIM over 12 months   
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4.5 Sensitivity Analysis 
In order to explore the robustness of the results and to understand the relationships 
between dependent and outcome variables, several sensitivity analyses were 
performed to determine potential differences between participants who completed 
questionnaires at all four time points (n=47), and the ones who did not (n=13). Table 
4.4 shows that there was no significant difference between the baseline 
characteristics for the completers and non-completers, which suggests there was no 
particular reason that the thirteen participants dropped out during the one-year 
follow-up related to these baseline characteristics. Therefore, casewise deletion was 
adopted, with subsequent results presented only for the completers (n=47). There 
was no missing data in VAS, sfBPI, or SF36 at all-time points.  
Table 4 4 Comparison of baseline characteristics of participants who did or did not complete 
outcome measures for all four time points 





Age 52.13 (14.656) 52.00 (10.614) 0.977 
Female 74.5% 69.2% 0.705 
Married/living with partner 48.9% 38.5% 0.503 
College/diploma & above 68.1% 53.8% 0.341 
Not working/employed part-time due to 
ill health/retired 76.6% 61.5% 0.277 
Professional/technical/skilled 80.9% 69.2% 0.368 
English as 1st language 76.6% 76.9% 0.980 
White British/white other 74.5% 69.2% 0.705 
Christian 40.4% 61.5% 0.176 
Non-smoker 74.5% 84.6% 0.444 
Non-drinker 66.0% 76.9% 0.452 
PEQ RLHIM 7.17 (1.579) 7.92 (1.706) 0.140 
PEQ CAM 7.21 (1.628) 7.92 (1.656) 0.171 
NEL CCG 38.3% 30.8% 0.871 
Received treatment for ≥12m 51.1% 50% 0.859 
Multiple treatments 44.7% 30.8% 0.368 
VAS 70.72 (19.935) 68.38 (18.478) 0.705 
sfBPI Pain Severity 6.42 (1.805) 6.02 (1.935) 0.488 
sfBPI Pain Interference 6.37 (2.279) 6.36 (1.984) 0.987 
SF36 Physical 26.809 (15.682) 22.981 (15.388) 0.437 
SF36 Emotional 35.632 (18.043) 35.141 (16.416) 0.930 
PEQ: patient expectation questionnaire, VAS: visual analogue scale, NEL: North East London, 
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CCG: clinical commissioning group, BPI: brief pain inventory 
Values shown are means (SD), or n (%); p calculated from independent t test for continuous 
data and chi- square for categorical data 
4.6 Changes in participants’ expectations 
Two scores of participants’ expectations were assessed at all-time points: one was to 
evaluate their faith in the treatment provided at the RLHIM; the other was to 
evaluate their faith in CAM treatment in general. Descriptions of how their 
expectations were measured are available in Section 3.4.2. Higher score means a 
higher expectation. Participants had a mean expectation score over 7 (out of 10) on 
both the treatment at the RLHIM and CAM in general before their initial 
appointment at the RLHIM (with a mean of 7.17 and 7.21 respectively, p>0.05) 
(Table 4.5).  
Table 4 5 Participants’ mean expectation scores at four time points 
PEQ Score 







PEQ RLHIM 7.17 (1.579) 6.74 (2.336) 6.66 (2.209) 6.60 (2.209) 
PEQ CAM 7.21 (1.628) 7.36 (1.607) 7.51 (1.692) 7.49 (1.999) 
SD=Standard Deviation 
Changes in participants’ expectations were compared over 12 month follow-up 
period using repeated measures ANOVA. The mean scores for participants’ 
expectations for treatment at the RLHIM or for CAM in general were not statistically 
significantly different over the 12 months follow-up, F(3, 138) = 1.647, p=0.181; 
F(3, 138) = 0.641, p=0.590.  
4.7 Changes in outcome measures 
Patient reported outcome measures in VAS, SF36, and sfBPI were evaluated at 
baseline, for some participants also at the second baseline (for those who were on a 
waiting list, n=18, results in Section 4.9). In addition to the raw data collected from 
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the completed questionnaires at baseline, 4, 8 and 12 months, the variables on SF36 
and sfBPI were computed and transformed as described in Section 3.6.1. The results 
presented are for the sample of n=47.  
4.7.1 Changes in primary outcome measures 
The level of pain dropped during the first four months and this lower level was 
sustained over 12 months as measured by VAS (Figure 4.5). A lower score in the 
VAS indicates less pain.  
Figure 4 5 Changes in pain over one year follow up as measured by the VAS 
 
As the mean changes in VAS were approximately normally distributed (Appendix 
4.2), and there were no outliers identified, one-way repeated measures ANOVA was 
conducted to compare the changes in VAS over four time points. It showed that the 
mean scores of VAS were statistically significantly different over the 12 months’ 
period, F (3, 138) =10.674, p<0.0005. Paired sample T tests were carried out to 
assess the difference between each pair of time points: they showed significant 
improvements with a moderate to large effect size in improvements in pain as 
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measured by VAS at four months (effect size SE=0.615), a small to moderate effect 
at eight months (effect size =0.490), and moderate to large effect at twelve months 
(effect size =0.574). Comparing to VAS at four months, it slightly increased at the 
eight month, following a minor drop at the twelve months. But these changes were 
not significant (Table 4.6). 
Table 4 6 Changes in VAS (pain) between baseline, four, eight and twelve months follow-up 
Compare Groups 
(n=47) 
Changes in Mean 
(SD) 95% CI P Value 
Baseline vs 4m 13.468 (21.907) (7.036, 19.000) <0.0005 
Baseline vs 8m 13.447 (27.452) (5.387, 21.507) 0.002 
Baseline vs 12m 14.617 (25.450) (7.145, 22.090) <0.0005 
4m vs 8m -0.021 (16.640) (-4.907, 4.864) 0.993 
4m vs 12m 1.149 (17.195) (-3.900, 6.197) 0.649 
8m vs 12m 1.170 (9.687) (-1.674, 4.014) 0.412 
SD=standard deviation, CI=confidence interval of the difference 
However, there was no statistically significant improvement in pain as measured by 
SF36 bodily pain dimension (Figure 4.6). A higher score in SF36 bodily pain 
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Figure 4 6 Changes in pain over one year follow up as measured by SF36 bodily pain 
 
One-way repeated measures ANOVA was conducted to compare the changes in 
SF36 bodily pain over four time points. Repeated measures ANOVA showed that 
mean scores of SF36 BP were not statistically significantly different, F (3, 138) 
=1.233, p=0.300. There was a non-significant but minor improvement in pain at 4 
months, 8 and 12 months. A summary of overall changes in pain as measured by 
SF36 bodily pain are presented in Table 4.7. 




Changes in Mean 
(SD) 
95% CI P Value 
Baseline vs 4m -4.787 (22.673) (-11.444, 1.870) 0.155 
Baseline vs 8m -3.191 (21.211) (-9.419, 3.036) 0.308 
Baseline vs 12m -0.638 (23.368) (-7.499, 6.223) 0.852 
4m vs 8m 1.596 (16.636) (-3.289, 6.480) 0.514 
4m vs 12m 1.149 (17.195) (-3.900, 6.197) 0.123 
8m vs 12m 2.553 (12.806) (-1.207, 6.313) 0.178 
4.7.2 Changes in secondary outcome measures  
Changes in the sfBPI (2 sub-outcome variables: pain severity and pain interference) 
and SF36 (2 sub-outcome variables: physical and emotional dimensions) were 
evaluated through the same approach. Internal reliability among sub-scales of sfBPI 
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and SF36 were high: Cronbach’s Alpha were 0.731 at baseline, 0.916 at four month, 
0.912 at eight month, and 0.919 at 12 months for sfBPI; and 0.758 at baseline, 0.875 
at four months, 0.907 at eight months, and 0.899 at 12 months for SF36. 
There were significant improvements in pain intensity: F (3, 138)=7.742, p<0.0005, 
and pain interference: F (3, 138)=5.522, p=0.001 as measured by the sfBPI at four, 
eight, and 12 months (Figure 4.7). 
Figure 4 7 Changes in pain over 12 months follow up as measured by sfBPI (left: 
pain severity subscale, right: pain interference subscale) 
 
As assessed by paired t test, comparisons between baseline and four, eight, and 12 
months are available for each subscale (Table 4.8). It shows that there were 
significant improvements with a moderate to large effect size in pain as measured by 
sfBPI pain severity subscale at four months (effect size =0.628), a small to moderate 
effect at eight months (effect size =0.499), and moderate to large effect at twelve 
months (effect size =0.523). Similar improvements in pain were observed as 
measured by sfBPI pain interference, with small to moderate effects at four and eight 
months (effect size SE=0.400 and 0.440 respectively, and moderate to large effect at 
twelve months (effect size SE=0.546). There was no significant change between four 
and eight months, four and 12 months, nor between eight and 12 months. 
Table 4 8 Means of 13 secondary outcome variables at four time points and changes in means 
comparing different time points 
Compare Groups (n=47) Mean difference, SD, p value 
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sfBPI Pain Severity sfBPI Pain Inteference 
Baseline vs 4m 1.259 (2.005), p<0.0005 1.024 (2.557), p=0.005 
Baseline vs 8m 0.925 (1.853), P=0.001 1.009 (2.292), p=0.003 
Baseline vs 12m 1.059 (2.024), p=0.001 1.176 (2.154), p=0.001 
4m vs 8m -0.195 (1.597), p=0.392 -0.106 (1.672), p=0.657 
4m vs 12m -0.016 (1.807), p=0.952 0.347 (2.38), p=0.311 
8m vs 12m 0.154 (1.242), p=0.399 0.356 (1.989), p=0.227 
SD=Standard Deviation 
On the other hand, as measured by repeated measures ANOVA, it failed to show 
significant changes in participants’ quality of life in terms of physical improvement: 
F (3, 138)=1.432, p=0.236 as measured by SF36 physical dimension, nor in terms of 
emotional improvement: F (3, 138)=2.565, p=0.057. Small to moderate improvement 
was only observed in physical functions comparing baseline to four months, with 
mean difference: -6.019 (SD=18.477), p=0.020, effect size=0.326; and in emotional 
function at four and 12 months: 4m mean difference: -8.306 (21.412), p=0.006, 
effect size=0.388 ; 12m mean difference: -6.148 (17.569), p=0.021, effect 
size=0.350. 
4.8 Prediction of responses 
As explained in Section 3.6.1, multiple linear regression analyses with forward 
selection method were performed to explore potential independent variables that 
influenced the changes in pain response as measured by VAS at four months 
(y1=VAS baseline – VAS 4m); and potential independent variables that may influence 
participants’ expectations in the treatment at the RLHIM (y2= PEQ RLHIM baseline – 
PEQ RLHIM 4m). As this was an exploratory analysis to explore which factors might 
influence participants’ pain outcome and their expectations, no correction was made 
for multiplicity.  
Predictor variables included in the model for exploring changes in VAS were: 1). 
Sociodemographics: age, gender, marital status, educational level, occupational 
status/group, mother tongue, ethnic origin, and religious affiliation; 2). Lifestyle: 
smoker or not, drinker or not; 3) Expectations in treatments at the RLHIM; 4). 
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Referral pathway; 5). Integrative treatment characteristics: length of treatment, 
complexity of treatment; and 6). Pain at baseline as measured by VAS.  
Assumptions of performing multiple regressions specified in Section 3.6.1.4 were 
assessed. Approximate normality was achieved. There was independence of 
residuals, as assessed by a Durbin-Watson statistic of 1.813, therefore meeting the 
assumption of collinearity. There were potential outliers as all cases had a LEV more 
than 0.2; No Cook's distance value above 1 was detected. All outliers were kept as 
they are in the analysis. 
The overall changes in VAS at four months might be partially predicted by adding 
two dependent variables: baseline VAS, and being a smoker.  Those participants who 
were non-smokers and those who had greater pain at baseline had a better 
improvement in pain at four months, F (2, 44)=7.914, p=0.001, R2=0.265. 
Regression coefficients and SEs are presented in Table 4.9. 





R2adjusted β p 
value 
Intercept -7.009 10.812 - - - 
Smoker or not -18.095 6.471 0.143 -0.364 0.008 
Baseline VAS 0.355 0.143 0.231 0.323 0.017 
B: unstandardised regression coefficient; SE: standard error; β: standard coefficient 
Predictor variables included in the model for exploring changes in participants’ 
expectations in the treatment at the RLHIM included all the independent variables 
used in exploring correlation with changes in the VAS mentioned above. Two 
additional variables: on waiting list or not, and the length of waiting time were also 
added. Overall changes in PEQ RLHIM at four months were partially predicted by 
participants’ baseline expectation in treatment at RLHIM, with a higher expectation 
at baseline having greater decrease in expectation at four months, F (1, 45)=9.218, 




Chapter 4 Quantitative Results 
4.9 Subgroup analysis 
4.9.1 Baseline one vs. baseline two 
As pre-specified in Section 3.5, participants who were put on a waiting list after their 
initial appointment at the RLHIM completed a second baseline before their first 
treatment (n=18). Two participants on the waiting list refused to complete the second 
baseline questionnaire as they believed there had been no change in their condition 
since baseline. With an average time on the waiting list of 10 days, it is 
understandable that these patients refused to complete the second questionnaire, 
particularly as one of the patients also had pain in her fingers, and the other had 
severe neck pain.  
Clinical outcome measures were compared between the two baselines. Apart from 
participants’ educational level, no significant differences were observed between the 
two baselines (Table 4.10). This indicated that the participants who were on the 
waiting list were representative for self-control comparison. However, considering 
the small sample size of 16 patients, self-comparison evaluation was not used as the 
final finding for limited effectiveness testing.   
Table 4.10 Comparison of baseline characteristics of participants who were on waiting list and 
those who were not 





Age, mean (SD) 50.94 (17.479) 52.52 (12.409) 0.697 
Female 62.5% 77.3% 0.253 
Married/living with partner 43.8% 47.7% 0.785 
College/diploma & above 43.8% 72.7% 0.037 
Not working/employed part-time 
due to ill health/retired 
75.0% 72.7% 0.860 
Professional/technical/skilled 75.0% 79.5% 0.705 
English as 1st language 12.5% 27.3% 0.232 
White British/white other 75.0% 72.7% 0.860 
Christian 43.8% 45.5% 0.907 
Non-smoker 75.0% 77.3% 0.854 
Non-drinker 75.0% 65.9% 0.503 
PEQ RLHIM, mean (SD) 7.81 (1.759) 7.16 (1.554) 0.170 
PEQ CAM, mean (SD) 7.25 (2.324) 7.41 (1.352) 0.799 
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NEL CCG 37.5% 36.4% 0.839 
Received treatment for ≥12m 43.8% 50.0% 0.668 
Multiple treatments 37.5% 43.2% 0.693  
VAS, mean (SD) 68.00 (17.937) 71.02 (20.174) 0.600 
sfBPI Pain Severity, mean (SD) 6.27 (1.566) 6.36 (1.926) 0.964 
sfBPI Pain Interference, mean (SD) 6.34 (1.924) 6.38 (2.316) 0.946 
SF36 Physical, mean (SD) 30.55 (10.728) 24.32 (16.790) 0.173 
SF36 Emotional, mean (SD) 36.56 (15.349) 35.22 (18.466) 0.827 
 
4.9.2 Outcomes of patients receiving different integrative treatments  
Subgroup analyses were performed for participants who received a single treatment 
(n=32), and the ones who received complex interventions (e.g. more than one type of 
treatment) at the RLHIM (n=28); and also for participants who received treatment 
for different lengths of time (less than 12 months, or ≥ 12 months).  Independent t 
tests showed that different complexity or different lengths of treatment did not affect 
the improvement in pain at four months (p complexity =0.616 and p length=0.780).  
4.10 Chapter Summary 
This chapter presented quantitative results on the feasibility of carrying out this 
research study. Issues were identified from recruiting eligible patients but follow-up 
responses and retention at 12 months were acceptable. Apart from the mCSRI, 
completion rate in the three selected PROMs were very good. Most participants were 
middle age, female Caucasians, with higher educational background and most of 
them were not working or working part time due to ill health or retired. Most 
participants had widespread pain in various locations, and low back pain and knee 
pain were the top two common location of pain identified. 37% participants were 
referred from NEL CCG, while 37% were referred outside greater London. The 
integrative treatments they received at the RLHIM during the follow-up period 
varied in terms of types, combinations, frequencies and amounts. Combination of 
treatments participants received ranged from one to four, with most of them only 
receiving one type of intervention apart from their assessment appointments (53%), 
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followed by receiving three types of treatments (22%). Acupuncture, homeopathy, 
and physiotherapy were the three most commonly received treatments. Participants’ 
expectations in treatment at the RLHIM and their expectations in CAM in general 
were assessed over the 12 month follow-up, with no significant difference detected. 
Improvements in pain severity were observed, with a moderate to large effect size as 
measured by VAS and sfBPI at 4 months, and this improvement was maintained 
between 4 and 12 months. Improvements were also observed in pain interference, 
physical function, and mental function, with a small to moderate effect size as 
measured by sfBPI and SF36. The results suggested that VAS and sfBPI appear 
sensitive to changes observed in integrative treatment for MSDs.  
Those participants who were non-smokers and those who had greater pain at baseline 
showed significantly better improvement in pain at four months; a higher expectation 
at baseline was associated with greater decrease in expectation at four months. 
However, analysis of potential predictors is exploratory due to limited sample size; 
these data should therefore be interpreted with caution. 
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Aims and Structure 
This chapter addresses the research questions concerning participants’ expectations 
prior to integrative treatment and taking part in the research study; their experiences 
of receiving integrative treatment at 12 month follow up and their experiences in 
participating research study (pre-specified in Section 1.6). For participants to have a 
clear memory regarding their experiences in completing the PROMs, they completed 
the first questionnaire pack right before being interviewed for the pre-treatment 
interviews, and they were asked to complete the last questionnaire pack in the few 
days before they were interviewed or on the day prior to the follow-up interviews.  
The sociodemographic details and clinical characteristics of patients who were 
interviewed were compared with those who were not interviewed, in order to ensure 
that the participants interviewed were representative of all study participants (Section 
5.1). The first research question was assessed by pre-treatment interviews, with 30 
one–to-one, face-to-face interviews with MSD participants before their initial 
appointment for a new episode of MSD treatment at the RLHIM (Sections 5.2 -5.8). 
The second research question was answered by the results from the follow-up 
interview: 15 one-to-one interviews and four focus groups (n=15 participants), 12 
months after their initial appointment at the RLHIM (Sections 5.9-5.15).  
Since the pre-treatment and follow-up interviews took place over different periods of 
time and were largely aiming to answer different research questions, these were 
analysed separately (details in Section 3.6). Regarding the follow-up interviews, one-
to-one interviews and focus groups were analysed together, but with ‘FG’ marked 
for those who took part in a focus group. In order to keep the results consistent, and 
to best show the changes over the one year, the framework developed for the follow-
up interviews was based on the framework developed for the pre-treatment 
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interview. This means that the naming of categories and themes were as much the 
same as for those in the pre-treatment framework as possible.  
In accordance with a framework analysis approach, most themes identified (Sections 
5.2-5.9, 5.13-5.15) directly reflected the questions the research student asked in the 
interviews, with new themes emerged under each category. Three themes (Sections 
5.10-5.12): self-awareness and reflection, self-directed integrative approach, and 
imbalance in supply and demand emerged from analysing the follow-up interview 
data analysis. These emergent themes are given first, after providing the general 
picture of how participants lived with MSDs (Section 5.9). This was because 
emergent themes were considered higher value as they were not directly asked about, 
were generated from multiple questions; and indicated topics the participants were 
interested in talking about. Apart from those emerging categories, all categories for 
both pre-treatment and follow-up interviews are presented as two sets of stories, in a 
sequential and logical order, to guide the audience.  
Rather than using a weighted rubric, the themes and sub-themes are presented in 
order of importance as determined by the number of participants who commented or 
quoted on that theme. A summary of results on themes and sub-themes generated 
from the two qualitative studies are presented after each theme. Table 5.1 shows the 
symbols used in presenting the results in this chapter.  
Table 5 1 Symbols used in presentation of qualitative results 
Symbol Explanation 
… Omissions of quotes 
[ ] Research student’s interpretation or observational data 
‘’ Participants’ own words 
Capital letters Shouting or emphasising 
Identification  Pre-treatment: 1st: participant ID 
Follow-up interviews or focus groups: 1st: (FG=focus group) 
participant ID; 2nd: treatment(s) received at the RLHIM for MSDs 
during Jan 2014-April 2015, e.g. FG28, Acu+Homeopathy 
Figure 5.1 and 5.2 shows the connections of the themes generated from pre-treatment 
and follow-up interviews. Details of how and why they are connected are available 
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in the introduction of each theme in the subsequent sections. Comparisons and 
combinations between the pre-and-follow-up interviews are reported at the end of 
this chapter (Section 5.16). A summary of the findings from the two parts of the 
qualitative study are presented in section 5.17,  with the main findings of patients’ 
decision making, expectation, and experiences  presented first, followed by the 
findings on feasibility in terms of participating in the research study.
123 
 
 Figure 5 1 Connections between categories (Pre-treatment)  
 




 Figure 5 2 Connections between categories (12 month Follow-up) 
 
‘Follow-up’ indicates categories with same titles in pre-treatment interviews identified from follow-up interviews
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5.1 Baseline characteristics of interview participants 
Although initially the plan was to purposively select 30 participants for both pre-
treatment and follow-up interviews, ethical approval and recruitment took longer 
than expected. In addition, insufficient numbers of patients appeared available to 
attend an interview and for completing questionnaires one and a half hours before 
their first appointment. Therefore, patients were invited sequentially until 30 were 
interviewed for the pre-treatment interviews. Similarly, for follow-up interviews, 
seventeen participants were sequentially interviewed one-to-one; and fourteen were 
interviewed in four focus groups. Altogether 28 participants were interviewed, as 
three participants also requested to attend a focus group after being interviewed 
individually. Five participants who dropped out from the quantitative study were 
interviewed at the 12 months (Table 4.1).  
Among those participants who were interviewed, 19 individuals were interviewed in 
both pre-treatment and follow-up interviews; and 40 were interviewed in either pre-
treatment or at follow-up interviews. In order to check whether participants 
interviewed in either pre or follow-up interviews were no different to those who 
were not interviewed, differences in baseline characteristics between those who were 
interviewed and those who were not interviewed were evaluated. All continuous data 
are presented as means (standard deviations); and all categorical data are presented 
as numbers (percentages). 
Drinkers were more likely not to have been interviewed than those who were non-
drinkers, x2(1)=4.660, p=0.032; and  mean pain severity as measured by sfBPI (was 
significantly higher in those who were interviewed), mean difference 1.156 (95% CI, 
0.194 to 2.118), t(58)=2.406, p=0.019. There may be a variety of explanations for 
this; either because participants who were drinkers were less likely to have healthy 
lifestyles and may be less open to health advice or face to face communication with 
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the researcher, or alternatively those participants who were drinkers were more 
sociable, able to get out more and therefore were less willing to participate in 
research. This association could have created some bias. There was no difference in 
other baseline characteristics between interviewed participants and non-interviewees 
(Table 5.2). 
Table 5 2 Comparison of baseline characteristics of interviewed and non-interviewed participants  
Baseline characteristics Interviewed (n=40) 
Not interviewed 
(n=20) p 
Age 52.43 (14.489) 51.45 (12.634) 0.799 
Female 70.0% 80.0% 0.308 
Married/living with partner 45.0% 50.0% 0.463 
College/diploma & above 60.0% 75.0% 0.196 
Not working/employed part-time due 
to ill health/retired 67.5% 85.0% 0.127 
Professional/technical/skilled job 77.5% 80.0% 0.552 
English as 1st language 77.5% 75.0% 0.535 
White British/white other 77.5% 65.0% 0.233 
Christian 37.5% 60.0% 0.084 
Non-smoker 77.5% 75.0% 0.535 
Non-drinker 77.5% 50.0% 0.032* 
PEQ RLHIM 7.60 (1.630) 6.80 (1.508) 0.071 
PEQ CAM 7.60 (1.766) 6.90 (1.294) 0.121 
NEL CCG 42.5% 25.0% 0.149 
Received treatment for ≥12m 52.5% 40.0% 0.262 
Multiple treatments 50.0% 25.0% 0.056 
VAS 72.63 (18.999) 65.40 (20.080) 0.178 
sfBPI Pain Severity 6.72 (1.660) 5.56 (1.935) 0.019* 
sfBPI Pain Interference 6.51 (2.143) 6.09 (2.347) 0.482 
SF36 Physical 24.39 (14.288) 29.16 (17.827) 0.267 
SF36 Emotional 32.84 (16.801) 40.89 (18.265) 0.095 
*Bold indicates statistically significant differences between interviewed and not interviewed 
participants 
5.2 Living with musculoskeletal disorders (Pre-treatment) 
The theme ‘living with MSDs’ contains information generated when participants 
were asked the following question: “Can you tell me about the condition for which 
you have been referred to the hospital?” Relevant data when answering other 
questions were also coded under this theme. This section provides an overall picture 
of how participants perceived living and adapting their life as a result of having an 
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MSD and other existing conditions. In most of the interviews, participants were keen 
to share their history, symptoms, the impact on their life, and the strategies they 
used. This information was offered spontaneously to the research student. Figure 5.3 
shows the themes under living with MSDs (Pre).  
Figure 5 3 Sub-themes under the theme living with MSDs (Pre) 
 
5.2.1 Various musculoskeletal disorders with co-morbidity 
All participants shared their MSDs history. Although participants were not 
purposively sampled, they were relatively representative as their baseline 
characteristics were similar to those who were not interviewed (Section 5.1, Table 
5.2). 
Most participants (n=23) had widespread pain over the body, including osteoarthritis 
(OA) or rheumatoid arthritis (RA) in multiple joints (n=11), fibromyalgia (n=7), 
scoliosis (2), complex regional pain syndrome (n=1), myalgic encephalopathy (ME) 
(n=1), and joint hypermobility syndrome (JHS) (n=1). Seven participants had 
primarily localised pain in their back (n=5), shoulder (n=1), and face (n=1). Most 
participants’ MSD(s) were with varying levels of degeneration (n=23, 77%), some 
were caused by accidents (n=6, 20%).  
Nine participants stated that they had other health issues which were unrelated to 
MSDs such as headaches and digestion problems, or had ‘a lot of things wrong’. 
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5.2.2 Various symptoms 
Apart from one participant who stated having stiffness with no pain, all participants 
(n=29) expressed varying levels of pain in joints, muscles or ligaments, with ‘good 
days’ and ‘bad days’ and pain fluctuating or appearing unexpectedly.  
It’s got better and then it’s got worse. Some days I have good days, some days I 
don’t (11). 
I mean sometime it’s okay you know, it’s just, you’re aware that it’s not as 
settled as it used to be. Other time it really hurts. Other times it’s like there is 
glass in you, you know, it’s changeable (20). 
Participants also reported restriction and limitations in movement caused by 
stiffness, muscle weakness, or joint degeneration (n=18).  
For example my wrists are completely melted together. So I cannot move them 
at all. And I have some limitations on my hips and this also for example if I 
don’t lift it [left leg]… I’m very limited because I have limited movement. My 
joints don’t have the normal range of movement that other people do (19). 
Stiffness in my neck. Sometimes stiff neck, and interferes daily routine (03). 
Some participants (n=6) reported feeling tired or exhausted because of the pain or 
feeling uncomfortable, which sometimes resulted in psychological change. 
I’ve suffered a lot with the fatigue, and the weakness. But you know, it’s like I 
have pains here, and with headache, joint pain and I’m just, you know, just 
feeling fatigue. So I haven’t got the energy, you know, to go (23). 
I think it is the exhaustion that perhaps affects me the most. It is such an effort 
to remain upright and cheerful when the whole of my body is aching really 
severely with nothing able to relieve the ache. Even if I am perfectly relaxed the 
pains are very much present (05). 
In two unusual cases, the participants experienced joint dislocation, one of whom 
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5.2.3 Long term musculoskeletal disorders 
Most participants (n=25) had at least one MSD for more than two years. They came 
to the hospital for treatment because they suffered and wanted to find some relief 
from the symptoms. 
Because I can have quite a flare up in my symptoms, which I found really really 
hard to manage by myself… I mean on a daily basis, probably the worst 
problem, or the things affect me the most now, but, you know, I will suffer quite 
a lot of kind of acute problems, although it’s a chronic condition (10). 
Many participants (n=15) expressed that long term conditions (LTCs) can result in 
the use of many prescribed medicines and poorer health, which could have been 
related to the severity of their conditions. 
Three years is different from having it for 15 years! And there is difference as 
they [patients who] have been given less medicines. They had less medicine, 
less drugs, so they are still a bit healthier than me (19). 
5.2.4 Unclear diagnosis 
Some participants (n=10) had difficulties getting a diagnosis for their MSDs. They 
spent a long time, and often trying many kinds of tests before receiving a proper 
diagnosis. One lady had been actively involved in research studies, trying to identify 
what condition she had, but was still waiting to get an answer. 
And he did all sorts of tests. Oh I used to go to conferences and saw lots of 
consultants from all over the world, and they questioned me, but no one ever 
sorted anything out. And he thought, in the end, maybe I have some sort of new 
disease. They thought I might have had Crohn's disease, and then he said we 
might have a Fabry disease by the end we finished. But they never really got it 
sorted…. And I was assured, every time, I used to go to [hospital], every 4 
months, every 6 months, and I was assured every time I went, they say ‘oh it’s 
just it, this is what it is, and just deal with it like that’, and they did, and I was 
assured next time will be the time. And I'm still waiting 43 years, for that, to 
sort that out (05). 
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In one case, the participant suddenly became severely disabled. It was suggested that 
he either had an acute treatable disease, Lyme disease, or stiff person syndrome 
(SPS), which currently has no cure.  
Because my concern is that – what I hope is misdiagnosis. And hopefully, this 
Lyme disease, which is very different to SPS [stiff person syndrome]. I’m 
hoping it’s a[n insect] bite and it might be Lyme disease. That’s what I’m 
hoping for. Because that is very treatable. If it’s this SPS, then I’m not sure 
about what they can do for me. As far as I see relief in pain - well not pain, 
discomfort, to relax my muscles (06). 
In another case, the participant was diagnosed as having one condition which was 
subsequently changed to a different diagnosis.  
I went to the GP, she said it is carpal tunnel, which is why I went to the 
orthopaedic. … the consultant, and he said he thought it’s complex pain, hmm, 
and referred me to the other hospital, down the road here. And I went to see the 
specialist physiotherapy and he said yes, he thought all the symptoms seems to 
stress that it’s complex pain, complex regional pain syndromes (47). 
5.2.5 A hidden disability 
A common perception was their condition is a ‘hidden disability, as it is not 
understood or recognised by other people because they ‘look very well’, their ‘grip 
strength [is] perfectly normal’, or they have a ‘normal range of movement’. Eight 
participants experienced difficulties in explaining and proving how they feel, both 
physically and emotionally. 
It's kind of mad because if you see me walking around, you'd think "Oh, it 
doesn't look so bad." But it's -- well, it's the stopping, you know? And I walk for 
a little bit and then the pain comes on and have a little bit of rest. And then 
straightaway you get the pain from sitting because I stop at bus shelters or 
things like that (08). 
Another thing is – people don’t understand you. For example, if you chop off an 
arm, they see you don’t have an arm, it’s something obvious. What I've got is not 
something visible, something obvious. It’s difficult for them to understand that 
THIS ARM DOES NOT MOVE! I cannot lift things, I can’t get things from the 
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shelves because I can’t lift my both arms, I can’t take it just with one. And it’s 
just hmm, very difficult. Because they say, ‘you look so healthy!’ [laugh] (19). 
An example was given by a lady with JHS where she was abused/challenged while 
on public transport. Because JHS is not widely understood by the public, she did not 
expect everyone to understand her condition, but wished she could ‘let others know 
how you feel’.  
When I asked to sit down [on the London underground], a lot of people would 
be quite abusive, verbally aggressive. And I will get challenged, and get told ‘I 
look fine, they had a hard day at work’, or ‘about to have a hard day at work’, 
what’s wrong with me. Hmm, if I tell them [that I have JHS] and they ask for 
evidence…. And, I think, just in general level, I think some people think I’m 
being kind of precious about myself, they think you’re kind of asking special 
favours, because they can’t see anything wrong, hmmm… I don't even think that 
it’s just lack of understanding. I don't expect every person in the street to 
understand about hypermobility (10). 
Inadequate awareness at work or by the public was reported by five 
participants.  
In theory, your employer is supposed to let you move. But in practice this 
didn’t happen… Actually I have to struggle [to get support]. I asked them to 
get me an ergonomic mouse, to support my wrist. And it took months and 
months, and my boss never bought it. So I ended up buying it for myself. So 
it’s, it’s, in theory, they SHOULD because this, hmm, I even spoke with this 
person who is responsible for the workers, you know, for the wellbeing of the 
workers… Those are the things make big difference for me (19).  
Summary of living with MSDs (Pre) 
• Participants had a variety of MSDs with most of them having widespread 
pain all over their body caused by degeneration, with additional other 
non-MSD health issues;  
• Participants experienced various physical and emotional symptoms 
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• Participants suffering from chronic MSDs was described as being 
associated with polypharmacy and poor health; 
• Some participants had an unclear or a changing MSD diagnosis ; 
• Participants felt MSDs were often hidden disabilities as they ‘looked 
normal’, or had difficulties explaining how they felt. They felt there was 
a lack of public awareness about their disability. 
 5.3 Impact of musculoskeletal disorders (Pre-treatment) 
Information generated when asking participants the following question: “How does 
your condition affect your daily life?” explored the impact of MSDs. Participants 
reported that MSDs affected their life in various ways, including their activities of 
daily living, emotional impact, impact on relationships with their families and 
friends, and impact on their work and study which also impacted on their cost of 
living. This was closely associated with the theme living with MSDs (Pre) (Section 
5.2) as MSD symptoms affected quality of life; and was associated with physical, 
emotional, work or income. Figure 5.4 shows themes under impact of MSDs. 
Figure 5 4 Sub-themes under the theme ‘impact of MSDs’ 
 
5.3.1 Impact on activities of daily living  
All participants reported that their MSDs in some way affected various aspects 
of daily life, from simple tasks like running a bath, completing housework, to 
major choices like not having a baby. Participants felt they achieved less than 
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they wanted to; or reported they used to be very active and now had to 
compromise their activities, subsequently lowering their quality of life. It’s all 
simple things like eating, talking, these little things are much more difficult. … 
And simple things like jumping into the van, going down to the coast, being by 
the sea for a few days. It’s simple pleasure. But now, none of those is possible 
(06). 
It's not easy, you know, hoovering, or even washing up because if I stand still for 
too long, I have to take the pressure off one leg, so. I’m used to it. I make 
allowances now but it’s still not normal… If I didn't have this pain and there’re 
a lot of things I’d love to do, you know (38). 
I've just had a wet room [installed] so I can shower myself now, but up until 
then, he’ll [46’s husband] have to wash me. Do you know what that’s like? I’ll 
be down in the bathroom to wash myself and have your independence. And that 
had – that was going on for probably about two years. It’s had a big effect (46). 
But it’s actually diminishing the quality of many people’s life really severely. 
But that doesn't seem to count. Well I’m getting in the late in my age - it’s too 
late for kids, but I wouldn’t really want it [JHS] on them… It’s ruined my life, it 
really has, it makes thing incredibly tough (10). 
Thirteen participants reported difficulties in sleeping because of the pain.  
I can't sleep even when I take a sleeping tablet. I took one last night. I only got 
four hours of sleep. I used the hammer one day and next thing I hurt my arm, I 
couldn't sleep, I couldn't move and I can't pick nothing up in the morning. … 
You know, basically when you knock yourself out and then you have a few beers, 
you know you're comatose, you'll be zonked out. You know in that way you can 
get some sleep (08). 
5.3.2 Emotional impact  
Almost every participant (n=29) described the psychological effects of their MSD 
such as being frustrated, upset, anxious, sad, angry, or depressed. These emotional 
changes were perceived as being linked with each other.  
Frustration was the most common emotional response reported by the participants 
(n=19). These emotional responses emerged when patients experienced restrictions 
and limitations due to their MSDs as they were less able to achieve things, or when 
they were tired of explaining their conditions to friends or families.  
134 
 
Chapter 5 Patients’ Expectations and Experiences 
You feel very frustrated, you know, very alone, and it can actually cos you 
mental disturbances which can make your condition even worse… At the 
moment, I’m actually hmm, because I isolated myself a lot. So at the moment, 
I’m in, hmm, in an institution or whatever you call it, where people are helping 
me to deal with these problems, emotional problems. But I still believe that 
everything is linked (43). 
I’m in pain, yeah. Yet, I want to cook. That’s my job. I’ve done it for so many 
years, 40 years. You’re not doing it right. I get frustrated, you know…  And then, 
you lose things in my kitchen because he [046’s husband] needs to move them, 
and I get angry. It’s MY kitchen. Do you understand? (46). 
So yeah, it’s frustrating, because it’s, you know, people said ‘what’s wrong with 
you?’, and I said, and then I go ‘okay’. I just thought I was going crazy, you 
know. I thought perhaps it is in my head. Perhaps I am making it up [laugh] 
(47). 
Stress and anxiety particularly developed when patients felt they were isolated 
especially from their social contacts (n=11).  
When I came out from the hospital, obviously it’s a big drop. It’s not so 
scary from hospital to get back home. But to not be well, and to not be 
looking like I’m going to get better, there’s only way that I can get worse. 
Suddenly I become independent. That’s huge.. …But when you are on 
your own, sadness comes back, that’s all what you can do (06). 
Participants got emotional and sometimes depressed because of their difficult life 
with MSDs (n=11). This may be because their MSDs evoked a mixture of different 
emotional reactions so that they were not able to cope with. 
When you’re not able to do the simplest of tasks, it gets you down. And you feel 
you cannot enjoy your life anymore because you’re stuck inside and not being 
able to live a life as normal as you’d like to be. So, it does get you very 
depressed. The brain sometimes takes over everything. It doesn’t allow you to be 
the person you are (15). 
I was a bit desperate, so the physical took over the emotional. So I was feeling 
very low and very depressed (43). 
In rare cases, fear (n=3) and anger (n=2) not necessarily directly due to their MSDs 
were less frequently expressed as an emotion, usually as a response to challenge. 
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I can tell you I’m petrified to be in a car, petrified. I have a car, but I wouldn’t 
drive in London, and I won’t drive more than 2 miles down the road. I’m 
petrified. I’m shaking all the time. If a car gets too close to the back of me, I’m 
in a very bad state mentally, I mean just absolutely traumatised me the car 
because if anyone hits me again, what would happen next? What damage would 
happen? It changed my life there in the car…. I’m strong in mind until the pain 
gets to the point where I just want to look at him [046’s husband] and say “put 
a knife to my head just get rid of the pain”. When the pain gets to that 10 plus, 
they always say, “What’s your pain level, 1 to 10?” I’ve gone about in the 20s 
now. Now, I get a gun and pull ahead because there’s nothing to stop the pain. I 
guess that’s how it affected my life (46).  
But what I do resent is being quizzed and challenged about having a health issue 
if I asked to sit down in the tube, and so it could be really personal upsetting, 
and it can make me quite angry at times (10). 
One participant refused to talk about the emotional impact of MSD. 
Don’t ask me that time. I don’t want to go that far, but it did affect me a lot. I 
really do have a hard time. I don’t even want to talk about it. It was a hard time 
for me to go through, my health and my relationship. I don’t want to hurt my 
children either, but there was only me for them. It was a hard time, anyway (33). 
5.3.3 Impact on family and friends  
Most participants (n=26) reported their MSDs had affected their relationship with 
friends or family. This was caused by various reasons, both physically when patients 
were unable to go out to meet people or because they were too tired to communicate, 
and mentally when they were dealing/coping with so much pain that they had no 
energy left to talk to others or were unable to concentrate on conversations. 
When I got the pain, I don't go out. I CAN'T, because I'll be all over the place, 
you know, wondering what I was doing [laugh]. I don't sort of, umm, now and 
again I can get uptight with people when I'm out shopping and someone stands 
in me way and I wanna do it quickly, you know. It aggravates me to get home 
because; the sooner I get home the better. But if I'm okay, I'll stay out all day. I 
would. … And you are just not interested in, you're not listening what they 
[friends] say, and you're answering wrong (20). 
I’ve noticed I’ve fallen out of touch, or not in touch with friends as much as I 
previously was, and that needs to change, but, you know, it’s harder when I’m 
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trying to work full-time. So, when I’m done with my day at work, I’m not always 
feeling like I would be able to, say, get in the train to central London to see 
some friends for a few hours and then come home. I feel like I need to, kind of, 
go home, and I’m working home a lot now, and so, I don’t have that interaction 
as much. …You’ll feel that you don’t want to keep talking about it with your 
family and friends because you always - it’s kind of a constant state (39).   
Some participants (n=7) explained that when they were in pain, their relationship 
with friends, partner, or family was affected as it affected their mood.    
You know, I’d scream at him [her husband]. It’s affected obviously our 
marriage in that sense, although we’ve got a long marriage. We’re old. He’s not 
going to leave me. No way. We’ve been married too long, but it’s still not nice to 
him, so it’s affected him very badly, the way I treat him. I can’t be helpful. I 
can’t do all the things that a woman does (46,). 
I had the closest relationship, and romantic or sexual and loving relationship or 
intimate relationship, because I think the role is getting confused, you know, are 
you partners or are you caring and carer for, and I think, you know, that's not a 
very good role to bring in, and I certainly think it caused a lot complications to 
my current relationship (10). 
In a rare case, one participant stated they had an unsupportive family, which made 
her life even harder. A second participant stated that she would only like to talk with 
people who have the same experiences. 
If you haven’t got a supportive daughter, you haven’t got a supportive husband, 
or, you know, then – and he is quite violent, on and off, you know, and hmm, it’s 
like walking on egg shells, you know (54). 
A lot of people I don't speak to anymore, but the ones that are obviously my real 
friends and – and, I know it's not lucky, but it is unlucky for her, but we've got -- 
one of my friends has got the same condition. She's had it a lot longer than me. 
It was her that actually said that, "You know I think that you might have this," 
you know? So she helps. She helps because she does the same. She doesn't want 
to go out. She can't be bothered it. So we sort of -- you know, we sort of cheer 
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5.3.4 Work/study and financial consequences 
Most participants (n=24) reported that their MSDs affected their ability to work. 
Some participants (n=13) were working part time because of ill health, or working 
full time but struggling with the available facilities or work environment.  
It’s like desk based, having to be sitting constantly, in the same position, for 
example, this is the right shoulder, and there are some connection between me 
standing there and doing the mouse, with my hands afterwards (19). 
Among these participants, some reported (n=11) not working due to ill health. They 
felt it was vitally important to be able to work as it provides meaning and structure to 
their life, which produces feelings of achievement.  
It would be good to get back to some kind of job. That’s what I’m trying 
to do in my life, to work really. …. So structure is always providing by 
work. I’m thinking to interact with other people would be good (06). 
Some reported a lack of interaction with colleagues (n=5), which may be due to 
having unexpected pain during working hours. This affected their work efficiency as 
well as their communication with colleagues.  
I mean, I was working in Switzerland in March, and after the day of work, the 
restaurant was like 15 minutes’ walk. But I couldn’t go, because I couldn’t walk. 
So, you know, that was fine. I just sat in the bar, had a bar meal. But it affects … 
because when you are doing that, you are meeting people and it’s networking. 
So it does actually affect the work because that’s how you find out what’s going 
on, and what happened. So everybody thinks that you’re just having a nice meal 
but actually you’re still working in reality, but in fact I end up sitting on my own 
in the bar because no way I could walk for 15 minutes (20). 
Participants explained that it is a vicious circle as patients with MSDs could not 
work due to their pain, and thus could not afford treatment to improve their 
conditions. Five participants reported that MSDs affected their income, which 
affected their quality of life and the availability of being able to afford CAM 
treatment privately.  
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My wife and I lost our whole wage. It gets difficult, in a very basic boring way. 
But it’s still reality (06,). 
I'm not sure if they have any idea of what it's like trying to survive on an 
incredibly low income when you're ill and disabled (10).I used to earn a 
thousand, two thousand pounds a week. Life was a dream, and you have an 
accident, and then you argue over money with your wife and your kids because 
they want stuff and you can’t afford stuff. … I just had to cut out a lot what I 
used to do. I used to travel a lot; I used to go out a lot. Now I don’t go out at all; 
I don’t drink anymore; I don’t smoke anymore. These are not health things but, 
that’s part of socialising in this country. Nothing [long silence] (11). 
There were participants (n=2) who felt that their career progression and ambitions 
regarding work had been compromised by MSDs in what they could achieve.  
I was quite ambitious. I was so high achieving. I worked long hours, you know, I 
was planning on being much more advanced in my career than I am now. But 
because I was set back so hard, and how I struggled doing a day at work and 
concentrating on my work because I can’t… If I have two more days off work in 
the next six months or so, then I get disciplinary problem, you know, and 
eventually if I keep having to take a bit of time off, which is what has been 
happening periodically, I have to take a little bit of time off, then I’ll get into 
trouble and it can lead much over that, that’s kind of a main, the main reason 
for trying to sort things out really (39).   
So it certainly had affected my work. Because I can’t do – I was sort of 
progressing in my career, and I have to kind of pull back, and get rid of all of 
that, and just be a teacher. I’m hoping that I’m doing a good job. Hmm, 
sometimes I’m incredibly tired, and then, it’s hard. But I am really trying hard, 
you know, that it doesn’t affect my work. So, I just have to see how it goes really. 
We can’t really afford me to go part time, at the moment [laugh]. … I’ve given 
up all responsibility at work. So I was a deputy head. So I’ve given up, I’m 
literally a teacher, given up everything that I could (47). 
Summary of impact of MSDs (Pre) 
• MSDs affected a wide range of physical aspects of life and quality of life, 
and interfered with sleep; 
• The psychological impact of MSDs included feelings of being frustrated, 
stressed, anxious, sad, angry, depressed and fearful; 
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• MSDs affected participants’ relationships with their friends and family, 
both physically and mentally; 
• MSDs affected participants’ ability to work and work efficiently; being 
able to work was considered vitally important as it provided a meaning 
and structure to their life, which produced feelings of achievement; 
• Being unable to work caused financial insecurity and ability to pay, 
which affected participants’ quality of life.  
 5.4 Previous personal or healthcare experiences 
The theme ‘previous personal or healthcare experiences’ contains information 
generated from the following question: “What treatments have you used to try to 
improve your condition?” Relevant data when answering other questions were also 
coded under this theme. This theme contains two parts: the first part (Sections 5.4.1 
& 5.4.2) presents participants’ previous experiences with conventional treatments; 
the second part (Sections 5.4.3 – 5.4.5) presents participants’ previous experiences of 
CAM.  At the end of this section, a lack of communication with healthcare providers 
is discussed (Section 5.4.6). This theme is closely associated with participants’ 
MSDs as all their experiences were around finding appropriate treatments for their 
MSD. Figure 5.5 shows sub-themes under the theme previous personal or 
healthcare experiences. 
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5.4.1 Extensive experience with conventional treatments  
Most participants (n=22) had extensive experience of and had used several types of 
conventional treatments either in the past or currently. Oral pain killers (n=21) 
included: 1). non-steroidal anti-inflammatory drugs (NSAIDS) (n=13): ibuprofen, 
naproxen; 2). (Semi-synthetic) opioids (n=8): codeine, oxycodone, hydrocodone, 
morphy, oxycontin; 3). Anti-depressants (n=7): nortriptyline, amitriptyline; 4) 
paracetamol and compound analgesics (n=2): co-codamol, Co-proxamol. Other 
forms of medications included steroid injection (n=8), pain 
plasters/cream/patches/gel (n=7).  
Although only two participants specifically stated that they took more than six types 
of medications, which is commonly defined as polypharmacy (Fialova Daniela et al., 
2005), many participants (n=13) had two or more medications for treating the same 
MSD. The definition of polypharmacy is complex and individualised, and 
prescribing may involve; duplication of medication, drug/drug interactions, possible 
side effects/toxicity signs, and two or more medications to treat the same condition 
(Bushardt et al., 2008).  
Physiotherapy was the second most common treatment reported by participants 
(n=18). This included exercises, hydrotherapy, and some manipulation. Six 
participants had previously had psychological treatments including: diazepam, 
psychologist consultation, counsellor consultation; eye movement desensitization 
and reprocessing (EMDR), cognitive behavioural therapy (CBT), and mirror therapy. 
Four participants had taken supplements, including vitamin D, vitamin B12, vitamin 
D, vitamin B compound, vitamin C, zinc, and folic acid. Immunomodulating drugs 
(antimalarials and steroid treatment for rheumatoid conditions, methotrexate) were 
stated by three participants who were referred for rheumatoid conditions. Three had 
experiences of a pain management clinic. Other participants received metabolic 
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treatment, arthroscopy for knee, laminectomy, plasma exchange, and plastic surgery 
(all single cases).  
A few participants who had other health issues stated they were having conventional 
treatments for their underlying circulatory system diseases (blood pressure tablets, 
defibrillator), or diabetes (medications) (n=4).  
5.4.2 Conventional treatments: Disadvantages more than advantages  
Although many participants (n=16) had previously benefited from various 
conventional treatments, including medications (n=11), injections (n=4), 
hydrotherapy/swimming (n=3), physiotherapy (n=3), and surgery (n=1), a lot of 
them felt they were associated with side effects, or the effects did not last long. 
Fourteen participants (88%) stated that they were trying to avoid medications or 
(frequent) injections as they believed that these were closely linked to side effects. 
They ‘numb your brain’, ‘make you drowsy/dizzy’, ‘destroy your stomach, guts, 
busted the intestines’, ‘weight gain’, ‘antibiotic allergy’, or lead to medication 
resistance or kidney/liver problems, especially when taking for long period of time.  
I think I’ve been dependent on tramadol for so long. I found it hard to wean 
off  - made me shaky and cold… My liver, I think, has been affected due to 
the long term that I have been taking the medications (15). 
It [anti-malarial] has basically helps or not helps basically it lets me lose 
quite a lot of weight, stomach cramps, vomit, nausea, headaches (23). 
Conventional medicine has always kept the symptoms largely at bay, and the 
side effects are horrendous (21). 
It [anti-depressant]can make you drowsy and you need it all the time, you 
know you take it and then your body gets used to it and then you take tablets, 
and anti-depressants are not very healthy (12). 
I’m going to have to ask my husband to tell you exactly because my memory 
with the tablets and everything isn’t very good… My kidneys and my liver, 
they did nearly fail Christmas before last because of all the medications (46). 
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Especially since I started taking my pills, I’m much more sensitive with it 
than I was before, and my girlfriend used to hate it when I was out of things 
in the evening, you know. She would be able to tell I wasn’t there (39).   
This is particularly obvious when participants had co-morbidities and were taking 
many medications for their health issues at the same time (n=3).  
So all these [medications] work, but it feels false, feels not good for you. 
It’s not good for you especially for a long period of time… These are 
serious anti-depressants I suppose. There’re several different varieties of 
problems around me, some with stroke, some with diabetes, and with 
complications. So it’s worst with these complications. So I don’t have the 
habits, with drinking habits etc. It’s a combination of life issues and 
people doing what they could fit in (06). 
Apart from three participants who found physiotherapy helped in strengthening 
muscles or helped in “realising postures”, 10 out of 13 participants found no benefit 
from physiotherapy or even made pain worse, especially with the non-guided 
physiotherapy (when only one instruction was given, then patient left to practice 
himself at home) as the participant was not sure if he had done it properly. 
I went to physio and it was rubbish, a lot of rubbish and they didn't know…They 
gave me exercises and then I went back next time they said, "You're doing too 
many exercises." And I said, "But last time, you said I wasn't doing enough, and 
now I'm doing too much." And then again we less and you know -- and anyway. 
And so, they didn't ask me to go back so I felt good because it was like a waste, a 
waste of time (08). 
Four participants, who stated injections were helpful, all felt it was excellent in 
relieving pain. Injections helped them for different lengths of time ranging from 5 
weeks to one year. However, they all reported that after a while the injection started 
to wear off.  
5.4.3 Physical and mental benefits of CAM 
Thirteen participants had no previous experience of CAM therapies before their 
RLHIM appointments, for those who had previously experienced CAM, 12 
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participants (71%) experienced CAM in a private setting, 11 (65%) received CAM 
treatment previously in an NHS setting, and four participants received both. 
Acupuncture and massage were the most commonly received CAM therapies 
reported by participants.  
Acupuncture was the most popular or valued treatment stated by the participants who 
experienced benefits of using it. Of the 15 participants who had previously received 
acupuncture for their MSD, 13 (88%) perceived acupuncture to have been beneficial. 
Other helpful CAM treatments which participants reported were Pilates, osteopathy, 
massage, herbal medicine, Alexander technique, reflexology, and tuina. Acupuncture 
(n=11/15, 73%), Pilates (n=3/4), and homeopathy (n=2/17) helped in reducing pain; 
acupuncture (n=5/15) and osteopathy (n=2/4) helped in improving movement; 
Pilates helped to strengthen muscles (n=3/4) while acupuncture was reported in 
“softening the muscle” (n=1/15); and one (out of three) participants felt reflexology 
had helped with sleep and appetite. Three out of 15 participants also reported that 
acupuncture helped in reducing the conventional medications, and one participant 
found acupuncture especially helped during winter.  
But with the acupuncture, they tend to soften it [the pain] a little bit… 
Acupuncture will cut that pain down quite well. It won’t get off it [pain] 
altogether. But it makes it a lot more manageable (11). 
I just started Pilates as well. I’ve only done one Pilates session and I want to 
continue, because that makes your tummy strong, but in a gentle way. It’s quite 
kind to your back, you know… I know some Pilates moves like turning in chairs 
just slowly and just breathing, and that’s helped me as well (38). 
In terms of mental health, participants reported benefits from acupuncture (n=4/15), 
mindful breathing (n=1/2), yoga (n=1/3), and massage (n=1/6) made them feel 
relaxed or helped with fatigue. One participant felt tai chi made her more aware. 
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Five participants reported benefits of receiving integrative treatment packages in 
pain management courses, and acupuncture in addition to aqua fit or other exercises.  
I’m seen by the doctor plus the dietician, physio, and everything - acupuncture. 
It’s more than I was expecting and it helped me a lot. I mean I’m really 
happy…Like I said, everything is helped, not only with one thing. Everything is 
helped… plus talking to them as well, they help further (33). 
However, in a few cases, participants reported that CAM helped, but the effects 
tended to wear off (acupuncture n=3, Pilates n=1).  
5.4.4 Unaffordable private CAM  
Many (n=12) believed that private CAM clinics were too expensive and that they 
could not afford them.  
For me, personally, I believe they helped me a lot. It’s just the fact if I’m not 
working, I cannot afford to do it privately (23). 
How can you afford alternative therapy? You can’t really. It’s only if you’re 
lucky (38). 
That was the most expensive thing I’ve done because the sessions were so 
long… It was £90 to £100 each, so I did about three. … Basically, in the first 
year, I was doing mixtures of those [NHS and private acupuncture], but it was 
too expensive to carry on doing it (39).   
Among those participants who felt that private CAM clinics were unaffordable, three 
reported this was due to their lack of ability to work as a result of their MSDs.  
So if I wanted to do stuff like that [acupuncture], I have to be privately funded, 
which, when I only get disability money, it’s just not, it’s not physically possible 
to afford things like that (40). 
Some participants (n=4) who reported benefit from CAM by receiving treatment 
within the NHS argued that they needed to finance further private treatments 
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Because in that [hospital], the physiotherapist there does six sessions of 
acupuncture, and it helped me a lot, it did. And they said to me that ‘you can 
have it regular’, but I couldn’t afford to pay (03). 
5.4.5 Lack of communication 
Four participants thought there was insufficient communication or explanation from 
the practitioners they had seen previously outside the RLHIM. Two stated that 
medications were always the first option GPs considered for pain under any 
circumstances; one participant stated that limited time was given in consultations.   
If I see my GP, they give me medicine, see me in five minutes, and give me the 
medicine, and that’s it (33). 
More details on participants’ communication with their GPs regarding their RLHIM 
referral are discussed in 5.6.4. 
Summary of previous personal or healthcare experiences 
• Participants tried various types of conventional treatments, including various 
painkillers, and multiple medication use, physiotherapy, psychological treatment, 
supplements, and pain management. Some of them were taking additional 
conventional treatments for other health issues; 
• More disadvantages than advantages were identified by participants who took 
conventional treatments, particularly medications and injections, which were 
believed to be closely associated with various side effects, especially in the long 
term. These side effects have made their health worse, especially when they had 
other co-morbidities and polypharmacy. Most participants stated physiotherapy 
was not helpful; injection was helpful but effects were not sustained; 
• Nearly half of participants had no previous experience of CAM. For those who 
did,  acupuncture and massage were the most common received CAM treatment 
in participants’ previous experiences; 
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• Participants who had used CAM treatments previously experienced physical 
benefits in reducing pain, improving movement, strengthening or softening 
muscles, and improving sleep and appetite; and mental benefits in relaxing and 
fatigue, and being self-aware. Another benefit reported was reducing 
medications taken. Integrative packages of treatments were perceived beneficial 
for some participants. A few participants reported these benefits tended to wear 
off; 
• Participants reported private CAM clinics were unaffordable, particularly given 
participants were exacerbated by a lack of ability to work due to their MSDs. 
Some participants, who had previously had CAM via the NHS,  had to go 
privately after several treatments, and typically found this an economic burden;  
• Negative experiences of CAM included perceived lack of effect, make pain 
worse, and restrictions in movement during the treatment; 
• A small amount of participants felt there was a lack of communication with 
practitioners about their previous experiences. 
 5.5 Self-management and self-care of musculoskeletal disorders 
This section contains information mainly generated when asking participants the 
following question: “What self -help measures have you used to try to improve your 
condition?” Participants touched on relevant data when answering other questions 
and these were also coded within sub-themes under this theme. Participants reported 
various strategies to cope or to treat themselves. These included self-care strategies 
for their MSDs, managing their thinking about their MSDs, and making changes in 
their lifestyles to adapt. Sub-themes under this theme are closely linked to 
participants’ MSDs and their previous personal or healthcare experiences (Sections 
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5.2-5.4). Figure 5.6 shows the sub-themes under self-management and self-care of 
MSDs. 
Figure 5 6 Sub-themes under the theme ‘self-management and self-care of MSDs’ 
 
5.5.1 Self-care 
Half of participants (n=15) reported they used self-treatments at home, to help 
manage their MSDs. Similarly half (n=14) experienced benefits from doing physical 
exercises. The intensity of exercises depended on their conditions. Participants in 
comparably better health were able to do more exercises and more likely to benefit. 
Reported exercises included: walking, dancing, stretches and strengthening 
exercises, deep breathing, tai chi and Qigong, yoga, swimming (and aqua fit), use of 
a Wobble board, and Pilates.  
I’m trying to do the exercises that I got from that course [pain management 
course] most days. I’m at least doing the warm-up and these exercises. I’m 
mainly trying to do all the stretches and the strengthening exercise as well. … I 
think, I mean, all the pain management making the change yourself and doing 
the exercises and modifying your lifestyle, but I don't know. Just look at the 
problem from a different direction, and I thought that was a good thing (39).   
It’s [tai chi] very gentle stretches and you know, all the time, his voice was 
saying ‘think about your breathing’, you know, are you sort of going like this 
and on his phone he recorded himself going through the breathing technique. So 
any time I can, just plug into my phone, just listen, and relax (47). 
I think there were six sections [of pain management, including exercise, mindful 
breathing, understanding of the pain] to start with, and that was really really 
helpful because they explained, you know, how to sort of rearrange your life 
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really, to trying cope with this ongoing pain... We did exercises, hmm, so 
mindful exercises, you know, all the time, kind of thinking, ‘how’s that feel, 
how’s my breathing’. We did mindful breathing... And he actually managed to 
make us a DVD with exercises on, so we can do [at home] (47). 
Well, it's [physiotherapy] brilliant. You sort of inflate it yourself, this thing 
[wobble board], and lift your legs a little all over the place, and of course, it 
makes you keep still to keep your balance. You know you're doing all the 
exercises without realising, because you've got to sit like that. So I went and 
bought one [Wobble board]. We looked at it and she told me what to do and I've 
been doing that regularly. And to me, that's doing something (31). 
During the interviews, two participants reported benefits in having healthy diet (one 
was in a macrobiotics programme). However, it may be the case that some 
participants felt they already had a healthy diet so felt no need to change it or to 
mention it as this was not asked in interview. 
5.5.2 Managing the ways of thinking 
Some participants (n=9) recognised that part of the progression of MSD symptoms is 
also part of their life. They tried to be positive and cheerful, to carry on with daily 
life. 
When I said about my life, I don’t mean I'm giving up. What I mean is, I was 
married, I had my son, I looked after my mom when she was ill, and I looked 
after my brother when he was ill, and now it was my time of life (02). 
I’ve learned now, you know, as the years going back, that you have to be 
positive and stay optimistic because if you don't maybe take control over the 
situation, the actual disease will take control of your life and then you will be 
very sad (23). 
I just -- a part of the depression was -- with me, was though I couldn't accept 
that I couldn't do what I used to do. But now, I just -- I don't put pressure on 
myself now. I just get up and I have breakfast and I have a coffee you know, and 
then I'll think, "Well yeah, I can do that today." And I don't force myself to do 
anything because when I force myself to do anything, it sets off my anxiety which 
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5.5.3 Distraction, keep themselves occupied 
Eight participants were actively involved in various activities as it helped distracting 
them from their MSDs and keeping them occupied. These activities included: 
reading and studying, knitting, arts and crafts, jigsaws, gardening, having ‘chill’ time 
(watching a film, having a bath ), going shopping, and joining different clubs 
(reading, language, rugby).  
I keep myself busy at all times, either mentally or physically, doing a variety of 
things, but I am spending more and more time reading. I don't feel I can do 
more to distract myself. … When it became obvious that I was not going to be 
able to return to nursing I decided I had to keep my brain active so I enrolled at 
my local college for Spanish classes. I have gone on from there to learn French, 
German and Russian, plus a year of Greek and Latin (05). 
When I’m doing something, reading, I can’t read, that’s the problem, cos when 
you are reading, you’re conscious of your pain as well. Because when I’m active 
and you are doing things, your mind is completely different and you’re moving. 
When you are stationary, and you read, suddenly, you feel ‘oh dear!’ You know 
what I mean? When you’ve done what you’re doing, physically, and you’re 
concentrating on that. When you do eventually stop, you thought ‘oh it hurts!’ 
But it didn’t hurt at first. So you just, rest a bit, and then carry on (09). 
5.5.4 Understanding their conditions 
A few participants (n=6) were trying to keep updated with information about their 
conditions. They felt that being knowledgeable could help them understand the 
condition, explain their symptoms, and identify possible treatments and how they 
might work.  
I do reading to understand what would benefit me. So, like things like 
reflexology and acupuncture I like to do a lot of self-knowledge. So it’s not, it’s 
not, you know, only maybe the hospitals and GPs that … told you what to do. 
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5.5.5 Careful planning of activities  
Some participants (n=5) reported that since having MSDs, they have had to carefully 
plan their activities, schedule or arrange how they do things to adapt to their MSDs.  
My strategy for coping has always been to plan each day well ahead of time 
and then no matter how I feel, I do what I have decided for that day. I never ask 
myself how I'm feeling today (05). 
 If I’m running a bath, you know I have to lean on the bath. If I put some 
trousers on, pick up one leg but I can’t pick up the other. You know everything I 
do, it affects it. It isn’t the same. It absolutely affects everything (38). 
I’m very conscious that I need to try and better plan out and manage what I do 
and, you know, things like carrying shopping bags from the supermarket is not a 
good idea. You know, …[I] break up my shopping into smaller ones, going with 
my girlfriend or friend (39).   
In one case, a participant stated having MSDs affected her decision making and the 
choices she made in her daily life.  
Hmm, so I sort of, have to make new decisions. To start, I need to make new 
decisions, you know, when I had this pain, it was fatigue, I was really tired. I 
couldn’t, I couldn’t, I didn’t go out. I couldn’t drive, you know. It took a while 
for me, just to sort of, build up, gradually (47). 
Summary of self-management and self-care of MSDs 
• Self-care of MSDs included various types of conventional physical exercises 
such as walking and stretches, and CAM exercises such as Tai chi, yoga, and 
Pilates; and healthy diet; 
• Self-management strategies included distraction from their MSDs, self-learning 
and understanding the MSDs, and carefully planning daily activities to suit their 
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5.6 Pathway to treatment  
The theme ‘pathway to treatment’ contains information generated when asking 
participants the following question: “Can you tell me how you came to be referred to 
the Royal London Hospital for Integrated Medicine?” Participants who touched on 
relevant data when answering other questions were also coded within sub-themes 
under this theme. This theme contains two sections: the first section (5.6.1 – 5.6.3) 
presents participants’ decision making process of coming to the RLHIM, which is 
closely linked with participants’ previous personal or healthcare experiences; the 
second section (5.6.4 & 5.6.5) presents participants’ experiences in getting access to 
the treatment at the RLHIM. Figure 5.7 shows sub-themes under the theme pathway 
to treatment.  
Figure 5 7 Sub-themes under the theme ‘pathway to treatment’ 
 
5.6.1 Family/friends and healthcare authorities’ suggestions 
Many participants (n=10) decided to try CAM therapies as their friends or families 
had previously benefited from these therapies. 
My wife totally agrees with acupuncture and what most people class as 
witchcraft we class as normal healing like herbal medicine, and stuff because 
they all work. We know they work. What’s that, what they call it? Homeopathy! 
Yes. My wife went and had a course of it (11). 
Or they were recommended by their GPs or consultants (n=4). 
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I’ve had injections, and he [GP] said he’s been trying to help me get 
acupuncture, as it goes between, to trying help with, in between when I get the 
pain, cos I don’t want too many injections. I think twice a year is quite enough 
(02). 
My doctor, Dr [GP], believes in it [acupuncture]. He’s actually trained in 
acupuncture. So he said ‘you get as many as you can, if it can get you back on 
your feet’ (11). 
5.6.2 Based on previous healthcare experiences or knowledge 
Some participants (n=8) had tried many different types of treatment but found 
nothing helped, so they were open minded to try any available therapies for their 
MSD.   
I think if you get to the stage where I am, that all these conventional therapies 
couldn't help you at all, then you'll try whatever comes along (05). 
For patients who have a problem like I have, in short periods you're using these 
medicines [conventional medications]… Because I’ve had it for 15 years, and I 
destroyed myself with medicines. Maybe it would work much better for me if I 
used nature medicine, for me to recover, for me to have any benefit. I want to 
try it. I don’t mind if I don’t see any benefit. I wish I could get rid of all these 
[conventional] medicines… I have beliefs in nutrition (19). 
It was because nothing had worked so maybe taking another route would be 
better (32). 
I’ve seen, you know, even it's only just TINY TINY benefit, I’ve seen the benefit 
for it [acupuncture] so, you know, I’m quite open. I’ll give anything a go (40).  
Participants’ personal interests may also influence their decision making in using 
CAM: two participants worked in the CAM field (one studied homeopathy, the other 
was a Reiki healer); and one participant was fascinated about the use of herbs since 
the 13th century and were having beliefs in them. 
5.6.3 Because it is Royal London Hospital for Integrated Medicine (NHS) 
When asking participants why they were referred to the RLHIM, some participants 
(n=6) expressed the feeling that they trusted RLHIM and believed that the healthcare 
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professionals at the RLHIM are well qualified and knowledgeable in the field, and 
would provide a high level, professional job.  
They’re all doctors and they know what they are doing. I know in the private 
clinics, basically as long as someone has the ability to practice, no matter 
qualified or whatever, you can take a separate course in it, and still practise it, 
so yeah. But I know that here is actually full on medical acupuncturist and so 
on (04). 
It’s one of the leading homeopathy hospitals in the country… And as such, he 
[RLHIM Dr] will do professional job (20).  
I mentioned to him [RLHIM Dr] about this prolotherapy. And he knew what 
exactly it is … And the doctor said ‘oh yes I’m involved in that study’ (38). 
5.6.4 Difficulties in getting referrals 
Most participants (n=27) were pleased with the length of time they had to wait once 
their GPs agreed to refer them to RLHIM. However, many (n=22) had issues 
communicating with their GPs in order to get a referral to the RLHIM.  
My GP is absolutely useless. He’s no good at all. I had difficulty with my GP, 
cos my GP, you see, the hospital consultant couldn't refer me direct, he wasn't 
allowed to do that. So I have to go through my GP. So I went to my GP, he said 
‘I can't refer you to the hospital, it isn't an NHS’, but I know it is cos I was under 
UCH anyway. My GP is very difficult. He told me all sorts I can't believe it! He 
told me in alternative medicine, no doctors are fully trained. It was 
UNBELIEVABLE! My GP is absolutely against it. ... I think all of it is because 
his practice has to pay for me to come here, and he's always concerned about 
his money (05). 
Hmm, it is to do with NHS funding. So, for - there is a whole protocol. With 
shoulder things, they can do it if you’ve tried a lot of stuff (27). 
Many participants (n=13) found there was inadequate access to CAM treatments as 
they were not available in their local GP practices. Some (n=5) interpreted it as due 
to a lack of NHS funding for CAM treatments. 
The thing is you don’t get offered anything like that [CAM treatments] do we at 
home? It’s part of the fibromyalgia thing. My consultant, as I said, my pain 
consultant, who’s Chinese, believes in all that kind of stuff, but he can’t get any 
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funding on anything to refer any of his patients to things like that. So if I wanted 
to do stuff like that, I have to be privately funded (40). 
5.6.5 Being ‘insiders’ 
Some participants (n=9) were referred to RLHIM through a referral letter from 
specialists in UCH and the group of hospitals associated with UCH, such as the 
National Hospital for Neurology and Neurosurgery (NHNN). 
Some participants (n=6) believed that whether they are referred to RLHIM or not, 
and for how long, was a ‘postcode lottery’, based on different referral schemes in 
different boroughs and on which conditions they had.  
I’m not sure why, but if I do want something [CAM treatment], they’ll say, 
“Oh, it’s out of the borough. It’s not in our borough. Why do you need to go 
there? You should go here.” Then, I’ll have to explain to them the problems 
with them, and then, eventually I did get the referral. And then, that’s when I 
started to get treatment and diagnosis as well (15). 
So, I’m extremely lucky. It is in my patch. In my borough [Camden] (27). 
It’s the postcode lottery. It [referral to RLHIM] depends on where you live. 
How good your services are and whether you are in this part (38). 
In one case, the participant who had experience dealing with CAM services 
suggested that people can ‘no longer get homeopathy’ at the RLHIM and the best 
way to get homeopathy treatment is to get referred to rheumatologists (who is also a 
homeopath therapist), under a specialist in the RLHIM.  
I said to him [GP] that they [CCGs] may, probably won’t fund it 
[homeopathy], if you do it to the RLHIM. So I suggested he write to [RLHIM 
doctor], as a rheumatologist, consultant of rheumatologist, at UCLH, but put 
this address, which is what he did. And that’s how I got through. Because the 
rheumatology doesn’t come under the sort of like, easy access (20). 
Summary of pathway to treatment 
• Participants decided to try CAM treatment as their families and friends had 
previous positive experiences, or it was suggested by healthcare professionals; 
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• The decision for using CAM was also influenced by those who seldom had any 
positive impact from conventional treatment, or their personal knowledge or 
interests;  
• Having qualified, knowledgeable professionals was one reason participants 
came to the RLHIM; 
• Most participants were pleased with the time they waited to get referred, but 
experienced difficulties in persuading their GPs to refer them to the RLHIM. 
They believed lack of access to CAM services may be caused by a lack of 
funding; 
• Participants felt two aspects affected whether they could get referred: which 
borough they were in, whether they were referred from another doctor in the 
same group (e.g. UCH or NHNN). 
 5.7 Patient expectations 
The theme ‘patient expectations’ contains information generated when asking 
participants the following question: “Can you tell me what your expectations are for 
your treatment at the hospital?” Relevant data obtained when answering other 
questions were also coded within sub-themes under this theme. The issue in 
participants using the terms expectation and hope inconsistently is discussed below 
(5.7.1). Their expectation and acceptability of the treatment at the RLHIM are also 
discussed (5.7.2 -5.7.8). Content in this theme was closely linked with participants’ 
MSDs and their decision making process, discussed in Section 5.6. Figure 5.8 shows 
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Figure 5 8 Sub-themes under the theme patient expectations 
 
5.7.1 Inconsistent use of expectation and hope  
When asking about their expectations of the upcoming treatment at the RLHIM, 
most participants (n=26) talked about their hope, and the terms “expect”, “hope”, 
“want”, “think”, and “believe” were used interchangeably. Expectation refers to ‘a 
strong belief that something will happen or be the case’; while hope refers to ‘want 
something to happen or be the case’ (Oxford Dictionaries, 2014).  
I have great expectations [laugh] that they’ll be able to cure me from my 
pains [laugh] (02). 
My expectation? I hope I could be pain free and I could hold my head up for 
long, longer than now (03). 
Though participants inconsistently used the words expectation and hope, some (n=6) 
of them were aware of the clear differences between the two. 
I don't have any expectation apart from hope that I feel better, that it 
works but that's because I've been to so many people and they all said, 
"Oh, we can't help you (36). 
I am, [long hesitation], there's a hope. There's a hope, is one thing, and 
expectation is another. I have high hope, but my expectation is umm, 
pragmatic. It will or it won't. You know, it doesn't always work. It doesn't 
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5.7.2 Pragmatic, realistic expectation 
A lot of participants (n=18) stated having pragmatic, realistic, or neutral expectations 
for the upcoming treatment at the RLHIM as they had long term experiences with 
their MSDs. Some (n=7) also shared their experiences in how to manage their 
expectations.  
It’s being realistic, that my expectations are day to day, not look into the 
future. I can’t look into the future. Today is the future. Although 
tomorrow is the future, I don’t want to know how I feel tomorrow. I want 
to know how I feel now, today. So I live today and I don’t worry about 
tomorrow, where some people would worry ‘what’s going to happen to 
me in ten years’ time’. Oh my god I don’t think that far. Cos I’ve 
travelled since 1983, with this pain. I’m still here, and I’m living, I’m 
doing most things, not everything I can do (09). 
Hmm, I try not to build my hope up so much now, cos up till then, every 
time I saw a new person, I thought, ‘this is gonna be it’. And then at the 
end, 2 months, nothing happened and you get, oh dear, I'm really dying 
for a day or two, then I say no it's no good. So I try not to raise my hope 
so much now. Whatever I get will be a bonus (05). 
5.7.3 Acceptable treatment at the RLHIM 
When asked were they expecting any issue with the treatment at the RLHIM, most 
participants (n=18) had no concerns about coming to the RLHIM for their treatment 
at all as they believed the CAM/IM treatments are mostly non-invasive, or they did 
not state any concerns in the interview.  
M: do you think there will be any side effects? 
Not that I’ve ever hear, no. hmm, I found it really strange that people ... 
Actually I’m very interested in it [acupuncture]. It’s funny because I don’t 
like needles. But with this, because that’s [the needle] so thin, I don’t see why 
it’s a problem (04). 
I’ve seen it [acupuncture] on television, you know. I think because I had so 
many different kinds of tests and you know, blood tests, millions of blood 
tests, so it’s [blood test needle is] bigger [laughs]. I’m quite open to anything 
really. If somebody said, ‘right, this is going to help’, [I would try it] (47). 
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Some participants (n=7, all living outside London) stated that the journey from their 
home to the hospital was quite time consuming and that was one of their concerns. 
There was one participant who was concerned about perceived inadequate evidence 
behind treatment provided at the RLHIM.  
There is evidence for acupuncture, but there's no evidence for homeopathic 
and there's no evidence for herbal medicine, like these teas and there's no 
evidence for Chinese herbal medicine. They do studies, trials. They have to 
do trials (12). 
Several participants (n=4) were worried about whether they would get re-referred 
after this episode of treatment.  
They [doctor in previous experience] said, you know every -- if we can do it 
every 12 weeks, 12 sessions I got and just keep getting yourself re-referred. 
And as long as it can be funded (31). 
5.7.4 Hopes for better health 
Participants hoped that the treatment at the RLHIM could help improve their health 
status, particularly including symptom relief (n=30), improving functional ability 
(n=17), and to minimise the amount of medications they were taking (n=9).   
All participants hoped to have some degree of symptom relief. Pain relief was the 
outcome expectation most frequently stated. Other symptoms such as stiffness, stress 
related to the MSD and sleeping disorders were also discussed.  
To get at least be able to manage my pain, if not completely cured. I know 
some things like arthritis, they’ll never go away, but at least [to] be able 
to manage myself and manage to take care of myself or look after myself 
and manage the level of pain. Even that would be a big bonus for me 
(15). 
I’ll be okay as long as I get some help. If I can get 20 percent or 30 
percent less pain, I’ll be a happy lady. I can put up with pain. I’ve got 
pain most of my life. I can put up with pain. But if I can get rid of just that 
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I had [acupuncture] once before and it helped with getting my movement 
back. I was in a lot less pain… I was getting aggravated, stressed. It cut 
down stress a lot because there wasn’t so much pain (11). 
In association with pain and other symptoms caused by MSDs, functional ability is 
closely linked to quality and enjoyment of life. Their functional ability was often 
focused around work, hobbies, social life, or daily living activities.  
Well, I hope the treatment here will provide me with a better health, 
better standards of living for me personally where I was not in so much 
pain (43).  
But you know, if I would go back to swimming, I’m able to do all my 
strokes, with actually, actually no pain. … But if they can get me in the 
right movement and reduce the pain. I do know people who have, you 
know, really good success with acupuncture. So I am very open and I am 
up to it (27). 
A few participants (n=2) stated that they needed some meaningful activities, such as 
getting back to work, which would enable them to interact more with people and also 
build their self-worth.  
There are a lot of things to do, and distractions. But purpose has gone. If 
you see the distinction. It would be good to get back to some kind of job. 
That’s what I’m trying to do in my life, as being work, really. And now, 
just money, but just structure, and I’m very disciplined, otherwise – don’t 
drink too much. So structure is always providing by work. I’m thinking to 
interact with other people would be good (06). 
5.7.5 Ideal integrative treatment  
Nineteen participants (63%) had something in their mind before receiving treatment 
at the RLHIM, among which thirteen were aware of which treatment they could be 
expected to receive before their initial appointment at the hospital: acupuncture 
(n=10; one specified Western acupuncture, one eastern acupuncture); homeopathy 
(n=1); physiotherapy (n=1); one patient was on the waiting list for a combination of 
CBT, mindfulness and acupuncture. Five participants had no idea what they would 
receive but had a clear idea of what they hoped for: acupuncture (n=3); homeopathy 
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(n=1); pain management (n=1); assessment (n=2: one specified they ‘desperately’ 
wanted a CT/CAT scan). One participant was referred for joint injection but was 
looking forward to trying reflexology if available. 
The remaining eleven participants (37%) stated that they had no idea of what 
treatment they were expecting or hoping for. Some had an open mind to any 
treatment as long as it was not medication; some placed their trust in the practitioner 
and believed they would be offered the most appropriate treatment for their 
conditions. Participants expressed what kind of treatments they hoped to receive at 
the RLHIM.  
Many participants (n=10) hoped to have individualised treatment and wanted their 
whole situation to be considered by the practitioner. They believed that the treatment 
protocol that works for one patient may not work for another. 
Basically what I do expect is that first, you know, for my case history to 
be taken into account and something devised that is going to be beneficial 
for ME. That’s my only expectation of the treatment and such, but other 
than that, you know, I have no expectations (21). 
Because I do believe that herbalism is a very individual thing. You know, 
it’s from patients. It’s not - what works one, might not works for another 
(43). 
Some participants (n=7) hoped to have ‘natural’, ‘organic’, and ‘non-invasive 
treatment’. 
This way to me is non-invasive, it’s natural. And that’s how I would like 
to be treated, you know. I don’t want to feel sick, or things like that, you 
know (54). 
Some participants (n=6) believed that both CAM and conventional treatments have a 
place for MSDs and the practitioner should use the optimum treatment(s) for their 
conditions and also gave examples to illustrate their ideas. 
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I don’t know what I’m going to get. Because this is a hospital for 
integrated medicines, and what will happen is they would assess my 
condition, and decide what they think is appropriate for me. And if it is 
homeopathy, or diet, or acupuncture, or physio, or a bit of one two three 
things. That’s what they will do. … That’s not to say that I’m anti-
conventional medicine. Because I’m not, I think it has a place. I think 
they ALL have a place…. They WILL give you what you need. That’s why 
when you say are you getting homeopathy, well I hope I do. But at the 
same token, they will only give it to me if they think it’s appropriate 
treatment to have and they may give me something that I would prefer not 
to have but at least I know they are conventionally trained, and they will 
assess it accordingly. Because they are also trained in complementary 
and they’ll know whether something will work or not. And if they don’t 
think it will work, then they’re not going to waste my time (20). 
I mean, I am not an idiot. If I fall or do something to myself, I will 
immediately take an ibuprofen. I’ll take an anti-inflammatory, so I’m not 
stupid. But you know for chronic condition, I’d rather try work them out 
with complementary….THAT [a combination of CAM and conventional 
treatments] is the sensible approach into integrated medicine. It is not 
seeing them as two different things. My son lived in [an Asian country] 
for a little while. And we were talking on Skype one day and he’d been to 
a doctor. I think he had a stomach upset. And he said, ‘look what they 
gave me!’ He held up a load of like little blister packs, four pills each 
pack and it’s like that was his dose. … And two of them were 
conventional medicines, and the other two pills were complementary, to 
deal with the side effects. You see, so to me, that is really integrated 
medicine (27). 
A few participants (n=4) hoped that the treatment could help them get rid of the 
condition from the root, to solve the pain completely, rather than suppress it.  
And I realised that the medicines, you become dependent on them. You’ve 
got side effects on them, and after, I’ve got to try something alternative, 
which is not just medication, but something that can get to the root of the 
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5.7.6 Patient-practitioner communication 
Many participants (n=9) hoped to have better communication with the practitioners 
they were going to see at the RLHIM, in terms of receiving more up to date medical 
information or professional advice (n=5).  
But you know, really I just want up to date information and knowledge 
about treatments, which was initially why I asked to go and be referred to 
the hypermobility clinic at UCH because I was coming up against 
situations where, particularly physios, might say, "Well, we don't 
recommend that now for hypermobility." But that's what I've been told as 
kind of an article of faith in my pain management course, and I thought 
"Well, I actually need to find out now what I should be doing then, what 
the latest research suggests." (10). 
It’s nice to have the words of an expert, you know, somebody is 
knowledgeable in that field to guide me, more than just the internet (43). 
A few participants (n=6) stated the importance of patient engagement in treatments, 
which they believed could help the treatment. They wanted to be listened to and they 
cared whether the practitioner is a good listener or not. They hoped to have more 
understanding and mental support from the practitioners. 
I don’t want to be shut up. I just want to be listened to, I don’t want some 
doctors to go and shove a fistful of pills in my mouth. I want somebody to 
hear what’s coming out of my mouth (21). 
If patients were engaged in it [treatment], they felt better as a result, as 
just being involved in it, you know. And that is a holistic thing. You feel 
better, if you’ve been spoken to, as a human being, and you’ve been 
involved and you feel sort of empowered…. And made her feel relaxed 
and made her feel somebody cared about her actually. Basic caring, 
which is all the NHS supposed to be about, isn’t it? You know, people 
caring for you, and doing their best, you know (54). 
5.7.7 Qualified professionals and teamwork 
The contents in this sub-theme overlapped with participants’ decision making 
process of coming to the RLHIM (Section 5.6.3), but this was also an emergent new 
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sub-theme in the patient expectation theme. It was a sub-theme as participants firmly 
clarified these beliefs. 
Many participants (n=8) stated that they trusted medically qualified doctors more 
than CAM practitioners in private clinics, where the practitioner may start practising 
after simply attending a short course.  
They’re all doctors [at RLHIM] and they know what they are doing. I 
know in the private clinics, basically as long as someone has the ability 
to practise, no matter qualified or whatever, you can take a separate 
course in it, and still practise it, so yeah. But I know that here is actually 
full on medical acupuncturist and so on (04). 
A few participants (n=3) emphasised the importance of teamwork and 
multidisciplinary team work together to help resolve their health conditions.  
The people here will work in conjunction with the other professionals that 
see me, so they won’t do anything that’s going to and they won’t say, 
“Stop the steroids and have this herb or whatever.” (21). 
5.7.8 More integrative treatments are needed 
Some participants (n=9/17) who had previously experienced CAM treatment felt the 
CAM treatment available in the NHS is not enough and they would like to receive 
more. They wish to experience long term effects and continue to receive treatment at 
the RLHIM to maintain their symptoms at a bearable level. 
They [physiotherapists in UCH] only provided six sessions [of acupuncture], 
in physiotherapy, for free. So they referred me, they said to me ‘go back to 
your GP, and she’ll refer you’. Cos I was benefited from the acupuncture, the 
pain relief was quite good. I was in pain in a way, but I could move my neck, 
stretch my neck. It was a lot better. So my GP referred me to this homeopathy 
hospital, to see if I could have it, on a long term, with the NHS, so that I 
could have good quality of life (3). 
But the problem is this – you can only have six treatments [acupuncture in an 
NHS setting]. They won't give you any more because it’s obvious they must 
see other patients. So the only way I can get treatment is if I’m referred to 
different hospitals, and that’s why, I’m hoping I can get it done here. … I 
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think, I think, this is what I want to check with the doctor, when you have 6 
treatments, you can be referred back again. You see, if I’ve got chronic pain, 
I don’t know if I can get regular, maybe once a week, or once a month (9).  
Participants (n=7) who had previous experiences in CAM treatments also argued that 
they were only allowed a certain number of sessions in their previous treatment at 
the RLHIM. They were hoping to have more long term, regular treatment.  
Well, it looks like I'm getting in this particular referral, six sessions of 
acupuncture, which for the time period that I have them, which would be 
over about 12 weeks. … So anyway -- but no, it will help. Oh, I'm sure it 
will help. It has in the past but -- and I'll just have to see at the end of it if 
I've got any money to pay privately to keep it going until possibly I can 
get another referral peeking in (10). 
Three participants expressed their wish to have CAM treatment as ‘in-between’ 
treatments to complement conventional treatment, to help with their MSDs. Among 
these, one participant mentioned the need for “hands on manipulation”.  One 
participant thought that more practitioners are needed in order to meet the demand 
for IM treatment.  
Summary of Patient Expectations 
• The terms expectation, hope, and want were used loosely and inconsistently by 
most participants; 
• Majority of participants had pragmatic and realistic expectations towards the 
treatment provided at the RLHIM as they believed that the hospital was 
experienced in treating MSDs, which involved actively managing their 
expectations; 
• Most participants had no concern about their impending treatments at the 
RLHIM as they believed the treatments would be non-invasive. Living far 
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• Most participants were aware of the treatment they were expecting and hoping 
for. Acupuncture was the most common treatment they expected; 
• Participants hoped to have better health in terms of symptom relief (pain, 
stiffness, related stress, sleeping disorder), improving functional ability (better 
quality of life, meaningful activities), and to be able to reduce medication; 
• Participants hoped to receive individualised, non-invasive treatment through 
having optimum treatment, and treating their conditions from the root cause; 
• Participants hoped to better communicate with RLHIM practitioners, and 
hoped to be engaged in the treatments; 
• Participants expected RLHIM practitioners to be skillful professionals, who 
worked in conjunction with other healthcare professionals; 
• Participants who had previously benefited from CAM treatment wanted to 
receive more; they hoped to have long term effects with more follow-up CAM 
treatments on a regular basis as a result of the RLHIM provision. 
 5.8 Feasibility of the research design (Pre-treatment) 
The theme ‘feasibility in research design’ contains information generated when 
participants were asked the following two questions: “Can you tell me what do you 
feel about taking part in the study?”, and “What are your expectations being involved 
in the study?”. Relevant data when answering other questions were also coded within 
sub-themes under this theme. Participants demonstrated their level of acceptability of 
the process by their completion of the outcome measures (Section 5.8.1); and in the 
reasons for participating, their doubts and concerns, and their expectations regarding 
participating in the research study (Sections 5.8.2 - 5.8.4). The data were associated 
with the theme living with MSDs (Section 5.2) as participants experienced various 
symptoms with fluctuating pain and fatigue which affected their acceptability of 
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participating in this research study. Figure 5.9 shows the sub-themes under the theme 
feasibility in research design. 
Figure 5 9 Sub-themes under the theme feasibility in research design  
 
5.8.1 Simple outcome measures 
Most participants (n=20) found the questionnaires easy to follow and quick to 
complete and stated no difficulties in completing them. Pain scales (VAS and sfBPI) 
were the two most popular outcome measures as they were easy to follow and took 
minimal time to complete, though some participants (n=8) had difficulties deciding 
what score to put on the pain scales. This is mainly due to having fluctuating levels 
of pain which were affected by what they were doing and whether it was a ‘good’ or 
a ‘bad’ day.  
I mean sometimes it’s okay you know, it’s just, you [are] aware that it’s not 
as settled as it used to be. Other time it really hurts. Other times it’s like 
there is a glass in you, you know, it’s changeable. So it’s not really. … It 
depends, if you asked me, say one day, then I might put higher scores, and on 
other day it would be lower (20). 
The least popular measure was the mCSRI which assessed the overall costs during 
the past three months. Participants (n=9) reported difficulties in remembering 
treatments received during the past three months, or felt that there were sensitive 
questions asked in the mCSRI (n=9). In two cases, the participants did not answer 
the questions asking about their insurance and national insurance benefits at the 
beginning but answered after the researcher explained why they were asked. 
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Well, apart from those 2 questions I told you that I was not sure what is the 
point of it [2 questions about patients’ income and benefit], but then you did 
tell me about why you put them there, so that’s fine. I’m happy with it (26). 
5.8.2 Participating to help research and MSDs patients 
The main reason for patients to participate in this research study was to help research 
in CAM/IM for MSDs, and ultimately help patients who have similar conditions. 
Many participants (n=14) stated that they were taking part to help evaluate the 
practice provided at the RLHIM.  
I actually feel that, this is my personal view, that through research, and 
asking different types of people then, I think there should be more research 
done in this field in order to have a clear and a better idea of what is the 
global, you know, a general idea (43). 
As much as you need me [for the research], and I trust that you will collate 
the information you take from me every day [study data] and, you know, do 
something proactive with it. I’m not sure that conventional medicine when 
they take these surveys do proactive things with it, you know because they’re 
not looking for cures for anything (21). 
Participants (n=13) also took part in the study to help provide information in the 
field, to help other patients with MSDs to better understand how their life was with 
their condition.  
I don’t mind taking part in this study because I feel if you can help me [to 
understand my condition] and then if my experiment, whatever you do would 
help other people who go through similar pain, to help them (15). 
I am happy to help. Because mostly when I’m sick, I feel so down. I think 
other patient will feel the same as well (13). 
Some participants (n=6) expressed that they participated to help the research student 
as a person.  
Well I don’t know if I would benefit anything from you, but as you are a 
student, and you are learning, I just thought I come along and have a chat 
with you and if I can help in any way I will (02). 
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Other reasons included: for clinicians to better understand their condition (n=5), to 
help themselves understand their conditions (n=3), to return to the RLHIM as they 
previously benefited from it (n=2), and to help them in getting more follow-up 
treatments at the RLHIM (n=2). 
5.8.3 Doubts and concerns in participating 
Many participants (n=12) claimed that they had no problems in participating in the 
research study because the study procedure was clearly described, the way of being 
contacted by the research student was acceptable, and it did not involve drugs. 
However, this was not supported by some observational data within the interviews. 
Participants’ concerns were mainly due to their MSDs or other health issues, and due 
to a lack of time.  
Ten participants experienced physical barriers in participating in the research study. 
These included a need to move and stretch during the interview (n=8); having 
difficulties in completing questionnaires due to hand deformities (n=2); and getting a 
headache during the interview (n=1). One participant had dyslexia. But they all 
completed the questionnaires themselves and completed the interview.  
I can’t hold my neck up high, I can’t do housework, it starts, pain. I can’t see 
too much TV, I can’t see newspaper, find it hard to filling forms, because I 
have to bend my neck down. That’s why I don’t take [part in] research (3). 
Concerns associated with the study design (n=9) included: participants worried about 
time before their appointments (n=7, one was interviewed before completing 
questionnaires as participant requested); insisted being interviewed outside the clinic 
room in the corridor (n=3); and wanting to leave early as they had travelled from 
outside greater London therefore interview was shortened (n=3). One participant 
found the explanation in the patient information sheet unclear (reconfirmed study 
aim, did not understand what was a ‘focus group’). 
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In rare cases, emotional changes in participants were observed. Three participants 
cried during the interview when they were talking with the research student about 
their life and experiences with MSDs. 
Sometimes – I know it sounds depressing but sometimes I just want to run 
away, you know, sort of – it IS very depressing. But I try not to depress other 
people with it, you know what I mean. [started crying] I don’t want to 
depress you (54. 
One participant refused to answer a question.  
M: Do you think this affects you emotionally? 
33: It did that time. Don’t ask me that time. I don’t want to go that far, but it 
did affect me a lot. 
One particular participant argued that patients’ anecdotal experiences should 
be taken as evidence for CAM, rather than keep on conducting clinical trials.  
It might be anecdotal, but if ten people have found it works for them, then 
I’d believe those ten people… And if it works, why do you need loads of 
evidence? Why do you need it? Why do you need to keep on doing clinical 
trials, clinical trials, when people had said it worked for them!… Just 
trust the patients, talk to the patients, if it’s helping with them, why are 
you so bothered about it, for goodness sake, you know. You know, it’s just 
ridiculous, isn’t it? (54). 
5.8.4 No expectation about the research  
When asked about their expectations in participating in this research study, most 
participants (n=25) gave very short answers claiming that they had no expectation, or 
were very ‘open-minded’ to this research. Answers to this question were very similar 
to reasons for participating in the research study that they were to help research and 
patients with similar experiences (Section 5.8.2) 
Summary of acceptability in research design (Pre) 
• VAS and sfBPI were the most acceptable outcome measures as they were 
simple to follow and quick to complete. Difficulties in completing them 
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included being unable to give a score due to fluctuating pain. mCSRI was the 
least acceptable outcome measure, with difficulties reported in remembering 
previous treatments, and finding some questions too sensitive  
• Participants took part in the study mainly because they felt research is needed 
in the field and they wanted to help other patients like themselves;  
• Though participants claimed that they had no concern participating in the 
research study, the research student noticed physical barriers to them 
completing questionnaires and interviews; concerns about time during the 
interviews; and unclear explanation in the patient information sheet; emotional 
changes were observed in some interviewees; 
• Participants had no clear expectations for the research study; their expectations 
about taking part in the research study were associated with their decision 
made to participate. 
Sections 5.2-5.8 presented findings generated from the pre-treatment interviews 
immediately before patients received their initial appointments at the RLHIM. From 
Section 5.9 onwards (Sections 5.9-5.15), the results presented are generated from the 
follow-up interviews and focus groups, which took place 12 months after 
participants’ initial appointments at the RLHIM, with a different sample of people to 
the pre-interviews. For the follow-up interviews, findings generated from the 15 one-
to-one interviews and the four focus groups were similar, therefore used the same 
framework. Findings were presented together, except in Section 5.11.4 (self-care), 
Section 5.14.3 (empathy and shared decision making), and Section 5.15.2 
(engagement and benefits in participating) where particular findings were presented 
on focus groups. At the end of this chapter, a comparison of pre-treatment and 
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5.9 Living with musculoskeletal disorders (follow-up) 
Though the research student did not ask questions directly related to participants’ 
experiences of living with MSDs, all participants shared their experiences of living 
with MSDs when being asked the following question: “Has the treatment changed 
your symptoms, wellbeing and quality of daily life? If so, how?” Relevant data when 
answering other questions were also coded within sub-themes under this theme. The 
changes attributed by participants to treatment are detailed later in 5.13.2 (theme 
‘experiences at the RLHIM’ – sub-theme ‘effects of treatment at RLHIM’).  
This section starts by introducing participants’ MSD symptoms, their long term 
complex health experiences, and how MSDs were affecting their life (Sections 5.9.1 
– 5.9.3); following their understanding of MSDs and how their MSD pain was not 
understood by others (5.9.4 & 5.9.5). Figure 5.10 shows the sub-themes under living 
with MSDs (Follow-up). 
Figure 5 10 Sub-themes under the theme living with MSDs (Follow-up) 
 
5.9.1 Various long term musculoskeletal disorders with co-morbidities 
All participants in this phase of the study (follow-up interview) had chronic MSDs 
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Among those participants, 13 participants stated that they had pain all over their 
body; eight stated they had rheumatoid conditions: joint hypermobility syndrome 
(n=4), rheumatoid arthritis (n=3), lupus and myasthenia (n=1); six stated they had 
fibromyalgia; three osteoporosis. There were also rare cases: one participant had a 
primary progressive multiple sclerosis, another had stiff person syndrome. Seven 
participants stated that their conditions were associated with degeneration; while 
three suggested problems due to a car accident, one was due to a bad fall. 
Many participants had other health issues as well as their MSDs. Many participants 
(n=11) reported sleeping problems. Some participants (n=5) felt that they had a 
mental health problem but it was unclear whether this occurred before or was as a 
result of their MSDs. Other participants had conditions such as; thyroid problems, 
glaucoma, and hypersensitivity.  These co-morbidities may or may not have been 
related to their MSDs. 
When you're suffering from an auto immune you can't turn it off (55, 
Physio+Homeopathy+Insomnia clinic+MDT/OT). 
But I suppose I have quite bad memory. They said it’s because of mental health 
related stress and depression and stuff like that (FG7, Acu). 
5.9.2 Various fluctuating symptoms 
All participants in the one-to-one interviews and focus groups shared their symptoms 
of their MSDs. Most of them had experienced various levels of pain (93%) and 
restrictions in movement (75%). Some experienced stiffness (57%) and fatigue 
(21%).  
Many participants (n=19) shared their experiences of fluctuating pain or immobility.  
The pain is permanently there. And the severity of it depends on the weather, 
depends on what I’ve done, how I’ve been sitting, whether I’ve been 
travelling, all various things. So like today, for being on the train, cos 
obviously it was really rattily and jerky. So tomorrow, that will be really bad. 
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My lower back and the hips will be really bad… Yeah, just – everything 
triggers different things (40, Homeopathy). 
5.9.3 Adapting to life with MSDs 
Almost all participants (n=27) reported that their MSDs impacted on a wide range of 
aspects of life, both physically and emotionally. Among these participants, many 
(n=17) changed the way they do things, to adapt to life with MSDs. This is linked to 
the sub-theme lifestyle-management and awareness of self-help, which were both 
categorised as self-directed integrative approach (Section 5.11).  
Sit on the stool and vacuum with…. I just bend over and move the thing 
backwards and forwards, you know. And it – that’s all I can do (F14, 
Acu+Homeopathy+Physio). 
 [I am] eating properly and sleeping well, and making right choices and 
decisions (55, Physio+Homeopathy+Insomnia clinic+MDT/OT). 
Some participants (n=6) expressed feeling disabled or functionally restricted, which 
may lead to a feeling of lacking independence and relying on help from others. 
Well, you see, I don’t want my wife doing everything for me. She’s done all the 
housework; she’s taking care of me. It’s just, everything is pushing you on (F7, 
Acu). 
Uhhm, and so when you get home, when you’re on your own, and you collapse 
and you see your family is aware of how it is. So maybe it might be useful to 
bring my husband or my son here then they to tell you how it is at home (FG41, 
Mindfulness training). 
5.9.4 Patient understanding of musculoskeletal disorders 
Some participants (n=8) shared their understanding of their MSDs, which included 
how they interpreted the conditions, and how they understood the mechanisms 
operating with MSDs.   
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Well, your whole body is made up of connective tissue... well, your muscles are 
tense even it’s not physically – you know what, I mean, your muscles inside, 
when they are trying to hold you together (05, Homeopathy+Physio+AT). 
Your muscle…, wrong messages is going to your brain doing that, when it’s 
painful, when it isn’t because they’ve been bombarded which messages of pain. 
So it’s just re-educating the muscle, the messages. Actually, that’s a good 
movement, so do it repeatedly. So that’s what I do. And that tends to work 
(FG41, Mindfulness training). 
In some cases (n=5), participants shared their understanding of the possible 
psychological associations with their MSDs.   
If I’m in pain, I just don’t have the mental facility for it [socialise] all the time... 
I think, like depression, for example, it’s one of the symptoms of fibromyalgia; 
anxiety is a typical symptom of hypermobility. And I do get quite stressed out 
(FG10, Homeopathy). 
Some participants (n=5) believed that their way of thinking affects the progress of 
their conditions. One participant took her friend as a role model and explained that 
people’s interpretations of pain vary. 
I think you got to believe in it [acupuncture can help with the knee pain] as well, 
because if you have a negative mind, sometimes nothing works. You know, don’t 
forget this. Things like ‘oh, I got pain in my knee’, it depends how you relieve 
the pain in your knee, or how you think about it (09, Physio+Acu). 
So I do think when you treat the physical symptoms, your emotional health 
improves as well (FG10, Homeopathy). 
I asked her [a friend as a role model of 41] – I did say to her, ‘are you in pain?’ 
She was like, ‘oh no, no. hmm, it’s more of an annoyance’. She won’t say it’s 
painful. And it’s painful... So her relationship to pain is not like my relationship 
to pain. I realised it must be painful. But she calls it ‘an annoyance’, or ‘it’s 
restriction’, or ‘stiffness’. Hmm, I think her relation to pain will be like if you 
gash your hand open, or bang your head somewhere, that will probably be pain 
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5.9.5 Not being understood 
A few participants (n=5) expressed the feeling that their MSDs were not understood 
by others because they found it difficult to explain their MSDs. 
Uhhm, but [although some people will tell you,] you cannot mindfulness 
awareness your pain away. You cannot visualise it away. You cannot exercise it 
away. It’s there. It’s not in your imagination because they are physical things 
that are there (FG41, Mindfulness training). 
Summary of living with MSDs (follow-up) 
• Participants had various chronic MSDs and other co-morbidities; 
• MSD symptoms included pain, restrictions in movement, stiffness, and fatigue. 
Participants experienced fluctuating pain and immobility;  
• MSDs impacted on a wide range of physical aspects of life but participants 
changed the way they do things to adapt to their MSDs; 
• For some participants physical and functional restrictions had an emotional 
effect, particularly being dependent on others; 
• Participants shared their understandings of their MSDs, the psychological 
associations , and how their way of thinking may impact the progress of MSDs; 
• Small numbers of participants felt their MSDs were not understood by the 
majority of people. 
5.10 Self-awareness and reflection 
Four sub-themes under the theme ‘self-awareness and reflection’ were emergent. No 
direct questions on these topics were asked. Sub-themes emerged mostly from 
participants' explanations of their experiences with MSDs and various interpretations 
due to different personalities and background characteristics. Participants’ awareness 
of the progression of their MSDs and importance of themselves as their disease 
progressed (Sections 5.10.1 & 5.10.2) and validation in themselves when seeking 
consensus from practitioners (Section 5.10.3) are discussed.  Participants' 
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experiences of ‘discrimination’ are included under this sub-theme as some 
participants felt they were being discriminated against (Section 5.10.4). This theme 
is associated with the theme self-directed integrative approach and the theme patient-
practitioner relationship. Figure 5.11 is shown under the sub-themes of self-
awareness and reflection. 
Figure 5 11 Sub-themes under the theme self-awareness and reflection 
 
5.10.1 Accepting the consequences  
Many participants (n=14), who had long term experiences of MSDs, expressed that 
they had to accept the fact of having an MSD and live with it.  
I know my body's never going to be well again (55, 
Physio+Homeopathy+Insomnia clinic+MDT/OT). 
I know I’ll never get cured… For 20 years on and off, and how that, kind of, 
almost, physical experience gets embedded in the, kind of, tissues in your body. 
To some extent, you, kind of, carry it with you (FG10, Homeopathy). 
A few participants (n=3) expressed positive thinking.  
You got to keep your mind, uhmm, positive. You know, sometimes I think that 
I’m getting depressed and I’m going to cry or something. But, no, I mustn’t. I 
fight against it. Uhmm, mind is very, very important (FG14, 
Acu+Homeopathy+Physio). 
One participant accepted she had to live with her MSD but needed help with it. 
177 
 
Chapter 5 Patients’ Expectations and Experiences 
I am accepting defeat [laugh]... I’m not the kind of person to give in. But I’m not 
getting acknowledgement of that. Or I’m getting ‘she can manage’. But I’m not 
managing and I don’t want to be on the floor before I get the help. I want the 
help now! (41, Mindfulness training). 
5.10.2 Importance of self-help  
Many participants (n=14) expressed an understanding of the importance of self-help.  
If you are doing nothing, it’s the worst thing in the world… But I think it is very 
important that, yes, people have to help themselves. It’s no good having 
acupuncture, and then you don’t help yourself. There’s no point (09, 
Physio+Acu). 
I think it’s more of a self-directed package of care. It was ME who insisted to 
get acupuncture, and physio, and some homeopathic remedies because I know 
three of them together are going to work. And I keep on reading, to be updated 
with new methods. I think that’s very important (FG12, 
Acu+Homeopathy+Physio). 
The vitamin D level, that was affecting me physically as well. So now we’ve 
dealt with that. That’s out the way. But again, that was ME recognising that. 
(41, Mindfulness training). 
Some other participants gave examples of what they had done to better manage their 
conditions. 
Cos as a patient - a lot of patients don't help themselves. They do expect to come 
to these places or general hospitals and have a doctor or someone just fix them 
without helping themselves. And I think a lot of patients aren't informed enough 
and aren't willing to do the work themselves. You know, like eating properly and 
sleeping well, and making right choices and decisions. So- and when their 
health suffers they don't understand why. And they want a magic pill to fix it. So, 
you know it's a two way street. And I know a lot of patients aren't good patients, 
either. Which must frustrate the doctors as well I think (55, 
Physio+Homeopathy+Insomnia clinic+MDT/OT). 
In a few cases (n=4), participants expressed feeling that they had inadequate 
knowledge to help themselves. This potentially links ‘awareness of self-help’ to the 
sub-theme ‘informative’ under the sub-theme ‘patient-practitioner relationship’. 
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I’m not aware of what I can or can’t do. If I’m not having a twinge, ‘oh, is that 
something to worry about’, or, ‘is that just a muscle’ and I can just carry on. 
I’ve been carry on for years (41, Mindfulness training).  
5.10.3 Self-validation  
The sub-theme self-validation represents the use of other health professionals’ or 
carers’ words to confirm their health conditions, or to confirm what treatments 
would be beneficial to them.  
In nine cases, participants quoted other health care professional’s words, and carers 
(partner or family member, or friends) also attended the interview with the research 
student (n=5), to help provide a better picture of what the participants were going 
through. This was interpreted as a way of trying to validate what was happening to 
them.  
But what I need to do is, go back to my GP and say, ‘can you do me a, a sheet of 
paper, which tells me what you think I’ve got’… But it’s validation that he said as 
well. Looking the piece of paper [laugh] (FG35, Homeopathy). 
So she’s [21] absolutely valid in her, you know, her assessment to Dr [RLHIM]. 
It’s not personal. It’s just something, you know, I’ve seen it as well. Cos we [21 
and 21’s mom] made a difference sometimes (21’s mother) (21, 
Homeopathy+Diet). 
And he said with these connective tissue disorders, and these muscle skeletal, 
things tense up very quickly and um, quite severely. And without that manipulation 
to get rid of them, and of course we can't exercise as well because we're just too 
tired and everything hurts (55, Physio+Homeopathy+Insomnia clinic+MDT/OT). 
5.10.4 Experiencing discrimination 
Some participants (n=6) felt that they were treated differently because of their 
prolonged unexplainable pain conditions and being elderly, for example being ‘put in 
a group’, with labels like ‘old lady with chronic conditions’ or feeling that their 
opinions are less valued. 
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They put me on cod liver tablets and that’s all. I’m not seeing Dr [RLHIM] any 
more. It appears the older you are, you get the less you are valued. An old lady 
with chronic conditions [pooh] (FG54, Homeopath). 
FG10:  I think if I go to my GP now, they just think, ‘she’s middle aged and 
perimenopause’. 
FG14:  yeah, that’s it! That’s it! 
FG10:  when you get over certain age, it’s like boom - we don’t really give a 
damn. 
FG14:  yeah. All the GP seems to want to do is write up another prescription. 
They got too many patients. Get you out the door.  
FG10:  absolutely.  
FG14:  yeah, out the door. That’s right.  
(FG10, Homeopath; FG14, Acu+Homeopathy+Physio). 
Summary of self-awareness and reflection 
• Participants who had long term MSDs had generally accepted it and adapted 
their lifestyle to MSDs; 
• Participants were aware of the importance of self-help; 
• Participants felt more information on self-help was needed to guide them; 
• Participants tended to used health professionals’ or family members’ words to 
confirm their statements regarding their MSDs; 
• Some participants felt less valued as they were labelled as ‘old ladies’ with 
‘chronic conditions’. 
5.11 Self-directed integrative approach 
Participants were taking an important role in controlling their health. As their own 
‘health keeper’, they often directed the ways that MSDs were managed and how they 
coped with things (Sections 5.11.1, 5.11.4, 5.11.5), as well as trying to understand 
how this interfered with the decision on when and what kind of treatments they 
required (Sections 5.11.2 & 5.11.3). Their understanding of the best treatments 
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presented in this section may have influenced their expectations on the treatments at 
the RLHIM as what they felt were the best options for them may not have met their 
expectations. Participants’ self-directed integrative approach may also be associated 
with the patient-practitioner relationship, as potentially good informative 
communication may provide more guidance to self-management and self-awareness. 
Figure 5.12 shows the sub-themes under the theme self-directed integrative 
approach.  
Figure 5 12 Sub-themes under the theme self-directed integrative approach 
 
5.11.1 Lifestyle management 
Many participants (n=18) shared the way they managed their lifestyle to adapt to 
their MSDs. This included various strategies that helped them manage life with 
MSDs, which included healthy eating, planning schedules ahead of time, distraction 
from MSDs, and attending various social events.  
Apricot juice is supposed to be great. I drink loads of apricot juice (FG10, 
Homeopathy).  
I sort of keep myself occupied, get distracted (05, Homeopathy+Physio+AT). 
I changed a lot of how I do things. I get the meat already ready, already skinned 
and cut. So I don’t have to do that. I made changes to the home taps. And to 
make things easier, we changed the dish washer. So I’m doing my part at home. 
And I’m looking at new stuff that takes less time to do as well. Hmm, but if I 
want a curry, and I don’t like – we do eat up, we do get takeaways but you can’t 
live like that, you can’t afford it (41, Mindfulness training). 
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Some participants (n=4) shared their experiences of attending courses or clubs, 
which they found helpful.  
I go away for a weekend and I go to all sorts of different courses, which I find 
fascinating (05, Homeopathy+Physio+AT). 
In fact last September I joined a "Singing for Fun" group at my local church. We 
started with just 12 people now we have more than 70 members.  Isn't that 
amazing. We meet each Friday and every week I wish I wasn't going but once 
there am glad I made the effort. It's such a joyful group of people (FG12, 
Acu+Homeopathy+Physio). 
5.11.2 Optimum package of treatments 
Some participants (n=12) shared their understanding of having an optimum package 
of treatments and the decisions they made in receiving those treatments. This 
included the situation where participants who were receiving a package of treatments 
and benefited from them, as well as those who had not necessarily received a 
package but pointed out the importance of having a package of treatments.  
Having these three things [acupuncture, exercise, and medication] helps, you 
know, reduces pain. In other word, it affects you – medication on its own, yes, it 
reduces pain only for so what? And then you do medication and you exercise 
every day, it means a little bit more; and then when you have the acupuncture, 
and the medication, and the exercises, it reduces even more still (09, 
Physio+Acu). 
I can’t just stop seeing all these other, you know, conventional medical doctors. 
Hmm, but I want something that could complement it and make me better, you 
know (21, Homeopathy+Diet). 
Twelve participants mentioned the treatment they would like to have. ‘Hands-on’ 
therapy was the most popular theme of treatments participants mentioned (n=9), 
including acupuncture, chiropractic, myofascial treatment, massage, and acupressure. 
Other treatments on participants’ wish list included naturopathy and herbal medicine. 
Two participants stated they want to try ‘something else’, but ‘no idea what’.  
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There were also cases (n=4) when certain treatments were unsuitable for them, so 
they made the decision to choose the ‘right’ treatment that suited them. 
I mean, when I saw the physiotherapist she gave me exercises to take home and 
do at home, she gave me a sheet of paper with stuff to go and do at home, and 
whenever she would see me she would ask if I've done them and of course I'd 
say, 'not a lot,' because I don't know if they understand the pain and the 
exhaustion that you're in (55, Physio+Homeopathy+Insomnia clinic+MDT/OT). 
And that condition in the foot with the nerve is caused because of the joint 
hypermobility. My ankles are very lax so I go over on my feet a lot. So you do, 
you risk falling, you risk hurting yourself so exercise is difficult to keep the body 
loose and - you know keep things moving (FG10, Homeopathy). 
5.11.3 Information seeking 
Some participants (n=9) stated they searched for information on their conditions 
and/or possible treatments. As this was not a target of questioning and the sub-theme 
emerged, most of the quotes were short statements without any further explanation 
of them.  
I did some research on all the possible treatments (07, Acu). 
Among these participants, one gave an example of watching a medical TV 
programme, which indicated the importance of media to patients.  This was linked 
with the sub-theme ‘self-validation’ (Section 5.10.3, under the theme ‘self-awareness 
and reflection’) and ‘empathy’ (Section 5.14.1, under the theme ‘patient-practitioner 
relationship’)  
I watched a very interesting programme called ‘Horizon’. It’s all about placebo 
and I don’t know if any of you have watched it. Did you watch it? That should be 
on a training programme for every trainee getting trained. Because at the end of 
it, the interesting thing is I found was how you got treated – whether you had a 
sort of empathic friendly type clinician, or whether you had one said, ‘no, 
don’t’, you know, that sort of clinicians. And it made 20% better, just by the 
person being friendly and empathic and stuff (FG54, Homeopathy). 
183 
 
Chapter 5 Patients’ Expectations and Experiences 
5.11.4 Self-care 
Some participants (n=6) shared their experiences of treating themselves. Different 
examples of treatments were given, including: yoga, TENS machine, acupressure, 
homeopathic tablets, and ‘rubbing feet’. 
I meant not to and only take them when pain was very bad. I tried a lot of stuff to 
avoid taking pain killers. I used ice packs for inflammation and it helped a bit 
(FG47, Acu+Homeopathy+Physio). 
A few participants (n=3) tried self-care at home themselves but had inadequate 
knowledge. This may link the sub-theme ‘self-care’ with the sub-theme 
‘informative’ under the theme ‘patient-practitioner relationship’.  
I have a TENS machine at home and I have absolutely no idea where to put it. 
(FG46, Homeopath). 
I had come long ago for the physiotherapy. And I finished all sessions, which I 
all had. So I’m done with them. So I just have to practice which I do, 
occasionally [Laughter]. And the pain starts again, that’s the time to [stop] 
(FG58, Acu+Physio). 
Summary of self-directed integrative approach 
• Healthy eating, planning schedules ahead of time, distraction techniques, and 
attending social events were some of the strategies participants used to manage 
their lifestyle; 
• Participants played an important role in deciding an optimum (package of) 
treatment(s) they receive. ‘Hands-on’ therapies were the most popular 
treatments; 
• Participants actively read and learnt about their MSDs and the treatments 
available; 
• Participants treated themselves using a range of CAM self-care options 
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including yoga, TENS, acupressure, homeopathic tablets, and massage, but 
found inadequate information available to guide them. 
5.12 Imbalance in supply and demand 
An imbalance in supply and demand is a sub-theme that emerged by cross reading 
the framework matrix. When discussing the treatment they received at the hospital or 
any treatment effects perceived, participants discussed their needs for integrative 
treatment and the perceived inadequate 'supply' of integrative treatment funded by 
the government. This imbalance was expressed in four main ways (Sections 5.12.1 & 
5.12.2) and participants’ attitudes towards this situation were revealed (Section 
5.12.3). Possible reasons for that were suggested by a few participants (Section 
5.12.4). This theme is associated with the theme living with MSDs as the nature of 
their MSDs required a prolonged treatment. Sub-themes under this theme are 
associated with the sub-theme RLHIM is unique (Section 5.13.6) under the theme 
experiences at the RLHIM. Figure 5.13 shows the sub-themes under the theme 
imbalance in supply and demand.  
Figure 5 13 Sub-themes under the theme imbalance in supply and demand 
 
5.12.1 Demand for integrative treatment  
Many participants (n=21) expressed feelings that there was inadequate treatment 
available at the RLHIM. This was closely associated with their chronic, ongoing 
conditions, therefore more frequent and prolonged treatments were needed. It was 
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also due to the unique position of RLHIM as an NHS hospital providing limited 
integrative treatments. The demands for the treatments at the RLHIM were reflected 
in several aspects: 
Most participants (n=17) directly stated that there was inadequate treatment provided 
at the RLHIM. Some of them (n=6) felt that with a chronic condition, they need 
consistent follow-up treatments.  
If you can have treatment every one or two weeks, it helps you... Having chronic 
pain for many many years, and when you found something that works, but you 
can’t have, it doesn’t make any sense, you know what I mean (9, Physio+Acu). 
I think it’s easy to push into a private arena these things are readily available if 
here £50 or 60 an hour. The thing is you can only have a taster with 6 or 8 
sessions or even less on the NHS. That’s not enough to make a difference (FG6, 
Acu). 
But it’s – when you get long term chronic condition, that's [getting re-referred] 
what you need. I need, I need acupuncture actually every month, would be 
brilliant. I felt much better when I had it... And [RLHIM 2] is right, she said, 
‘look, my service is in demand. Uhmm, you know, I can’t see the same people 
being re-referred all the time’ (FG10, Homeopathy). 
5.12.2 Need for consistent follow-up treatments 
Many participants (n=16) expressed their needs or hope for treatments based on their 
understanding of their conditions and how treatments could work. Eight participants 
expressed their wish for consistent follow-up treatments for their ongoing 
conditions; five wished for more frequent treatment.  
I have only managed to see Dr [RLHIM 2] 2 or 3 times a year, where ideally, it 
would be good to see him perhaps once a month, or once every couple of 
months, because, you know, if you are having ongoing – if you got long term 
chronic conditions, they are not going to get better. It’s the case of management. 
And say if you are getting a course of acupuncture once every 2 or 3 years, in 
the interim you did quite badly (FG10, Homeopathy). 
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Well, over a year, a period of a year of coming in here I don’t know, four or five 
times, no I don’t think that was enough (FG41, Mindfulness training). Some 
participants (n=5) experienced a long waiting time, either between sessions of 
treatments, or between re-referrals.  
I think it was at least a three or four month wait list. Because it is one of the few 
holistic integrated insomnia clinics in the country I think (55, F, 43, 
Physio+Homeopathy+Insomnia clinic+MDT/OT). 
It was quite late and it took a long time to get referral to this hospital, cos you 
know, oversubscribed [laugh] (FG47, Acu+Homeopathy+Physio). 
Some participants felt that the length of the consultation was limited (n=4); or there 
was a need for more treatment options at the RLHIM (n=3). 
They [treatment sessions] were very short. I know obviously there's only one of 
her [physio’s patient in the clinic] but in- in all in all I would think within a half 
an hour session, you might have only got around fifteen minutes of actual 
treatment, and I felt like just as it was starting to work then it was time to go (55, 
Physio+Homeopathy+Insomnia clinic+MDT/OT). 
5.12.3 Stressed practitioners 
Some participants (n=6) said that they felt the practitioners whom they saw were 
always under stress or under pressure.  
Sometimes they've got lots of people to do acupuncture and they look very under 
pressure… So that's why sometimes I think when they are very busy and they've 
got lots of clients booked they don't give the proper attention, single - single time 
(22, Acu+Homeopathy+Hypnosis/CBT). 
The practitioner I’m seeing has to see several patients at one time in order to 
actually be able to deliver physical treatment. So he tends to be very stressed, 
which is difficult to cope with as a patient, though I don’t blame him personally, 
but rather the hospital’s administration or the clinical director (FG15, Physio). 
One participant expressed that more practitioners working in the field are needed as 
education takes time to turn around. 
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You see, the number of young physicians who work in the field is decreasing. 
They struggle with mainstream mindfulness and general wellbeing... But there 
are not enough trained people to do it. These people need the experiences and 
time to turn around (FG6, Acu). 
5.12.4 Precious opportunity 
A few participants (n=4) expressed their gratitude at having CAM treatments at the 
RLHIM. By screening the framework matrix, these participants all had more than 
two years’ history with MSDs and had already tried a variety of types of treatments. 
But they were very kind enough to give me one [appointment] in 2 weeks. And I 
thought, ‘I have to accept that. Maybe I have to make sure I get here on time. 
Leave earlier or whatever, anticipate train delays’ (41, Mindfulness training). 
There was one particular participant who reacted badly to acupuncture during her 
menstrual period, but insisted going for the treatment as she had waited a long time 
to get it and did not want to cancel it. 
I mean, the other thing I noticed is if I’m near my period, having acupuncture is 
hideous because my pain perception is really high. So if I realise, you know, I 
think ‘oh god, I’m in my period and I got acupuncture’, you know you are in for 
a bad one. It really gonna hurt. But you really can’t cancel it because it needs 
wait MONTHS, you know (FG10, Homeopathy+Acu). 
5.12.5 Inadequate resources 
A few participants (n=3) expressed worries about inadequate funding available for 
the treatment at the RLHIM.  
And obviously with funding constraints over the years, it’s got more and more 
difficult to get [referred] back in, you know (FG10, Homeopathy+Acu). 
In one focus group, two participants discussed their understanding of a 'patient led 
service' in the hospital. 
NHS supposed to be patient led, so we can be given a budget. And if I would like 
that amount to be spent on massage, rather than medication, that’s what they 
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should follow. I would like to decide what treatment I have (FG54, 
Homeopathy). 
If that happened, then there would be a really long waiting list for these kinds of 
manual therapies. I’ve been waiting for a long time to get acupuncture here. 
(FG7, Acu). 
Summary of imbalance in supply and demand 
• Integrative treatments at the RLHIM were in demand for chronic MSDs. 
Demand outweighed the availability of types and number of sessions of CAM 
treatments provided, and consultation time; 
• Participants felt practitioners were under stress due to having too much work; 
• Having integrative treatment at the RLHIM was seen as a precious opportunity; 
• A few participants felt there was a lack of funding resources and that might be 
the reason in terms of limited number of treatments and long waiting time 
5.13 Experiences at the Royal London Hospital for Integrated Medicine 
The theme ‘pathway to treatment’ contains the information generated when 
participants were asked: “Can you tell me about the treatment you received at the 
RLHIM and the experiences you have had during the treatment?”.  Relevant data 
when answering other questions were also coded within sub-themes under this 
theme. 
The first three sub-themes (Section 5.13.1-5.13.3) presented in this section are 
related to direct questions, while sub-themes presented in Sections 5.13.4-5.13.7 are 
emergent sub-themes. The sub-themes under this theme are presented in a sequential 
order to provide a picture of what treatments participants received (Section 5.13.1) 
and the effects perceived (Section 5.13.2), followed by their experiences in 
integrative treatments for MSDs at the RLHIM (Sections 5.13.3-5.13.6). 
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Participants’ experiences with the practitioners at the RLHIM are presented 
separately in the next section (Section 5.14) as it has a lot of content and can stand 
alone. This theme is associated with the theme self-directed integrative approach. 
Figure 5.14 shows the sub-themes under the theme experiences at the RLHIM.  
Figure 5 14 Sub-themes under the theme experiences at the RLHIM 
 
5.13.1 Various types of treatments and assessments 
Acupuncture, homeopathy, and physiotherapy were the most common treatments 
received for MSDs at the hospital. Most participants (n=18) who had had 
acupuncture stated that it was given weekly or biweekly or monthly for about 6 
sessions. The treatment was approximately 15-30 minutes.  
Homeopathic (n=16) treatment included prescriptions such as Arnica, Bryonia, 
Ignatia, Stramonium, Lachesis, and Cimicifuga (Actea Racemosa); as well as 
supplements such as phosphorus, fish oil, EPA [eicosapentaenoic acid], EFA 
[essential fatty acid], fish oil, cod liver oil, vitamin D, calcium. Supplements were 
also recommended by dieticians. Some participants (n=4) were asked to change their 
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Six participants had physiotherapy at the RLHIM. In the physiotherapy session, they 
had exercises to help strengthen the muscles, and some experienced short sessions of 
acupuncture or manipulation provided by the physiotherapist.  
Participants also received other treatments; physical manipulation (n=5), osteopath 
(n=3), occupational therapy (n=2; one with inner soles made, the other received help 
in sleeping), cognitive behaviour training which includes education, awareness and 
mindfulness courses, and recommendation on books (6 sessions, n=1), transcranial 
magnetic stimulation (TMS) (n=1), insomnia clinic (6 weeks course) (n=1), marigold 
therapy (n=1), podiatry (n=1).  
Some participants (n=9) stated that they received assessments at the RLHIM, which 
include blood test, x-rays, weight, blood pressure, MRI, and bone density testing. 
5.13.2 Effects of treatments at RLHIM 
Most participants (n=19) experienced benefits such as pain relief or functional 
improvements. They expressed that they were in less pain which they attributed to 
the treatments they received at the hospital, or they became more mobile and 
managed to do more exercises.  
I’m moving up and down stairs without having to pull myself up… I went 
swimming, which I haven’t been doing it for a long time, which is good… Well 
the cat can walk on me now without me feeling bruised, which is good. Uhhm, I 
can switch the indicate -- like you know, if I am driving flick it up the indicator 
and switch it with your finger, that would hurt. I mean just flicking a switch 
would hurt, which is crazy. Now, only sometimes…. Still, I mean it’s not all gone 
but compared to how I was a year ago, you know, huge, huge difference (20, 
Homeopathy+Acu). 
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The treatment has made me feel better in myself, although the pain in various 
places can still be quite intense (48, Homeopathy+Hypnosis/CBT). 
A few participants (n=3) stated that the treatments helped them reduce the 
medications they were taking, and felt better for themselves.  
Do you know what, I've got to tell you this. I don't take all of these [medications] 
anymore. And I've been taking all of these tablets for many, many years but in 
the last six months I've managed to start not taking all of them tablets which is 
good. Yeah, very good. ….. Yeah I don’t take all of them anymore. I'm better as 
a person (26,  Acu+Homeopathy+Osteopathy). 
However, some participants (n=7) noticed changes in effects when they were 
receiving treatments at the RLHIM and felt the effects were associated with the 
length of treatment they had.  
I definitely feel like I'm benefitting more lately than what I was before. 
Definitely... I used to have facet joint injections and I was under them for quite a 
long time and I had six courses of facet joint injections. Um, and I felt great 
afterwards for like a few weeks but then I felt back again whereas this time I 
actually feel like I'm- I'm improving, yeah… Consistently improving rather than 
improving and then going back to where I was. Yeah, so hopefully (26, 
Acu+Homeopath+Osteopath). 
But since I finished acupuncture a few weeks ago after my 6 sessions, I have had 
extremely vivid nightmares and night terrors (34, Homeopath). 
The problem is that given the chronic nature of my health conditions, my 
improvement does not persist without treatment, so that I relapse between 
treatment sessions has ceased (FG15, Physio). 
Sixteen participants responded when they were asked if they perceived any adverse 
events (AEs). Participants gave most feedback on acupuncture and homeopathy: pain 
when inserting the acupuncture needle was the most common AE (n=6). But they all 
felt it was fine and ‘it’s just the way it goes’, apart from two participants: one 
received electroacupuncture and found it very painful when the adjustment was over 
what she could tolerate, the other reacted badly to western acupuncture as it made 
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the pain worse and therefore terminated the treatment. Other participants reported 
being sleepy, thirsty, and having nausea during their acupuncture. One participant 
stated that she experienced non-epileptic seizures which she felt was due to the 
homeopathic tablets she had taken. Eight participants reported no AE. 
5.13.3 Perceptions and experiences of integration 
When asking participants, “do you think you are receiving an integrative package of 
care at the RLHIM?”, most participants explained in detail the treatment they 
currently have for their conditions, as well as whether they were currently waiting 
(treatments that had been referred for but have not received yet), not specific to 
RLHIM or MSDs. Several aspects emerged and are discussed. These include 
participants' experiences or understanding of integration.  
Individualised treatment  
The idea of receiving individualised treatment was mentioned by many participants 
(n=14). This included those who wished to have individualised treatment, those who 
felt already received integrative treatment at the RLHIM, and those who talked about 
their understanding of individualised care.  
Many participants (n=9) expressed their wish to have individualised treatment. 
And not all one’s health conditions can be managed in one treatment and so one 
has to spread one’s concerns and requests for treatment over the course of 2 to 
3 appointments, taking 12 to 18 months to have them addressed (FG28, 
Acu+Homeopathy). 
But I have to insist that he hears me, and not treat me like the masses. I’m this 
patient. And this is what happens to me. And this is how I’m responding to this, 
or not responding to that. So I think he heard that. He’s heard that now. But I’m 
tired of doing that. … And if you work in pain management, each person is 
different and you should be more, more aware or more sensitive to how you deal 
with that person (41, Mindfulness training). 
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We need more integrated services with physicians who can see us as individuals, 
who can talk to us, explain to us (FG6, Acu). 
In a few cases (n=5), participants expressed feeling the treatments they received at 
the RLIHM were personalised and tailored to them.  
I’ve got to know them [RLHIM doctors and nurses] all very well. And they’re all 
extremely kind, each and every one of them. It is very individually tailored to me 
-- your needs. And anything – if you ask for anything extra, they’re always 
happy do it. I find them extremely very pleasant and very caring and helpful 
(FG31, Acu+Homeopathy). 
A few participants (n=2) shared their understanding of the importance of 
individualised treatment. 
But it [acupuncture] doesn’t help everybody. You know, as I was saying, I know 
people who had acupuncture and say to me, ‘[09’s name], it’s [acupuncture is] 
a waste of time. It hasn’t worked on me’. But you see, they don’t help themselves 
afterwards, or it [acupuncture] doesn’t help (09, Physio+Acu). 
Horizontal integration with multidisciplinary collaborative teamwork  
Many participants (N=13) mentioned their experiences in UCLH and NHNN as they 
were referred from there, or they were receiving or previously received treatments or 
assessments in the above hospitals. The research student had difficulties trying to 
distinguish between treatments/assessments received at the RLHIM from those 
received in the other two hospitals as participants felt they are the same group of 
hospitals and should be of interest to the research student.  
The research student found that for six individuals, their experiences of integrative 
treatment could not be separated from the treatments they had elsewhere for their 
MSDs and those for their other co-morbidities. This also led to more discussion on 
treatments they received elsewhere. 
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In one case, the use of the hospital CDR system was mentioned as the participant 
believed the research student could extract the information that was needed on her 
treatment from the hospital system. 
But other than that, I would say, it’s fine. And the only thing I didn’t have or I 
don’t have, is all the medications that Dr [RLHIM] has prescribed me. So, I’m 
sure you can get hold of that from the system (40, Homeopathy). 
Treating all aspects of life – whole person/holistic care 
Some participants (n=5) stated that the practitioners at the RLHIM considered other 
aspects of their life apart from their MSDs.  
Dr [RLHIM] mentioned that my liver function wasn't as good as it might be and 
I didn't think to ask him (FG12, Acu+Homeopathy+Physio). 
55: But what I find, perhaps even there a little bit, but more with the NHS 
doctors is that when you go to a consultant for a certain issue like the thyroid, 
they never really look at the body as a whole. They will isolate that body part 
and only give you treatment for that. Even if you say to them, 'I'm suffering with 
this’, they very rarely connect the whole.  
M: Okay, and in this hospital? 
55: I- I will say that Dr. [RLHIM] does because he will ask me about my foot, he 
will ask me about my thyroid and he'll ask me, you know all the things, obviously 
and he knows my whole history  (55, Physio+Homeopathy+Insomnia 
clinic+MDT/OT). 
Interestingly, in three cases, participants talked about who was taking care of their 
health: two felt that the practitioners at the RLHIM are taking care of their health, 
one felt that she was her own health keeper.  
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5.13.4 RLHIM is unique  
Some participants (n=8) expressed their feeling that RLHIM is unique and their 
understanding of differences between the RLHIM and other hospitals. This included 
different techniques of treatment: 
Well, in the other hospitals, they pinpoint where you got the pain, so the needles 
go in where the pain is. Whereas in the integrated hospital, the needles were in 
certain lines, may not necessary be where the pain is. But it works. In other 
word, if I got pain in my knee, they can put it [needle] in my ear. Because they 
were explaining to me that there’re so many thousands of meridians, what they 
call ‘lines’, where you can feel the sensation up or along the meridians. And to 
be honest with you [the research student’s name], it was a completely different 
feeling to the acupuncture that I had before. So it was completely different, and I 
would say, better (09, Physio+Acu). 
It also included differences in general impression of the hospital: 
But I have to say, generally, I think the standard of care within this group seems 
to me, is better on the whole than I had elsewhere (F10, Homeopathy+Acu). 
And that it is a NHS hospital that was providing integrative treatment: 
I think the fact that it’s been done by the NHS makes me very favourable. I don’t 
fancy going into some acupuncturist in the high street, I really don’t; and I 
wouldn’t. No way where I’d go and see a chiropractor anyway. But I wouldn’t if 
I could. Uhhm, and I think the fact that it is run by the NHS or orthodox 
medicine, gives it so much more credibility. That’s my opinion (FG31, 
Acu+Homeopathy). 
5.13.5 Interaction between expectations and experiences  
By cross checking the framework matrix, the research student noticed all the 
participants (n=7) who had some negative experiences at the hospital had high hopes 
to some extent, either in terms of high expectations for the hospital and the 
practitioners, or high expectations due to the efforts they made to come to the 
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hospital, or conversely that the treatments they received were not what they had 
expected. 
40: For me to come all this way, and a consultant of his standing, I was kind of 
expecting him to do a little bit more [laugh]…  
M: you made a lot of effort to come in 
40: yeah. He kind of didn’t put the same effort back, which you know, is 
disappointing… He [RLHIM practitioner] went to the board, for me. And 
basically said, ‘we got this lady’, bla bla bla, and the board said ‘no’. And 
that’s probably everybody has been promised. And he doesn’t explain, you 
know? He just goes, ‘oh you can’t be inpatient because there’s not enough 
funding, rahrahrahrahrah’ (40, Homeopathy). 
I think it was raining that day when we left the hospital. Yeah, it was raining. 
We were sort of park across the way. And I must just stand there for about an 
hour. I don't think he even realised it had that effect on me. He didn't realise 
how desperate I was. He’s obviously the wrong person to see (44, 
Acu+Homeopathy). 
There were also two cases where participants were not confident with what they 
were going to receive, but had positive experiences.  
[Treatment] More than met my expectations because as I’ve said, I was very 
skeptical about the -- I don’t believe in alternative medicine. I’m very orthodox 
medicine because I don’t what it’s done for me. It kept me up frightened. And so 
I was a bit skeptical. And having tried that therapy before that didn’t help, 
uhhm, now it -- I have to say it’s more than met my expectations. I’m pleasantly 
surprised really [Laughter]. I’m grateful (FG31, Acu+Homeopathy). 
5.13.6 Changes in RLHIM over years 
Some participants (n=6) who had long term experience of receiving treatment at the 
RLHIM expressed their understanding of the changes in the hospital over the years, 
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Referral pathway 
Participants explained their long waiting time of getting re-referred to the RLHIM. 
Some participants (n=4) had noticed the change in procedures by not allowing 
internal referrals, so the only option was to ask their GP to go through the whole 
process again, which they found to be very time consuming.  
Unless you are having an ongoing issue, it doesn’t really work for it, by the time 
you get in there, you know, you need to be there 3 months before, which himself 
[RLHIM doctor] has acknowledged….Uhmm, and I think, although I’m in the 
system now, I think my health authority doesn’t have a contract here or 
something or I’m on some very old one. So if got kicked out now, I got to get a 
new referral in. I won’t manage to get acupuncture. But I’m not sure how that 
would work. I think I might be in difficulty. And there’s really no elsewhere to 
go, not in the NHS. Whether we’ve still got any NHS left which is another issue 
but, anyway [laugh] (FG10,  Homeopathy+Acu). 
Funding restraints 
There were also participants (n=3) who had noticed the cuts in funding in NHS over 
the years.  
I know about the budget cuts of the NHS. And I know about the strain on 
resources and all of that (41, Mindfulness training). 
And it’s been incredibly efficient you know. I sort of -- with the suggestion of one 
of the nurses who does the acupuncture, that I’d do it about after I get to session 
number six or number seven, I put the ball, you know, and start ball rolling so 
that it would run smoothly and I’d just keep hoping that the funding keeps going 
for as long as possible because it is certainly helping (FG31, 
Acu+Homeopathy). 
Summary of experiences at the RLHIM 
• Participants received various types of treatments at the RLHIM, among which 
acupuncture, homeopathy, and physiotherapy were the most commonly 
received. A range of assessments were received at the RLHIM including blood 
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tests, x-rays, weight, blood pressure, MRI, and bone density testing; 
• Most participants perceived more positive than negative changes in their 
MSDs. Frequently perceived improvements were pain relief, better functional 
movements, feeling relaxing, better sleep, or reducing the medication taken; 
• Effects of treatments were reported to be in proportion to their length (longer 
treatment, better perceived effects); 
• Most participants experienced no AEs during their treatments at the RLHIM. 
Most frequently adverse events occurred when having acupuncture was minor 
pain, and perceived by participants as “it’s the way it goes”; 
• Individualised treatment was reported to be an important aspect of integrative 
treatment but small amount of participants felt they received individualised 
treatment at the RLHIM; 
• Participants’ experiences at RLHIM, UCL and NHNN could not be 
differentiated from each other. This might be related to the multidisciplinary 
teamwork and the integrative treatments for MSDs. Also, treatment for MSDs 
was not easily separated from that for co-morbidities;  
• Some participants had positive experiences from the integrative treatments and 
believed that they had treatments that considered all aspects of life; 
• Participants felt RLHIM was unique in terms of the professional treatments 
provided, their general impression of it, and that it is covered by the NHS;  
• Participants’ experiences at the RLHIM and their expectations were inversely 
related; 
• Participants with extensive previous experience at the RLHIM observed 
changes in the referral pathway and funding restraints at the RLHIM. 
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5.14 Patient-practitioner relationship 
This sub-theme is presented separately to patients’ experiences at the RLHIM due to 
the large amount of time participants discussed and focused on it. There were no 
direct questions targeted at participants' interaction with practitioners at the RLHIM 
in the protocol; and this is a sub-theme that emerged in the early stage of this follow-
up interview study, when asking about their experiences of the hospital. Therefore, a 
question was added (from the 8th participant) asking about their interaction with 
practitioners during treatments and consultations in thereafter. Participants expressed 
their impression of the practitioners at the RLHIM (Sections 5.14.1&5.14.2), as well 
as their experiences in communicating with the practitioners (Section 5.14.3) and 
techniques practitioners used to improve their treatment experiences (Section 
5.14.4). This theme is associated with self-directed integrative approach as 
knowledge availability at the RLHIM influenced the degree participants could care 
for themselves. It is also associated with the theme living with MSDs as 
communication with practitioners may influence participants’ emotional status as 
supported by the following discussion in this section. Figure 5.15 shows the sub-
themes under the theme patient-practitioner relationship. 
Figure 5 15 Sub-themes under the theme patient-practitioner relationship 
 
5.14.1 Informative 
Many participants (n=18) stated that the practitioners at the RLHIM explained and 
provided information to them during the consultation.  
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She [RLHIM nurse] was lovely. She explained everything. She was doing -- walk 
through what she’s going to be doing, talk though the rationale (FG27, Acu). 
In a few cases (n=3), participants expressed feeling grateful that the practitioner 
shared medical knowledge with them, but felt worried as there was not enough 
further follow-up input. This is linked to self-care under self-directed integrative 
approach theme (Section 5.11.5).  
What I quite like about him [RLHIM doctor] is that he shares – to be honest 
there’re a lot going in my head, but he will share quite technical medical 
information. And if that’s okay, I’ll say, ‘what does that mean’. He’ll explain 
that. I think the shame for him is that sometimes he knows – he’s really very 
knowledgeable and he recommends stuff that isn’t available here. And 
sometimes I’ll go and try find that myself. But I’m not sure what I found is 
exactly right, or in what kind of dosage to take, if it’s not something that the 
hospital can prescribe. So I find that a slight issue. It might be good if they could 
have a follow up, because you are not seen for another 4 months. When you 
really need something, you really don’t want to wait 4 months. Say if I found it, 
but I don’t know whether to take it once a day, twice a day, or should I just take 
a higher dose, or lower dose (FG10, Homeopathy+Acu). 
5.14.2 Expertise 
Participants (n=14) trusted the practitioners at the RLHIM as they felt they had 
professional knowledge which could reassure them and make participants feel 
understood. 
I’ve just seen my practitioner earlier. I'm not travelling to different hospitals to 
find out exactly what is wrong, and I've got more information in the hour that 
I've been today, than I have in two years of seeing all different doctors (FG15, 
Physio). 
There's pain here. I can say it's here so they [RLHIM practitioners] know the 
pain and how to [treat] fibromyalgia spreads pain. So they [RLHIM 
practitioners] put it [needles] everywhere. It's not like other private treatments; 
they don't know about this [fibromyalgia]. They might only put the needle to 
where I say the exact place. That's the thing that's different (13, Acu). 
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The others did not comment particularly on practitioners’ expertise. In one rare case, 
a participant with primary progressive multiple sclerosis was given the suggestion to 
have a warm shower, which the participant felt was an ‘absolutely wrong 
suggestion’. 
5.14.3 Empathy and shared decision-making  
This sub-theme refers to participants’ understanding or experiences of practitioners 
being empathetic. Empathy represents the ability to understand and share the feelings 
of another (Oxford Dictionaries, 2015). Many participants (n=14) expressed positive 
experiences in interacting with practitioners at the RLHIM. These included the idea 
of being listened to, shared decision-making, and practitioners making equal effort to 
patients. The words participants used to describe this experience in this research 
study were ‘two-way consultation’, ‘bedside manner’, ‘shared decision’. These 
reflect participants' experiences or their hope of an active interaction with the 
practitioner, with shared feelings. 
Most of the practitioners here [RLHIM] appear to be empathetic and 
compassionate, and so receiving personal attention from them also probably 
helps one feel better (FG28, Acu+Homeopath). 
The thing I found in this hospital is that I was listened to and it’s a two-way 
consultation (FG47, Acu+Homeopathy+Physio). 
I saw Dr [RLHIM] last week and he was disappointed that there was no 
improvement but still he's hopeful.  As am I (FG12, Acu+Homeopathy+Physio). 
In some cases (n=7) where participants did not notice changes in their MSDs, they 
did not blame the practitioner, as they believed that their idea or suggestions were 
listened to and they made had a shared decision with the practitioners, or they felt 
they were understood by their practitioners.  
And as I said, I wasn’t keen on doing it [autogenic training] anyway, you know, 
mentally. He [RLHIM practitioner] sort of, virtually agreed with me, although 
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he thought it might do some good… But I don’t blame him. It’s just that my 
condition is difficult. You know, he tried various things but nothing has done any 
good (05, Homeopathy+Physio+AT). 
To be honest, I couldn’t blame Dr [RLHIM 1]. He’s the only doctor who was 
willing to try, to try the neurotherapy. Hmm, and it's something that’s not done 
by people any more. But I’ve actually spoken to the original doctor who's now 
quite elderly, who did the trial in neurotherapy up in Scotland thirty, forty years 
ago. So you know, I did come to the hospital [RLHIM] for the information. At 
least Dr [RLHIM 1] offered to do it [neurotherapy] (44, Acu+Homeopathy). 
Well, they [RLHIM practitioners] understood me and they understand my 
problem. You know, they feel sorry in the end that, you know, you are only 
allowed [certain numbers of sessions] (09, Physio+Acu). 
On the other hand, some participants (n=7) had negative experiences as they felt the 
interaction between the practitioner and themselves was inadequate, or they felt not 
listened to.  
He’s [RLHIM Dr.] done a lot of blood tests, he’s done this, he’s done that. But 
everything he does, I have to ask him to do. I asked him for specific blood test; I 
asked him to weigh me; I asked him to do my blood pressure. He didn’t do that 
automatically, which – like I say, for me to come all this way, and a consultant 
of his standing, I kind of expecting him to do a little bit more [laugh] (40, 
Homeopathy). 
I feel not listened to. I feel you don’t want to know how I feel. I feel 
misdiagnosed. Or you come to them, and they have a presumption of your 
condition from what they are seeing you, what they are treating you for already. 
So you present them with your symptoms, or you present them with new things. 
But they don’t hear it because it’s obviously directed by whatever they are 
seeing you for already. I don’t know how well to explain it… I think sometimes 
when doctors are seeing patients, they get desensitise themselves and they forgot 
that we are not commodity. We are actual people, with feelings (41, Mindfulness 
training). 
In a few cases (n=2), participants felt they were not listened to and this lead to 
psychological changes, which links this sub-theme to the theme living with MSDs.  
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I know it sounds depressing but sometimes I just want to run away, you know, 
sort of – it IS very depressing. But I try not to depress other people with it, you 
know what I mean. I don’t want to depress you guys. And I don’t want to depress 
Dr [RLHIM]. But I do feel the times that I wasn’t listened; do you know what I 
mean? I’m not trying to get sympathy because sometimes people think you are 
just trying to get sympathy. It’s just – there’s nowhere for it to come out, you 
know (FG35, Homeopathy). 
5.14.4 Expectation management 
During the interviews, some participants (n=6) stated that practitioners they saw at 
the RLHIM tried to manage their expectations.  
They [RLHIM practitioners] are always very good about actually managing 
your expectations and kind of breaking bad news quite gently. And getting you 
to realise it is a long term chronic condition, not a cureable issue, and things 
like that… But it’s always done in a very sensitive, quite constructive way here, 
which is kind of making things better than it can be… But it’s that, yeah, at least 
the fact even people showing interest, you feel, ‘right, I know I won’t get cured. 
But you know what? I might manage myself better. I might be able to do more 
things’. And that’s really encouraging (FG10, Homeopathy+Acu). 
Summary of patient-practitioner relationship 
• Practitioners at the RLHIM have professional expertise and some shared 
information freely; 
• Practitioners’ empathy and shared decision-making were positively related to 
participants’ having positive experiences, while lack of interaction lead to 
negative experiences. This sometimes in turn affected participants’ mental status;   
• In several cases, participants reported that their expectations were managed by 
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5.15 Feasibility of research study (follow-up) 
The theme experience in research contains information generated when asking 
participants the following question: “What is your experience of taking part in this 
study?”  Relevant data when answering other questions were also coded within sub-
themes under this theme. Participants’ experiences in completing the outcome 
measures (Section 5.15.1), engaging in the research study and communicating with 
the research student (Sections 5.15.2 & 5.15.3), and suggestions in improving the 
study design and service at the RLHIM (Section 5.15.4) are discussed. At the end of 
this section, potential bias while interviewing the participants is presented (Section 
5.15.5). This theme is associated with the theme living with MSDs. Figure 5.16 
shows the sub-themes under the theme feasibility of research study.  
Figure 5 16 Sub-themes under the theme experience with the research  
 
5.15.1 Integrative outcome measures 
Ease of completing pain scales 
The majority of participants (n=25) commented on their experiences completing 
VAS and sfBPI and the comments of the two tended to be very similar as described 
as ‘pain scales’. Most participants (n=18) felt they were easy to follow and quick to 
complete; while others (28%, n=7) felt it was difficult to decide a score for their 
fluctuating pain or felt they were 'too literal', or 'ambiguous'.  
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M: is there a questionnaire which you think best explained your conditions?  
21: well, the first one and the last one. They are quite straightforward and easy 
and quick to complete (21, Homeopathy+Diet). 
I filled in the scale of – because one day it will be very good and one day it’s 
very bad, so what I did is that I just averaged it on how I usually feel. On most 
days. Hmm, so I just put the average on. I thought it was quite straightforward. 
(FG7, Acu). 
Narrative Approach to explore all aspects of Life 
Some participants (n=8) felt that the questionnaires were not sensitive enough to 
capture all changes they observed, and would prefer a narrative approach by talking 
with the research student.  
I’m able to be more precise [by talking with the research student]. And I think 
that might be the problem that this [questionnaire] is not precise. And I would 
say it all depends. Cos every Wednesday at 10 o’clock I feel worse. I’m joking. 
But you see what I mean [laugh]. It’s different day to day, you know. Maybe 
when I have a bad sleep it will change… But I mean, I think it’s a standard 
problem with trying to fit human being into a square hole. But I can also see 
that you have to fit these into a computer that has a section specifically you 
can’t have 50 different answers cos you can’t analyse them. But that’s not my 
problem [laugh] (20, Homeopathy+Acu). 
 I haven’t had any acupuncture for 10 weeks now. So it is a major change... 
There’s no room for all of that on the form that you sent me (FG6, Acu). 
In a few cases (n=4), participants felt that it was necessary to include lots of 
questions to fully understand their conditions, or felt that changes were slow and 
subtle and difficult to detect. 
No it was perfect, it was fine. Let me put it like this, [the research student’s 
name], I felt it is important because everything that you asked for, you need it. 
You know what I mean? You can’t just ask one question. It’s important because 
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I’ve changed. It’s a major difference to the ordinary medicine approach... 
There’s no room for all of that on the form that you sent me. But the changes are 
slow and subtle from going one direction because the sun’s out and spring is in 
the air (FG6, Acu). 
Various views about mCSRI 
Many participants (n=13) commented on the completion of the health economic 
questionnaire (mCSRI) and all expressed concerns, which included difficulties in 
remembering several types of treatments they were taking in the previous three 
months (n=9) and unclear boundaries between conventional treatment and CAM 
(n=2). 
And then, how many days did you take it in the last 3 months. Well, 9 out of 10 
people with fibromyalgia, they are taking every single day probably for the rest 
of their life. So, yeah, I don’t quite understand that (40, Homeopath). 
also, questions 8 and 10 of the mCSRI were quite tricky and very time-
consuming, particularly question 8. Some nutritional supplements and 
homoeopathic preparations can have a lot of different constituents, say a 
multivitamin. So completing this in full wasn’t realistic. I’d prefer simply listing 
the brand and specific product for the researcher to follow up on the detailed 
ingredients listings (FG28, Acu+Homeopath). 
On the other hand, some participants (n=7) were interested in the CAM options 
listed in the questionnaire and saw them as suggestions to try in the future. 
5.15.2 Engagement and benefits in participation  
Most participants (n=22) had positive experiences of the research study during the 
year. But answers tended to be very short, stating they were 'fine' with participating. 
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In terms of it helped with self-reflection, advice/information from patients with 
similar conditions or from the questionnaires, and feeling better 'mentally' with the 
research or hospital environment.  
Actually I found the questionnaires quite good. It made me think what I’ve had 
in the past few months and how I felt. I didn’t think about it until I really looked 
into what precise treatment I had (FG7, Acu). 
Uhhm, I’d probably say I don’t get a lot of support at home; mentally, 
physically, really, anyway. I’m quite often made to feel I’m a burden. If I say 
anything, I’m only talking about myself. I could go on forever [Laughter]. I 
think I’d finish that up actually. So, yeah, when I’m here, I would feel mentally 
better. Yes. Maybe because I’m away from my environment. It could be that 
(FG31, Acu+Homeopathy).  
The interaction among participants in the four focus groups, led to  shared 
experiences (4/4 FGs), seeking confirmation (3/4 FGs), providing information (3/4 
FGs), as well as emotional changes such as feeling assured when discussing with 
their peers (2/4 FGs). 
In normal circle, people think you are bloody mad! ‘why the hell you got 
problem with that!?’ But if you are around other people, say with fibromyalgia, 
or got all these musculoskeletal issues or chronic pain, and you find you 
actually have a lot of similar issues. And that’s a BIG BLOODY RELIEF!... And 
when I come here, it’s like, I almost just physically relax as I enter the building. 
(FG10, Homeopathy+Acu).  
In a few cases (n=3), the participants expressed wishing to provide positive feedback 
to support the research study. This might lead to possible research bias which is 
discussed later.  
I think basically to try help the situation in the hospital and the funding 
situation; and to gather information, to show the service offered, the treatment 
offered – actually do have a beneficial effect. So I think I was quite strategic 
really, in, in my participation. I just thought, ‘well, anything I could do to 
support it or help’. And the government is looking to cut funding for 
complementary therapies. … I just wish I had more money and didn’t just have 
Prince Charles propping them up and uhmm, because I do wonder, a bit like you 
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were saying, if you haven’t had this treatment, you’re not sure if you were still 
able to walk. If I haven’t had this hospital, I’m sure I’d still be around in one 
way or another of course, but I wonder how much more incapacity it might be 
(F10, Homeopathy+Acu). 
I mean, I did this study because I thought that was important. You know, this 
hospital has been threatened with closure several times. And if this could help in 
any way, to show that musculoskeletal in homeopathic treatment helps, then I’m 
very happy to do it (F47, Acu+Homeopathy+Physio). 
In one case, a participant expressed her wish to secure treatment by participating in 
research, although this was not the goal of this particular treatment.   
I think more of an emphasis [in the study] upon actually securing treatment 
would have been helpful and what happens when a patient is not able to carry 
on receiving treatment or accessing it in the first place. Having said this, I 
realise that this was not central to your research study, although I think it is a 
big feature of the patient’s experience of treatment at the hospital (FG28, 
Acu+Homeopathy). 
5.15.3 Communication with researcher 
Most participants (n=23) expressed that they had a good experience with the 
research study and the research student. They found the study process, including 
being recruited, being sent the information sheet and consent forms, and the 
communication with the research student was good. 
I think your approach has been perfect. You’ve been very friendly (FG31, 
Acu+Homeopathy). 
 And I thought, you know, you asked questions as well about all the paper work. 
I thought you are very clear about our participation and making clear that it’s 
voluntary. You know, made it known that we will come back and ask questions 
and so – and I was quite sure about the confidentiality and anonymization and 
so. So no, I was very happy to take part (FG10, Homeopathy+Acu). 




Chapter 5 Patients’ Expectations and Experiences 
It’s all great. You are a good communicator by email, post and text. I can 
understand you and I can better plan my time that way (34, Homeopathy). 
5.15.4 Suggested improvements  
Some participants gave suggestions to improve research design (n=6), which 
included giving feedback to the practitioners who they were seeing (n=5). 
It would be great if you can give feedback to Dr [RLHIM] on my progress as 
only in that way this could be beneficial for us, isn’t it? Also, I’d like to know if 
I’m expected [to come to his clinic] or not (44, Acu).I think if Dr [RLHIM 2] 
asked about this. You can just tell him, the patient came across very angry. But I 
was angry because clearly he hadn’t read my notes and he didn't know anything 
about MS (44, Acu). 
And providing assessment within the study (n=1).  
And I am happy to have an assessment included and possibly questions on 
fibromyalgia and family history might help, cos I think my mum is a sufferer [of 
fibromyalgia] but has never been diagnosed. My sister and cousin also have 
fibro (48, Homeopathy+Hypnosis/CBT). 
In one focus group, suggestion was also given to improve the hospital service by 
having a support network available to patients who have similar experiences at the 
hospital (n=1).  
One thing this hospital doesn’t do, and I know there are support group out 
there, but if they do more sign posting to sources of support, or even have like 
patient user group... But you’ll be interested if the hospital could perhaps kind 
of provide some support network.  Cos often I know it is really interesting in the 
pharmacies. ‘Oh I had a really good discussion. Shall we swap numbers’, and 
then you go away and you don’t – perhaps if something is organised, once a 
month or once every 2 months people could come along. And you don’t have to 
make the way yourself. All you have to do is show up (F10, Homeopathy+Acu). 
5.15.5 Potential bias 
As discussed in Chapter 1 (Section 1.3), the research student was born and educated 
in China, had a background in traditional Chinese medicine. She noticed that 
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participants sometimes gave further explanations to her, to explain a certain term, or 
certain events that the research student may not be familiar with. During the 
interviews, some participants (n=7) asked certain questions regarding the research 
student’s background, or sought therapeutic information and advice. 
So, you come from a different culture, and obviously, you come from a 
wonderful country China. Have you got any pain relief that’s better than the 
pain relief [05’s name] gets because I don’t know how she lives with this level of 
pain. Not occasionally, but every single day, wakes her husband up during the 
night, being very pleased for her life to come to an end… Can you think of 
anything we don’t have, but you have in China? (05’s friend, 
Homeopath+Physio+AT). 
Summary of experience in research 
• Participants suggested integrative outcome measures, including simple pain 
scales and a narrative approach including questions targeting all aspect of life, 
in order to understand participants’ chronic complex MSDs; 
• A range of concerns were expressed on the utility and appropriateness of 
mCSRI (difficulties with recall, unclear boundaries between conventional 
treatment and CAM); however, some participants found the CAM options in 
mCSRI inspiring; 
• Participants had positive experiences participating in the research study; they 
benefited from self-reflection, acquiring information from patients with similar 
experiences, and some felt it helped them mentally;  
• Benefits from focus groups included sharing experiences, seeking confirmation, 
providing information, and feeling assured; 
• A few participants reported wishing to provide positive feedback to support the 
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• Participants had positive experiences in communicating with the research 
student and taking part in the research process. Most participants liked to be 
contacted by text or email; 
• Participants gave various suggestions on how to improve the research design 
and also the hospital services, including: sending feedback to practitioners, 
providing medical assessment/examination in the research study, and to 
improve the support network at the RLHIM;  
• The research student’s background was asked about during the interviews, 
which may have introduced some bias.  
5.16 Summary of pre-treatment and follow-up interview results 
As stated previously in this chapter (aim and structure), some sub-themes generated 
from the follow-up interviews (Sections 5.9-5.15) are similar to the sub-themes 
generated in the pre-treatment interviews (Sections 5.2-5.8). These similarities 
existed particularly in themes stating participants’ experiences living with MSDs 
(Sections 5.2, 5.2 &5.9), their perceptions in self-management (Sections 5.5, & 5.10, 
5.11), and their acceptability and experience in participating in this research study 
(Sections 5.8 & 5.15). Therefore, before triangulating and merging the quantitative 
and qualitative results, qualitative results from the pre-treatment and follow-up 
interviews in these three categories are compared and summarised with final 
qualitative results generated. This comparison and merging process involved the 
research student’s interpretation and should be interpreted with caution as the two 
sets of qualitative interviews were conducted with not the exactly same group of 
participants and at different time points. Figure 5.17 shows where most of the 
overlaps in the pre-treatment and follow-up interviews were. 
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5.16.1 Comparison in participants’ MSDs experiences and impact 
Comparing the results of pre-treatment and follow-up interviews reveals that 
participants tended to report more about their life experiences with MSDs and how 
their life was affected by MSDs in the interviews before they received treatment. 
This may because of direct questions regarding their MSDs and their impact in the 
pre-treatment interviews. However, a new sub-theme emerged in the follow-up 
interviews about how participants adapted their life to MSDs, and shared more 
understanding of MSDs and how their understanding could influence the progress of 
MSDs. A summary of sub-themes identified on living with MSDs with overlapping 
sub-themes in pre-and-follow-up interviews presented in bold; different/additional 
sub-themes identified are presented not in bold (This rule is applicable throughout 
Sections 5.16.1-5.16.3). 
• Various MSDs (Pre: with unclear diagnosis) 
• Chronic (Pre: polypharmacy associated) 
• Co-morbidities 
• A hidden disability (Pre: with inadequate publicity awareness) 
• Fluctuating physical and emotional symptoms 
• MSDs affected participants’ life physically and emotionally  
(Pre: relationship with family and friends, ability to work and financial impact)  
(Follow-up: adapt life to MSDs; understanding of MSDs) 
5.16.2 Comparison in self-management 
Self-care and self-management were seen as important in both pre-treatment and 
follow-up interviews, but participants tended to report more techniques in the follow-
up interviews, especially on various CAM self-care techniques, and more control in 
their integrative and prolonged care which could have resulted from practitioners or 
directed by the practitioner they saw. In the follow-up interviews, participants shared 
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• (Follow-up: accepting the consequences; importance of self-help; self-
validation; experiencing discrimination) 
• Self-care includes various exercises and healthy eating (Follow-up: TENS, 
acupressure, homeopathic tablets and massage; inadequate guide) 
• Self-management strategies include plan daily activities, get distracted, and 
self-learning 
• (Follow-up: Self-directed integrative and prolonged treatment) 
5.16.3 Comparison of the acceptability and experience of the research 
Participants’ acceptability of outcome measurements in pre-treatment and follow-up 
interviews were similar, participants preferred the same two pain scales, and 
consistently felt that mCSRI was their least preferred outcome questionnaire. In the 
follow-up interviews, participants reported having CAM options listed in the mCSRI 
as helpful. They also suggested a narrative approach, in order to get the whole 
picture of their MSDs. Participants’ decision making process in participating in the 
research study was consistent before and after.  
• VAS and sfBPI were preferred (Follow-up: narrative was preferred) 
• mCSRI was the least popular (Follow-up: although it provided some CAM 
options which were useful) 
• Participated to support research and help other patients (Pre: no 
expectation) 
5.17 Chapter Summary 
This chapter presented the qualitative results of the feasibility study. Both qualitative 
data collected at pre-treatment and follow-up provided original and detailed results 
targeting different aspects of patients’ perspectives on receiving integrative 
treatments for MSDs at the RLHIM: one focused on participants’ expectations and 
the other focused on participants’ experiences. Patients experiences in participating 
the research study are also summarised in this chapter.  
Participants’ had a variety of MSDs with most of them experiencing widespread pain 
all over their body priory to their treatment at the RLHIM. Patients had physical and 
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emotional symptoms and their MSDs tended to be associated with polypharmacy and 
poor general health. MSDs often affected all aspects of participants’ quality of life.  
Most participants had tried various types of conventional treatments and found more 
disadvantages than advantages in taking them. 57% of participants (n=16) had 
previous experiences in CAM treatments in either the NHS or privately, mainly 
acupuncture and massage being the most beneficial treatments. These participants 
perceived physical benefits from using CAM treatments but found private clinics 
unaffordable. Participants’ self-help techniques included various types of 
conventional exercises; distraction from their MSDs, self-learning and understanding 
their MSDs, and carefully planning daily activities to suit their MSD. Participants’ 
decision making processes to try CAM and how they came to receive treatment at 
RLHIM varied. Most were pleased with the time they waited to get referred but felt 
that ease and timeliness of referral depended on a number of factors. 
In the pre-treatment interviews, participants’ expectations prior to their initial 
treatment at the hospital were extensively explored. The terms expectation and hope 
were used inconsistently in interviews, with most believing that they had pragmatic 
and realistic expectations of the treatment. Most participants had no concerns about 
their impending treatments at the RLHIM and were aware of the treatment they were 
expecting and hoped for. Participants hoped to have better health in terms of 
symptom relief, improving functional ability, and to be able to reduce medication; 
they hoped to receive individualised, non-invasive treatment through having 
optimum treatment, and treating their conditions’ root cause. Participants also 
expressed their hopes for better communication with RLHIM practitioners and 
engagement in the treatments; they expected RLHIM practitioners to be skilful 
professionals, working in conjunction with other healthcare professionals. Long term 
effects with more follow-up CAM treatments on a regular basis were also hoped for.  
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The follow-up interviews explored participants’ experiences of receiving integrative 
treatments for their MSDs at the RLHIM. Similarly, these participants had various 
types of chronic MSDs and other co-morbidities, associated with various symptoms 
that affected a wide range of aspects of their life. During the interview, they shared 
their understandings of MSDs and how they were affected by them, with small 
number of participants feeling their MSD was a hidden disability. Participants who 
had a long term relationship with MSDs had generally accepted and adapted their 
life style to MSDs and were aware of the importance of self-help. Healthy eating, 
planning schedules ahead of time, distraction techniques, and attending social events 
were some of the strategies participants used to manage their lifestyle. 
There was high demand for integrative treatments at the RLHIM and participants felt 
practitioners were under stress for the amount of work required. Participants received 
various types of treatments and a range of assessments at the RLHIM with more 
positive than negative experiences. Frequently perceived improvements were pain 
relief, better functional movements, feeling relaxed, better sleep, or reducing the 
medication taken. Participants believed that practitioners at the RLHIM are 
professional experts who share information with their patients.  
In terms of the feasibility of performing the research study, participants took part in 
the study because they felt research is important and they wanted to help other 
patients with similar conditions. They generally had positive experiences in taking 
part in the study. Although participants claimed that they had no concerns 
about participating in the research study, physical barriers were observed during the 
interviews. VAS and sfBPI were the most acceptable outcome measures due to their 
simplicity and being less time consuming to complete, while the mCSRI was the 
least acceptable outcome measure, with difficulties reported in recall details and 
some sensitive questions. A narrative approach including questions targeting all 
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aspects of life was also suggested. Various suggestions were given to improve the 
study design and the hospital service.  
Findings on patients’ expectations and experiences of receiving integrative 
treatments at the RLHIM, and their expectations and experiences in participating in 
the research study have been presented in this chapter. Further interpretation and 













Chapter 6 Integration, Comparison and 
Triangulation of Quantitative and Qualitative 
Results   
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Aims and structure 
In line with the convergent mixed methods design described in Section 3.1.1, this 
chapter integrates, compares and triangulates the results of the quantitative and 
qualitative data reported in Chapters 4 and 5. These data provide details concerning 
the feasibility as required and outlined in the MRC framework for complex 
interventions. It provides some answers regarding whether it is feasible to carry out a 
mixed methods study on integrative treatment for MSDs in the UK.  
Previously in Section 3.1.2, the approach taken to determine the feasibility of the 
research study was explored in relation to four main issues adapted from the 
Bowen’s feasibility framework:  perceived outcome of integrative treatment (Section 
6.1); their acceptability of, and demand for integrative treatment for MSDs at the 
RLHIM (Sections 6.2 & 6.3); and practical issues regarding study design (Section 
6.4). In addition, the quantitative and qualitative dimensions used to guide the 
reporting of this mixed methods feasibility study are presented alongside the four 
issues (O'Cathain et al., 2015; Shanyinde et al., 2011).  
This is achieved by providing the QUAN and QUAL results using side-by-side 
comparison tables with evidence provided for each issue of feasibility (tables 6.1-
6.4). In the side-by-side tables, column one and two represent the four feasibility 
issues and sub-dimensions based on the findings of the research study; column three 
and four represent the dimensions of quantitative and qualitative data; column five 
represents the final triangulated findings. The extent of congruency and divergence 
between the two sets of results are discussed for each dimension. Justification of how 
the final results are generated from the two strands is provided in each section for 
each of the Bowens’s four issues of feasibility.  
In order to generate explicit findings of the mixed methods feasibility study, this 
chapter only presents triangulated findings from these two strands. Its implications 
and further interpretation and implementation for future research are discussed in 
detail in Chapter 7. Findings that are based on the research student’s interpretation or 
reflections on conducting the research study are mentioned, if related, but discussed 




Chapter 6 Integration, Comparison and Triangulation of Quantitative and Qualitative Results  
6.1 Limited-outcome testing 
This section compares and summarises the findings on interventions provided for 
MSDs at the RLHIM and the outcomes of the interventions provided. Potential 
factors that may be associated with the treatment effects are also explored (table 6.1).  
This mixed methods feasibility study explored the existing integrative NHS services 
routinely provided for people with MSDs at the RLHIM (row 1). QUAN and QUAL 
findings appeared to concur that MSD patients received a variety of integrative 
treatments; and that acupuncture was the most frequently received treatment, 
followed by homeopathy and physiotherapy. QUAN results provided additional 
information regarding the complexity of the treatment provided, especially in terms 
of the length and the numbers of modalities involved. QUAL results provided 
additional information on receiving diagnostic assessments and patients’ 
understanding of treatment (row 2). Diagnostic assessment is an essential part of the 
IM practice and it is recommended that it should be explored and reported in future 
research. The unit costs of treatments provided by the hospital during this research 
study could not be provided and were not made available to the researcher (row 3).  
Both QUAN and QUAL results demonstrated improvements in pain severity, 
physical function, and emotional status (row 4). QUAN findings provided 
preliminary evidence for the sample size calculation for pain severity, physical and 
emotional function at four, eight, and 12 months. This would depend on the future 
study design especially any control group(s). Additional QUAL findings reported by 
participants included changes in medication usage (reductions), minor but acceptable 
AEs experienced, changes in the way of thinking and adapting to living with their 
MSDs. 
There were several components that appeared to potentially influence the effects of 
the integrative treatments provided for MSDs (row 5). QUAL results suggested a 
relationship between length of treatment and treatment effects, while QUAN results 
showed that positive changes may peak at four months but were maintained at up to 
12 months. The QUAL participants were a sub set of QUAN participants that 
represented 60% (28/47) of the whole participants and only seven of these felt the 
treatment effects were associated with the length of treatments they received. As a 
sample size of seven was too small to run any robust statistical analysis, subgroup 
221 
 
Chapter 6 Integration, Comparison and Triangulation of Quantitative and Qualitative Results  
analysis of the QUAN data for this group was not conducted. QUAN findings tended 
to suggest being non-smoker was a positive indicator of better pain severity 
improvement; while QUAL findings suggested individualised treatment, 
multidisciplinary collaborative teamwork, a holistic approach treating all aspects of 
life, and the patient-practitioner relationship were key components of the integrative 
treatment package. Since this research study was an exploratory uncontrolled 
feasibility study, none of these suggested components can be definite predictors of 
treatment effects. A larger sample size to explore the relationship between treatment 
effects and patients’ lifestyle as a potential predictor, and a qualitative study to 
further explore these suggested components is warranted. 
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 Table 6 1 Triangulation of QUAN and QUAL findings: limited outcome testing 





































1. Intervention development*** 
To what extent does the planned intervention need to be refined or adapted to make it more acceptable to users or more relevant or useful to the specific context in which it 
is delivered? 
This issue was irrelevant to this research study as the mixed methods feasibility study assessed the routine clinical practice in providing integrative treatment for MSDs at 
the RLHIM, rather than developing a new integrative treatment package.  
Explored existing integrative 
treatment for MSDs at the 
RLHIM. 
2. Intervention received 
Acupuncture, homeopathy, and physiotherapy 
were the most commonly received. Length, 
frequency and type of treatment varied 
between participants (Section 4.4). 
Interventions received  
Participants received various types of treatments at the RLHIM, among which acupuncture, homeopathy, and 
physiotherapy were the most commonly received. 
A range of assessments were received at the RLHIM. 
Services provided at the RLHIM were integrative with the services at UCH and NHNN. 
Many participants reported their expectations were managed by practitioners at the RLHIM (Section 5.13.1). 
Patients received varied 
complex diagnostic and 
therapeutic integrative 
treatments, which involved 
expectation management and 
horizontal integration with other 
hospitals outside the RLHIM 
3. Cost and duration of intervention** 
Was it possible to calculate intervention costs and duration? 
Cost data were collected using the mCSRI but not analysed because unit costs from the RLHIM were unavailable to the research student. In addition the completion rate of 
the mCSRI was low and patients disliked completing it. 
Mean number of sessions of treatments received was 11.5, from one-off treatment to treatments lasting more than 12 months. 
It was unclear how much the 
integrative treatments for MSDs 
cost at the RLHIM during the 







4. Sample size calculation** 
Effect sizes in pain, physical, emotional 
function, as measured by: VAS: 4m=0.615, 
8m=0.490, 12m=0.574; sfBPI pain severity: 
4m=0.628, 8m=0.499, 12m=0.523; sfBPI pain 
interference: 4m=0.400, 8m=0.440, 
12m=0.546; SF36 physical: 4m=0.326; SF36 
emotional: 4m=0.388, 12m=0.350 (Section 
4.7). 
Breadth of outcomes***  
Do some trial participants feel that they have experienced or noticed improvements in some outcomes that need to be 
included in the full trial? 
Participants experienced improvements in pain, physical and emotional function, and reduction in medication taken. 
Treatment produced minor but acceptable AEs. Participants who had a long term MSD accepted and adapted life to 
their MSD (Section 5.13.2). 
 
Potential improvements in pain 
severity and HRQoL at 4 
months, sustained at 12 months; 
reduction in medication use. 
Effect sizes provided 
preliminary evidence for sample 
size calculation. 
Treatment produced minor but 
acceptable AEs. 
Patients accepted and adapted 
their life to MSD. 
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5. Potential predictors of outcome 
No relationship between length, complexity of 
treatment, or location of pain for primary 
outcome. Those participants who were non-
smokers and those who had greater pain at 
baseline showed significantly better 
improvement in pain severity at four months: 
F(2, 44)=7.914, p=0.001, R2=0.265;  
A higher expectation at baseline had greater 
decrease in expectation at four months: F(1, 
45)=9.218, p=0.004, R2=0.170 (Section 4.9.2). 
Intervention components*** 
How do the intervention components and delivery processes work in the real world? Consider the different aspects of 
the intervention and which are fixed and flexible. The intervention may be different in practice from the planned 
intervention and may need to be documented so it can be delivered consistently in the full trial. 
Several components were suggested important by participants including: 
• Length of treatment (Section 5.13.2) 
• Individualised treatment (Section 5.13.3) 
• Multidisciplinary collaborative teamwork (Section 5.13.3) 
• Treating all aspects of life (holistic) (Section 5.13.3) 
• Patients’ expectation (Section 5.13.4) 
• Patient-practitioner relationship (Section 5.14) 
Participants shared their understanding of MSDs mechanism and possible psychological associations related to their 
MSDs (Section 5.9.4). They were aware of the importance of self-help and a self-directed integrative approach; they 
received options for self-care techniques from the RLHIM (Section 5.16.2 summarised from 5.5&5.10).  
It was anticipated that all patients would be triaged from a MSK physician. Potential patients referred through BMAS 
and ‘choose and book’ service were missed.  
Larger samples are needed to 
explore lifestyle and life styles 
changes as predictor s of 
integrative treatment effects. 
Qualitative studies to explore 
associations between treatment 
effects and individualised 
treatment, holistic approach, 
patient-practitioner relationship, 
multidisciplinary collaborative 
teamwork, and self-help are 
warranted. 
 
Mechanisms of action***  
How might the intervention be working? How might it produce the outcomes important to the trial?  
Data collected to address these questions may be interpreted in relation to the theory upon which the intervention is 
based or may help to develop new theory. 
Participants perceived that their positive experiences of integrative treatment were associated with the components 
stated above. 
*indicates the four issues in feasibility (Bowen et al., 2009); ** indicates methodological items suggested for reporting quantitative feasibility study (Shanyinde et al., 2011); *** indicated dimensions suggested for 
reporting qualitative feasibility study (O'Cathain et al., 2015); N/A: Not available 
The explanations of dimensions (texts in table in blue) were designed for reporting trials or qualitative research along trials. However, these feasibility frameworks are not restricted to trial therefore were used as a 
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6.2 Acceptability of integrative treatment 
This section presents participants’ decision making process, their acceptability of the 
referral pathway, their adherence to intervention, and their acceptability of receiving 
integrative treatment at the RLHIM (Table 6.2). There were various reasons which 
prompted patients to decide to seek CAM treatments but the main reason participants 
sought treatment at the RLHIM was that they believed the practitioners were 
qualified, knowledgeable professionals (row 1). This finding on patients’ decision 
making processes was only based on QUAL results and there were no QUAN results 
to support or refute this.  
There was approximately 1.5 months between participants getting referred to the 
RLHIM to them receiving their initial appointment (QUAN) and this was perceived 
to be acceptable by participants (QUAL) (row 2). Additional QUAL results indicated 
that participants encountered initial difficulties in getting referred to RLHIM; and 
shared their understanding about possible factors/barriers and the ease of referral to 
the RLHIM. The research student subsequently explored the quotes of participants 
who were referred from different boroughs (presented in Section 4.3). QUAN results 
show that 37% of participants’ GPs belonged to North East London CCG, which 
tended to agree the QUAL findings that the postcode where they lived /or their GP 
was registered may have affected their chances of obtaining a referral to the RLHIM. 
Further interpretation was carried out to explore whether there was a high demand 
for treatment at the RLHIM, which proved to be true as presented in the next section 
(6.3). 
Patients’ adherence to treatment appointments was good over the 12 months follow-
up (QUAN) (row 3), and the acceptability of the integrative treatment provided at the 
RLHIM was considered good as evidenced by congruent QUAN and QUAL findings 
(row 4). Good adherence and retention indicated the treatments provided were 
acceptable (QUAN), while QUAL findings suggested good acceptability in terms of 
benefits perceived in symptoms relieved and positive experiences with practitioners. 
QUAL findings indicated that both practitioners and patients themselves played 
important roles in the treatments provided at the RLHIM, therefore practitioners or 
healthcare professionals’ perceptions about  how they provide  integrative treatments 
at the RLHIM are warranted (in Section 7.7.2). Due to the uniqueness of the 
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integrative treatments provided for MSDs at the RLHIM, these findings may 
represent the specific situation within NHS secondary care, and should be interpreted 




 Table 6 2 Triangulation of QUAN and QUAL findings: acceptability of integrative treatment 

















1. N/A Decision to seek RLHIM treatment  
Participants decided to try CAM treatment because of their families and friends and their relationship at the suggestion 
of healthcare professionals, previous conventional treatments not helping, personal knowledge or interests. Having 
qualified, knowledgeable professionals were the main reason participants came to the RLHIM (Section 5.6.1-5.6.3). 
Various reasons enabled 
participants to decide to seek 
CAM treatments; having 
qualified, knowledgeable 
professionals was the main reason 






2. Acceptability of referral pathway 
Though not directly assessed, mean time 
interval between referral & 1st 
appointment: 44.0 (24.9) days. GPs 
location: NEL (37%), non-NEL CCG 
(27%), outside greater London (37%). 
Acceptability of referral pathway  
Most participants accepted the amount of time they had to wait for a referral. 
Many experienced initial difficulties in persuading their GPs to refer them to the RLHIM. They believed it was due to a 
lack of access to CAM services, caused by a lack of funding. 
Participants felt which borough they were in and who referred them were two main aspects affected whether they could 
get referred (Sections 5.6.4&5.6.5). 
44 days referral time was felt to 
be acceptable. Participants 
experienced difficulties in getting 
referred; potential factors 
influencing referral were where 








3. Adherence to intervention** 
Did participants adhere to the 
intervention? 
Initial appointment cancelled/changed (by 
hospital or patients): 9/60 (15%). Overall 
cancelled/changed: 26/60 (43%). 
Apart from three participants, all attended 
all treatments. 
N/A Although there were some 
cancel/changes in schedule, there 
was good adherence to treatment 
appointments. 
 
4. Acceptability of intervention** 
Was the intervention acceptable to the 
participants? 
Despite not directly assessed, high rate in 
cancelled/changed appointments but good 
adherence to interventions (above, row 3) 
and good retention at 12 months (Table 
6.4, row 9) indicated good acceptability.  
Perceived value, benefits, harms or unintended consequences of the intervention*** 
What value do service providers and intervention users place on the intervention and the outcomes it plans to deliver? 
What benefits and harms do they feel they have experienced from the intervention so that these can be measured in the 
full trial? 
Participants perceived benefits in symptoms relieved (Table 6.1, row 4) with minor acceptable AEs (Section 5.13.2). A 
few participants had positive experiences in sharing experiences with the Friends volunteers (Section 5.13.7). 
Practitioners perceived by patients were professional expertise who shared information, interacted with patients, and 
tried to manage their expectations (Sections 5.14.1-5.14.4). Patients took an important role in their intervention as they 
actively involved in lifestyle management; were the main driver/direct of seeking consistent follow-up treatment; played 
an important role in an optimum package of treatment; and treated themselves using a range of CAM self-care options 
(Sections 5.11.1-5.11.5).  
Positive experiences with 
practitioners, perceived benefits, 
and good adherence to treatment 
indicated good acceptability of 
integrative treatment at the 
RLHIM. High cancelled/changed 
but good adherence. The MSD 
service at the RLHIM was unique 
and should be interpreted 
carefully when used in other 
settings.  
Acceptability of intervention in principle*** 
Are service users or health care providers unhappy with any aspect of the content or delivery of the intervention? 
#Healthcare providers’ experiences of the integrative treatment provided were not explored in this research study and are 
recommended for future study (Section 7.7.2). 
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Feasibility and acceptability of intervention in practice*** 
What are service users or health care providers’ views of the implementation of the intervention? Has implementation 
varied by setting? Are there any important intervention-context interactions? Should implementation be tailored by 
setting? 
Intervention implementation was irrelevant to this research study as the mixed methods feasibility study assessed the 
integrative treatment for MSDs already provided at the RLHIM, rather than developing an integrative treatment 
package. 
The integrative treatment service for MSDs was perceived as unique in terms of the professional treatments provided, 
their general impression of it, and that it was covered by NHS (Section 5.13.6);  
#Healthcare providers’ experiences of the integrative treatment provided were not explored in this research study and are 
recommended for future study (Section 7.7.2). 
*indicates the four issues in feasibility (Bowen et al., 2009); ** indicates methodological items suggested for reporting quantitative feasibility study (Shanyinde et al., 2011); *** indicated dimensions suggested for 
reporting qualitative feasibility study (O'Cathain et al., 2015); N/A: Not available 
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6.3 Demand for integrative treatment 
This section presents the findings on participants’ demand for integrative treatments at the 
RLHIM (Table 6.3). Findings on the four dimensions: living with MSDs, previous personal 
or healthcare experiences, participants’ expectations and hopes, and imbalance in supply and 
demand are presented. The first two dimensions (rows 1&2) are stated in this section as they 
are related to participants’ demand for integrative treatment, and will help understand the 
reasons behind the demand.  
Most patients had complex musculoskeletal pain (QUAN), and their MSDs tended to be 
chronic, associated with polypharmacy and co-morbidities, and affected all aspects of life and 
they felt this needed more public awareness (QUAL) (row 1). Patients’ diagnoses were 
unclear as ICD codes were unavailable for most participants, therefore the identification of 
the conditions were only based on the patient-reported location of pain (QUAN). QUAL 
results complement the QUAN results and provided information on participants’ life 
experiences with their MSDs.  
Findings on patients’ previous healthcare experiences were purely based on QUAL results, 
suggesting that their previous conventional healthcare experiences were not satisfactory; 
some had previously benefited from CAM treatments but found them unaffordable (row 2). It 
is worth noting that patients’ previous consultation histories were partially available on the 
hospital system but not explored quantitatively as it was not part of the initial study design 
protocol and subsequent ethical approval.  
Patients’ MSD experiences and their previous healthcare experiences potentially influenced 
their expectations. QUAN and QUAL findings complemented each other showing that 
patients felt their expectations were pragmatic and realistic (7/10 on the hospital at the same 
time, although these expectation VAS), and tended to be consistent over 12 months (row 3). 
Higher expectations tended to be associated with poorer treatment experiences (QUAL). 
While QUAN findings showed no change in expectation score over the 12 months’ period, 
QUAL findings provided useful additional information on what exactly participants expected 
or hoped for; and their needs in more IM services 
There tended to be an imbalance in supply and demand of integrative treatment provided for 
MSDs at the RLHIM (row 4), which was supported largely from the QUAL results. QUAN 
findings available were limited, however 37% patients travelled from outside of greater 
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London. Patients were given 11.5 sessions (median) of integrative treatment during the 12 
months’ period. This approximately once per month treatment was regarded by patients as 
insufficient as evidenced by QUAL findings, suggesting that the treatments were in demand 
in terms of variety and quantity. They felt thankful to have treatment at the RLHIM and felt 
the practitioners were working under stress due to an imbalance in supply and demand. 
Potential reasons for the imbalance were substantiated by patients (QUAL). 
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1. All participants had pain: 35% 
had widespread pain, 25% low 
back pain, 12% knee pain; 18/60 
primary ICD codes not available 
(N/A); 60/60 secondary ICD 
codes N/A. 
Most participants had various and multiple chronic MSDs; they believed that MSDs were associated with 
polypharmacy and co-morbidities; fluctuating symptoms affected all aspects of their life. Some participants had an 
unclear diagnosis; Some felt MSDs were ‘hidden disabilities’ with inadequate public awareness (Section 5.16.1 
summarised from 5.2, 5.3 & 5.9). 
Chronic MSDs tended to be associated 
with polypharmacy and co-
morbidities, affect all aspects of life 























2. Partially available from the 
hospital but was not collected as 
this was not  included in the 
protocol or included in the ethical 
approval 
Participants had extensive experiences with various types of conventional treatments for their MSDs and some other 
health issues, and were concerned about AEs caused by conventional therapies, especially in the long term and with 
their co-morbidities (Section 5.4.1&5.4.2). 
Nearly half of the participants had no experience of CAM previously. Most participants who had CAM/IM treatments 
previously experienced physical and emotional benefits and improved quality of life. They were becoming reliant on 
CAM but felt private clinics ere unaffordable and the effects worn off (Section 5.4.3-5.4.5). Participants felt there was 
a lack of communication with previous practitioners (Section 5.4.6). 
Participants had extensive experiences 
in various conventional treatments but 
were concerned about AEs in long 
term; they had previously benefited 
from CAM treatment but felt they 
were unaffordable; they felt there was 
a lack of communication (not 













3. Participants’ expectation score 
pre-treatment: mean (SD): 7.17 
(1.579). No significant change 
during the 12 months follow-up: 
F(3, 138) = 1.647, p=0.181. 
Most participants believed they had pragmatic and realistic expectations (Section 5.7.2); they had no concern in their 
upcoming treatments apart from travelling far and difficulties in getting re-referrals (Section 5.7.3); while they did 
have some difficulties in getting referrals (Section 6.2, row 2). 
Most participants were aware of what treatment they were going/hoped to receive; they hoped to have better quality 
of life with meaningful activities in long term; they hoped to receive more integrative treatments with individualised, 
non-invasive treatment that adopted optimum treatment, treat their conditions from the root, and to better 
communicate with skilful practitioners and engage in the treatment (Sections 5.7.4-5.7.8). 
Participants’ pre-treatment expectations and their follow-up experiences at the RLHIM were inversely related (Section 
5.13.4). 
Participants felt they had pragmatic, 
realistic expectations which seemed to 
be consistent over 12 months, but 
tended to be inversely related to their 
follow-up treatment experiences. 
Participants hoped IM would alleviate 
symptoms and improve quality of life; 

















4. Though not directly assessed, 
37% participants travelled from 
outside greater London (Section 
6.3.3) may suggest RLHIM 
treatment was in demand; A 
median of 11.5 sessions/patient 
were provided over 12 months 
(Section 6.2.1) 
Dose of intervention*** 
Is the right amount of the intervention getting to the right recipients in the right way? 
Integrative treatments at the RLHIM were in demand in terms of availability of different types, amount of sessions, 
and length (both consultation and follow-up sessions) of CAM treatments provided for their chronic complex MSDs; 
and input on self-help information (Section 5.12.1). Participants felt practitioners were under stress with the amount 
of work required (Section 5.12.2). They perceived having integrative treatment at the RLHIM as a ‘precious 
opportunity’ and felt there was a lack of funding resources and that was the reason for inadequate amount of treatment 
(Sections 5.12.3&5.12.4). 
Participants’ with extensive experience at the RLHIM observed changes in the referral pathway and funding restraints 
at the RLHIM over  time (Section 5.13.5); 
Participants felt RLHIM was unique in terms of the professional treatments provided, their general impression of it, 
and that it is covered by NHS (Section 5.13.6). 
Patients perceived the integrative 
treatments provided at the RLHIM 
were in demand. 
*indicates the four issues in feasibility (Bowen et al., 2009); ** indicates methodological items suggested for reporting quantitative feasibility study (Shanyinde et al., 2011); *** indicated dimensions suggested for 
reporting qualitative feasibility study (O'Cathain et al., 2015); N/A: Not available 
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6.4 Feasibility of research design 
This section details twelve dimensions addressing the practical issues in the 
feasibility of conducting this mixed methods research. It mainly focuses on two 
categories: aspects of study design, conduct and processes (row 1-10), and aspects of 
outcome measures (row 11&12) (Table 6.4). Final findings presented in the Table 
6.4 are mostly generated from both QUAN and QUAL findings as they 
complemented each other, with QUAN findings giving precise data and QUAL 
findings explaining how and why. A few dimensions are generated solely from one 
strand: a). Solely QUAL findings on study participation (row 5) and impact of study 
on staff, the researcher, participants, and the health system (row 9), and b). The 
research student’s reflections and experiences in conducting this research, included: 
issues in identifying eligible patient (row 1), the feasibility in carrying out 
multicentre study (row 7), and reflections on patient involvement (row 10). 
Being ineligible for recruitment into the study was mainly due to unexpected staff 
turnover and issues in reliance on administration staff and clinicians potentially 
missing identifying MSD patients within their busy clinics (row 1). Recruitment was 
very difficult (37%) and the reasons patients participated in this research study 
varied, mainly due to the desire in supporting IM research (QUAL) (row 2). 
However, it was unclear whether the participants would have been willing to be 
randomised or not. Retention (78%) over 12 months was acceptable and encouraging 
(row 3). In this research study, patients were not purposively sampled and were 
recruited sequentially. The majority were middle aged, female, Caucasian, with a 
higher educational background (QUAN). They were also a group of patients who 
were with chronic complex MSDs and were aware of the importance of self-
management, healthy lifestyle and self-care (QUAL) (row 4).  
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Findings on patients’ perceptions and experience of taking part in research were 
solely based on the QUAL results. Their positive experiences with the research 
student, and their experiences of the process of participation including; being 
contacted, providing informed consent, and arranging appointment was acceptable. 
QUAL findings also suggested that patients felt that they had benefited from 
participating and provided their opinions on how the research could be improved 
(row 5&6).  
The logistics of running a multicentre research study (row 7) and the fidelity and 
reach of intervention was not assessed (row 8) in this feasibility study as this 
research study evaluated an NHS routinely delivered integrative treatment service at 
the RLHIM rather than developing an intervention. Findings from this research study 
can be used in future IM research at the RLHIM or in similar settings but needs to be 
interpreted with caution (details in discussion Section 7.7.2). Potential impact on 
patients and practitioners, and advantages of having a patient involved suggested by 
this research study are worth considering in future research (row 9&10). Future 
study exploring patients’ acceptability in randomisation, and qualitative research 
exploring healthcare providers’ experiences in study recruitment are warranted 
(discussed in Section 7.7.2). 
Convergent QUAN and QUAL findings tended to indicate that the outcome 
measures selected in this research study assessed and captured main concerns of 
patients (row 11). The completion of outcome measures were considered successful 
(row 12) as evidenced by good completion rates. Additional QUAL findings 
provided details in what they believed were key in capturing their MSDs; and 
patients’ acceptability in completing the cost questionnaire was less positive. 
233 
 
 Table 6 4 Triangulation of QUAN and QUAL findings: feasibility of study design 



















































What factors influenced eligibility and what proportion of those approached were eligible? 
161 patients were eligible. Several issues in identifying eligible participants occurred due to unexpected staff turnover and issues in reliance on 
administration staff and missed identification of some potential patients (discussed in Section 7.5). 
Ineligibility was mainly due to nothaving 
MSDs and potential failures in identifying 
patients. 
2. Recruitment** 
Was recruitment successful? 
121/161 eligible patients not willing to 
take part; 
Changes in administration staff at the 
RLHIM may influence recruitment.  
Two major ethical revisions were 
applied to improve the recruitment rate 
(detailed in Section 7.6.4) 
Recruitment*** 
How do the planned recruitment practices work in the field? Do recruitment practices need to be improved to 
increase recruitment rates and levels of informed consent? If so, how? Are the trial participants willing to be 
randomised? Are clinicians willing to recruit patients, or are they uncomfortable?  
Reasons for participating included to support research, help other patients, and to help the research student 
(Section 5.16.3 summarised from 5.8.2). 
Though participants claimed that they had no concerns participating in the research study, some physical 
restrictions were noticed during the interviews; Participants had no clear expectation for the research study 
and their expectation seemed to be associated with their decision to participate (Sections 5.8.3&5.8.4). 
Randomisation was not assessed due to the design of this mixed methods feasibility study; #Healthcare 
providers’ experiences in study recruitment were not explored in this research study and are recommended in 
future study (Section 7.7.2). 
Recruitment was very difficult, mainly due to 




Was retention to the study good? 
10%, 17%, and 22% dropped out at 4, 
8, and 12 months (Section 4.1).  
Retention*** 
Are there ways in which trial procedures could be improved to increase retention rates? 
Five participants dropped out from the quantitative study but were interviewed at the 12 months, but no 
obvious sub-theme identified these from other participants (Section 4.1). 
Retention over 12 months was acceptable and 
encouraging. There was no clear feature for 
loss follow patients. 
4. Participants’ characteristics 
Most of the participants were middle 
age, married, female, married, white 
British, native English speakers 
Christian; with a most common 
education level as college/diploma 
level or above. 68% participants were 
not working full time or retired and 
78% were 
professional/technical/skilled. Most 
participants were in chronic widespread 
pain, LBP or knee pain (Section 4.2). 
Diversity of participants*** 
Are the planned recruitment practices likely to result in recruitment of the desired range of participants for 
the trial? If not, how might recruitment practices be improved? 
Participants with chronic complex MSDs (Table 6.3, row 1); had a basic understanding of self-management 
and self-care (Sections 5.5.1-5.5.5). 
Most patients were middle age English, with a 
higher educational background, who were with 
chronic complex MSDs and were aware of the 
importance of self-management, healthy 
lifestyle and self-care. 




How is the planned trial communication implemented by recruiters and received by participants? How can 
trial communication be improved to ensure recruiters understand patients’ views about participating in the 
trial? 
Participants had positive experiences in communicating with the research student regarding the research 
process (Section 5.15.3). The MSK physician (who helped identifying eligible pstients)’s  perspectives were 
not explored and worth researching in future study (recommended in section 7.7.2). 
Participants’ experiences in the research 
process were acceptable; they perceived some 
benefits in participating and suggested several 
improvements to the study. 
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Acceptability of the research study in practice***  
Is the trial design acceptable to patients, recruiters and service providers in practice, or are there ways in 
which participants try to alter the procedures? 
The research study helped participants self-reflection; they reported benefits particular from focus groups in 
sharing experiences, seeking confirmation, providing information, and feeling assured (Section 5.15.3). 
Participants were happy to be contacted by text or email by the research student (Section 5.15.4). 
Participants suggested improvements to the research study included: sending feedback to their practitioners, 
providing medical assessment/examination in the research study, and to improve the support network at the 
RLHIM (Section 5.15.4).  
Acceptability of the research study in principle*** 
Is the trial design acceptable to patients, recruiters and service providers in principle? 
According to acceptable retention rate, it was anticipated that participants’ acceptability was generally good.  
6. Consent** 
Did eligible participants consent? 
60/161 (37%) consented 
Ethical conduct*** 
Are the informed consent procedures appropriate and acceptable to likely trial participants? 
No theme particular identified on participants’ acceptability on informed consent procedures but their general 
experiences of participating were good (Section 5.15.3).  
Low conversion to consent 
7. Logistics of multicenter** 
Were the logistics of running a multicenter trial assessed? 
This has not been assessed  
 
8. All components of the protocol 
work together** 
Did all components of the protocol 
work together? 
Another primary outcome measure: 
VAS was added; participants were 
selected sequentially due to difficulties 
in recruitment; cost data were not 
analysed as part of this research study.  
Fidelity and reach of intervention*** 
Do those delivering the intervention and/or receiving it adhere to the planned intervention? If not, what are 
the reasons for this? What are the limits of acceptable tailoring of the intervention? 
Since this research study evaluated a developed integrative treatment service at the RLHIM rather than 
developing an intervention, fidelity and reach of intervention was not assessed. 
Minor revisions to the pre-set protocol; Fidelity 
and reach of intervention was not assessed. 
 
Adaptation of research study conduct to local context*** 
Will the planned trial procedures allow the trial to operate effectively in the proposed context? Do any 
changes need to be made to these procedures? 
Findings of this research study can be used in future IM research at the RLHIM or in a similar setting. A few 
participants wished to provide positive feedback to support the research. Details of changes recommended 
are in Section 7.7.2. 
9. Impact of research 
N/A 
Impact of trial on staff, researchers, participants and the health system***  
Does this trial have any unanticipated negative impacts on recruiters, participants, other stakeholders and the 
health system? How can these impacts be minimised (e.g. workload involved in recruitment, numbers of 
measures undertaken)? 
Participants felt practitioners were under stress with the amount of work required (Section 5.12.2). One 
participant asked to be withdrawn from the research study (discussed in Section 7.6.4).  
# Further qualitative study with recruiter and stakeholders to explore their acceptability in recruitment, 
numbers of measures undertaken are recommended (Section 7.7.2). 
There were potential impacts on patients and 
practitioners caused by the research study 
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10. Patient and public involvement*** 
How is patient and public involvement best achieved in the trial? 
One patient representative (RP) was involved in the study design (Section 3.1). 








11. Selection of most appropriate 
outcomes** 
Were outcomes measured those that 
were the most appropriate outcomes? 
VAS, sfBPI, and SF36 captured 
changes in pain severity, pain 
interference, and HRQoL over 12 
months (Section 4.7). 
Selection of outcomes*** 
Are outcomes important to service users selected for measurement in the full trial—both primary and 
secondary? 
Pain severity and interference and quality of life were important for participants as most of them had chronic 
various MSDs and co-morbidities, with pain and physical and emotional symptoms, affecting all aspects of 
their life. This required them to adapt life to their MSDs (Section 5.16.1 summarised 5.2&5.9).  
Outcome measures tended to assess main issues 
patients concerned; VAS and sfBPI, and a 
narrative approach were preferred. 
12. Outcome assessment** 
Were outcome assessments completed? 
Questionnaire completion was good at 
12 months: VAS, sfBPI and SF36: no 
missing data for completers. 77% 
completed the mCSRI at 12 months.  
Cost data were collected (mCSRI) but 
not analysed mainly due to unit costs 
from the RLHIM being unavailable to 
the research student. Thirty participants 
were interviewed pre-treatment; 28 at 
follow-up. 
Accuracy of measures*** 
Are the process and outcome measures valid for this participant group? 
See below row. 
PROMs completion and interview attendance 
were good over 12 months 
 
Cost was not assessed but quantitative data 
were collected, participants’ acceptability in the 
mCSRI were discussed; Participants had 
individualised length of intervention 
 
PROMs in integrative treatment targeting 
patients’ holistic HRQoL are warranted.  
Completion of measures***  
Can completion rates of measures be improved? 
How outcome measure completion rate can be improved was not directly asked in interviews, participants 
reported that they felt measures that were easy and quick to understand, and the opportunity to talk ( a 
narrative approach) were preferred as questions can target all aspects of life are needed to understand 
participants’ chronic MSDs. The contents in mCSRI were inspiring but wording can be improved; 
Participants also expressed difficulties in remembering what they spent in past three months, and found 
unclear boundaries between conventional treatment and CAM (Section 5.16.3 summarised from 5.8&5.15).  
Development of measures***  
If validated measures do not exist for all the outcomes to be measured in the full trial, can they be developed 
in preparation for the trial? 
VAS, sfBPI, and SF36 tended to be appropriate outcome measures (Section 4.7), however, PROMs on 
integrative treatment that capture holistic aspects of patients’ conditions are warranted. 
*indicates the four issues in feasibility (Bowen et al., 2009); ** indicates methodological items suggested for reporting quantitative feasibility study (Shanyinde et al., 2011); *** indicated dimensions suggested for 
reporting qualitative feasibility study (O'Cathain et al., 2015);   N/A: Not available 
#Refers to future research that can be done, which are discussed in Section 7.7.2.
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6.5 Summary of findings 
This chapter presented the final triangulated results on the feasibility of carrying out 
a mixed methods study within an existing integrative treatment programme for 
MSDs at the RLHIM. Results showed that complex integrative treatments, including 
diagnostic assessment, expectation management, and horizontal integration provided 
at the RLHIM had the potential to produce moderate pain relief and improved 
HRQoL at four months, which was sustained (with smaller effect size) at 12 months. 
Effect sizes of PROMs at different time points provided preliminary data for future 
sample size calculation. Integrative treatments produced a few minor but acceptable 
AEs. Through this treatment process, participants accepted and adapted their lifestyle 
to MSD; and had an increased awareness on a self-directed integrative approach. 
Possible key components that may be associated with treatment effects were; 
lifestyle, complexity of treatment, level to individualisation, holistic approach, 
patient-practitioner relationship, multidisciplinary collaborative teamwork, and self-
management.  
Patients had experienced some difficulties in getting referred, while their 
acceptability of the integrative treatment was generally good. This was evidenced by 
acceptable referral time, good adherence to treatment appointments, positive 
experiences and perceived benefits in what they hoped from receiving the integrative 
treatments.  Patients’ acceptability on treatments received may be associated with 
their decision making process. In this research study, the reasons patients seek CAM 
treatments varied, but having qualified, knowledgeable professionals was the main 
reason participants came to the RLHIM. Therefore, qualifications and theoretical 
background of practitioners may be worth exploring in future research as this may 
affect patient expectations and outcome.  
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Patients’ demand for integrative treatment for MSDs was explored. Their personal or 
healthcare experiences in MSDs were potential influential factors of patients’ 
expectation and hopes. Most patients had chronic MSDs associated with 
polypharmacy and co-morbidities. All aspects of life were affected by their MSDs 
and patients suggested more public awareness needs to be available. Patients’ 
previous unsuccessful conventional healthcare experiences enabled them to seek 
CAM treatment, which they benefited from and some became reliant on, but they felt 
were unaffordable with their health conditions. Patients felt their expectations were  
pragmatic and realistic and they seemed to be consistent over 12 months, and their 
expectations tended to be inversely related to their follow-up treatment experiences. 
Patients hoped for symptom alleviation and improvement in quality of life with IM 
care, and hoped to access self-help information. These expectations and hopes may 
potentially have an impact on their demand for treatments at the RLHIM. Patients 
hoped to receive more availability in types of integrative treatments, with more 
sessions, and longer length in consultation; and felt practitioners were under stress 
from the amount of work required. These all indicated a short supply of integrative 
treatment for MSDs, patients perceiving it being due to a lack of funding resources.  
In terms of the practical issues in the feasibility study design, ineligibility was 
mainly due to not having MSDs and potential failures in identifying patients. 
Recruitment was very difficult as it heavily relied on administrators at the RLHIM, 
while the retention over 12 months was acceptable and encouraging.  With a low 
conversion to consent, the sixty patients recruited in this research study may not be 
representative to population with different socioeconomic background as most of the 
patients were middle age, female, Caucasian, with a higher educational background. 
They tended to be aware of the importance of self-management, healthy lifestyle and 
self-care. This may be a self-selected group of patients, so findings should be 
interpreted with caution if this research was to be conducted in other settings. 
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Patients’ experiences of the research process and communication with the research 
student were reported as acceptable and often complimentary. They felt that the 
research study helped them with self-reflection and feeling assured. They also 
benefited from sharing experiences and information in focus groups. Findings also 
suggested VAS, sfBPI, and SF36 tended to assess main issues patients concerned, 
which were the alleviation in symptoms and improvements in quality of life. The 
completion rate of these PROMs and interview attendance were good over 12 
months. Patients preferred VAS and sfBPI, and a narrative approach to capture their 
conditions holistically. The mCSRI was perceived too long but patients found the 
CAM treatments listed in the form inspiring. Minor revisions made to the pre-set 
protocol should be noted.  
Some recommendations are given based on the feasibility aspects. Firstly, future 
research should use larger samples to explore lifestyle as a predictor of integrative 
treatment effects for MSDs. Quick-to-complete PROMs targeting integrative 
treatment for patients’ holistic HRQoL are warranted. Some of the wording of the 
mCSRI needs to be revised to be more comprehensive for participants. Patients’ 
recommendations on being contacted through text or email, sending feedback to their 
practitioners, providing medical assessment/examination in the research study, and 
improving the support network at the RLHIM are worth consideration. In future 
research, the logistics of running a multi-centre research, the fidelity and reach of 
integrative treatment, and the randomisation procedure should be assessed. Costs of 
the integrative treatment for MSDs should be compared over time. In addition, 
qualitative research exploring the association between suggested components and 
treatment outcomes, and the potential impacts on patients and practitioners caused by 
the research study is suggested.
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Aims and Structure 
This chapter answers explicitly the two research questions specified in Section 1.5; 
and discusses how these aims were achieved by comparing and contrasting with 
current available literature. Sections 7.1-7.5 discuss the results of the mixed methods 
feasibility study presented in Chapter 6 and related them to the findings from the 
reviews presented in Chapter 2. Specifically, an IM model is proposed in Section 
7.1. Sections 7.2-7.5 discuss the feasibility of the research study focussing on four 
pre-specified aspects of feasibility: limited outcome testing, acceptability, demand 
for integrative treatment, and feasibility of the study design (Section 6.1-6.4).  
Reflections on strengths and limitations encountered in conducting this research 
study are discussed (Section 7.6). The significant contributions to knowledge are 
highlighted in Section 7.7, and implications for research and IM practice and future 
directions are presented (Section 7.8), and the thesis ends with a conclusion about 
the whole study (Section 7.9).  
By adopting the complex intervention framework suggested by the MRC, this 
research study was able to add new knowledge by exploring the theoretical 
understanding of IM and assessing the feasibility of carrying out MMR on 
integrative treatment for MSDs in a secondary care NHS setting. The results of these 
steps lead to the future evaluation stage of the MRC framework by informing a 
definitive pragmatic trial. 
7.1 An integrative medicine model for musculoskeletal disorders 
This section summarises the potential key components of IM generated from 
findings identified from the patients’ perspectives (Chapter 6), a comparison and 
discussion in relation to the key components of IM as identified from IM definitions 
in the mapping review, and hypothesising a specific IM model for MSDs. Using this 
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approach, findings from the feasibility stage helped in interpreting and elaborating 
the discussion on the available IM components that is already available in the 
literature.  This approach allowed information on modelling the components of IM, 
which has been suggested to be essential in complex intervention development stage 
in the MRC framework. 
The IM model hypothesised in this study may provide a template to: guide further 
evaluation of IM practice, provide indicators and suggestions for monitoring the 
service at the RLHIM, or provision in other similar settings for MSDs (Figure 7.1). 
The suggested IM model consists of two parts: the inner circle represents the 
importance of a patient centred self-management approach for IM (Section 7.1.1); 
while the key IM components around the central figure are categorised into two 
groups: IM practice, and IM practitioners (Sections 7.1.2&7.1.3). These reflect the 
components previously identified from the mapping review (Section 2.2), and the 
many components identified as important in IM definitions in the literature and 
reported as being essential by patients in this research study. Explorations of the 
different sections of the model are discussed in detail.  
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7.1.1 Self-directed integrative care 
Patient’s self-direction is essential in their IM journey. The way they direct or 
manage themselves was associated with their personal and healthcare experiences, 
expectations, and their pathway to treatment (Figure 7.1, central part).  
This research study suggested that by receiving integrative treatment at the RLHIM, 
patients improved their basic understanding of MSDs and how their treatment and/or 
self-help techniques could help their MSDs. This in turn appeared to empower them 
to become their own “health keeper”. The realisation of the importance of self-help, 
along with the received information on self-care techniques from the RLHM may 
enable patients to actively engage in their MSDs journey. A self-directed integrative 
approach is considered essential for the management of widespread pain, especially 
when patients are likely to have various co-morbidities. This tended to influence 
their healthcare experiences, their expectations, and their pathway to treatment. The 
findings from this research also showed that non-smokers had significantly better 
improvements in pain scores at four months (Section 4.8). The majority of patients 
were non-smokers and non-drinkers, and this might indicate that patients with 
healthier lifestyles are potentially more actively engaged in health-seeking 
behaviours and self-management. This in turn may be associated with positive 
treatment outcomes. This seems to suggest that IM and self-help go hand in hand. A 
previous systematic review investigated the effectiveness of CAM self-care 
approaches to treat chronic pain conditions; and similarly showed preliminary 
positive evidence for treatments such as yoga, qigong, tai chi, acupressure, TENS, 
and relaxation (Delgado et al., 2014), which were beneficial and acceptable to 
patients (Cramer et al., 2013; Eyles et al., 2015). Attention to self-care using IM for 
a complex condition together with the investigation of the effectiveness of 
individualised self-management has been suggested (Delgado et al., 2014).  
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The importance of self-management was insufficiently emphasised in the IM 
definitions identified in the mapping review (Section 2.2.3). Given that self-help 
approaches were not initiated as part of treatment received in this research study, 
future research should explore this aspect in detail using a mixed methods approach.  
7.1.2 Integrative medicine practice 
Complex conditions therefore require an individualised diagnosis and treatment that 
holistically targets all aspects of life. Investigating complex integrative care 
packages in a holistic manner or as a whole systems approach is becoming more 
recognised by researchers (Verhoef et al., 2004). As identified from the mapping 
review (Section 2.2.3), 71% of IM definitions emphasised individualised and holistic 
approaches as key components of IM. Findings from the feasibility study showed 
patients valued being treated as individuals and having a consultation with their 
hospital practitioners which focussed on their expressed needs. Similar research in an 
NHS setting (Glasgow Homoeopathic hospital, now the Centre for Integrative Care), 
has also demonstrated the benefits of an individualised and a whole person approach 
(Mercer and Reilly, 2004). However, integration at diagnostic level, which has been 
suggested as being an important element in IM in the mapping review (Section 2.2), 
has rarely been reported in research (Hu et al., 2015b). Receiving diagnostic support 
and excluding pathology were suggested as the main reasons patients seek 
conventional care (Andersson et al., 2012). Patients tend to seek CAM treatments 
after they have received a diagnosis, mainly to ensure CAM treatments would not 
interfere with their conventional treatments; or to ensure there was no sinister 
pathology before receiving CAM treatment (Raphael et al., 2003; Nayak et 
al., 2003). 
The RLHIM has developed clinical services emphasising integration vertically, 
including various diagnostic assessments and various types of treatments with 
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different combinations, doses, lengths and frequencies, self-care and working closely 
with primary care (Sections 6.1&6.2). Although in the mapping review a high 
proportion (76%) of IM definitions emphasised the combination of CAM and 
conventional interventions in IM practice (Section 2.2.3), in the feasibility study, 
more than half of the patients received only one type of treatment at the hospital 
(Section 4.4). This indicated that although patients received different treatments, 
there was a lack of variability in the different combinations and these were only 
provided to a small number of patients at present in the RLHIM. It was unclear what 
patients may receive outside the hospital at the same time, although these were 
captured during interviews and in the mCSRI. An IM research study in the USA, 
where CAM is more integrated to main stream healthcare, observed treatment for 
pain at nine integrative clinic sites with non-standardised individualised treatments, 
and provided a larger variety of combination of treatments, with some patients 
receiving eight types of IM interventions and most receiving four IM interventions 
(Abrams et al., 2013). However, whether patients felt individualised treatments were 
successfully delivered was not explored (Abrams et al., 2013).  
Individualised and holistic treatments have been suggested to be key features of 
personalised care (Tarrant et al., 2003). Previous research has particularly 
emphasised the importance of individualised care in complex chronic conditions that 
required health services from multiple providers (Lion et al., 2014). Assessing and 
documenting individualised care is problematic and challenging (Kärkkäinen et al., 
2005). Mixed methods designs have been used to assess individual patients’ 
experiences and outcomes in receiving various individualised integrative care (Seers 
et al., 2009; Bronfort et al., 2012; Nichol et al., 2013; Lagesen, 2014). Findings on 
the association between individualised management and outcome remain sparse 
(Lion et al., 2014) but are worth emphasising and testing in future research. 
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Considering the needs for individualised and holistic care, providing a complex IM 
model of treatment is seldom achieved by a single practitioner and usually requires 
multidisciplinary teamwork with practitioners either from different departments in 
the same hospital, or practitioners working in different settings (Beswick et al., 
2008). The RLHIM horizontal integration strategy aims to promote collaboration in 
secondary and tertiary care, with clinical partners from other parts of UCH, such as 
the integrated pain service developed in collaboration with the Eastman Dental 
Hospital or that with the NHNN, where acupuncture, hypnotherapy, homeopathy, 
and autogenic training are provided to complement conventional treatments; an 
integrated antenatal service in collaboration with the Elizabeth Garrett Anderson 
Hospital (Fisher, 2015; Royal London Hospital for Integrated Medicine, 2015). 
Although these collaborations were reflected in the findings of this research study, 
and some patients were referred from partner hospitals, patients believed that they 
could get a better chance of referral if they were referred through a doctor from 
partner hospitals of the RLHIM (Section 6.2). As identified from the mapping 
review (Section 2.2.3), less than a quarter of the IM definitions emphasised the 
importance of a collaborative approach in IM. This indicates that integration in 
partner hospitals with a systematic collaborative teamwork is occurring in the UK, 
but this has not been sufficiently reflected in IM definitions and may not be well 
recognised as an essential component of IM. Bridge-building activities including the 
connection between research and clinical facilities, positive promotion of partnership 
and co-location of practices should be established for creating bonding between 
members of teams internal as well as externally in different health professions 
(Gaboury et al., 2012; Dobos and Tao, 2011; Gamst et al., 2006; Haahr and Launso, 
2006; McCarty et al., 2012). 
Collaboration between multidisciplinary teams is also an essential aspect of IM 
practice. Healthcare managers are essential in IM interprofessional collaborations. In 
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normal practices, it is common that patients find difficulty in choosing who to 
consult among various professional groups, which may involve exposure to 
competitive and conflicting claims on legitimacy and risk (Tovey and Adams, 2001). 
Therefore, it is important that healthcare managers are aware of the usage of 
potential multiple practitioners, and are prepared to discuss and communicate with 
their patients before and at commencement of their treatment (Broom et al., 2012). 
The system in both establishing leadership roles and responsibilities when CAM and 
CM practitioners collaborate within an IM system is still ambiguous (Gaboury et al., 
2012). Some CAM practitioners are against and distrust IM because they believe that 
CAM might be ‘co-opted’ or ‘adopted’ by CM (e.g. physiotherapists adopting 
acupuncture) (Tovey et al., 2003). However, one of the key challenges for 
interprofessional collaboration in IM is preserving the epistemological stance of 
CAM when it is used with other disciplines (Chung et al., 2012). The perceived 
power differential between the two paradigms needs to be reduced to promote 
interprofessional collaboration in IM (Chung et al., 2012). 
7.1.3 Integrative medicine practitioner 
IM practitioners play a vitally important role in ensuring the degree of integration 
achieved (Maizes et al., 2009). In this research study, some patients benefited from 
active communication with their practitioners, with shared information and patient 
centred empathetic care; while patients who had negative experiences at the RLHIM 
tended to have less interaction with their practitioners (Section 6.2). 71% IM 
definitions identified in the mapping review emphasised the importance of patient-
practitioner communication (Section 2.2.3). IM providers have the responsibility to 
ensure the creation and maintenance of best treatment plans for patients (Shelley et 
al., 2009) and the patient-practitioner relationship has been acknowledged as having 
an important therapeutic role and should be integral to clinical practice (Rao et al., 
2007). Since IM is not simply the process of simultaneous use of CAM and 
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conventional medicine, the value of open communication is essential between 
individual practitioners and among patients (Brien et al., 2011). A systematic review 
showed practitioners who adopt a warm, friendly, and reassuring manner provided 
more effective treatments than those who keep consultations formal and do not offer 
reassurance (Di Blasi Z et al., 2001). Meaningful communication that makes patients 
feel heard and respected was suggested essential to fostering lifestyle change 
(Maizes et al., 2009), which may offer a better method to encourage a self-directed 
integrative approach to patients. Research has also demonstrated a clinically 
significant effect for acupuncture provided with empathic consultations compared to 
non-empathic consultation (White et al., 2012) and benefits in compassion and 
caring, explanations and information, and shared decision making with patients 
(Mercer and Reilly, 2004). However, there is often misunderstanding and 
insufficient communication between practitioners and patients about the use of IM, 
particularly when ‘who is the health keeper’ is unclear. This may lead to inefficient 
care and could harm patients (Hsiao et al., 2006). Therefore, early input in delivering 
complex interventions from healthcare providers must avoid poor communication 
between clinician-initiated and patient-initiated treatments. 
Another important aspect in IM practitioner identified in this research study was 
practitioners being professional experts who were qualified and had the knowledge 
of IM (Section 6.2). Nearly half of the patients felt the practitioners they were seeing 
had the appropriate professional knowledge, which could make them feel reassured 
emotionally. Being seen by medically qualified professionals at the RLHIM was one 
of the main reasons patients reported coming to the RLHIM (Section 6.2). It has 
been suggested that IM should be led by ‘dual-trained’ practitioners who are familiar 
with the two divergent clinical paradigms as it allows them the ability of sharing a 
similar coherent conceptual framework (Hsiao et al., 2006). Therefore, education 
units that run courses on IM for qualified practitioners and healthcare managers may 
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improve the development of IM. Currently, the education department of the RLHIM 
runs various courses for all statutory registered healthcare professionals (UCLH, 
2015a). A course on integrating complementary medicine in everyday practice, 
focusing on six types of therapies including acupuncture, herbal medicine, 
homeopathy, nutrition, manual medicine and autogenic training is already provided 
(UCLH, 2015a).  
Patients’ expectations have increasingly been taken into consideration as a major 
determinant of patients’ satisfaction (McKinley, 2002). Findings from this research 
study suggested that patients noticed improvements associated with practitioners 
managing their expectations (Section 6.1), and a high expectation tended to be 
positively associated with a lowered treatment satisfaction (Section 6.3). It has been 
suggested that lowering patients’ expectations might be one of the ways of avoiding 
disappointment, if this is appropriately managed. Managing expectations is 
perceived essential in patient centred care and may improve outcome by ensuring 
highest quality healthcare delivery (Lateef, 2011); and could minimise the risk of 
confusing patients by offering different answers or suggestions by different 
healthcare professionals (Baker, 2011). Interviewing practitioners may help better 
understand whether expectation management is part of their integrative treatment 
strategies and their understanding of its contribution to treatment effects (further 
discussed in Section 7.8.1).  
A holistic patient centred approach is an essential component not only to the 
intervention process, but also in providing an appropriate referral pathway and a 
patient friendly setting. In some IM organisations, it is recommended that 
practitioners design their own “self-wellness plan” based on their experience 
(Greater Lawrence Family Health Centre, 2013). Sufficient consultation time in a 
welcoming setting that values human beings over technology and encourages 
patients’ involvement was highly valued by patients receiving integrative treatments, 
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and was considered essential in providing patient centred care (Mercer and Reilly, 
2004). However, patients in this research study reported otherwise as practitioners 
were perceived as being under pressure. The 2014/2015 RLHIM audit reported a 
maximum of 40 minutes as the standard pharmacy waiting time for completion of 
prescriptions which is needed to ensure the accuracy, compliance with all legal 
requirements, and double checking of patients’ names and labels on issued 
prescriptions (Berkovitz, 2014). Broader acknowledgement and the importance of a 
patient centred care between practitioner and the hospital setting are important and 
should be an open dialogue as receptionists, and facilities are part of the service for 
patients (Maizes et al., 2009). 
Section 7.1 discussed the IM components perceived important by patients in the 
mixed methods feasibility study. Active engagement in a self-management and a 
self-directed integrative approach was considered as a central key component in their 
IM journey. The importance of considering individualised holistic care with different 
treatment options, multidisciplinary teamwork and cooperation between different 
departments or partner hospitals were discussed. Patients valued communication 
with knowledgeable, empathetic practitioners who were happy to share information 
in a patient centred way, and were holistic individuals. They also benefited from 
expectation management by the RLHIM practitioners. These key IM components 
represented the opinion of patients who received IM service for MSDs in this UK 
secondary care NHS setting which shared many similarities with the theoretical basis 
of IM as evidenced in the mapping review. These components are worth exploring in 
future research, so that the connections between them and their potential contribution 
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7.2 Improvements in patient outcomes  
The IM model at the RLHIM and the complex integrative treatments delivered 
appeared to produce moderate pain relief and improved HRQoL at four months, 
which was sustained (with a smaller effect size) at 12 months. Although these are 
preliminary feasibility findings from this uncontrolled observational study, results 
showed a trend towards benefits in pain, physical and emotional function as 
indicated by the improvement in HRQoL (Section 6.1). Similarly, findings generated 
from the systematic review (Section 2.3) indicated integrative treatments appeared to 
be useful for relieving pain and improving function in LBP at equal or less than three 
months’ follow-up. Heterogeneity did not allow a meta-synthesis for trials with a 
more than three months’ follow-up, but 60% reported a statistically significant 
improvement in pain condition and back function. However, though included trials 
apparently evaluated packages of integrative treatments, information was inadequate 
to decide whether included trials evaluated authentic integrated practice. Therefore, 
this review should be interpreted with caution. Evidence available on various CAM 
modalities for MSDs tended to show a small to moderate effect size for treatments 
such as acupuncture (Vickers et al., 2012; Thomas et al., 2005), manipulation (UK 
BEAM Trial Team, 2004; Bronfort et al., 2008b), chiropractic (Cassidy et al., 2008), 
herbal medicine  (Christensen et al., 2008; Gagnier et al., 2004), homeopathy 
(Rossignol et al., 2012; Lert et al., 2014), nutraceuticals (Goldberg and Katz, 2007), 
and non-pharmacological or non-invasive interventions (Chou and Huffman, 2007; 
Hurwitz et al., 2008).  
Despite the fact that patients’ all aspects of life were severely affected by their MSDs 
at the follow-up (Section 5.16.1), they perceived improvements in MSD symptoms. 
Noticeably, the greatest improvements in pain and physical function observed in this 
research study occurred at four months, however, 78% of patients were still 
receiving treatment at the hospital after this period, and 48% received treatment for 
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longer than 12 months. This indicates that the increased costs of treatment for more 
than four months may fail to produce any additional value, in terms of a further 
significant reduction in patients’ pain severity or their functional ability, but there 
was evidence to suggest that these improvements may have been maintained. 
Providing a short course of integrative treatments could provide cost savings for the 
NHS but limited evidence supporting this was available from this research study. 
Previous research showed that a short course up to 10 sessions of individualised 
acupuncture significantly reduced LBP compared with usual care at 24-month 
follow-up (Thomas et al., 2005). An evaluation of a previous UK IM service 
reported changing 12 sessions of CAM treatment to six sessions could allow 
opportunity for re-referrals if the health issue was severe (Robinson, 2005). 
However, findings of the mixed methods feasibility study showed patients hoped to 
receive prolonged treatment for their MSDs given their chronicity and complex 
nature and this may have been related to their expectation as discussed above.  
CAM is mainly provided privately in the UK which patients in this research study 
reported was unaffordable, particularly given their limited ability to work due to 
long-term MSDs. The provision of 6-8 sessions of CAM treatments by the RLHIM, 
described by patients as a ‘taster’ was thought to be ‘not enough’ due to the long 
term chronic nature of MSDs. Therefore, the suggestion of limiting treatment length 
should be interpreted with caution as some patients may need more treatment in line 
with an individualised intervention. It was not clear whether improvements occurred 
even before four months; whether dispersed treatment with less frequent treatments 
spread over a longer period of time would be beneficial. In addition, there are many 
factors that may influence treatment outcome such as changes in patients’ 
expectations, whether patients started to engage in more self-help activities. This 
needs further exploration with a larger sample size.  
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Apart from experiencing benefits in pain reduction and physical function, patients 
reported experiencing relaxation and having better sleep which they attributed to 
treatment at the RLHIM. This confirms previous clinical research conducted after 
standard 8-week autogenic training (AT) at the RLHIM reported improvements in 
additional quality of life (QoL) indicators; sleep patterns, well-being, anxiety and 
depression scores (Bowden et al., 2012); and other research which showed positive 
changes in patients’ beliefs about their MSDs (Bishop et al., 2015). Previous trials 
on integrative treatment for LBP have focused on pain and physical function and 
have rarely considered emotional factors or patients’ general quality of life (Section 
2.4.1). This may suggest a need to use more holistic integrative outcome measures in 
research. A similar observational study on IM emphasised the importance of whole 
person care and showed significant improvements in mood, stress, quality of life, 
fatigue, sleep, well-being, and increase in 25-hydroxyvitamin D levels at 12 weeks 
(Abrams et al., 2013). Being able to reduce medications is a benefit perceived by 
patients with complex conditions. Frequently this was a driver for them seeking 
other treatment. In the qualitative interviews conducted prior to taking part in the 
research, many patients reported wishing to reduce or stop their medications. This 
data suggests that these personal aims were partially met by receiving integrative 
treatment at the RLHIM.  
7.3 Acceptable integrative treatment model 
Patients’ acceptance of treatments provided may be affected by their previous 
healthcare experiences, expectations, and their decision making process. Having 
qualified, knowledgeable professionals appeared to be the main reason participants 
came to the RLHIM (Section 6.2). This tends to confirm the previous arguments on 
important role of practitioners (Section 7.1) in patients seeking IM practice.  
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Patients’ acceptance of integrative treatment for MSDs was considered generally 
good as adherence to treatment appointments was good. A larger observational study 
has shown that patients’ adherence to IM practice over six months period was 
acceptable, and this may be associated with acceptance of individualised integrative 
treatment and benefits perceived by patients (Abrams et al., 2013). Patient perceived 
symptom improvements and positive experiences with practitioners tended to 
suggest good acceptability of integrative treatment at the RLHIM (Section 6.2). 94% 
of patients recommended the services at the RLHIM on the NHS choice (NHS 
Choices, 2015b). Issues regarding difficulties in getting referred may indicate the 
demand for treatment and may be related to policy and regulation. These are 
discussed in Section 7.4. 
The qualitative findings identified that patients receiving acupuncture reported minor 
AEs, including pain, feeling sleepy, thirsty, and nausea. The AEs tended to be 
acceptable by patients as they felt ‘it’s just the way it goes’ (Section 6.2). This is 
similar to previous research, in which acupuncture related AEs reported were minor 
pain, circulatory problems, minor aching, minor discomfort, soreness, or no severe 
AE (Hu et al., 2015a). A large scale survey suggested that acupuncture is a relatively 
safe intervention when practised by regulated practitioners; most commonly reported 
AEs were severe tiredness and exhaustion, pain at the site of needling, and headache 
(MacPherson, 2004a). A prospective observational study showed a small number of 
minor AEs from acupuncture provided by physicians, most common AEs were 
bleeding or haematoma, pain and vegetative symptoms, suggesting the treatment was 
relatively safe (Witt et al., 2009). Other studies showed fewer AEs in conventional 
treatments using acupuncture compared to conventional treatments alone (Leibing et 
al., 2002; Meng et al., 2003). In this research study, one patient had non-epileptic 
seizure whilst enrolled in the study. It was unclear whether this was a reaction to 
homeopathic tablets, or to other treatments the patient may have been receiving at 
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the time, an interaction between them or an unrelated event. Research suggests that 
classical homeopathy has few AEs or toxic effects when properly used (Bornhoft et 
al., 2006). Patients receiving homeopathy reported less AEs (7.8%) compared to 
those who had conventional treatment (22.3%) in a primary care setting (Riley et al., 
2001). Similar results have been observed for patients taking St John’s Wort who 
experienced fewer AEs than those taking antidepressants (Linde et al., 2008). There 
are however other considerations when using herbal medicines as there may be 
interactions. For example, St John’s Wort may alter the metabolism of various 
cancer treatments including Irinotecan, Imatinib and Docetaxel (Meijerman et al., 
2006). Although various CAM treatments may help in reducing medication used 
(Rossi et al., 2009), which may in turn help reduce the chances of having ADRs, 
there is still a lack of research on exploring interactions between different modalities 
within an integrative treatment package. It was also unclear whether an AE can be 
attributed to any specific component of the treatment package. Potential interactions 
should however be documented and should be explored. 
7.4 Integrative treatments in demand  
This research study has highlighted the demand for integrative treatments for MSDs 
but patients perceived limited resources within the NHS to support IM (Section 6.3). 
As previously discussed in Section 7.1, the demand for integrative treatments may be 
associated with the complexity surrounding patients with MSDs. Although in this 
research many patients reported benefit from various conventional treatments, they 
were not satisfied with their long term progress. Patients were reliant on and hoped 
to receive CAM treatment within the NHS setting as private CAM was unaffordable 
given their health problems and possibly lack of employment. This confirms findings 
from other qualitative research on patients’ (Bishop et al., 2011; Bishop et al., 2013; 
Son et al., 2013)  and practitioners’ (Zhang and Verhoef, 2002; Bishop et al., 2012)  
perspectives, which reported that patients were financially restricted in seeking CAM 
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privately but NHS care was constrained by Trust policy. For those with chronic 
MSDs, they wished to have long term integrative treatments at the hospital to 
maintain their health.  
Qualitative research suggests that market demand for CAM is the primary 
motivation for most insurers and hospitals (Hsiao et al., 2006). Apart from consumer 
demand, health service managers, and influential stakeholders responsible for 
organising and directing health care policy and practice are essential to facilitate 
effective IM practice (Singer and Adams, 2013). In the UK, IM services could be 
funded by CCGs, previously primary care trusts (PCT). In England, 50% GP 
practices and 43% of PCTs provided access to CAM healthcare (Thomas et al., 
2003; Wilkinson et al., 2004). In 2010, the UK government has committed to 
extending patient choice through their policies of Any Qualified Provider (AQP) for 
appropriate services to empower patients and carers and to improve practice (DH, 
2010) and the use of personalised budgets has subsequently been piloted. In the 
transitional year 2012/2013 for the AQP program, musculoskeletal services for back 
and neck pain were identified as a priority for implementation by the DH, which 
could enable MSD patients more power to select the treatment they preferred.  
However, current resources available for IM may not meet patient demand. This 
research study identified that patients found getting referrals problematic within 
current referral schemes allowed by their local CCGs. Particularly, those patients 
who had previous extensive experience attending the RLHIM who now perceived it 
was more difficult to get referred, and if they were successfully referred, fewer 
sessions and types of treatments were received. They believed this was due to recent 
funding restraints and budget cuts due to service reprovision. In England, CCGs 
have specific and different policies on the extent to which patients can access CAM 
treatment. GPs are the gate keepers in giving patients access to specialist treatments 
by considering patients’ individual conditions and their wishes (NHS Career, 2015). 
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Findings from this research suggest that patients who were referred from the North 
East London CCGs experienced an easier referral pathway as there were specific 
contracts with the RLHIM (NHS Career, 2015) and this appeared to be the main 
route for referral.  
Apart from issues of referral schemes, patients felt IM practitioners were working 
under stress, with limited time available for each patient. This is a common situation 
in the NHS, where practitioners experience anxiety and depression, not exclusively 
in IM practice (Jalmbrant, 2015). In the UK as well as some other western countries, 
IM practices are emerging, with current literature focusing on IM models and 
strategies for integration within health care settings and systems (Coulter et al., 
2010; Adams et al., 2009; Singer and Adams, 2014). Findings from this research 
study tended to suggest there is a lack of IM resources in terms of available 
practitioners and treatments offered to patients.  
7.5 Feasibility of integrative medicine research  
This section discusses the feasibility and issues experienced in carrying out this 
mixed methods feasibility study and its potential generalisability to IM research in 
other settings (Section 6.4). The research student’s interpretation and reflection on 
the feasibility issues in conducting the research study and some practical issues are 
also presented in this section.  
7.5.1 Identification of eligible patients and recruitment 
Although many eligible MSD patients were identified in this research study, issues 
arose as not all patients were identified. Several clinical codes were considered as 
rheumatoid arthritis and were not recorded as MSDs. These were included 
immediately after this issue was realised. Another factor affecting recruitment was 
that some GPs used a ‘choose and book’ system or booked through the British 
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Medical Acupuncture Society (BMAS), without going through patient service 
department. A ‘choose and book’ service was available for patients to choose which 
hospital, clinic or service to go to. This service was available for patients seeking 
CAM interventions from 2008 (The National Archives, 2015) but replaced by an 
NHS e-Referral Service in June 2015 (NHS Choices, 2015a; National Archives, 
2015). This eligibility identification and recruitment issue should be considered in 
any clinical research conducted within the NHS. Considering the RLHIM is the 
largest sector providing IM service in the UK, identifying eligible patients for 
research is an issue for other UK IM research, especially considering the imbalance 
in supply and demand for IM practices and increased stress on practitioners.  
In this study, 63% of eligible patients (101/161) refused to participate. This may be 
because the patients were a special group of patients with chronic, complex MSDs, 
for whom all aspects of life were affected by MSDs. Other problems were due to 
changes in hospital administration, and lack of commitment and awareness of 
clinicians to the research study and potential failure in identifying patients. Working 
with and relying on busy NHS practitioners and healthcare professionals was one of 
the key challenges in this research study.  There was unexpected staff turnover and 
issues meaning reliance on administration staff, for example, a key person who 
initially made first contact with patients resigned from the hospital during the 
research study. Half way through data collection, the fact that some potential patients 
attending clinics had not been approached was realised. After discussion with the 
clinical director, this was resolved with the clinical team and recruitment improved. 
As previously mentioned (Section 3.8), two substantial ethics amendments were 
submitted, aiming to improve recruitment. The first amendment application was 
submitted in January 2013, requested changes to the invitation letter and patient 
information sheet making them user-friendly and easier to understand by a lay 
person (Appendix 7.1), the second amendment application requested changing the 
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initial contact to patients by two members of the research team (the research student 
and JH) rather than patient service staff, who were under time pressure and lacked 
the knowledge to answer patients’ questions regarding the research study (Appendix 
7.2). In this research study, one of the members in the research team was the key link 
between the research student and all the clinicians and patients. As a practitioner 
seeing participants at the RLHIM, he was also involved in the development of this 
research study. This potentially helped in gathering the musculoskeletal physicians at 
the hospital to help with screening patients, and locating staff in patient service 
department, data department to help with contacting patients and obtaining 
participants’ ICD codes. This highlighted the vigilance required in monitoring 
recruitment which is reportedly the same for any clinical research study (Rai, 2011). 
The trial recruitment processes should be carefully planned and piloted regardless of 
size or complexity. In this feasibility MMR, the research student was the only 
investigator managing the study, and recruited, interviewed, informed patients about 
the study and questionnaire, and analysed, interpreted, and disseminated the results. 
This may potentially have introduced performance, detecting, and reporting bias 
(Higgin and Green, 2011). 
The NIHR HTA programme recommends the involvement of a dedicated trial 
manager, who has a lead role in the whole process of planning, coordinating, and 
completing a project, which is  key to the success of all primary research (Farrell et 
al., 2010). Active management for every aspect of a trial requires the trial manager to 
be good at communication and presentation, with the ability to organise and motivate 
others, and with motivation, enthusiasm, innovation and leadership when faced with 
challenges. It has been suggested that factors affecting recruitment levels of both 
collaborators and participant may include general aspects such as changes in the 
season, and other more specific aspects such as ethnic makeup of the population, or 
may be due to problems within the collaborating centres (Ward et al., 2010). 
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Offering educational programmes to stakeholders and practitioners may improve 
recruitment when there are difficulties in recruitment due to collaborator factors 
(Ward et al., 2010). 
7.5.2 Participant retention 
Retaining participants is always important and challenging, especially with a long 
term follow-up. However, the retention over 12-month period was good for this 
research study. Several strategies for retaining participants were used (Robinson et 
al., 2007) : 1). Community involvement: as pre-specified in Section 3.1, one patient 
was involved in the research and was involved in the design stage of the study, gave 
ideas on when/how to contact patients, and provided suggestions on designing 
several questionnaires (Fischer et al., 2014; Burston et al., 2014); 2). Study identity: 
All documents including the patient information sheet, consent form, questionnaire 
package, and reminders to participants were formatted using similar colours and 
fonts, with a project logo, LSBU and RLHIM logos as headers. (Appendices 3.1- 
3.3); 3): Study description: Patients felt the description of research process was clear; 
4) Reminders: Phone calls or text reminders were sent to participants one week 
before sending out the questionnaire package; before both pre-treatment and follow-
up interviews took place, consented participants were sent a text reminder the day 
before interviews and patients preferred to be contacted by text or email; at the end 
of initial appointment with the participants, the research student reminded the 
participants about the research timeline; 5). Visit characteristics: In order to 
minimize participants’ burden, the research student tried to contact participants at a 
convenient time, e.g. working participants were contacted after work hours, retired 
patients were contacted during morning workdays; the research student also offered 
flexible appointments to the participants.  
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Apart from these five strategies supporting retention, some techniques suggested in 
securing patient retention were not fully achieved in this research study. For 
example, the research student was the only research personnel who contacted 
participants. Contacting and scheduling was only carried out by the research student, 
rather in a systematic monitoring approach such as using electronic 
patient tracking systems (Nhavoto et al., 2015). No special tracking method was 
utilised to follow-up patients. Updating participants’ contact information every two 
months has been suggested (Pappas et al., 1998) and multiple attempts to contact 
subjects for complete data by phone and mail (Goldberg and Kiernan, 2005). 
Inadequate funding meant there was no financial incentives/reimbursement for 
participating in this research study. Patients were generally seen on routine 
appointments to minimise cost of travelling. A small amount of travel expenses were 
reimbursed to participants as part of the research study, when requested. Findings 
from this research study also revealed patients wanted to have a more supportive 
patient group at the RLHIM and have a free physical examination (Section 6.4). 
Patients asked about access to possible publications during the interview. Non-
financial incentives in this research study reported by patients included benefits in 
self-reflection, acquiring and sharing information, empowerment for health and 
social changes and their mental status. Previous research suggests financial 
incentives tend to influence judgment (Halpern et al., 2004), therefore it remains 
challenging to establish a balance between encouraging research participants and 
avoiding coercion that might affect the integrity of a study or compromise respect for 
individuals and justice (Groth, 2013). 
7.5.3 Participants’ characteristics 
This research study was conducted in London. Patients participating were 
predominantly middle aged, female, Caucasian, and generally with a higher 
educational background. They tended to be a group of patients with healthy lifestyle 
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and were aware of the importance of self-management. They may have been a self-
selected group of patients so findings may not be generalisable to other settings. 
Patients who were interviewed were not purposively sampled. Some patients did not 
participate in the follow-up interviews as they were not receiving any treatment by 
the time they were contacted by the research student. This may have led to potential 
bias as patients who participated in the follow-up interviews may have had more 
treatment thus perceived more benefits, therefore findings should be interpreted with 
caution.  
7.5.4 Patients’ experiences in participating 
In this research study, patients generally reported they had a positive experience 
communicating with the research student and felt that the research procedure was 
clear. This was encouraging as most participants were chronic MSDs sufferers; some 
patients had health restrictions which hampered participating in the research study, 
such as completing questionnaires, or committing additional time to meet the 
research student for interview. During the research, some participants sent regular 
greeting emails and Christmas cards to the research student, which exhibited a good 
communication between them. The research student showed her empathy towards 
participants in scheduling appointments and cancellations. However, there was a 
potential issue with the research facilities. From December 2014 to April 2015, there 
was a shortage of rooms available for patients’ interviews at the hospital. This 
potentially affected the quality of the interviews as sometimes there was no quiet 
environment and participants may have felt anxious as they were not close to the 
consultation room for their appointment. Interviewing patients in a quiet and private 
environment can also emphasise patient autonomy and active involvement in the 
interview (Lichstein, 1990). One patient asked to be withdrawn from the study after 
consenting. No reason was given and they were withdrawn with their data not used. 
Anecdotal communication data between the research student and patients in 
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arranging appointments and explaining the research study were generated through 
emails, texts and letters. Although these data were not analysed or reported in this 
research study, these data could provide additional information on the study 
feasibility, particularly on communication between researcher and patients.  
Timing of interviews was also crucial: conducting interviews immediately before a 
participants’ appointment may have saved time and was convenient for the 
participants, but may have produced anxiety as some patients checked the time 
during the interviews. Benefits from participating in the research study included 
helping patients reflect on their conditions, gain information, feeling reassured and 
better mentally. Patients sought confirmation about what they were having and how 
they were being treated by communicating with patients who shared similar 
experiences. In the focus groups, seeking confirmation, providing information, and 
sharing experiences was valued by patients. Choosing to participate in this research 
study was mainly because participants wanted to help other patients like themselves, 
and they felt research was needed (Section 6.4). The researcher’s friendliness and 
helpfulness and the status of the administering practitioner largely affected 
participant recruitment and retention, and may have also influenced the reporting of 
study outcomes. This highlights that outcomes of trials should be interpreted as 
products of complex environmental, social, interpretive and biological processes 
(Scott et al., 2011).  
Patients gave various suggestions for improving the research design as well as 
hospital services. They expressed their willingness in being contacted by the 
researcher through text or email. A systematic review showed digital interventions 
such as supporting patients remotely by giving them self-care information showed 
small but significant effects in health management (Webb et al., 2010). This may 
also potentially enhance patients’ experiences in participating in research. In terms of 
research benefits, they hoped additional diagnostic assessments could be offered as a 
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result of the research; and hoped that the researcher would be able to feedback to the 
practitioners. They also expressed their wish to have a support group where they 
could communicate and share their experiences with peers. These aspects are 
highlighted to be considered for service change (Section 6.4).  
7.5.5 IM outcome measures 
In terms of data collection, accessing patients’ ICD codes to classify musculoskeletal 
disorders by diagnosis was problematic and depended on the hospital administrative 
staff providing this information. Slow recruitment at the beginning of the study 
added to the already lengthy study. Patients’ MSDs were therefore categorised based 
only on the location of pain collected from the sfBPI body graph. Disagreement 
between clinically observed changes and patients’ perceived changes may be 
attributable to inaccurate recollection (recall bias), especially with a longitudinal 
cohort design (McPhail and Haines, 2010). In this research study, the completion 
rate of mCSRI over the study period was not high (77% at 12 month). For example, 
participants had difficulties in remembering things such as money spent on petrol. 
This potential recall bias will tend to result in an under or overestimation of the 
association between exposure to a risk factor and outcome (Bayona and Olsen, 
2004). 
Currently there is no consensus on the use of a well-recognised outcome measure for 
IM or holistic whole system research. As IM practices emphasise patient tailored 
care with a holistic approach, patient-identified health outcomes such as MYMOP 
and the patient generated index were considered. However, the patient generated 
index is complicated and tends to have a high rate of invalid scoring, and MYMOP 
can only measure one or two symptoms, whereas patients using IM usually have 
comorbidities (Hunter and Leeder, 2013). IM stakeholders suggest that, apart from 
evaluations of physical and mental health, lifestyle, health-related aspects of life 
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satisfaction, quality of life, and healthcare evaluation are important topics worth 
assessing for IM (Hunter et al., 2013). 
This research study suggested that both quantitative PROMs and qualitative 
interviews were critical. The PROMs used in this research study tended to assess the 
main patient concerns. The VAS and sfBPI were generally considered acceptable, 
comprehensive, easy and quick to complete. Potential cognitive bias effects have 
been suggested to be greater when using PROMs due to their subjective nature 
outcomes (Wood et al., 2008). Narrative approaches, e.g. interviews or open ended 
questionnaires may be useful in understanding complex MSDs. These were 
evidenced by good completion and interview attendance over a 12 months’ period. 
In addition, quantitative findings showed that VAS and sfBPI captured the changes 
in pain severity and functional status of MSD patients at four, eight, and 12 months. 
Other outcome measures successfully captured changes in individualised integrative 
treatments for MSDs included a combination of pain measures using NRS with 0.5 
to 12 months follow up (Sundberg et al., 2009; Eisenberg et al., 2012; Eisenberg et 
al., 2007), physical function and HRQoL measures using SF12 with 0.5 to 12 
months (Eisenberg et al., 2012; Eisenberg et al., 2007), SF36 with 3-12 months 
(Little et al., 2008; Hollinghurst et al., 2008; Sundberg et al., 2009), mRMDQ with 
0.5 to 18 months (Little et al., 2008; Hollinghurst et al., 2008; Hurwitz et al., 2002; 
Hurwitz et al., 2006; Eisenberg et al., 2012; Eisenberg et al., 2007), and wellbeing 
score at 10 weeks follow up (Grunnesjo et al., 2011). Apart from these quantitative 
changes, a holistic integrative understanding of patients’ MSDs requires qualitative 
research input, to understand the change process (Hsu et al., 2010; Cramer et al., 
2013) and to help understand the potential contribution of important components in 
IM practice such as communication between patients and practitioners, being 
knowledgeable, empathetic, and kind, from patients’ perspectives (Rowell and 
Polipnick, 2008).  
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Although cost data are not presented in this research study, data were collected for a 
12 months’ period. Data were often incomplete and patients reported that the mCSRI 
questionnaire used was too long and complicated. A range of concerns were 
expressed on the utility and appropriateness of the mCSRI including; having 
sensitive questions, difficulties in patients separating the treatments participants had 
for MSDs and those they had for other health conditions, unclear boundaries 
between CAM and conventional treatments, and difficulties in recalling information 
in the previous three months. However, CAM treatments listed in the mCSRI 
inspired patients to some extent. Since interactions within IM may be triggered by 
having CAM treatments or conventional treatments, it needs to be holistically 
evaluated by someone who has knowledge of both systems. This requires sharing 
clinical notes, assessments results, which challenges the model unless there is a 
shared medical system. Two earlier research studies evaluated costs of NHS services 
using CSRI (over three to 15 months) (Wye and McClean, 2012; Thompson et al., 
2014), showing how the measure could be used to evaluate CAM. Though a mixed 
methods design was utilised (McClean et al., 2015), the acceptance of patients using 
CSRI was not explored in these two studies.  
Overall, the feasibility of carrying out a mixed methods research study on integrative 
treatment for MSDs in a secondary care NHS setting was considered acceptable. 
This has been evidenced by patients’ perceived benefits in symptoms and an 
improvement in HRQoL, acceptance and demand in integrative treatments, and a 
comparably smooth experience of participating in the research study. Issues with 
recruitment, patients sampling, and shortage in research facilities are part of the 
limitations of this research study (Section 7.6) and should be considered carefully. 
Minor revisions that were made to the pre-set protocol should be noted. Patients’ 
suggestions about outcome measures and the way patients are contacted  
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7.6 Strengths and limitations 
This section discusses the research student’s reflection on the methodological 
strengths, weaknesses and limitations of performing this research study. Strengths 
and limitations in conducting the mixed methods review in order to develop a 
theoretical understanding of IM (Section 7.6.1), and in carrying out the mixed 
methods feasibility study on integrative treatment for MSDs are discussed (Sections 
7.6.2&7.6.3).  
7.6.1 Strengths and limitations of the literature review 
The mixed methods review contained three reviews: a mapping review on the 
available definitions of IM, a systematic review which evaluated clinical 
effectiveness and safety of integrative treatment for LBP, and a narrative review on 
qualitative research exploring patients’ experiences of receiving CAM treatments 
(Chapter 2).  
There were many strengths of this mixed methods review, among which the most 
important was that it provided a broad summary of both empirical and theoretical 
literature utilised, based specifically on IM (Whittemore, 2005). Secondly, both the 
systematic review (as the main part of the mixed methods review) and the mapping 
review (potentially determined the theoretical background of IM) were performed in 
both English and Chinese language data bases, in order to provide and facilitate a 
broader understanding of IM. As a common language is being built among CAM 
practitioners internationally (Linde et al., 2001; Napoles-Springer et al., 2005), 
increasingly non-Chinese researchers and clinicians are starting to notice the 
importance of not discarding Chinese articles and Chinese researchers and 
practitioners are starting to publish papers in English as well. International 
conferences and research collaborations contribute to this dissemination which may 
influence government and policy decisions. Relevant organisations have invested 
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more effort and funding in multi-national conferences and developing research 
cooperation all over the world (Lee et al., 2007; Joos et al., 2008; Boon et al., 2004), 
which indicates the policy makers’ interests in developing IM. However, Chinese 
literature fails to be widely cited due to language and potential publication bias 
(Efficace et al., 2006; Chan, 2008). Chinese research has been criticised for various 
reasons such as imprecise inclusion and exclusion criteria, inadequate follow-up, 
high dropout rates, lack of blinding and allocation concealment details and poor 
choice of endpoints and inappropriate statistical procedures (Pittler et al., 2000). 
The biggest limitation of the mixed methods review was that apart from the mapping 
review, which focused on IM definitions, the systematic review and the narrative 
review were not specifically focused on IM due to the difficulties identified with a 
lack of standard terminology. The term IM and CAM are used interchangeably with 
much less research focused on IM. This resulted in problems when trying to identify 
and synthesise studies on IM. A wide range of search terms are necessary to identify 
all potential IM studies due to the absence of standardised terminology or definition 
of IM and a lack of a shared conceptual framework and taxonomy for IM models, 
therefore many studies are not labelled as IM so may not be captured in searches 
using IM keywords/MeSH terms; and many studies purport to be ‘IM’ but they may 
not be (Khorsan et al., 2011; Hu et al., 2015a). In addition, reporting details of 
studies are imprecise, making it difficult to distinguish whether IM was intrinsic to 
the intervention. Further challenges are also faced with regards to inadequate 
information to decide whether authentic IM practices were provided or not, and 
differences between countries and manuscripts published in different languages, with 
extensive work required in order to identify search terms and synthesise findings (Hu 
et al., 2015a).  
It has been suggested that systematic reviews are inappropriate for complex 
interventions and a realistic review, explaining rather than judging and using 
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qualitatively narrative synthesis, may be more appropriate (Khorsan et al., 2011). 
Rather than attempting to review all examples of IM worldwide, the mapping review 
reported results from such a qualitative narrative review of IM definitions in 
literature from the US, UK, Australia, and China, provided a starting point to begin 
to explore the issues faced when synthesising IM research and practice for research 
purposes. However, the mapping review compared and discussed the situation in 
only four countries which was limited especially as resource and regulation of IM 
vary in other countries. In addition, key components were identified solely by the 
research student using thematic analysis.  
Though there are many difficulties in evaluating IM evidence, it was important to 
conduct the systematic review as guided by the MRC framework to evaluate existent 
evidence on the target intervention. Due to a lack of standard definition of IM, IM 
treatment was narrowed down to integrative treatment that provided combined 
conventional and CAM treatment in the same clinical settings or clinical partners 
settings. This was controversial as researchers have argued that IM is not simply a 
synonym of conventional medicine with CAM (Bell et al., 2002; The Bravewell 
Collaborative, 2015; Osher Center for Integrative Medicine, 2015; Rees and Weil, 
2001; National Institute of Integrative Medicine, 2015; Boon et al., 2004); and more 
details on the model/framework of integration should be provided (Caspi, 2001; 
Morrell, 2001; Woolfson, 2001). As there are few trials evaluating the effectiveness 
of a package of IM in western countries, this exploratory systematic review was 
restricted. The trials conducted were poor in terms of reporting and methodological 
quality. Inadequate information on randomisation and the lack of allocation 
concealment may result in study bias. Many trials did not have a sham control design 
thus specific effects of treatment cannot be identified. The inclusion criteria were 
tightened compared to the pre-set protocol as there were abundant eligible trials with 
the pre-set criteria. Therefore, trials using global assessment/effect rate without any 
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recognised/standard/validated outcome measurements were excluded, which largely 
reduced the amount of eligible trials. Apart from one systematic review on IM there 
were no trials evaluating IM and LBP (Lee et al., 2011), there were no previous 
reviews that investigated integrative treatment and compared it to single CAM or 
conventional treatment. Issues around IM definitions should be addressed. Before 
carrying out another update on IM evidence, clear reporting guidance for IM is 
urgently required (as summarised with potential recommendations in Section 7.7.2). 
However, this review provided previously unexplored aspects of integrative 
treatment which should be considered in future IM reviews. Though only LBP was 
evaluated in the exploratory systematic review, most MSDs, as complex conditions, 
may benefit from an integrative approach and deserve further exploration (Park et 
al., 2010).  
There were various limitations in the narrative review on patients’ experiences of 
receiving CAM for MSDs and these included: only English databases were searched, 
although Chinese qualitative research is rare; and the research student was the only 
reviewer of the qualitative research. The search topic was focused on CAM for 
MSDs rather than IM specifically due to the limit in reporting IM which has been 
discussed above. However, this provides information on patients’ perspectives on 
receiving CAM treatment and enables comparison with this study, added theoretical 
basis of understanding IM.  
7.6.2 Strengths and limitations on overall research design 
The absence of a control group is the major limitation of this MMR study design. It 
could be argued that the improvements shown in the limited outcome testing 
(Section 6.1) may not be related to the integrative treatments provided at the 
hospital. A few design issues were not assessed in this research study: Firstly, the 
theory and the feasibility of designing a suitable control group for IM was not 
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assessed. Standard care is one control option, but there are potential issues with this 
approach. Variability in terms of what may be involved in usual care is often unclear, 
for example, the NHS care provided may vary between different CCGs; patients may 
have CAM privately and there may be inadequate information sharing between 
private and NHS sectors regarding multidisciplinary input into patient care. For 
example, many patients choose to use private CAM alongside their conventional 
NHS care (Sawni-Sikand et al., 2002; Thomas et al., 2001). In addition, as IM 
practice is not simply combination of CAM and conventional treatment, there may 
be cases when only single CAM or single conventional treatment is provided in IM 
group. Open dialogue between practitioners is recommended to improve the 
integration (Brien et al., 2011). Secondly, randomisation was not assessed in this 
study therefore it is unclear whether randomisation would be feasible or acceptable 
to patients, and how many patients may dropout after randomisation. The suitability 
of the selection of control and patients’ psychosocial context of randomisation 
procedure still needs to be assessed (Barlow et al., 2011). Thirdly, this research 
study was restricted as the sample recruited were mainly middle aged, female, 
Caucasian, with a higher educational background. However, this reflects those 
individuals who tended to visit the hospital at the RLHIM. This may restrict the 
generalisability of the findings to other IM settings with more diverse populations. 
Situated under a pragmatic epistemology, this research study explored personalised 
and individualised treatments routinely provided for MSDs at the RLHIM, with no 
change to or standardisation of treatments. The whole-system approach considering 
complex, multicomponent IM interactions as a whole has increasingly been 
recommended due to its high external validity and the individualised nature of IM 
interventions (Langevin et al., 2011; Ritenbaugh et al., 2003; Verhoef et al., 2005). 
Researchers have recommended whole system research (WSR) using pragmatic, 
observational, and mixed methods approaches to overcome the challenges of 
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evaluating complex interventions such as IM (Verhoef et al., 2005). However, 
pragmatic trials have been suggested to be conducted once evidence of the 
intervention has been proved (Power and Hopayian, 2011). Power and Hopyian 
argued that the evaluation of a ‘package of care’ is misleading and unscientific as 
pragmatic trials and exploratory trials share valuable but distinct responsibilities 
(Thorpe et al., 2009; Power and Hopayian, 2011). Some authors argue that the 
exploration of components in the ‘black box’, such as patients’ expectations and 
relationship with practitioners, should not be an excuse for focusing on the package 
of care rather than the components; and doing so does not close the integrative 
medicine evidence gap (Power and Hopayian, 2011)(Macfarlane et al., 2012). On the 
other hand, policy makers use evidence based on non-specific effects from unblinded 
pragmatic trials. NICE guideline (NICE, 2009) and German federal joint committee 
of physician and health insurance plans have suggested the use of acupuncture based 
on the overall effect of evidence (O'Connell et al., 2009). The King’s Fund also 
called for more unblinded pragmatic trials on CAM (Black, 2009). 
In order to address the accepted challenges to enhance internal validity of 
observational design, it has been suggested that medical documentation, baseline 
measurement, and a non-randomised comparison group can be used (Verhoef et al., 
2005). In this research study, patients’ medical documents including their clinical 
notes, referral information were checked on the UCH system; there was no major 
significant difference in baseline characteristics between patients who were on a 
waiting list or not. It was planned that patients who were on the waiting list could be 
used as their self-control, to avoid issues in these and randomisation when patients 
prefer target treatment (Haake et al., 2007). However, the number of patients who 
were on waiting list control was too small to provide information on effectiveness 
and the average time on the waiting list was approximately 10 days. Having access 
to patients’ clinical notes and the hospital digital system assisted in providing data on 
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patients’ conditions, detailed treatment provided during the period of research, and 
their GPs’ locations, which helped in understanding their referral pathway and 
expectations. This sharing system may allow incorporation of EBM to the real world 
by combining three sources: research evidence, clinical practice, and the patients’ 
story in a new medical model as suggested by Jones et al. (Jones et al., 2009). 
In this research study, the number of participants in any one theme of MSDs and 
who had one theme of interventions was small and therefore statistical subgroup 
analysis was not carried out on integrative care provided for any specific single 
MSD. Therefore, this research study shows the overall effects of real world practice 
individualised to each patient at the RLHIM. Observational design has also been 
recommended for use in assessing side effects of an intervention and deciding which 
conditions respond well to interventions (Flower et al., 2012), and for framing future 
research questions more effectively (MacPherson et al., 2009). In this research, 
patients reported their experiences of minor AEs (Section 6.2) though it was not a 
target question in the qualitative study. 
The length of follow up in this research study with good retention is considered 
appropriate and allowed adequate observational information to be collected. In 
addition, for some cases, there were long gaps between patients’ treatment and some 
treatments were limited in their provision. Therefore, though the most significant 
benefits were observed at four months, a 12 months follow up was considered 
appropriate to detect difference over the long term, and a long term follow up is 
considered appropriate for an observational design with chronic conditions (Verhoef 
et al., 2005).  
Apart from the limitations identified in conducting the mixed methods feasibility 
study, several issues emerged from its design. One major limitation was that 
frameworks to guide and explore feasibility were not involved in design stage but 
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were utilised only at the interpretation stage of the research study. This potentially 
restricted the findings identified as specific questions on feasibility were not asked 
directly in interviews, e.g. how did patients feel about the consent process. The 
feasibility frameworks would have guided developing research questions, identifying 
questions asked in interviews, which may also guide the data analysis process 
(Bowen et al., 2009; Shanyinde et al., 2011; O'Cathain et al., 2015). The main 
reason for not doing this was that this research study was initially designed as a full 
mixed methods study but the ethics committe requested it was changed to a mixed 
methods feasibility study but the design kept the same. This was because no study 
exploring IM for MSDs had been carried out at the RLHIM prior to this research 
study. Therefore, further feasibility research should use the feasibility frameworks to 
guide design, data collection, data analysis, interpretation, and reporting. Another 
minor issue limiting the research study was that information on precise treatments 
received by patients relied on the research student reading through participants’ 
clinical notes as completion of treatment log was very poor, which is time 
consuming and likely to be inaccurate. These all require close collaboration with 
clinicians and careful project management planning. 
7.6.3 Strengths and limitations of the mixed methods design 
The mixed methods design is the main strength of the research study. Using both 
quantitative and qualitative methods of data collection and data analysis allowed the 
exploration of different aspects posed by the same overall research question on 
feasibility and provided a more comprehensive account of the situation. Themes 
generated from qualitative study could help in framing future research questions and 
maybe help researchers understand the potential active components that may 
contribute to the overall effects of integrative treatment. For example, associations 
between patients’ expectation management and treatment effects may be worth 
further exploration; how this enables self-care, the patient-practitioner relationship, 
275 
 
Chapter 7 Discussion and Conclusion 
and a holistic individualised approach and these seem to be essential as part of IM 
treatment.  
Appropriate, well recognised research methods are essential to secure qualitative 
credibility (Shenton, 2003).The adoption of interviews and focus groups were both 
recognised as appropriate methods to explore patients' expectations and experiences 
of integrative treatment at the RLHIM and in participating in this research study. 
Similar findings of patients’ experiences with MSDs and treatments they received at 
the hospital were presented by patients in one-to-one interviews and in focus groups 
(Sections 5.9-5.16), while participants in focus groups felt they engaged and 
benefited in participating in the research study by exchanging their health 
information, self-help techniques, and experiences of receiving integrative care at the 
RLHIM (Section 5.15).  
There is a lack of research focusing on the difference between one-to-one interviews 
and focus groups on the topic of IM/CAM but qualitative research literature 
suggested focus groups require more careful time and budget planning (Morgan, 
1997). The research student felt that the interactions with participants as a group was 
different to the way she interacted with patient in one-to-one interviews as in the 
latter, she was more sensitive to the topics that patients were reluctant to discuss or 
expand in focus groups as discussing a topic that participants felt uncomfortable with 
is not productive in qualitative research (Morgan, 1997).  
Though the follow-up interviews aimed to have 6 to 10 participants in each focus 
group with a total of two to five groups for the qualitative part of this research study, 
fewer patients participated in each focus group therefore altogether four focus groups 
were arranged (Section 5.1). Recruitment to the focus groups tended to be more 
challenging compared to one-to-one interviews, especially later in the study (late 
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2014 and early 2015) when interview room space could be booked for limited time 
and focus groups required an appropriate room in the hospital.  
Random sampling of individuals serving as informants has been recommended as 
essential to improve credibility in qualitative research (Shenton, 2003). Minimising 
sample bias with purposively selected samples rather than achieving generalisability 
may improve data quality and has been recommended in focus groups (Morgan, 
1997). However, qualitative participants were not randomly sampled or purposively 
sampled as there were challenges in recruiting participants for the research study 
from the outset; therefore a sequential approach was adopted. Participants were self-
selected volunteers, which may lead to bias e.g. patients who are more positive about 
the treatments provided at the RLHIM.  
Becoming familiar with the culture of participating organisations may aid in 
improving credibility in qualitative research (Shenton, 2003). Before starting the 
research study at the RLHIM, the research student had several research group 
meetings in the hospital; and one meeting with all MSD practitioners at the RLHIM. 
The research student was familiar with the interview room as they were the places 
she was based in the hospital, when extracting patients' data from the hospital system 
etc. During the recruitment period, the research student was based in the hospital 
approximately 2/5 days per week. 
Other methods of securing credibility achieved in the qualitative study include using 
triangulation of different methods (Shenton, 2003). In this research study, four 
sources of data, quantitative outcome measures, interviews and focus groups, 
participants’ clinical notes, and treatment logs completed by the practitioners at the 
RLHIM were triangulated. In order to ensure honesty in informants and data 
collection dialogues, debrief sessions between researchers and superiors, ensure peer 
scrutiny of project with reflective commentary (Shenton, 2003), two supervisors  
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checked every single transcript by reading the transcripts. Regular meetings were 
carried out during the process of qualitative data collection and analysis, with inter-
rater coding conducted with two supervisors who are experienced in the topic and 
qualitative research for 10% of the transcripts in both pre-treatment interviews and 
follow-up interviews. These utilised extensive extracts of text and gave more 
contexts to the second coders to aim for greater concordance. Negative case analysis 
(Shenton, 2003) was presented with rare or extreme cases stated in the results. 
Background, qualifications and experience of the researcher are important in 
improving credibility (Shenton, 2003) and have been provided in Section 1.2.   
Transferability of qualitative research provides   background data to establish context 
of study and detailed description of phenomenon in question, allowing comparisons 
to be made (Shenton, 2003). Details on the process of qualitative data recruitment, 
data collection, and framework analysis were provided in the methods chapter 
(Chapter 3). Transferability was also improved by taking field notes, self-reflexivity 
and inter-rater coding, which allowed the readers to decide whether the prevailing 
environment is similar to the situation in the RLHIM and whether the findings from 
this research study could be applied to other settings (Shenton, 2003). 
Dependability of this qualitative study was improved by employing overlapping 
methods (Shenton, 2003) including one-to-one interviews and four focus groups in 
the follow-up interviews. In-depth methodological descriptions (Shenton, 2003) 
were presented throughout methods chapter (Chapter 3) to allow the study to be 
replicable, with quantitative, qualitative, and mixed methods reporting guidelines 
considered.  
Methods in improving confirmability in qualitative research included reporting 
admissions of the research student’s beliefs, and the epistemology and ontology 
perspectives (Shenton, 2003) (Section 1.2); recognising shortcomings by discussing 
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limitations (Section 7.3) in study design and their potential effects (Shenton, 2003); 
presenting detailed justification of methodological design (Section 3.1) to allow 
integrity of research results to be scrutinised (Shenton, 2003); and presenting 
diagrams to explain audit trails (Shenton, 2003). This allows readers to trace the 
course of the research step-by-step via the decisions made and procedures described 
(Section 3.3).  
7.7 Contribution to knowledge  
This research study builds on the available definitions and evidence of IM in the 
literature. It goes some way towards filling the evidence gap between the high 
prevalence of MSDs and increasing popularity and benefits in the use of CAM, and 
the limited evidence on IM for MSDs. As far as we know, this is the first mixed 
method study assessing the feasibility of evaluating IM for MSDs in a secondary 
NHS setting in the UK.  
This study has provided essential information needed to move the evidence base for 
IM in the UK forward. The effect size presented for various PROMs at different time 
points allows sample size calculation for future research. Although this research 
study was limited by the absence of a control group and lack of power to test 
effectiveness, findings provide valuable insights on patients’ experiences of the 
treatments and participating in the research study. This mixed methods feasibility 
study has also provided original data on the practical issues of performing study in 
this setting, with this special group of patients who had all aspects of their life 
affected by their MSDs. These findings may provide information useful to the 
participating hospital but most importantly it can inform decisions on the future 
definitive research directions for IM, not only in the field of MSDs. 
The IM model proposed in this research study is new, reflecting what patients 
perceived good IM practice would be. Key components in the model were verified 
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both from patients’ perceptions and the IM literature. These components may 
provide previous unexplored aspects of integrative treatment for consideration in 
future IM reviews and IM research, and could influence reporting requirements of 
clinical trials. In particular exploring possible interactions between components and 
the contribution of these components to the overall IM effects may be important. 
These components can also be considered in IM practice as a reflection of patients’ 
hopes.  
7.8 Implications and future directions 
7.8.1 Implications for IM research 
The key IM components for MSDs proposed in the IM model in this research study 
need further exploration. IM is the optimum (package of) treatment(s) which 
considers the aspects of both CAM and conventional treatments. It emphasises an 
individualised holistic approach, active self-management, with cooperative 
multidisciplinary teamwork from practitioners who are patient centred, empathetic, 
happy to share information, and actively manage patients’ expectations. From this 
research study, it is unclear whether the interactions between these IM components 
or the change process of these components contributed to the overall effects of IM 
treatment. Future research confirming or adding to the proposed IM model, 
developing methods to measure these components and investigating the impact of 
the proposed IM model are warranted (Coulter et al., 2014). 
Having established the feasibility of this study, the next step following the MRC 
framework is to develop a definitive trial evaluating the effectiveness of IM. 
Considering the IM components in the IM model, testing comparative effectiveness 
using a mixed methods design will yield the most useful information in researching 
the complexity of IM in a real world situation and is recommended. Researchers in 
the field have also recommended that the first phase of evaluating IM should not 
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unpack the ‘black box’ of IM, but rather assess IM as a whole system medicine by 
evaluating the overall effects of IM (Fischer et al., 2012; Fischer et al., 2014; 
Institute of Medicine, 2009; Jones et al., 2009). 
This research study provided valuable insights into the detailed procedures of 
evaluating IM services for MSDs provided at the RLHIM which may have 
implications for future research. Potential issues with recruitment and possibilities in 
failing to identify patients due to relying on busy NHS healthcare professionals; and 
inability to purposively sample, suggested that recruitment strategies need to be 
clearly articulated and thoughtfully considered. Researchers are recommended to 
realistically anticipate challenges and develop contingency plans. Effect sizes should 
be applied with caution in research in other IM settings due to the uniqueness of the 
RLHIM and the population recruited. A larger sample would be needed to explore 
predictors of integrative treatment effects before any definitive conclusion can be 
made. The use of the VAS and sfBPI with a long term follow up, and a mixed 
methods approach with interview performed at follow up point can be recommended. 
Patients’ suggestions for improving IM research should be considered to improve 
their engagement in research. Future research should also explore the logistics of 
running a multi-centre research, the fidelity and reach of integrative treatment as 
these were not addressed in this research study. 
Looking to the future, evaluating IM using a pragmatic mixed methods design 
comparing IM with usual care could be one option. Potential usual care could be 
standard conventional treatment provided in collaborating GP practice. Another 
potential option for future research would be exploring large scale epidemiological 
and clinical observational data using data mining. Data mining has been 
recommended in healthcare, with promising outcomes (Raghupathi and Raghupathi, 
2014), and has been particularly suggested for individualised care such as IM (Li and 
Liu, 2015). Various features of IM such as syndrome differentiation, genetic 
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disposition, omics, biomedical assessments, various symptoms, data on patients’ 
expectations, practitioners’ education and qualifications etc. can be explored, with 
components identified as key features of IM. This would suit research on complex 
interventions such as IM where regular statistical tests are not perfect in calculating 
too many predictors. Among different data analytic approaches, Bayesian analysis, 
the natural method of assessing inductive/abductive scientific reasoning (starting 
from data and assessing the probability of effect, p(H0|data), may significantly 
impact on the interpretive nature of the qualitative research, and reduce the 
complexity of the data during the data transformation process (Martin and Felix-
Bortolotti, 2014). However, this approach is controversial and still under discussion 
(Chen et al., 2007). 
Funding is needed for IM research as commissioners and service providers want to 
see data on cost effectiveness, especially in the NHS. The most common obstacles in 
IM are lack of research on efficacy and health economic data and the next step 
should consider evaluating cost effectiveness alongside the pragmatic trial. In this 
research study, economic data as measured by the mCSRI was documented, and 
patients’ experiences in completing mCSRI explored. A user friendly mCSRI 
requires simplification and consideration of the potential for recall bias is needed. 
Challenges in gathering unit costs from NHS hospitals should be addressed if 
economic analysis is to be feasible.  
Locating IM research funds is problematic as research funding agencies are prone to 
support research evaluating individual components of IM in line with a traditional 
scientific reductionist approach (Abrams et al., 2013). New interpretation on 
methodological issues in assessing a whole system approach requires cooperation of 
both healthcare professionals and policy makers, and attention and support from 
policy makers and commissioning.  
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7.8.2 Implications for reporting IM research 
In order to spread the use of standard terminology to help research, stakeholders in 
this field are recommended to limit the inappropriate use of the umbrella term of IM 
in research, policy making and education. From the definitions identified (presented 
in Section 2.1.1), it became clear that there are a number of similarities as well as 
differences in ways of interpreting the key elements of IM, which need to be taken 
into account if IM is to be reported in a standardised way, not only considering the 
integration at therapeutic level, but also at the theoretical and diagnostic level. Future 
research using a Delphi design could be considered to facilitate the standardisation of 
the IM terminology and developing guidelines for reporting IM research, which may 
ultimately add to improving the evidence for IM.  
7.8.3 Implications for IM practice 
This research study provided insights into the feasibility of evaluating IM treatment 
for MSDs at the RLHIM, identifying potential areas for service improvement and 
possible cost saving.  
Although CAM treatments were generally considered safe, reliable research 
investigating AEs is scarce (Fischer et al., 2014). Mechanisms of possible interaction 
within a package of care such as IM have not been extensively investigated. Risk and 
cost-benefit ratio has been recommended to be one of the core areas to focus on in 
the next five years (Fischer et al., 2014). Therefore, monitoring AEs of IM as a 
whole package is recommended, as well as single components of IM. Understanding 
of potential AEs in IM treatments by IM practitioners is encouraged in order to 
ensure good IM practice. 
This research study identified an imbalance in supply and demand for IM. 
Challenges in getting referred and a shortage of availability in types of integrative 
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treatments, with more sessions, and longer consultation time was perceived as 
important by patients along with the high demand for IM for MSDs. Findings of this 
research study showed six to eight sessions were considered insufficient for their 
chronic MSDs which had associated polypharmacy and co-morbidities. In addition, 
more qualified healthcare professionals who are dual trained in IM are needed to 
alleviate the stressful clinical environment. Educational programmes for IM 
practitioners with consultation techniques such as patient centeredness, information 
sharing, being empathetic; and working collaboratively with other practitioners 
should be emphasised. Potential biotechnological development such as sharing 
clinical history among different hospitals may help improve IM services.  
After the IM evaluation has been completed, the final stage of the MRC framework 
is implementation into practice. Dissemination, surveillance and monitoring of 
integrative treatments for MSDs with long term follow-up are essential during the 
implementation stage. This will contribute to the cyclical complex intervention 
framework, which ultimately aims to promote health (Craig et al., 2008). High 
demand for IM services suggests secure funding is required in this area to strengthen 
IM research capacity. The most appropriate way to influence commissioning 
decisions may be the use of evidence-based guidelines (Ubbink et al., 2013). 
Although the use of CAM is increasing, a large number of CAM professional bodies 
are unaware of clinical guidelines which include their therapy (Lorenc et al., 2014). 
Between 2006 and 2013, 60 (45 from NICE and 15 SIGN guidelines) available 
guidelines mentioned CAM (mostly on acupuncture), with recommending and 
advising against CAM equally common (Lorenc et al., 2014). Improving the western 
medical health professionals’ awareness of CAM guidelines and the evidence base 
might help integrate CAM into healthcare provision, and may ultimately influence 
commissioning. The recent WHO Traditional Medicine strategy 2014-2023 has clear 
aims for harnessing the use of traditional medicine to improve population health 
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(World Health Organization, 2015b). The WHO is currently developing the 
11th version of ICD codes and traditional medicine will be included in this version 
(Morris et al., 2012). These indicate the potential to open up significant doors for 
integration into the mainstream medical systems, and may assist IM practitioners to 
diagnose in a common language that can be understood by the majority. 
7.9 Final conclusion 
This research study is the first step in evaluating IM for MSDs. Following the MRC 
framework, the theoretical understanding of IM and the feasibility of carrying out a 
MMR on IM for MSDs in the NHS were explored. Although IM services are 
increasingly being developed and used in practice, the current evidence on IM for 
MSDs is still lacking, especially in the UK. Identification of previous studies of truly 
integrated treatments was not possible due to lack of reporting of the intervention 
details and components. The lack of a standard definition of IM and an absence of 
guidelines for reporting IM has hindered the process of developing its evidence base. 
This research study is the first mixed methods study to demonstrate the feasibility of 
assessing the effectiveness of integrative treatment for MSDs in a secondary care in 
NHS outpatient setting. The overall study was feasible as evidenced by patients’ 
perceived moderate pain relief and improved HRQoL at four months, which were 
sustained (with smaller effect size) at 12 months. The effect sizes identified from 
various PROMs at different time points could allow estimation of sample sizes for 
future definitive studies, depending on their design. Apart from problems with 
referrals, integrative treatment for MSDs provided at the RLHIM was generally 
acceptable in terms of the treatment process. Integrative treatments for MSDs 
provided at the RLHIM were in demand. Most patients had chronic complex MSDs, 
with associated co-morbidities and polypharmacy, having tried various conventional 
treatments with little persistent improvement. Though patients stated they had 
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realistic expectations, they hoped to receive prolonged, non-invasive, patient centred 
treatment, from practitioners who were qualified and interacted with patients. The 
feasibility findings showed that identifying eligible patients and recruitment were 
challenging, but there was a high attendance and good completion at 12 months. This 
was reflected in the qualitative findings where participants reported positive 
experiences in the research process. VAS and sfBPI targeting patients’ specific 
symptoms, pain and physical function, and a narrative approach to explain their 
complex MSDs holistically were preferred.  
An IM model has been developed based on components of IM perceived as 
important by patients for MSDs. Patients’ self-management was an essential part of 
their IM experiences. Other key components of IM include: providing individualised 
treatment in a holistic approach; considering different treatment options including 
both CAM and conventional treatment; and working collaboratively in a 
multidisciplinary team. It also emphasises the communication between patients and 
practitioners, who are professional experts, patient centred, empathetic, share 
information, and actively manage patients’ expectations. These components are 
recommended to be explored in future research.  
The mixed methods design is the strength of this research study. Utilising both 
quantitative and qualitative methods of data collection and data analysis has allowed 
to answer different questions regarding feasibility of the research study. 
Triangulating the data during the interpretation phase has enabled a more 
comprehensive account of the data. However, the absence of a control group raises 
the question as whether the effects are really attributable to the treatment. Lack of 
ethnic and socioeconomic diversity of participants does not permit generalisation of 
these findings to other populations of MSDs patients. Considering the increasing 
population with MSDs, the increasingly elderly population and the demand for IM 
service, evidence on IM effectiveness, cost-effectiveness and safety are required to 
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develop guidelines for IM provision. Future mixed methods research developed 
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 Appendix 2 3 Definitions of integrative medicine identified from the mapping review 
The practice of medicine that reaffirms the importance of the relationship between 
practitioner and patient, focuses on the whole person, is informed by evidence, and makes 
use of all appropriate therapeutic approaches, healthcare professionals and disciplines to 
achieve optimal health and healing… 
Integrative Medicine is the practice of medicine that reaffirms the importance of the 
relationship between practitioner and patient, focuses on the whole person, is informed by 
evidence, and makes use of all appropriate therapeutic approaches, healthcare 
professionals and disciplines to achieve optimal health and healing. 
(The Consortium of Academic Health Centers for Integrative Medicine, 2009) 
 
Represents a higher-order of system of care that emphasizes wellness and healing of the 
entire person (bio-psycho-socio-spiritual dimensions) as primary goals, drawing on both 
conventional and CAM approaches in the context of a supportive and effective physician-
patient relationship"  
(Bell et al., 2002b)       
 
Integrated medicine brings together conventional medicine with safe and effective 
complimentary medicine. It emphasises the importance of the doctor-patient relationship 
and the use of all appropriate therapeutic approaches, healthcare professionals and 
disciplines to achieve healing and optimal health. 
(Royal London Hospital for Integrated Medicine, 2015) 
 
Integrative medicine combines mainstream medical therapies and CAM therapies for 
which there is some high-quality scientific evidence of safety and effectiveness… Involve 
bringing conventional and complementary approaches together in a coordinated way. 
(National Center for Complementary and Alternative Medicine, 2015)
361 
 
Appendices 2.3 Definitions of integrative medicine identified from the mapping review 
Integrative medicine is healing-oriented medicine that takes account of the whole person 
(body, mind, and spirit), including all aspects of lifestyle. It emphasizes the therapeutic 
relationship and makes use of all appropriate therapies, both conventional and alternative. 
(The Bravewell Collaborative, 2015)  
 
Integrative medicine is a new term that emphasizes the combination of both conventional 
and alternative approaches to address the biological, psychological, social and spiritual 
aspects of health and illness (MeSH term). It emphasizes respect for the human capacity 
for healing, the importance of the relationship between the practitioner and the patient, a 
collaborative approach to patient care among practitioners, and the practice of 
conventional, complementary, and alternative health care that is evidence-based. 
(Osher Center for Integrative Medicine, 2015) 
 
Integrative care is personalized, participatory, relationship-based care, promoting optimal 
health. It emphasizes healing of the whole person to achieve each individual’s unique 
physical, emotional, mental, spiritual, and social health goals. The primary therapies used 
to achieve these goals are healthy habits (nutrition, activity, sleep, mindful self-care and 
fellowship) in a healthy habitat (social, natural and built environment). Integrative 
healthcare skillfully uses the best of both conventional and complementary strategies to 
attain patients' health goals.  
(The Ohio State University, 2015) 
 
Key concepts from the book cover (fromamazon.com) include: 1) combining 
complementary and conventional therapies; 2) evidence-based 
(Lee and Kligler, 2004) 
 
Integrative medicine is defined as healing-oriented medicine that takes account of the 
whole person, including all aspects of lifestyle. It emphasizes the therapeutic relationship 
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between practitioner and patient, is informed by evidence, and makes use of all 
appropriate therapies.  
(Arizona center for Integrative Medicine, 2015) 
 
Integrated medicine focus on health and healing rather than disease and treatment. It 
views patients as whole people with minds and spirits as well as bodies and includes these 
dimensions into diagnosis and treatment. It also involves patients and doctors working to 
maintain health by paying attention to life-style factors such as diet, exercise, quality of 
rest and sleep, and the nature of relationships. 
(Rees and Weil, 2001) 
 
Integrative medicine is healing oriented and emphasizes the centrality of the doctor-patient 
relationship. It focuses on the least invasive, least toxic, and least costly methods to help 
facilitate health by integrating both allopathic and complementary therapies. These are 
recommended based on an understanding of the physical, emotional, psychological, and 
spiritual aspects of the individual. 
• Provide relationship centered care 
• Integrates conventional and complementary methods of treatment and prevention 
• Involves removing barrier to activate the body’s healing response 
• Uses natural, less invasive intervention before costly, invasive ones when possible 
• Engages mind, body, spirit, and community to facilitate healing 
• Healing is always possible, even when cursing is not 
(Rakel, 2012b) 
 






Appendices 2.3 Definitions of integrative medicine identified from the mapping review 
Integrative medicine… contains elements of a) combining complementary and 
conventional; b) evidence-based; c) whole person, addressing mental, emotional, and 
spiritual as well as physical well-being 
(Wisneski and Anderson, 2009) 
 
Integrative Medicine combines conventional medicine with evidence-based complementary 
medicine, therapies and lifestyle interventions for optimal outcomes in health, healing and 
disease prevention with a supportive and empowering practitioner-patient relationship. 
The practice of IM focuses on the whole person, is informed by evidence, and makes use of 
all appropriate therapeutic approaches, healthcare professionals and disciplines. IM takes 
into account the physical and psychological state of the person to help create overall 
health and wellbeing, now and in the future. 
(National Institute of Integrative Medicine, 2015) 
 
Integrative medicine is healing oriented and emphasizes the centrality of the doctor-patient 
relationship. It focuses on the least invasive, least toxic, and least costly methods to help 
facilitate health by integrating both allopathic and complementary therapies. These are 
recommended based on an understanding of the physical, emotional, psychological, and 
spiritual aspects of the individual. 
• Provide relationship centered care 
• Integrates conventional and complementary methods of treatment and prevention 
• Involves removing barrier to activate the body’s healing response 
• Uses natural, less invasive intervention before costly, invasive ones when possible 
• Engages mind, body, spirit, and community to facilitate healing 
• Healing is always possible, even when cursing is not 
(Rakel, 2012b) 
 
“Integrative Medicine and the Health of the Public” from the prestigious Institute of 
Medicine, summarizing the 2009 summit by the same title (IOM Summit on Integrative 
Medicine and the Health of the Public), published by National Academies Press in 2009. 
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On page 5, in the Summary, there is a box listing themes from the summit: 
• Vision of Optimal Health as per the WHO, more than the absence of disease 
• Conceptually inclusive across prevention, to treatment, to rehabilitation and 
recovery 
• Lifespan perspective 
• Person-centered 
• Prevention-oriented 
• Team-based  
• Care integration across providers and institutions 
• Science integration 
• Integration of approach 
• Policy opportunities 
Don Berwick offered 8 principles of IM (p11) 
• Place the individual at the center 
• Individualize care 
• Welcome family and loved ones 
• Maximize healing influences within care 
• Maximize healing influences outside of care 
• Rely on sophisticated, disciplined evidence  
• Use all relevant capacities – waste nothing 
• Connect helping influences with each other 
Harvey Fineberg, President of the IOM, listed 5 critical dimensions of integrative care 
(p.27-28) 
• Broad definition of health – more than absence of disease; physical, mental, 
emotional, and spiritual well-being 
• Wide range of interventions – prevention, treatment, rehabilitation and recovery  
• Coordination of care 
• Patient-centered care  
• Variety of modalities- complementary and conventional 









Appendices 2.3 Definitions of integrative medicine identified from the mapping review 
中西医结合的方式和途径有以下几个主要方面：结合疾病的诊治、结合中西医诊断
方法的研究、结合中医治法治则的研究、结合中医学基础理论的研究。 
IM in China always refer to integration of Chinese and Western medicine [中西结合医
学]. It combines TCM and CHM knowledge and methods with western medicine, in order 
to improve clinical efficacy, explain mechanisms and to develop new understandings of 
medicine. IM is a long term policy in China ever since the establishment of the 
government.  
It emphasises the integration in several levels, included integration in theoretical, 
diagnostic, and therapeutic levels. 









Integrative medicine emphasises: 
• TCM & western medicine methodology  
• New theory/method (discipline) 
• To explore body structure/function/system/environment (holistic) 




 Appendix 2 4 Detailed search terms and search strategy of the systematic review 
 MeSH  
terms 






Low back pain 
 
Low back pain, OR lumbago, OR low 
backache, OR lumbar herniation, OR 

























*Alternative therapy, Acupuncture Therapy, Anthroposophy, Auriculotherapy, 
Diffuse Noxious Inhibitory Control, Holistic Health, Homeopathy, Horticultural 
Therapy, Medicine, Traditional, Mesotherapy, Mind-Body Therapies, 
Musculoskeletal Manipulations, Naturopathy, Organotherapy, Phytotherapy, 
Reflexotherapy, Rejuvenation, Sensory Art Therapies, Speleotherapy (salt 
therapy) and Spiritual Therapies are under this category. 
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1 – Medline via Pubmed search strategy (searched Mesh Terms, 1st Jan 1980 
– 2nd Dec 2012) 
Integrative medicine [MeSH Terms] OR Complementary therapy [MeSH Terms] 
(162961) 
Low back pain [MeSH Terms] (12485) 
1 AND 2 (728)  
3 Filters: Meta-Analysis; Systematic Reviews; Clinical Trial; Humans; Chinese; 
English (313) 
2 – AMED (1985 – Dec 2012), Embase (1947 – Dec 2012), PsycINFO (1806 to 
Dec 2012) using Ovid 
 ("Integrative medicine" OR "integrative treatment" OR "integrative therapy" OR 
"integrative healthcare" OR "integrative medicine" OR "integrative treatment" OR 
"integrative therapy" OR "integrative healthcare" OR "complementary medicine" 
OR "complementary treatment" OR "complementary therapy" OR "alternative 
medicine" OR "alternative treatment" OR "alternative therapy" OR "complex 
intervention" OR "complex treatment" OR "complex therapy" OR "combined 
therapy" OR "combined treatment").mp. [mp=ab, hw, ti, sh, tn, ot, dm, mf, dv, kw, 
nm, ps, rs, an, ui] (105599) 
("low back pain" OR "lumbago" OR "low backache" OR "sciatica").mp. [mp=ab, 
hw, ti, sh, tn, ot, dm, mf, dv, kw, nm, ps, rs, an, ui] (49422) 
1 AND 2 (725) 
3 – Cochrane library (inception to Dec 2012) 
Integrative medicine [MeSH Terms] explode all trees (33) 
Complementary therapy [MeSH Terms] (11882) 
Low back pain [MeSH Terms] (1699) 
(1 OR 2) AND 3 (239)  
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4 – ScienceDirect (1823 – Dec 2012, all journals, all books, all source, Include 
Articles in Press, Limit by document type: articles) 
TITLE-ABSTR-KEY (("Integrative medicine" OR "integrative treatment" OR 
"integrative therapy" OR "integrative medicine" OR "integrative treatment" OR 
"integrative therapy" OR "complementary medicine" OR "complementary 
treatment" OR "complementary therapy" OR "alternative medicine" OR "alternative 
treatment" OR "alternative therapy" OR "complex intervention" OR "complex 
treatment" OR "complex therapy" OR "combined therapy" OR "combined 
treatment") AND ("low back pain" OR "lumbago" OR "low backache" OR 
"sciatica"))  (72) 
5 – CINAHL Plus via EBSCO (all years, searched abstract, Suggest Subject 
Terms) 
AB ((Integrative medicine or integrative treatment or integrative therapy or 
integrative healthcare or integrative medicine or integrative treatment or integrative 
therapy or integrative healthcare or complementary medicine or complementary 
treatment or complementary therapy or alternative medicine or alternative 
treatment or alternative therapy or complex intervention or complex treatment or 
complex therapy or combined therapy or combined treatment) AND ( low back 
pain OR lumbago OR low backache OR sciatica)) (119) 
6 – Index to Thesis (inception to Dec 2012) 
AB ((Integrative medicine or integrative treatment or integrative therapy or 
integrative healthcare or integrative medicine or integrative treatment or integrative 
therapy or integrative healthcare or complementary medicine or complementary 
treatment or complementary therapy or alternative medicine or alternative 
treatment or alternative therapy or complex intervention or complex treatment or 
complex therapy or combined therapy or combined treatment) AND ( low back 
pain OR lumbago OR low backache OR sciatica)) (2) 




Appendices 2.4 Detailed search terms and search strategy of the systematic review 
1 AND ((关键词=中英文扩展(结合) 或者(关键词=中英文扩展(联合) 或者 (关键词=中
英文扩展(合并) 或者(关键词=中英文扩展(配合) (精确匹配))（179） 
2 filters: 不包含=进展或者综述或者述评（114） 
8 – VIP (1989 - Dec 2012, Title and key words) 
(题名或关键词=腰痛或者腰痹) (4676) 
(题名或关键词= 结合) 或者(题名或关键词=联合) 或者 (题名或关键词=合并) 或者(题
名或关键词=配合) (751842)   1 AND 2 (329)
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Acu outpatient and 
surgery inpatient 
Dr 













EA+T vs. T EA: 20 min, once daily, 6 days / session;  T: 30 min, 














Acu+T vs. T Acu/ T: 30 min, q.d., 6 days / session, 1 day rest 
















Acu+T vs. T Acu: 30 min, q.d., 15 treatments/session, 2 sessions; T: 
















Acu+T vs. T T: 30 min, q.d.; 10 days / session, 5 days rest between 
















EA+T vs. EA vs. 
T 


















T: 20 min, q.d., 20 treatments/ session; Acu(+TT): 15-40 














































Acu+EI vs. Acu 
vs. EI 















vs. EA(+RT) vs. 
NB 
EA/ RT: 30 min, q.a.d., 12 treatments; NB: once the 
other 2 weeks, 3 treatments 
NB: 2-3 mL 2% lidocaine; 1 mL diprospan; 7 mg 
betamethasone; 0.5 mg cobamamide, together with 
















EA+EI vs. EI EA: 20 min, q.d., 21 days a session, one session; EI: 3 















EA+M2 vs. EA 
EA: 20 min, q.d., 10 days/ session, 2 sessions; M1: q.d., 
3 d; M2: q.d., 10 days 
M1: 10 mg dexamethasone in 0.9% sodium chloride 500 
mL, 250 mL mannitol (IV); 
















Acu+M vs. Acu 
vs. M/ No 
treatment 
control 
Acu: twice/w, 5 weeks; M: 15 mg, twice daily, 5w 






















Physio: 30 min, 26 sessions over 12 weeks; Acu: 30 min, 











































re vs. Standard 
care  
Standard care: NSAIDs, muscle relaxant, paracetamol, 
back exercises 




















Acu (sham Acu): 30 min, 3 treatments/week,4 weeks; 
COT: conventional COT includes physiotherapy, 





































TN+EI vs. TN TN: q.d., 7 treatments/session; EI: once every 10 days, 3 
days rest between each treatments, 1-3 treatments 
VAS T 
Li DJ  
(2011)(
LI et al., 









TN+EI vs. EI vs. 
TN 
TN: once every 10 days, 2 treatments; EI: once every 5 






















































TN+EI vs. EI EI: once/week, 3 treatments/session; TN/T:  30 min, q.d., 
20 treatment/session  
VAS T 










TN+EI vs. EI vs. 
TN 


















TN+EI vs. EI vs. 
TN 
EI: q.a.d., 3 treatments/week, 2 weeks; TN: 20 min, 


















TN+T vs. TN TN: 20 min, q.d.; EI (with TN): once every 2-month, 1 
week rest between treatments; T: 20 min, once every 5 













TN+T vs. T TN: 15-20 min, b.i.d-q.d., 10 treatments/session, 2-3 
sessions;  T: 20-60min, b.i.d.-q.d., 10 














TN+T vs. T TN/T: 30 min (at the same time), q.d.,  1-2 days rest in 












TN+T vs. T T: 30 min, q.d., 20 treatments/session; TN: once the 














TENS+T) vs. TN 
TN: 40 min; TENS: 15 min; T: 20 min; RT: 15 min; all 
approaches: q.d., 21 treatments 
VAS T 






























physio /session; M: q.d., 5-7 continuous days JOA 
Grunne














surgeons, GPs, and 
physiotherapists - 
trained in manual 
therapy 
Manual package 
+ injections vs. 
manual package 
Individualized manual therapies with no standardized 
treatment protocol but with a concept of ‘stay active’; 











urst S  
(2008)  
















ise vs. usual 
care 
For 6-session Alex: 2 lessons a week for 2 weeks then 1 
lesson a week for 2 weeks;  
12-s Alex: 22 lessons over 5 months, 1 revision lesson at 
7 months and 1 at 9 months; exercise: 6w. 































‘Frequency of chiropractic/physical therapy visits was at 





















CHM+T vs. T T: 30min, q.d. (6 treatments/week), 2 weeks/session, 2 

























































CHM+T vs. T CHM: b.i.d., 2 weeks/session, 2 sessions; T: 45-90 min, 



























CHM+EIvs.EI CHM: twice, 1 month a session; EI: QWK, 3 
times/session, 1 session (typical cases could have 2 
sessions) 
VAS T 












EI: 7-10 days rest between each treatment, 4 
treatments; CHM: once 2-3 days, 35 days /session, 3-
month rest between each session, 3 sessions/y; Ex: 15 
min, twice, 1 year 
VAS T 




























CHM: NR; EI followed by T, q.d., 5 treatments/session, 1 















CHM + Physio 
(WT) vs. CHM 
CHM: t.i.d., 30 days /session, 2 sessions; exercise in 






































vs. usual care 















care vs. CHM 
CHM: twice daily, 7 days; Physio (electromagnetic): 



















Acup/EI: 7 days rest between each treatment, 3 
treatments altogether 
m-JOA T 















Acup:  7 days rest between 2 treatments; TT: 20 min; M: 
Oxycodone and acetaminophen tablets, p.o., 1 pill 







































NR VAS T 
Eisenbe









group practice; CAM: 
private offices 
(Acu/msg/chiro)
+usual care + 
vs. usual care  
CAM: up to 10 sessions over 5 weeks and up to 5 

































Usual care includes: NSAIDS, muscle relaxants, limited 
























up to 2 treatments a week with up to 2 treatment 
modalities per session for up to 12 weeks 
IC: following services if needed - acupuncture, 
chiropractic, internal medicine consultation and referral 
as appropriate, massage therapy, occupational therapy, 
physical therapy, mind body techiniques, neurology 
consultation, nutritional counselling, orthopaedics 
consultation, and psychiatry and rheumatology 
consultation and referrals as appropriate) 
Usual care: nonsteroidal anti-inflammatory drugs, muscle 
relaxants, as-needed referrals to physical therapy, 






















+M vs. M 
M: 20 mg β-sodium aescinate in 0.9% sodium chloride, 
IV, q.d.,14 days; Acu/moxa: 20 min, q.d., 7 days 
/session, 2 sessions; Bleeding/cupping: once the other 2 



















ping+AA vs. M 
CHM: twice daily, 10 days / session, 3-5 days rest 
between sessions; Acu: 30 min; Cupping: 20 min;  AA: 1 
h, q.d., 10 days / session, 10 days rest between 
sessions; 30 days 












Primary care units 
N/A 
GP, certified CT 
providers 
CAM package + 
usual care vs.  
usual care 
Pragmatic/individualized 
Package: Swedish massage, manipulative therapy, 















T vs. M+T 
M: NR; T: 20 min, q.d., 4 weeks; CHM: t.i.d., 4 weeks; 









































+M+T vs. M 
M: q.d., 3w; CHM: p.o., b.i.d., Acu: 30 min; 7 days / 
session, 3 sessions; (Not given how many sessions 
should be given. But outcome measures assessed by 
the end of the 3rd week)M: 20% mannitol 125 mL, 5% 
glucose 250 mL + dexamethasone 10 mg, 10% glucose 
200 mL + Salvia 20 mL (IV); vitamin B1 100 mg and 


















M: q.d., 10-14 days; Acu: 30 min, b.i.d., 28 days 
M: mannitol 250 mL+ dexamethasone 5 mg, after 3 
days, changed the intervention to: 0.9% sodium Chloride 
250 mL added aescin 20 mg + 0.9% sodium chloride 
100 mL added Neurotropin + 5% glucose 250 mL add 







Notes: *Condition 1 (LDH: Lumbar disk herniation, 3rd LTPS: Third lumbar transverse process syndrome, NS: Non-specific); Condition 2 (A: 
Acute - < 6 weeks, SA: Subacute - 6-12 weeks, C: Chronic - > 12 weeks); N: no, Y: yes; ※End point: T-after treatment, F-after completion of 
treatment; 
NR: not reported, min: minute(s), MH: medical hospital; 
Acu: acupuncture, Acup: acupotomy, physio: physiotherapy, TN: Tuina, Rehb: rehabilitation, M: medication, AA: auricular acupuncture, CHM: 
Chinese herbal medicine, T: traction, EI: epidural injection, TT: thermal therapy, NB: nerve block, EA: electroacupuncture, RT: radiotherapy, COT: 
conventional orthopeadic treatment, TCMH: traditional Chinese medicine hospital,  IC: integrative care; 
q.a.d.: every other day, q.d.: once daily, b.i.d.: twice daily, t.i.d.: three times a day, QWK: every week; 
p.o.: by mouth or orally, IV: intravenous, IM: intramuscular (with respect to injections); 
VAS: visual analogue scale, JOA: Japanese Orthopeadic Association, mJOA: modified Japanese orthopeadic Association, sf-JOA: short form 
Japanese Orthopeadic Association, PDI: Pain disability index, HADS: hospital anxiety and depression scale, ODI: Oswestry pain disability index, 
(m)RMQD: (modified) Roland Morris Disability Questionnaire 
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 Appendix 3 4 QUAL topic guide for pre-treatment interviews and follow-up interviews and focus 
groups 
Topic guide for the pre-treatment interviews 
Questions Probes 
1. Can you tell me what do you feel 
about taking part in the study? 
Do you think taking part will effect/affect your 
treatment in the RLHIM, what is the main worry of 
taking part in the study? 
2. Can you tell me about the 
condition which you have been 
referred to the hospital for? 
When and how this developed, how they feel 
emotionally, symptoms, concomitant conditions. 
3. How does your condition affect 
your daily life?  
Has this condition has impacted on work, ability to 
perform everyday activities, their relationships with 
family/friends, their social life. 
4. What treatments/self help 
measures have you used to try to 
improve your condition? 
Any use of conventional and unconventional 
treatments (including CAM). 
5. Can you tell me how you came to 
be referred to the Royal London 
Hospital for Integrated Medicine? 
Own initiative or health practitioners recommendation; 
any barrier to accessing; perceptions of referring 
health practitioner/family/friends. 
6. Can you tell me what your 
expectations are for your treatment at 
the hospital? 
Expectations of benefit/adverse effects; what do they 
think the experience will be like. 
7. What are your expectations of 
being involved in the study? 
What they perceive it’s like taking part in research. 
OTHER PROBES AS DICTATED BY THE EMERGING CATEGORIES AND THEMES 
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Appendix 3.4 QUAL topic guide for pre-treatment interviews and follow-up interviews and focus groups 
Topic guide for the follow-up interviews and focus groups 
Questions Probes 
What is your 
experience of taking 
part in this study? 
How did you find the process of taking part in the study? Why 
you decided to take part in the study in the first place? How did 
you find the recruitment process? Do you feel the information 
we provided was sufficient to make an informed decision to 
take part [PIS, verbal communication] and if not how could it 
have been improved? Did you complete all the questionnaires? 
If not, why not?  How did you find completing the 
questionnaires [too long, had to complete on specified days etc] 
(show them copies)? Was there anything you did not 
understand? Which questionnaire do you think best explained 
your conditions? What do you think of having such an 
assessment included in the future study? Is there anything else 
we should have asked you? Were there 
anything/changes/symptoms we didn’t capture? [If not why 
not]? Did you have any problems taking part in the study? Do 
you feel taking part in this study is affected your treatment at 
RLHIM? Is there anything which you feel could have improved 
your experience of taking part? What do you think about the 
length of time you were in the study? Do you think you 
benefited from taking part in this study? Is there anything else 
you think we could have done differently?  
Can you tell me the 
treatment you received 
at the RLHIM and 
about the experiences 
you have had during 
the treatment? 
Did you attend all your treatment sessions? If not, why not? 
How did you feel during your treatment? (Emotionally, kinds of 
symptoms, concomitant conditions). 
Were there any barriers, adverse effects, new problems that 
emerged?What was it like receiving a package of care? 
Has the treatment 
changed your 
symptoms, wellbeing 
and quality of daily 
life? If so, how? 
Has the treatment changed the severity of the pain, sleeping,  
work, ability to perform everyday activities, their relationships 
with family/friends, their social life, did it meet your 
expectations. 
OTHER PROBES AS DICTATED BY THE EMERGING CATEGORIES AND THEMES 
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 Appendix 3 7 Framework analysis memo in Nvivo (partial) 
 
Examples of Ava's codes identified from the follow-up interviews and focus 
groups 















(chronic) pain effect of treatment (improvement/it work   referral/pathway to treatment NHS treatment
experience of disease integration (works) NHS organisation issues physio
symptom acupuncture GP
diagnosis (CAM) western medicine NHS funding consultant
complex condition long term effect (lack of) Mechanism of action? practitioner NHS
diagnostic tests maintaining the effect CCGs or funding private treatment
effect (pain/daily life) cost effectiveness NHS cuts hydroptherapy
seriousness of condition side effects previous experience CAM
complex life experience of treatment Reason for coming to RLHIM trust in profession
mental health duration of treatment





individualised effect reason for seeking treatment GP advice/opinion
problems with diagnosis enjoyment?










mechanism belief in CAM (lack of)
homeopathy RESEACH DESIGN expectation
consultation (length/booking/phone) questionnaire hope
holistic outcome measures expectation
advice
sf BPI often disapointed/not
satisfied/has very high
expectation
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41 FG2 40 9
Multiple morbidity Multi MSD morbidities Extent of pain and severity Access to treatment
Other health problems/issues Reason for referral Type of pain Outcomes of integrated care
Knee pain prior Treatment at hospital Frequency of pain Post RLHIM (continuity of care)
Carpal tunnel TMD Satisfaction with consultation Triggers Self-help
Mental affect Change in attitude as a result of treatment Access to other treatment Outcome of complex intervention
Coping with pain Treatment details Living with pain
Access to treatment in other NHS
location
Attitude to understanding own pain Experience of RLHIM treatment Treatment package Need for continuing care for pain relief
Wish for alternatives Experience of acupuncture treatment at RLHIM Other health problem Complex MSD
Barriers to exercise Amount of treatment Individual RLHIM treatment Access to other sources of help
Attitude to healthcare (another hospital) Experience of practitioner Perceived improvement
(difficult to get) Access due to costs of
treatment
Reason for coming to RLHIM Time allocated for treatment Length of consultation Prior use of CAM
Doctor ’ s approach (Dr. RLHIM1 referred
the patient to Dr. RLHIM2)
Time allocated for consultation Satisfaction with consultation Rationing of health care (referrals)
Previous experience of western drugs Frequency of contact
Satisfaction with health care
practitioner and consultation
Expectation of increased costs and
health outcomes
IM treatment given Provision + amount of time for treatment Patient satisfaction with treatment Satisfaction with CAM
Getting to travelling to appointment Referral results (difficulties in getting re-referred) Request for alternative treatment
Acupuncture as part of complex
intervention
Accessibility changing appointment Attitudes of GPs Previous use of CAM Side effect of acupuncture
Time taking to get an appointment Time to access to treatment Side effect of previous treatment Individualization of intervention
Patients’ perception of docs attitudes Patient need Other hospital treatment
Consultation experience of hospital
and barriers
Attitude to western medicine Use of services ? hospital Expectation for other care Experience of consultations
Beliefs in alternative (doctors views)? Time to treatment (time waited interim treatment) Experience of acupuncture Waiting time
Treatment received (at the RLHIM) Wish for additional treatment at hospital Experience of treatment Reception
Consultation content Use of conventional medicine Type of acupuncture Positive outcome
Treatment externally received Practitioner delivered integrated care Consultation practitioner input Side effects of intervention
Wish to seeking other approaches Seeking treatment Patient explanation of treatment Complexity of care
Other therapies patient would like Access to (RLHIM) care
Explanation given to patient on effect
of treatment
Needed to treat pain
Other self-care treatment used Provider of info Patient searching for information Side effects
Coping with pain Diet Satisfaction with treatment Hospital environment
Other treatment received from hospital
(not sure if this is RLHIM)
Relationship with practitioner
Experience after completion of
treatment
Problems accessing to services
Use of other treatment option Provision of care Outcome of treatment Amount of treatment alleviate
Attitude to treatment offered Advice from practitioner Expectation after initial consultation Problems of access
Outcome of treatment used Intervention experience Dissatisfaction with RLHIM care Attitude of pain
Expectation Patient control of intervention Communication with GP Limited/reduced access to care
Status of daily activities Understanding the intervention Access further care Costs
Self-help Referral Geographical location of patient Importance of complex care package
Attitudes to use of other treatments Intervention outcomes RLHIM service Effect of acupuncture care package
Doctor’s attitude Provision? of self-help advice Satisfaction with reception services effect of acupuncture
Belief in whether having integrative
treatment
Treatment provided Appointment waiting time integrated care package
Self-care Patients perception of doctors Consultation at the RLHIM other effects of treatment
Needs (on treatment) Adverse effect of intervention (acupuncture) Problems on questionnaire completion process of care
Access to RLHIM services (care pathway) Adverse effect of treatment Acceptability of questionnaire need for complex intervention
Patient control? (Extended treatment) Adverse effect of treatment (osteopathy) Affect of treatment on sleep
previous use and accessing
acupuncture elsewhere
Discharge process at RLHIM or
satisfaction? with care
Doctors explanation of intervention Problems of completing CSRI limited other access of treatment
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Appendix 3.7 Framework analysis memo in Nvivo (partial) 
Framework version 1 for the follow-up interviews and focus groups (partially), developed on the 25th March 2015 
 
This version framework was developed on the 25th March 2015, after coding 009/040/041/FG2/FG3 (with 9/30 participants)
Living with MSDs Previous Experiences Access to Treatment Patient Expectations Self-management
History of MSDs Previous CM experiences
Decision making process to
come to the RLHIM
Participants' understanding of

















Access to treatment -










Access to treatment -
practical  (e.g. time waited
interim treatment)

















MSDs e.g. mechanism, how
knowledge on health is found)
Worries of being treated Stress/Emotional management?
N.B 
Texts in brown represent same 
coding as the prior treatment 
qualitative study; 
Texts in black represent new 
categoris and codes generated 
from the post treatment 
qualitative study; 
Texts in red represent where 
changes were made, with 
comments explaining what 
changes have been made and 
why; 
Texts in green represent where 
codes were deleted; 




Appendix 3.7 Framework analysis memo in Nvivo (partial) 
Framework version 3 for the follow-up interviews and focus groups (partially), developed on the 25th March 2015
 
This version framework was developed on the 1st Apr 2015, after coding 30/30 participants
Living with MSDs Previous Experiences Access to Treatment Patient Expectations Self-management
History of MSDs Previous CM experiences
Decision making process to come to the
RLHIM
Participants' understanding of their
expectation (e.g. Lack of expectation,
avoid having expectation)
Coping with pain/condition
MSDs symptoms Previous CAM/IM experiences Access to treatment
Expectations and hope for type of
treatment (e.g. often disapointed/not
satisfied/has very high expectation)
Understanding of (Importance of) self-
help
Impact of MSDs Lack of CAM/IM experiences
Access to treatment - physical  (e.g.




treastment/seek for other approaches)
Exercise
Impact of non-MSDs
Access to treatment - practical (Referal
Pathway) (e.g. time waited interim
treatment; limited treatment available at
the hospital etc))
Hopes from the practitioner Things which impact condition
Self-management
Mechanism of action (e.g. not being
addresse because they are not in certain
scheme)
Hopes for future NHS CAM/IM access Self-directed integrative treatment
CAM Diagnosis
Rationing of healthcare
referrals/mechanism of action (e.g.
different approach/scheme for different
patients etc)
Treatment met expectation/satisfied Information seeking
Diagnostic tests Awareness of Strain in NHS Resources Worries of being treated Stress/Emotional management?
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Appendix 3.7 Framework analysis memo in Nvivo (partial) 
The research student’s charting reflections (partially) 
23rd Apr 2015 
Difference in using Excel and Nvivo framework matrix function: 
1. If wanted to make any changes in transcripts when coding/developing 
framework/charting/interpretation, one can easily do that and the whole project will 
be automatically updated 
2. Can re-code or un code nodes while charting: sometimes while charting, Mio 
found certain quotes were not belong to a code, it is easy to change it to another 
code or delete it when charting in framework matrix in Nvivo.  
3. Several tabs: easy to record memo and reflections as memo can be linked to 
the transcripts/framework/framework matrix etc 
4. If content was not clear, can easily get access to the whole transcripts and read 
and add stuff. 
 
Changes in codes while charting: 
Some codes were combined in the charting process of the follow-up interview 
analysis: for example, code ‘MSDs symptoms’ was combined with code ‘history of 
MSDs’ because much fewer quotes were on their MSD history and symptoms is 
part of medical history. 
 
24th Apr 2015 
While charting, Mio copied some of the quotes she likes to a separate word 
document.  
Language used in charting: 
There might be sentences difficult for supervisors to understand but Mio wrote 
down the sentences that she can best understand the content, as this is only for 
her interpretation.  
Category 1: Living with MSDs 
Most of the words Mio used to summarize or describe participants' history of 
MSDs and MSDs symptoms (1.1 &1.2) were their own words because it is what 
they believed they had. 
 
28th Apr 2015 
Mio found it is difficult not to interpret during charting. Mio must be descriptive and 
use the participants' own words as much as possible. There is no harm having a 
long summary for a quote. 
 
01st May 2015 
While charting, Mio have written down the ideas of possible themes and copied 
good quotes to a separate word file.  
 
In summary: 
There are altogether 3 versions of framework before finalizing the final framework. 
Details of the how codes were changed and reasons of them are available in 
memo: Framework v1-v3 and excel file: final framework.  
 
Version 1: developed on the 25th Jan 2015, after coding 009/040/041/FG2/FG3 
(with 9/30 participants) 
Version 2: developed on the 1st Feb 2015, after coding 
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Appendix 3.7 Framework analysis memo in Nvivo (partial) 
021/013/044/022/007/034/009/040/041/FG2/FG3 (with 13/30 participants) 
Version 3: developed on the 1st Apr 2015, after coding 30/30 participants 
 
24th Feb 2015 
Data saturation: 
Today I started working on drafting my framework as I feel no more new data is 
generating from the interviews (n=16). So far, I have transcribed 22 interviews 
altogether; 
• I kept all the categories and codes I had from the first part qualitative study 
when I started drafting my framework. I also feel this might help with identifying 
which are the extra/missing codes compared with the part one qualitative 
study; 
• I started from the interview No.41 as I remember this participant was quite 
active; 
 
There were a few mistakes in transcribing so I revised them in Nvivo directly as I 
think Nvivo will help me organizing my final data, including emails and texts that I 
will import later.  
 
26th Feb 2015 
Inter-rater coding reflections: 
Framework developed by five interviews  
Nicky: 041, FG2 (010, 014) – received on the 16th March 2015 
  040 and 009 – received on the 19th March 2015 
Ava: 009, 040, FG3 (027, 031, 058, 041) 
Nicky suggested Mio not to lead the question and not to give advice; Mio 
acknowledged these. 
 
What Mio did: 
1. Copy the codes given by Nicky, Ava and herself; all codes were only recorded 
once for each coder; 
2. Add in explanations by reading relevant quotes if the codes did not stand 
themselves; 
3. Grouped the codes and add category titles using track changes; 
4. Discuss with Nicky and Ava 
 
Copied categories and codes from the pre-intervention interview; 
added/deleted/grouped; 
Reasons (go to in method): 
Although research questions of the follow-up interview are focusing on 
participants’ treatment experiences and their experiences in participating in the 
research study, the researcher anticipated participants would explain their MSD 
experiences  
many similar categories and codes, e.g. codes under ‘living with MSDs’ and ‘’ 
 
Limitation: I sometimes need to make decision whether participants were talking 
about the treatment in the RLHIM, or they were talking about services in hospital in 
general? Also need to make decision on whether they are treatments received at 
the time of interview, or treatments received before. 
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Some useful information was wasted, e.g. a participant received acupuncture 
treatment (the treatment she really wanted to get but didn’t) after talking with other 
participants in focus group. 
 
Why not using ‘kappa’ to check similarity/trustness: it works well for researchers 
who have experiences in working on the same project before? 
What I found difficult: codes or themes? 
Difficulties in separate/group CM and CAM 
Ideas on theme (partially) 
24th Apr 2015 
Living with MSDs 
1.1 History of MSDs 
A Variety of Musculoskeletal Disorders 
Long term conditions 
Complex or multifactorial conditions 
Unclear diagnosis 
A hidden disability 
Fluctuating pain 
Stiffness and restrictions in movement 
Fatigue 
Accepting the truth 
Consistent pain 
Underlying pain all the time with severe flare-ups 
 
1.2 Impact of MSDs 
Affect all aspect of life 
Compromise doing things 
Feel all different when in pain 
Changed how they do things - self-management? 
Feel of dependent? 







 Appendix 4 1 Complexity of the frequency of treatments received by participants 
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Glossary of Terms  
Terms listed in this glossary are categorised into three groups: philosophy terms, research 
methodology terms, and definitions of other terms. Most of the definitions of philosophy 
terms were referenced from the SAGE research methods dictionary and the Oxford 




Also known as Ruism, an ethical and philosophical system, 
developed from the teachings of the Chinese philosopher 
Confucius (551-479 BCE); characterised with five concepts: 
"Jen" (benevolence), "Yi" (righteousness), "Chung" (loyalty), 




A research paradigm which believes truth is relative, values 
individual influences on what counts as knowledge and values 
subjective human experience over objectivity. 
Epistemology "Theory of knowledge". The branch of philosophy that studies the nature, origin, concerns criteria of knowledge. 
Interpretivism 
A philosophical concept in social science that opposes the 
positivism of natural science. A belief that someone can study 
qualitatively in inquiry in social science and related disciplines. 
Objectivism The belief that objective science is possible, often refers to research paradigm based on quantitative methods. 
Ontology The theory of the nature of being and existence. 
Paradigm 
Paradigms allow researchers to summarise their beliefs about 
how knowledge is created and allow for frameworks for research 
design, measurement, analysis and personal involvement. 
Paradigm is essential to provide world view and social contexts, 
guide actions, and allow framework for research design (Morgan 
2007). 
Positivism 
"Empirical study of phenomena"; the term was introduced by 
Auguste Comte (1798–1857). The most common way of 
interpreting it nowadays refers it to a belief that held by someone 
can study scientifically and/or quantitatively.  
Pragmatism 
A philosophical concept seeking the middle ground between 
(post) positivism/objectivism on which pure quantitative 
approaches are based and interpretivism/constructivism on which 
pure qualitative approaches are based  (Johnson and 
Onwuegbuzie, 2004), emphasising resolving the problem as the 
priority, using the best philosophical or methodology approach to 
answer a research question (Mackenzie and Knipe, 2005).  
Taoism 
Tao means way; major idea of Taoism was described as "Man 
models himself on earth, earth on heaven, heaven on the way, 





RESEARCH METHODOLOGY TERMS 
Adverse events 
Adverse events or adverse experience refer to any unfavourable or 
unintended sign or symptom, which may not necessary be caused by 
the intervention(s) taken. 
Bowen's feasibility 
framework 
A framework to guide design, evaluation, interpretation and 
prioritizes interventions for feasibility research (Bowen et al., 2009). 
Ceiling/floor effect 
Ceiling effect occurs when a measure possesses a distinct upper limit 
for potential responses and a large concentration of participants score 
at or near this limit (the opposite of a floor effect).  
Complex 
intervention  
Complex interventions are treatments that comprise of several 
interaction components. In this research study, integrative medicine 
is considered as a complex intervention as it may involve a variety of 
therapies or diagnostic approaches, and it may also involve 
components such as holistic lifestyle advice and patient-practitioner 
relationship (Campbell et al., 2000; Craig et al., 2008).  
Data saturation 
Data saturation in this research study refers to the point in qualitative 
data collection when no new theme emerges. This is a point which 




Deductive research begins with a hypothesis and which it seeks to 
confirm/falsify, while an inductive approach generates theory from 
the data (Lincoln and Guba 1985). Typical examples of deductive 
and inductive research are experimental trial and qualitative research. 
Abductive moves back and forth between induction and deduction 
and typical example is pragmatic research (Morgan 2007).  
Effect size 
Effect size is "the degree to which the null hypothesis is false". In 
this research study, Cohen's d was used to reflect difference in 
outcome for the average at different time points. It also reflects the 
measure of practical significance and provides statistical power. 
Feasibility study 
Feasibility research is a crucial stage of evaluating complex 
intervention as suggested by the MRC. It is often conducted to 
provide recommendations on whether efficacy/effectiveness testing 
should be performed for an intervention, to fill gaps in the literature, 
and to provide details in recruitment, study timelines, and to provide 
new criteria and suggesting measures to evaluate relevant outcomes 
(Glasgow et al., 2006). 
Framework 
analysis 
Framework analysis is a highly structured approach of qualitative 
data analysis, containing five stages included; data familiarization, 
identifying a thematic framework, indexing, charting, mapping and 
interpreting (Ritchie and Spencer, 1994). 
Homogeneous 
sampling 
The process of selecting a group of participants with same features or 
consisting similar parts. 
Homoscedasticity  
Homoscedasticity is a statistical term refers to the assumption that 
equal levels of variability between quantitative dependent variables 
across a range of independent variables that are either continuous or 
categorical. 





This is a term adapted from the "limited efficacy" in Bowen's 
feasibility framework. The framework recommended feasibility trial 
to report findings in efficacy, which are limited due to a feasibility 
design but can be used in the future definitive trial. Since this 
research study is a mixed methods feasibility study, quantitative and 
qualitative outcomes were tested (Bowen et al., 2009). 
Mapping review 
Mapping reviews often include a search which the completeness 
depending on time and scope, with no quality assessment required. 
By categorising or characterising key features of the target topic, this 
type of review often aims to commission further reviews or to 
identify gaps in literature (Grant and Booth, 2009). 
Mixed methods 
research 
Research that combines elements of both qualitative and quantitative 
research approaches, with an aim of exploring broad purposes of 




These terms refer to reviews that involve a combination of methods, 
e.g. reviews on both quantitative and qualitative literature, or reviews 
on outcome with process studies etc. (Whittemore, 2005; Grant and 
Booth, 2009). 
Narrative review 
Narrative review presented in this research study refers to a common 
literature review on qualitative literature, which explored published 
qualitative materials of recent or current literature. In this narrative 
review, there was no restriction on levels of completeness and 
comprehensiveness, with systematic search and quality appraisal not 
included (Grant and Booth, 2009).  
Observational 
study 
Non-experimental research that describes the health status of 
populations and generate evidence about determinants of health 
outcomes.  
Process evaluation 
Mostly in health services (not exclusively), refers to qualitative 
investigations conducted in parallel with quantitative evaluations in 
policy and practice interventions. Process evaluation always answers 
the question why an intervention has been successful or not. 
Publication bias 
Statistically significant findings are likely to be published, therefore, 
when performing meta-analysis, there might be more for meta-
analysis. This potentially arises publication bias. 
Purposive 
sampling 
A form of non-probability sampling, by researcher making decision 
on which individuals to be included in the sample based on a variety 
of criteria.   
Qualitative 
research 
Research that is predominantly conducted in an inductively, using an 
interpretive approach under a subjective view. 
Quantitative 
research 
Research that is mainly conducted in a deductive approach, using 
statistical analysis under an objective view. 
Reflexivity 
Reflexivity entails the researchers being aware of the fact that it is 
impossible to remain "outside" as their personal effects may have an 
influence on the process and outcomes of research.  




As defined by the Oxford dictionary, self-awareness represents 
"conscious knowledge of one’s own character, feelings, motives, and 
desires". In the context of this research study, the process of 
understanding and accepting MSDs can be painful but it might leads 
to greater self-awareness. 
Self-reflection 
As defined by the Oxford dictionaries, self-reflection represents 
"serious thought about one's character and actions". In the context of 
this research study, patients benefited in improved self-reflection by 
participating in the research.  
Side-by-side table 
Utilised to compare and triangulate quantitative and qualitative 




The sphericity assumption is a statistical priority of using univariate 
or mixed model analysis of variance in a within-subject design. In 
this research study, it assumes the variance of any linear combination 
of the measures over different time points is identical. 
Systematic review 
Systematic reviews often include an exhaustive and comprehensive 
search, quality appraisal, aiming to provide evidence by synthesising 
current available data (Grant and Booth, 2009). 
Triangulation 
Triangulation in this research study refers to the use of multiple 
methods, namely quantitative and qualitative research 
methodologies, with a purpose of compensating any single element 
by the strengths of the other.  
Trustworthiness 
Equivalent to rigour of research methods in qualitative research. In 
this research study, four aspects were considered for trustworthiness 
of the qualitative research, they are credibility, confirmability, 
dependability and transferability (Lincoln and Guba 1985). 
Validity 
Internal validity is always associated with experiment research, 
aiming to show the extent of results that can be attributed to the 
treatment in an ideal research setting; External validity 
(generalisability) indicates the extent of how the findings can be 






Acupotomy The name of acupotomy comes from words "acupoint" and "anatomy". It 
is a non-invasive surgery using a small needle scalpel into acupoint.  
Alexander 
technique 
A method of manual treatment that often provided for musculoskeletal 
conditions, to improved posture and movement, relax tensions in muscle. 
Autogenic 
training 
A form of relaxation technique involving engagement in mind and body 




Complementary and alternative medicine refers to a broad set of 
healthcare practices that country's own tradition and are not integrated 
into the dominant health care system. It refers to different practices to 
health systems in different countries (WHO Collaborating Centres for 
Traditional Medicine, 2015). 
Dorsopathies A medical term for back pain or neck pain. 
Evidence based 
medicine 
The GMC Good Medical Practice guidelines described evidence based 
medicine as "provide effective treatments based on the best available 
evidence". Evidence based medicine is not only used in research, it also 
incorporates clinical expertise and patient values (General Medical 
Council 2006; Sackett et al. 2000). 
Holistic A holistic approach in clinical practice refers to whole person care 
considering physical, mental and social factors. 
Horizontal 
integration 
Horizontal integration at the RLHIM refers to interactions with other 
hospitals and departments within the Trust (RLHIM, 2015). 
Integrative 
medicine 
Findings of this research study suggested integrative medicine is the 
optimum treatment that considered the use of both complementary and 
conventional interventions; emphasises individualised holistic approach, 
patient-practitioner communication and expectation management, with 
interprofessional/multidisciplinary, collaborative. Teamwork. 
Musculoskeleta
l disorders 
As defined by the Centre for Disease Control and Prevention, MSDs are 
"injuries or disorders of the muscles, nerves, tendons, joints, cartilage, 
and disorders of the nerves, tendons, muscles and supporting structures of 
the upper and lower limbs, neck, and lower back that are caused, 
precipitated or exacerbated by sudden exertion or prolonged exposure to 
physical factors such as repetition, force, vibration, or awkward posture". 
The identification of musculoskeletal disorders were based on the 
international classification of diseases version 10 (Chapter XIII 
Diseases of the musculoskeletal system and connective tissue (M00-M99) 
(Centers for Disease Control and Prevention, 2012; ICD-10, 2010). 
Nutraceuticals Nutraceuticals refer to nutrition products that are believed to provide 
health related therapeutic or preventive benefits. 
Prolotherapy A method of injection irritant of an irritant solution to joint, ligament, or 
tendon to relieve pain. 
Self-care People who give themselves a diagnosis, treat their ill health themselves, 
or adopt health seeking behaviours (Terry 2002). 
Speleotherapy A method of treatment involving staying in underground environments, 
e.g. respiratory therapy infused air of caves or mines.  
Tuina Originated from China, tuina is a method of manual therapy nowadays 
commonly practiced over the world, with an aim of treating various 
conditions and enhancing people's general health.  
Vertical 
integration 
Vertical integration at the RLHIM refers to interactions between hospital, 
primary and self-care (RLHIM, 2015). 
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